0001332349-21-000065.txt : 20210507 0001332349-21-000065.hdr.sgml : 20210507 20210507161937 ACCESSION NUMBER: 0001332349-21-000065 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 77 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210507 DATE AS OF CHANGE: 20210507 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Brookdale Senior Living Inc. CENTRAL INDEX KEY: 0001332349 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050] IRS NUMBER: 203068069 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-32641 FILM NUMBER: 21902976 BUSINESS ADDRESS: STREET 1: 111 WESTWOOD PLACE STREET 2: SUITE 400 CITY: BRENTWOOD STATE: TN ZIP: 37027 BUSINESS PHONE: (615) 221-2250 MAIL ADDRESS: STREET 1: 111 WESTWOOD PLACE STREET 2: SUITE 400 CITY: BRENTWOOD STATE: TN ZIP: 37027 10-Q 1 bkd-20210331.htm 10-Q bkd-20210331
0001332349--12-312021Q1false00013323492021-01-012021-03-31xbrli:shares00013323492021-05-05iso4217:USD00013323492021-03-3100013323492020-12-31iso4217:USDxbrli:shares0001332349us-gaap:RestrictedStockMember2021-03-310001332349us-gaap:RestrictedStockMember2020-12-310001332349us-gaap:HealthCareResidentServiceMember2021-01-012021-03-310001332349us-gaap:HealthCareResidentServiceMember2020-01-012020-03-310001332349us-gaap:ManagementServiceMember2021-01-012021-03-310001332349us-gaap:ManagementServiceMember2020-01-012020-03-310001332349bkd:ReimbursementCostsManagedCommunitiesMember2021-01-012021-03-310001332349bkd:ReimbursementCostsManagedCommunitiesMember2020-01-012020-03-310001332349bkd:OtherOperatingIncomeMember2021-01-012021-03-310001332349bkd:OtherOperatingIncomeMember2020-01-012020-03-3100013323492020-01-012020-03-310001332349us-gaap:RealEstateMember2021-01-012021-03-310001332349us-gaap:RealEstateMember2020-01-012020-03-3100013323492019-12-310001332349us-gaap:CommonStockMember2020-12-310001332349us-gaap:CommonStockMember2019-12-310001332349us-gaap:CommonStockMember2020-01-012020-03-310001332349us-gaap:CommonStockMember2021-01-012021-03-310001332349us-gaap:CommonStockMember2021-03-310001332349us-gaap:CommonStockMember2020-03-310001332349us-gaap:AdditionalPaidInCapitalMember2020-12-310001332349us-gaap:AdditionalPaidInCapitalMember2019-12-310001332349us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001332349us-gaap:AdditionalPaidInCapitalMember2020-01-012020-03-310001332349us-gaap:AdditionalPaidInCapitalMember2021-03-310001332349us-gaap:AdditionalPaidInCapitalMember2020-03-310001332349us-gaap:TreasuryStockMember2020-12-310001332349us-gaap:TreasuryStockMember2019-12-310001332349us-gaap:TreasuryStockMember2020-01-012020-03-310001332349us-gaap:TreasuryStockMember2021-03-310001332349us-gaap:TreasuryStockMember2020-03-310001332349us-gaap:RetainedEarningsMember2020-12-310001332349us-gaap:RetainedEarningsMember2019-12-310001332349srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:RetainedEarningsMember2019-12-310001332349us-gaap:RetainedEarningsMember2021-01-012021-03-310001332349us-gaap:RetainedEarningsMember2020-01-012020-03-310001332349us-gaap:RetainedEarningsMember2021-03-310001332349us-gaap:RetainedEarningsMember2020-03-310001332349us-gaap:NoncontrollingInterestMember2020-12-310001332349us-gaap:NoncontrollingInterestMember2019-12-310001332349us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001332349us-gaap:NoncontrollingInterestMember2020-01-012020-03-310001332349us-gaap:NoncontrollingInterestMember2021-03-310001332349us-gaap:NoncontrollingInterestMember2020-03-3100013323492020-03-31bkd:segmentxbrli:pure0001332349bkd:HealthCareServicesMemberbkd:SecuritiesPurchaseAgreementMemberbkd:HCAHealthcareIncMember2021-02-242021-02-240001332349bkd:CARESActMember2021-01-012021-03-310001332349bkd:CARESActMember2020-01-012021-03-310001332349us-gaap:FairValueMeasurementsNonrecurringMember2021-01-012021-03-310001332349bkd:CARESActMemberus-gaap:LoansInsuredOrGuaranteedByUsGovernmentAuthoritiesMember2021-01-012021-03-310001332349bkd:CARESActMemberbkd:AcceleratedandAdvancePaymentProgramMember2020-01-012020-12-310001332349bkd:CARESActMemberbkd:HealthCareServicesMemberbkd:AcceleratedandAdvancePaymentProgramMember2020-01-012020-12-310001332349bkd:CARESActMemberbkd:CCRCVenturesLLCMemberbkd:AcceleratedandAdvancePaymentProgramMember2020-01-012020-12-310001332349bkd:CARESActMemberbkd:TheContinuingAppropriationsAct2021AndOtherExtensionsActMember2021-01-012021-03-310001332349bkd:CARESActMemberbkd:TheContinuingAppropriationsAct2021AndOtherExtensionsActMemberbkd:PeriodOneMember2021-01-012021-03-310001332349bkd:CARESActMemberbkd:PeriodTwoMemberbkd:TheContinuingAppropriationsAct2021AndOtherExtensionsActMember2021-01-012021-03-310001332349bkd:CARESActMember2020-12-310001332349bkd:CARESActMembersrt:ScenarioForecastMember2021-12-310001332349bkd:CARESActMembersrt:ScenarioForecastMember2022-12-310001332349bkd:CARESActMember2021-03-31bkd:community0001332349bkd:CommunitiesAcquiredPreviouslyLeasedOrManagedMember2020-01-012021-03-310001332349bkd:CommunitiesDisposedOfThroughSaleMember2020-01-012021-03-310001332349bkd:VentasIncMember2020-07-260001332349bkd:CommunitiesDisposedOfThroughLeaseTerminationsMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2020-01-012021-03-310001332349bkd:OneCommunityHeldForSaleMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMemberbkd:AssistedLivingAndMemoryCareMember2021-01-012021-03-310001332349bkd:OneCommunityHeldForSaleMemberbkd:CCRCVenturesLLCMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2021-01-012021-03-310001332349bkd:OneCommunityHeldForSaleMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2021-03-310001332349bkd:CommunitiesDisposedOfThroughSaleMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2021-01-012021-03-310001332349bkd:SaleOf1CommunityMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2021-01-012021-03-310001332349bkd:VentasIncMember2020-12-310001332349bkd:CommunitiesDisposedOfThroughSaleMemberus-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember2020-01-012020-12-310001332349us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMemberbkd:SaleOf2CommunitiesMember2020-01-012020-12-310001332349bkd:SaleOf1CommunityMember2020-01-012020-03-310001332349bkd:HealthCareServicesMemberbkd:SecuritiesPurchaseAgreementMemberbkd:HCAHealthcareIncMember2021-03-310001332349bkd:HealthCareServicesMember2021-03-310001332349us-gaap:FairValueInputsLevel2Member2021-03-310001332349bkd:LongTermDebtAndLinesOfCreditMember2021-03-310001332349bkd:LongTermDebtAndLinesOfCreditMember2020-12-310001332349us-gaap:FairValueMeasurementsNonrecurringMember2020-01-012020-03-310001332349us-gaap:SelfPayMemberbkd:IndependentLivingMember2021-01-012021-03-310001332349us-gaap:SelfPayMemberbkd:AssistedLivingAndMemoryCareMember2021-01-012021-03-310001332349us-gaap:SelfPayMemberbkd:CcrcsRentalMember2021-01-012021-03-310001332349bkd:HealthCareServicesMemberus-gaap:SelfPayMember2021-01-012021-03-310001332349us-gaap:SelfPayMember2021-01-012021-03-310001332349bkd:GovernmentReimbursementMemberbkd:IndependentLivingMember2021-01-012021-03-310001332349bkd:AssistedLivingAndMemoryCareMemberbkd:GovernmentReimbursementMember2021-01-012021-03-310001332349bkd:CcrcsRentalMemberbkd:GovernmentReimbursementMember2021-01-012021-03-310001332349bkd:HealthCareServicesMemberbkd:GovernmentReimbursementMember2021-01-012021-03-310001332349bkd:GovernmentReimbursementMember2021-01-012021-03-310001332349us-gaap:ThirdPartyPayorMemberbkd:IndependentLivingMember2021-01-012021-03-310001332349us-gaap:ThirdPartyPayorMemberbkd:AssistedLivingAndMemoryCareMember2021-01-012021-03-310001332349us-gaap:ThirdPartyPayorMemberbkd:CcrcsRentalMember2021-01-012021-03-310001332349bkd:HealthCareServicesMemberus-gaap:ThirdPartyPayorMember2021-01-012021-03-310001332349us-gaap:ThirdPartyPayorMember2021-01-012021-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:IndependentLivingMember2021-01-012021-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:AssistedLivingAndMemoryCareMember2021-01-012021-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:CcrcsRentalMember2021-01-012021-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:HealthCareServicesMember2021-01-012021-03-310001332349us-gaap:HealthCareResidentServiceMember2021-01-012021-03-310001332349us-gaap:SelfPayMemberbkd:IndependentLivingMember2020-01-012020-03-310001332349us-gaap:SelfPayMemberbkd:AssistedLivingAndMemoryCareMember2020-01-012020-03-310001332349us-gaap:SelfPayMemberbkd:CcrcsRentalMember2020-01-012020-03-310001332349bkd:HealthCareServicesMemberus-gaap:SelfPayMember2020-01-012020-03-310001332349us-gaap:SelfPayMember2020-01-012020-03-310001332349bkd:GovernmentReimbursementMemberbkd:IndependentLivingMember2020-01-012020-03-310001332349bkd:AssistedLivingAndMemoryCareMemberbkd:GovernmentReimbursementMember2020-01-012020-03-310001332349bkd:CcrcsRentalMemberbkd:GovernmentReimbursementMember2020-01-012020-03-310001332349bkd:HealthCareServicesMemberbkd:GovernmentReimbursementMember2020-01-012020-03-310001332349bkd:GovernmentReimbursementMember2020-01-012020-03-310001332349us-gaap:ThirdPartyPayorMemberbkd:IndependentLivingMember2020-01-012020-03-310001332349us-gaap:ThirdPartyPayorMemberbkd:AssistedLivingAndMemoryCareMember2020-01-012020-03-310001332349us-gaap:ThirdPartyPayorMemberbkd:CcrcsRentalMember2020-01-012020-03-310001332349bkd:HealthCareServicesMemberus-gaap:ThirdPartyPayorMember2020-01-012020-03-310001332349us-gaap:ThirdPartyPayorMember2020-01-012020-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:IndependentLivingMember2020-01-012020-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:AssistedLivingAndMemoryCareMember2020-01-012020-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:CcrcsRentalMember2020-01-012020-03-310001332349us-gaap:HealthCareResidentServiceMemberbkd:HealthCareServicesMember2020-01-012020-03-310001332349us-gaap:HealthCareResidentServiceMember2020-01-012020-03-310001332349bkd:DeferredRevenueAndCreditsMember2021-03-310001332349bkd:DeferredRevenueAndCreditsMember2020-12-310001332349us-gaap:LandMember2021-03-310001332349us-gaap:LandMember2020-12-310001332349us-gaap:BuildingAndBuildingImprovementsMember2021-03-310001332349us-gaap:BuildingAndBuildingImprovementsMember2020-12-310001332349us-gaap:FurnitureAndFixturesMember2021-03-310001332349us-gaap:FurnitureAndFixturesMember2020-12-310001332349bkd:ResidentAndLeaseholdOperatingIntangiblesMember2021-03-310001332349bkd:ResidentAndLeaseholdOperatingIntangiblesMember2020-12-310001332349us-gaap:ConstructionInProgressMember2021-03-310001332349us-gaap:ConstructionInProgressMember2020-12-310001332349bkd:AssetsUnderFinancingLeasesandLeaseholdIntangiblesMember2021-03-310001332349bkd:AssetsUnderFinancingLeasesandLeaseholdIntangiblesMember2020-12-310001332349bkd:IndependentLivingMember2020-12-310001332349bkd:IndependentLivingMember2021-03-310001332349bkd:HealthCareServicesMember2020-12-310001332349bkd:HealthCareServicesMember2021-03-310001332349us-gaap:MortgagesMember2021-03-310001332349us-gaap:MortgagesMember2020-12-310001332349bkd:VariableMortgagesMember2021-03-310001332349bkd:VariableMortgagesMember2020-12-310001332349us-gaap:NotesPayableOtherPayablesMember2021-03-310001332349us-gaap:NotesPayableOtherPayablesMember2020-12-310001332349bkd:FifthAmendedAndRestatedCreditAgreementMemberbkd:LetterOfCreditSublimitMemberus-gaap:LineOfCreditMember2021-03-310001332349us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMemberbkd:CreditAgreementWithCapitalOneNationalAssociationMember2020-12-110001332349us-gaap:LetterOfCreditMemberbkd:FifthAmendedAndRestatedCreditAgreementMemberus-gaap:LineOfCreditMember2021-03-31bkd:lease0001332349srt:MinimumMember2021-01-012021-03-310001332349srt:MaximumMember2021-01-012021-03-310001332349us-gaap:RestrictedStockMember2021-01-012021-03-310001332349bkd:RestrictedStockAndRestrictedStockUnitsRSUsMember2021-01-012021-03-310001332349bkd:RestrictedStockAndRestrictedStockUnitsRSUsMember2020-01-012020-03-310001332349us-gaap:PerformanceSharesMember2021-01-012021-03-310001332349us-gaap:PerformanceSharesMember2020-01-012020-03-310001332349bkd:FederalTaxAuthorityAndStateAndLocalJurisdictionMember2020-01-012020-03-310001332349bkd:CCRCVenturesLLCMember2020-01-012020-03-310001332349bkd:HealthpeakMember2021-01-012021-03-310001332349bkd:NonDevelopmentMemberbkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2021-01-012021-03-310001332349bkd:NonDevelopmentMemberbkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2020-01-012020-03-310001332349bkd:DevelopmentMemberbkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2021-01-012021-03-310001332349bkd:DevelopmentMemberbkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2020-01-012020-03-310001332349bkd:NondevelopmentReimbursableMemberbkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2021-01-012021-03-310001332349bkd:NondevelopmentReimbursableMemberbkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2020-01-012020-03-310001332349bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2021-01-012021-03-310001332349bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember2020-01-012020-03-310001332349bkd:AcquisitionOfCommunitiesFromHealthpeakMember2021-01-012021-03-310001332349bkd:AcquisitionOfCommunitiesFromHealthpeakMember2020-01-012020-03-310001332349us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2021-01-012021-03-310001332349us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2020-01-012020-03-310001332349bkd:CCRCVenturesLLCMember2021-01-012021-03-310001332349bkd:CCRCVenturesLLCMember2020-01-012020-03-310001332349bkd:ProceedsFromSaleOfAssetsNetMember2021-01-012021-03-310001332349bkd:ProceedsFromSaleOfAssetsNetMember2020-01-012020-03-310001332349bkd:HealthpeakMasterLeaseModificationMember2021-01-012021-03-310001332349bkd:HealthpeakMasterLeaseModificationMember2020-01-012020-03-310001332349bkd:NoncashLeaseTerminationAndModificationNetMember2021-01-012021-03-310001332349bkd:NoncashLeaseTerminationAndModificationNetMember2020-01-012020-03-310001332349us-gaap:OperatingSegmentsMemberbkd:IndependentLivingMember2021-01-012021-03-310001332349us-gaap:OperatingSegmentsMemberbkd:IndependentLivingMember2020-01-012020-03-310001332349us-gaap:OperatingSegmentsMemberbkd:AssistedLivingAndMemoryCareMember2021-01-012021-03-310001332349us-gaap:OperatingSegmentsMemberbkd:AssistedLivingAndMemoryCareMember2020-01-012020-03-310001332349us-gaap:OperatingSegmentsMemberbkd:CcrcsRentalMember2021-01-012021-03-310001332349us-gaap:OperatingSegmentsMemberbkd:CcrcsRentalMember2020-01-012020-03-310001332349bkd:HealthCareServicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310001332349bkd:HealthCareServicesMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310001332349bkd:ManagementServicesMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310001332349bkd:ManagementServicesMemberus-gaap:OperatingSegmentsMember2020-01-012020-03-310001332349us-gaap:OperatingSegmentsMemberbkd:IndependentLivingMember2021-03-310001332349us-gaap:OperatingSegmentsMemberbkd:IndependentLivingMember2020-12-310001332349us-gaap:OperatingSegmentsMemberbkd:AssistedLivingAndMemoryCareMember2021-03-310001332349us-gaap:OperatingSegmentsMemberbkd:AssistedLivingAndMemoryCareMember2020-12-310001332349us-gaap:OperatingSegmentsMemberbkd:CcrcsRentalMember2021-03-310001332349us-gaap:OperatingSegmentsMemberbkd:CcrcsRentalMember2020-12-310001332349bkd:HealthCareServicesMemberus-gaap:OperatingSegmentsMember2021-03-310001332349bkd:HealthCareServicesMemberus-gaap:OperatingSegmentsMember2020-12-310001332349bkd:ManagementServicesMemberus-gaap:OperatingSegmentsMember2021-03-310001332349bkd:ManagementServicesMemberus-gaap:OperatingSegmentsMember2020-12-310001332349bkd:CARESActMemberbkd:IndependentLivingMember2021-01-012021-03-310001332349bkd:CARESActMemberbkd:AssistedLivingAndMemoryCareMember2021-01-012021-03-310001332349bkd:CARESActMemberbkd:CcrcsRentalMember2021-01-012021-03-310001332349bkd:CARESActMemberbkd:HealthCareServicesMember2021-01-012021-03-31


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2021
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____________ to _____________

Commission File Number: 001-32641

BROOKDALE SENIOR LIVING INC.
(Exact name of registrant as specified in its charter)
Delaware20-3068069
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
111 Westwood Place,Suite 400,Brentwood,Tennessee37027
(Address of principal executive offices)(Zip Code)

(Registrant's telephone number, including area code)                    (615) 221-2250

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 Par Value Per ShareBKDNew York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes No

As of May 5, 2021, 185,166,149 shares of the registrant's common stock, $0.01 par value, were outstanding (excluding restricted stock and restricted stock units).

2


TABLE OF CONTENTS
BROOKDALE SENIOR LIVING INC.

FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2021
PAGE
PART I.
Item 1.
Condensed Consolidated Statements of Equity -
Item 2.
Item 3.
Item 4.
PART II.
Item 1.
Item 1A.
Item 2.
Item 6.


3


PART I.   FINANCIAL INFORMATION

Item 1.  Financial Statements
BROOKDALE SENIOR LIVING INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except stock amounts)
March 31,
2021
December 31,
2020
Assets(Unaudited)
Current assets
Cash and cash equivalents$303,952 $380,420 
Marketable securities134,933 172,905 
Restricted cash26,503 28,059 
Accounts receivable, net52,588 109,221 
Assets held for sale247,627 16,061 
Prepaid expenses and other current assets, net90,949 66,937 
Total current assets856,552 773,603 
Property, plant and equipment and leasehold intangibles, net5,018,409 5,068,060 
Operating lease right-of-use assets743,346 788,138 
Restricted cash71,468 56,669 
Investment in unconsolidated ventures4,972 4,898 
Goodwill27,321 154,131 
Other assets, net24,085 56,259 
Total assets$6,746,153 $6,901,758 
Liabilities and Equity
Current liabilities
Current portion of long-term debt$224,890 $68,885 
Current portion of financing lease obligations20,083 19,543 
Current portion of operating lease obligations140,339 146,226 
Trade accounts payable65,278 71,233 
Liabilities held for sale116,142  
Accrued expenses264,117 287,851 
Refundable fees and deferred revenue68,113 96,995 
Total current liabilities898,962 690,733 
Long-term debt, less current portion3,664,901 3,847,103 
Financing lease obligations, less current portion539,071 543,764 
Operating lease obligations, less current portion797,311 819,429 
Deferred tax liability9,876 9,557 
Other liabilities140,925 188,443 
Total liabilities6,051,046 6,099,029 
Preferred stock, $0.01 par value, 50,000,000 shares authorized at March 31, 2021 and December 31, 2020; no shares issued and outstanding
  
Common stock, $0.01 par value, 400,000,000 shares authorized at March 31, 2021 and December 31, 2020; 197,757,065 and 198,331,663 shares issued and 187,229,540 and 187,804,138 shares outstanding (including 2,063,391 and 4,349,421 unvested restricted shares), respectively
1,978 1,983 
Additional paid-in-capital4,213,095 4,212,409 
Treasury stock, at cost; 10,527,525 shares at March 31, 2021 and December 31, 2020
(102,774)(102,774)
Accumulated deficit(3,419,469)(3,311,184)
Total Brookdale Senior Living Inc. stockholders' equity692,830 800,434 
Noncontrolling interest2,277 2,295 
Total equity695,107 802,729 
Total liabilities and equity$6,746,153 $6,901,758 
See accompanying notes to condensed consolidated financial statements.

4


BROOKDALE SENIOR LIVING INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited, in thousands, except per share data)
Three Months Ended
March 31,
20212020
Revenue
Resident fees$664,350 $782,707 
Management fees8,566 108,715 
Reimbursed costs incurred on behalf of managed communities65,794 122,717 
Other operating income10,735  
Total revenue and other operating income 749,445 1,014,139 
Expense
Facility operating expense (excluding facility depreciation and amortization of $77,274 and $84,301, respectively)
556,312 588,482 
General and administrative expense (including non-cash stock-based compensation expense of $4,783 and $5,957, respectively)
49,943 54,595 
Facility operating lease expense44,418 64,481 
Depreciation and amortization83,891 90,738 
Asset impairment10,677 78,226 
Costs incurred on behalf of managed communities65,794 122,717 
Total operating expense811,035 999,239 
Income (loss) from operations(61,590)14,900 
Interest income421 1,455 
Interest expense:
Debt(35,351)(41,763)
Financing lease obligations(11,383)(13,282)
Amortization of deferred financing costs and debt discount(1,873)(1,315)
Gain (loss) on debt modification and extinguishment, net 19,181 
Equity in earnings (loss) of unconsolidated ventures(531)(1,008)
Gain (loss) on sale of assets, net1,112 372,839 
Other non-operating income (loss)1,644 2,662 
Income (loss) before income taxes(107,551)353,669 
Benefit (provision) for income taxes(752)15,828 
Net income (loss)(108,303)369,497 
Net (income) loss attributable to noncontrolling interest18 18 
Net income (loss) attributable to Brookdale Senior Living Inc. common stockholders$(108,285)$369,515 
Net income (loss) per share attributable to Brookdale Senior Living Inc. common stockholders:
Basic$(0.59)$2.01 
Diluted$(0.59)$2.00 
Weighted average common shares outstanding:
Basic184,011 184,186 
Diluted184,011 184,522 
See accompanying notes to condensed consolidated financial statements.

5


BROOKDALE SENIOR LIVING INC.
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited, in thousands)
Three Months Ended
March 31,
20212020
Total equity, balance at beginning of period$802,729 $698,725 
Common stock:
Balance at beginning of period$1,983 $1,996 
Issuance of common stock under Associate Stock Purchase Plan— 1 
Restricted stock and restricted stock units, net2 (6)
Shares withheld for employee taxes(7)(6)
Balance at end of period$1,978 $1,985 
Additional paid-in-capital:
Balance at beginning of period$4,212,409 $4,172,099 
Non-cash stock-based compensation expense4,783 5,957 
Issuance of common stock under Associate Stock Purchase Plan224 168 
Restricted stock and restricted stock units, net(2)6 
Shares withheld for employee taxes(4,322)(3,892)
Other, net3 18 
Balance at end of period$4,213,095 $4,174,356 
Treasury stock:
Balance at beginning of period$(102,774)$(84,651)
Purchase of treasury stock— (18,123)
Balance at end of period$(102,774)$(102,774)
Accumulated deficit:
Balance at beginning of period$(3,311,184)$(3,393,088)
Cumulative effect of change in accounting principle— (115)
Net income (loss)(108,285)369,515 
Balance at end of period$(3,419,469)$(3,023,688)
Noncontrolling interest:
Balance at beginning of period$2,295 $2,369 
Net income (loss) attributable to noncontrolling interest(18)(18)
Balance at end of period$2,277 $2,351 
Total equity, balance at end of period$695,107 $1,052,230 
Common stock share activity
Outstanding shares of common stock:
Balance at beginning of period187,804 192,129 
Issuance of common stock under Associate Stock Purchase Plan43 61 
Restricted stock and restricted stock units, net127 (504)
Shares withheld for employee taxes(744)(611)
Purchase of treasury stock— (3,063)
Balance at end of period187,230 188,012 

See accompanying notes to condensed consolidated financial statements.

6


BROOKDALE SENIOR LIVING INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
Three Months Ended March 31,
20212020
Cash Flows from Operating Activities
Net income (loss)$(108,303)$369,497 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Loss (gain) on debt modification and extinguishment, net (19,181)
Depreciation and amortization, net85,764 92,053 
Asset impairment10,677 78,226 
Equity in (earnings) loss of unconsolidated ventures531 1,008 
Amortization of entrance fees(364)(377)
Proceeds from deferred entrance fee revenue670 343 
Deferred income tax (benefit) provision319 (21,767)
Operating lease expense adjustment(4,664)(6,733)
Loss (gain) on sale of assets, net(1,112)(372,839)
Non-cash stock-based compensation expense4,783 5,957 
Other(1,416)(1,460)
Changes in operating assets and liabilities:
Accounts receivable, net(5,768)(2,033)
Prepaid expenses and other assets, net(6,769)(1,696)
Prepaid insurance premiums financed with notes payable(12,985)(17,434)
Trade accounts payable and accrued expenses(500)(47,919)
Refundable fees and deferred revenue7,717 (2,254)
Operating lease assets and liabilities for lessor capital expenditure reimbursements7,563 4,088 
Net cash provided by (used in) operating activities(23,857)57,479 
Cash Flows from Investing Activities
Change in lease security deposits and lease acquisition deposits, net(62)3,211 
Purchase of marketable securities(79,932)(89,414)
Sale and maturities of marketable securities117,995 50,000 
Capital expenditures, net of related payables(40,361)(69,385)
Acquisition of assets, net of related payables and cash received (446,688)
Investment in unconsolidated ventures(5,206)(268)
Proceeds from sale of assets, net3,760 304,617 
Net cash provided by (used in) investing activities(3,806)(247,927)
Cash Flows from Financing Activities
Proceeds from debt18,575 471,785 
Repayment of debt and financing lease obligations(49,924)(263,226)
Proceeds from line of credit 166,381 
Purchase of treasury stock, net of related payables (18,123)
Payment of financing costs, net of related payables(87)(5,815)
Payments of employee taxes for withheld shares(4,329)(3,898)
Other203 146 
Net cash provided by (used in) financing activities(35,562)347,250 
Net increase (decrease) in cash, cash equivalents, and restricted cash(63,225)156,802 
Cash, cash equivalents, and restricted cash at beginning of period465,148 301,697 
Cash, cash equivalents, and restricted cash at end of period$401,923 $458,499 

See accompanying notes to condensed consolidated financial statements.

7


BROOKDALE SENIOR LIVING INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1.  Description of Business

Brookdale Senior Living Inc. ("Brookdale" or the "Company") is an operator of senior living communities throughout the United States. The Company is committed to providing senior living solutions primarily within properties that are designed, purpose-built, and operated to provide quality service, care, and living accommodations for residents. The Company operates and manages independent living, assisted living, memory care, and continuing care retirement communities ("CCRCs"). The Company also offers a range of home health, hospice, and outpatient therapy services to residents of many of its communities and to seniors living outside of its communities.

The Company has five reportable segments: Independent Living; Assisted Living and Memory Care; CCRCs; Health Care Services; and Management Services. The Company expects to sell 80% of its equity in its Health Care Services segment, as described in Note 4.

2.  Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for quarterly reports on Form 10-Q. In the opinion of management, these financial statements include all adjustments, which are of a normal and recurring nature, necessary to present fairly the financial position, results of operations, and cash flows of the Company for all periods presented. Certain information and footnote disclosures included in annual financial statements have been condensed or omitted. The Company believes that the disclosures included are adequate and provide a fair presentation of interim period results. Interim financial statements are not necessarily indicative of the financial position or operating results for an entire year. These interim financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Brookdale and its consolidated subsidiaries. The ownership interest of consolidated entities not wholly-owned by the Company are presented as noncontrolling interests in the accompanying condensed consolidated financial statements. Intercompany balances and transactions have been eliminated in consolidation, and net income (loss) is reduced by the portion of net income (loss) attributable to noncontrolling interests. The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting.

Use of Estimates

The preparation of the condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, revenue, other operating income, asset impairments, self-insurance reserves, performance-based compensation, the allowance for credit losses, depreciation and amortization, leasing transactions, income taxes, and other contingencies. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from the original estimates.

Lease Accounting

The Company, as lessee, recognizes a right-of-use asset and a lease liability on the Company's condensed consolidated balance sheet for its community, office, and equipment leases. As of the commencement date of a lease, a lease liability and corresponding right-of-use asset is established on the Company's condensed consolidated balance sheet at the present value of future minimum lease payments. The Company's community leases generally contain fixed annual rent escalators or annual rent escalators based on an index, such as the consumer price index. The future minimum lease payments recognized on the condensed consolidated balance sheet include fixed payments (including in-substance fixed payments) and variable payments

8


estimated utilizing the index or rate on the lease commencement date. The Company recognizes lease expense as incurred for additional variable payments. For the Company's leases that do not contain an implicit rate, the Company utilizes its estimated incremental borrowing rate to determine the present value of lease payments based on information available at commencement of the lease. The Company's estimated incremental borrowing rate reflects the fixed rate at which the Company could borrow a similar amount for the same term on a collateralized basis. The Company elected the short-term lease exception policy which permits leases with an initial term of 12 months or less to not be recorded on the Company's condensed consolidated balance sheet and instead to be recognized as lease expense as incurred.

The Company, as lessee, makes a determination with respect to each of its community, office, and equipment leases as to whether each should be accounted for as an operating lease or financing lease. The classification criteria is based on estimates regarding the fair value of the leased asset, minimum lease payments, effective cost of funds, economic life of the asset, and certain other terms in the lease agreements.

Lease right-of-use assets are reviewed for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of right-of-use assets are assessed by a comparison of the carrying amount of the asset to the estimated future undiscounted net cash flows expected to be generated by the asset, calculated utilizing the lowest level of identifiable cash flows. If estimated future undiscounted net cash flows are less than the carrying amount of the asset then the fair value of the asset is estimated. The impairment expense is determined by comparing the estimated fair value of the asset to its carrying amount, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates and estimated lease coverage ratios (Level 3).

Operating Leases

The Company recognizes operating lease expense for actual rent paid, generally plus or minus a straight-line adjustment for estimated minimum lease escalators if applicable. The right-of-use asset is generally reduced each period by an amount equal to the difference between the operating lease expense and the amount of expense on the lease liability utilizing the effective interest method. Subsequent to the impairment of an operating lease right-of-use asset, the Company recognizes operating lease expense consisting of the reduction of the right-of-use asset on a straight-line basis over the remaining lease term and the amount of expense on the lease liability utilizing the effective interest method.

Financing Leases

Financing lease right-of-use assets are recognized within property, plant and equipment and leasehold intangibles, net on the Company's condensed consolidated balance sheets. The Company recognizes interest expense on the financing lease liabilities utilizing the effective interest method. The right-of-use asset is generally amortized to depreciation and amortization expense on a straight-line basis over the lease term unless the lease contains an option to purchase the underlying asset that the Company is reasonably certain to exercise. If the Company is reasonably certain to exercise the purchase option, the asset is amortized over the useful life.

Sale-Leaseback Transactions

For transactions in which an owned community is sold and leased back from the buyer (sale-leaseback transactions), the Company recognizes an asset sale and lease accounting is applied if the Company has transferred control of the community. For such transactions, the Company removes the transferred assets from the condensed consolidated balance sheet and a gain or loss on the sale is recognized for the difference between the carrying amount of the asset and the transaction price for the sale transaction.

For sale‑leaseback transactions in which the Company has not transferred control of the underlying asset, the Company does not recognize an asset sale or derecognize the underlying asset until control is transferred. For such transactions, the Company recognizes the underlying assets within assets under financing leases as a component of property, plant and equipment and leasehold intangibles, net on the condensed consolidated balance sheets and continues to depreciate the assets over their useful lives.

Additionally, the Company accounts for any amounts received as a financing lease liability and the Company recognizes interest expense on the financing lease liability utilizing the effective interest method with the interest expense limited to an amount that is not greater than the cash payments on the financing lease liability over the term of the lease.


9


Property, Plant and Equipment and Leasehold Intangibles, Net

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset group may not be recoverable. Recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company is required to recognize an impairment loss. The impairment loss is measured by the amount by which the carrying amount of the asset exceeds its estimated fair value, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates, estimated holding periods, and estimated capitalization rates (Level 3).

Goodwill

The Company tests goodwill for impairment annually during the fourth quarter or more frequently if indicators of impairment arise. Factors the Company considers important in its analysis of whether an indicator of impairment exists include a significant decline in the Company's stock price or market capitalization for a sustained period since the last testing date, significant underperformance relative to historical or projected future operating results, and significant negative industry or economic trends. The Company first assesses qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If so, the Company performs a quantitative goodwill impairment test based upon a comparison of the estimated fair value of the reporting unit to which the goodwill has been assigned with the reporting unit's carrying amount. The fair values used in the quantitative goodwill impairment test are estimated using Level 3 inputs based upon discounted future cash flow projections for the reporting unit. These cash flow projections are based upon a number of estimates and assumptions such as revenue and expense growth rates, capitalization rates, and discount rates. The Company also considers market-based measures such as earnings multiples in its analysis of estimated fair values of its reporting units. If the quantitative goodwill impairment test results in a reporting unit's carrying amount exceeding its estimated fair value, an impairment charge will be recorded based on the difference, with the impairment charge limited to the amount of goodwill allocated to the reporting unit.

3.  COVID-19 Pandemic

The United States broadly continues to experience the COVID-19 pandemic, which has significantly disrupted, and likely will continue to significantly disrupt for some period, the senior living industry and the Company's business. Due to the average age and prevalence of chronic medical conditions among the Company's residents and patients, they generally are at disproportionately higher risk of hospitalization and adverse outcomes if they contract COVID-19. The health and wellbeing of the Company's residents, patients, and associates is and has been its highest priority as it continues to serve and care for seniors through the pandemic.

Community Restrictions. To help protect the Company's residents, patients, and associates from contracting COVID-19, the Company imposed significant restrictions at its communities beginning in March 2020, including closing its communities to visitors and prospective residents, and in some cases restricting new resident move-ins, suspending group outings, modifying communal dining and programming to comply with social distancing and other regulatory guidelines and, in most cases, implementing in-room only dining and activities programming, requesting that residents refrain from leaving the community unless medically necessary, and requiring new residents and residents returning from a hospital or nursing home to isolate in their apartment for fourteen days. The Company has adopted a framework for determining when to ease restrictions at each of its communities based on several criteria, including regulatory requirements and guidance, completion of baseline testing at the community, and the presence of current confirmed COVID-19 positive cases. The Company may revert to more restrictive measures if the pandemic worsens, as necessary to comply with regulatory requirements, or at the direction of state or local health authorities. As of April 30, 2021, 100% of the Company's communities have opened for visitors and new prospects.

Pandemic-Related Expenses. The Company incurred $27.3 million of facility operating expense during the first quarter of 2021 for incremental direct costs to respond to the pandemic. Such costs include those for: acquisition of additional PPE, medical equipment, and cleaning and disposable food service supplies; enhanced cleaning and environmental sanitation; increased employee-related costs, including labor, workers compensation, and health plan expense; increased expense for general liability claims; and COVID-19 testing of residents and associates where not otherwise covered by government payor or third-party insurance sources. On a cumulative basis, the Company has incurred $152.9 million of pandemic related facility operating expense since the beginning of fiscal 2020. The Company recorded non-cash impairment charges in its operating results of $9.0 million for the three months ended March 31, 2021, for its operating lease right-of-use assets, primarily due to the COVID-19 pandemic and lower than expected operating performance at communities with impaired assets.

10



Liquidity. As of March 31, 2021, the Company's total liquidity was $438.9 million, consisting of $304.0 million of unrestricted cash and cash equivalents and $134.9 million of marketable securities. The Company's cash flows from operations, excluding management agreement termination fees and the impact of the Coronavirus Aid, Relief, and Economic Security Act of 2020 ("CARES Act") funding, have been insufficient to cover its operating expenses, capital expenditures, and required interest and lease payments during the pandemic. However, the Company was able to satisfy its liquidity needs over such period utilizing a portion of its preexisting liquidity, together with CARES Act funding. The Company currently estimates that its cash flows from operations, together with cash balances on hand, cash equivalents, marketable securities, and proceeds from the pending sale of 80% of the equity in its Health Care Services segment will be sufficient to fund its liquidity needs for at least the next 12 months. The Company continues to seek opportunities to enhance and preserve its liquidity, including through maintaining expense discipline and increasing occupancy, continuing to evaluate its financing structure and the state of debt markets, and seeking further government-sponsored financial relief related to the pandemic. There is no assurance that debt financing will continue to be available on terms consistent with the Company's expectations or at all, that its efforts will be successful in seeking further government-sponsored financial relief or regarding the amount of, or conditions required to qualify for, any such relief, or that the closing of the pending transaction will be completed in accordance with the Company's expectations, or at all, or generate cash proceeds to the Company in the amount it anticipates.

Financial Relief. The CARES Act, signed into law on March 27, 2020, and Paycheck Protection Program and Health Care Enhancement Act, signed into law on April 24, 2020, provide liquidity and financial relief to certain businesses, among other things. Certain impacts of such programs are provided below.

During the first quarter of 2021, the Company accepted $0.8 million of cash from grants from the Public Health and Social Services Emergency Fund ("Provider Relief Fund") administered by the U.S. Department of Health and Human Services ("HHS"), under which grants have been made available to eligible healthcare providers for healthcare related expenses or lost revenues attributable to COVID-19. The grants represented incentive payments made pursuant to the Nursing Home Infection Control Distribution, which related to the Company's skilled nursing care provided through its CCRCs. HHS continues to evaluate future allocations under the Provider Relief Fund and the regulation and guidance regarding grants made under the Provider Relief Fund. The Company intends to pursue additional funding that may become available. There can be no assurance that the Company will qualify for, or receive, such future grants in the amount it expects, that additional restrictions on the permissible uses or terms and conditions of the grants will not be imposed by HHS, or that future funding programs will be made available for which it qualifies.

During the year ended December 31, 2020, the Company received $87.5 million under the Accelerated and Advance Payment Program administered by CMS, $75.2 million of which related to its Health Care Services segment and $12.3 million related to its CCRCs segment. Recoupment of advanced payments will begin one year after payments were issued at a rate of 25% of Medicare payments for the first eleven months following the anniversary of issuance and at a rate of 50% of Medicare payments for the next six months. Any outstanding balance of advanced payments will be due following such recoupment period. Pursuant to the Purchase Agreement providing for the sale of 80% of the Company's equity in its Health Care Services segment (as described below), its net cash proceeds at closing will include a reduction for the then outstanding balance of such advanced payments related to its Health Care Services segment.

During fiscal 2020, the Company deferred payment of $72.7 million of the employer portion of social security payroll taxes incurred from March 27, 2020 through December 31, 2020 pursuant to the CARES Act. One-half of such deferral amount will become due on each of December 31, 2021 and December 31, 2022. Pursuant to the Purchase Agreement providing for the sale of 80% of the Company's equity in its Health Care Services segment, its net cash proceeds at closing will include a reduction for the $8.9 million of deferred payroll tax payments related to its Health Care Services segment. The Company expects to pay approximately $32 million of the deferred payments in both December 2021 and 2022.

The Company is eligible to claim the employee retention credit for certain of its associates under the CARES Act. The credit for 2020 is available to employers that fully or partially suspended operations during any calendar quarter in 2020 due to orders from an appropriate governmental authority limiting commerce, travel, or group meetings due to COVID-19, and is equal to 50% of qualified wages paid after March 12, 2020 through December 31, 2020 to qualified employees, with a maximum credit of $5,000 per employee. During the first quarter of 2021, the Company recognized $9.0 million of employee retention credits on wages paid from March 12, 2020 through September 30, 2020 within other operating income. The credit was modified and extended by subsequent legislation for wages paid from January 1, 2021 through December 31, 2021, and the Company is assessing its eligibility to claim such credit. There can be no assurance that the Company will qualify for, or receive, credits in the amount or on the timing it expects.


11


In addition to the grants described above, during the three months ended March 31, 2021, the Company has received and recognized $0.9 million of other operating income from grants from other government sources.

The Company cannot predict with reasonable certainty the impacts that COVID-19 ultimately will have on its business, results of operations, cash flow, and liquidity, and its response efforts may continue to delay or negatively impact its strategic initiatives, including plans for future growth. The ultimate impacts of COVID-19 will depend on many factors, some of which cannot be foreseen, including the duration, severity, and breadth of the pandemic and any resurgence of the disease; the impact of COVID-19 on the nation’s economy and debt and equity markets and the local economies in the Company's markets; the development, availability, utilization, and efficacy of COVID-19 testing, therapeutic agents, and vaccines and the prioritization of such resources among businesses and demographic groups; government financial and regulatory relief efforts that may become available to business and individuals, including the Company's ability to qualify for and satisfy the terms and conditions of financial relief; perceptions regarding the safety of senior living communities during and after the pandemic; changes in demand for senior living communities and the Company's ability to adapt its sales and marketing efforts to meet that demand; the impact of COVID-19 on the Company's residents’ and their families’ ability to afford its resident fees, including due to changes in unemployment rates, consumer confidence, housing markets, and equity markets caused by COVID-19; changes in the acuity levels of the Company's new residents; the disproportionate impact of COVID-19 on seniors generally and those residing in the Company's communities; the duration and costs of the Company's response efforts, including increased equipment, supplies, labor, litigation, testing, vaccination clinic, and other expenses; the impact of COVID-19 on the Company's ability to complete financings and refinancings of various assets, or other transactions (including dispositions and the pending sale of 80% of the equity in the Company's Health Care Services segment) or to generate sufficient cash flow to cover required debt, interest, and lease payments and to satisfy financial and other covenants in its debt and lease documents; increased regulatory requirements, including unfunded, mandatory testing; increased enforcement actions resulting from COVID-19; government action that may limit the Company's collection or discharge efforts for delinquent accounts; and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or the Company's response efforts.

4.  Acquisitions, Dispositions and Other Transactions

During the period from January 1, 2020 through March 31, 2021, the Company acquired 27 communities that the Company formerly leased, disposed of eight owned communities (including the conveyance of five communities to Ventas, Inc. ("Ventas")), and sold its ownership interest in its unconsolidated entry fee CCRC Venture (the "CCRC Venture") with Healthpeak Properties, Inc. ("Healthpeak"), and the Company's triple-net lease obligations on five communities were terminated.

The Company expects to sell 80% of its equity in its Health Care Services segment, as described below. Additionally, one unencumbered community in the Assisted Living and Memory Care segment and one unencumbered community in the CCRCs segment were classified as held for sale, resulting in $14.0 million being recorded as assets held for sale within the condensed consolidated balance sheet for senior housing communities as of March 31, 2021.

The closings of the various pending and expected transactions described within this note are, or will be, subject to the satisfaction of various closing conditions, including (where applicable) the receipt of regulatory approvals. There can be no assurance that the transactions will close or, if they do, when the actual closings will occur.

Completed Dispositions of Owned Communities

During the three months ended March 31, 2021, the Company completed the sale of one owned community for cash proceeds of $2.7 million, net of transaction costs, and recognized a net gain on sale of assets of $0.5 million.

In addition to the conveyance of five communities to Ventas, during the year ended December 31, 2020, the Company completed the sale of two owned communities for cash proceeds of $38.1 million, net of transaction costs, and recognized a net gain on sale of assets of $2.7 million. These dispositions included the sale of one owned community during the three months ended March 31, 2020 for which the Company received cash proceeds of $5.5 million, net of transaction costs, and recognized a net gain on sale of assets of $0.2 million.

Pending Sale of Health Care Services

On February 24, 2021, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") with affiliates of HCA Healthcare, Inc., providing for the sale of 80% of the Company’s equity in its Health Care Services segment for a purchase price of $400 million in cash, subject to certain adjustments set forth in the Purchase Agreement, including a reduction

12


for the remaining outstanding balance as of the closing of Medicare advance payments and deferred payroll tax payments related to the Health Care Services segment, which were $75.2 million and $8.9 million respectively, as of March 31, 2021. The Purchase Agreement also contains certain agreed upon indemnities for the benefit of the purchaser. The closing of the sale transaction is anticipated to occur in the early second half of 2021, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Purchase Agreement. Pursuant to the Purchase Agreement, at closing of the transaction, the Company will retain a 20% equity interest in the business.

The assets and liabilities of the Health Care Services segment are included within assets held for sale and liabilities held for sale, respectively, within the Company’s condensed consolidated balance sheet as of March 31, 2021. As of March 31, 2021, assets held for sale and liabilities held for sale of the Health Care Services segment consisted of the following:

(in thousands)
Accounts receivable, net$62,401 
Property, plant and equipment and leasehold intangibles, net1,964 
Operating lease right-of-use assets9,688 
Goodwill126,810 
Prepaid expenses and other assets, net32,722 
Assets held for sale$233,585 
Trade accounts payable$1,201 
Accrued expenses30,030 
Refundable fees and deferred revenue75,223 
Operating lease obligations9,688 
Liabilities held for sale$116,142 
Refer to Note 16 for selected financial data for the Health Care Services segment.

5.  Fair Value Measurements

Marketable Securities

As of March 31, 2021, marketable securities of $134.9 million are stated at fair value based on valuations provided by third-party pricing services and are classified within Level 2 of the valuation hierarchy.

Debt

The Company estimates the fair value of its debt using a discounted cash flow analysis based upon the Company's current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding long-term debt with a carrying amount of approximately $3.9 billion as of both March 31, 2021 and December 31, 2020. Fair value of the long-term debt approximates carrying amount in all periods presented. The Company's fair value of long-term debt disclosure is classified within Level 2 of the valuation hierarchy.


13


Asset Impairment Expense

The following is a summary of asset impairment expense.
Three Months Ended
March 31,
(in millions)20212020
Operating lease right-of-use assets$9.0 $65.7 
Property, plant and equipment and leasehold intangibles, net
1.7 11.0 
Investment in unconsolidated ventures 1.5 
Asset impairment$10.7 $78.2 

6.  Revenue

Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by payor source as the Company believes it best depicts how the nature, amount, timing, and uncertainty of its revenue and cash flows are affected by economic factors. Resident fee revenue by payor source and reportable segment is as follows:
Three Months Ended March 31, 2021
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$118,322 $370,494 $52,213 $337 $541,366 
Government reimbursement460 16,444 12,487 67,465 96,856 
Other third-party payor programs  7,079 19,049 26,128 
Total resident fee revenue$118,782 $386,938 $71,779 $86,851 $664,350 
Three Months Ended March 31, 2020
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$135,290 $440,613 $64,703 $170 $640,776 
Government reimbursement572 16,866 19,405 73,689 110,532 
Other third-party payor programs  10,439 20,960 31,399 
Total resident fee revenue$135,862 $457,479 $94,547 $94,819 $782,707 

Contract Balances

The payment terms and conditions within the Company's revenue-generating contracts vary by contract type and payor source, although terms generally include payment to be made within 30 days. Resident fee revenue for recurring and routine monthly services is generally billed monthly in advance under the Company's independent living, assisted living, and memory care residency agreements. Resident fee revenue for standalone or certain healthcare services is generally billed monthly in arrears. A portion of the Company's reimbursement from Medicare for certain healthcare services is billed near the start of each period of care, and cash is generally received before all services are rendered. The amount of revenue recognized for periods of care which are incomplete at period end is based on the Company's historical average percentage of days complete on each period of care and any unearned amounts are deferred and recognized when the service is performed. Additionally, non-refundable community fees are generally billed and collected in advance or upon move-in of a resident under the Company's independent living, assisted living, and memory care residency agreements. Amounts of revenue that are collected from residents in advance are recognized as deferred revenue until the performance obligations are satisfied.

The Company had total deferred revenue (included within refundable fees and deferred revenue, liabilities held for sale, and other liabilities within the condensed consolidated balance sheets) of $146.0 million and $138.3 million, including $30.1

14


million and $21.1 million of monthly resident fees billed and received in advance, as of March 31, 2021 and December 31, 2020, respectively. Such amount of total deferred revenue as of both March 31, 2021 and December 31, 2020 also included $87.5 million received in the year ended December 31, 2020 under a temporary expansion of the Accelerated and Advance Payment Program administered by CMS. Refer to Note 3 for additional information on such program. For the three months ended March 31, 2021 and 2020, the Company recognized $30.8 million and $48.3 million, respectively, of revenue that was included in the deferred revenue balance as of January 1, 2021 and 2020, respectively.

7.  Property, Plant and Equipment and Leasehold Intangibles, Net

As of March 31, 2021 and December 31, 2020, net property, plant and equipment and leasehold intangibles, which include assets under financing leases, consisted of the following:
(in thousands)March 31, 2021December 31, 2020
Land$504,698 $505,298 
Buildings and improvements5,222,741 5,215,460 
Furniture and equipment953,773 945,783 
Resident and leasehold operating intangibles305,960 307,071 
Construction in progress64,003 61,491 
Assets under financing leases and leasehold improvements1,534,468 1,523,055 
Property, plant and equipment and leasehold intangibles8,585,643 8,558,158 
Accumulated depreciation and amortization(3,567,234)(3,490,098)
Property, plant and equipment and leasehold intangibles, net$5,018,409 $5,068,060 

Assets under financing leases and leasehold improvements includes $0.4 billion of financing lease right-of-use assets, net of accumulated amortization, as of both March 31, 2021 and December 31, 2020. Refer to Note 10 for further information on the Company's financing leases.

Long-lived assets with definite useful lives are depreciated or amortized on a straight-line basis over their estimated useful lives (or, in certain cases, the shorter of their estimated useful lives or the lease term) and are tested for impairment whenever indicators of impairment arise. The Company recognized depreciation and amortization expense on its property, plant and equipment and leasehold intangibles of $83.9 million and $90.7 million for the three months ended March 31, 2021 and 2020, respectively.

8.  Goodwill

The Company's Independent Living and Health Care Services segments had a carrying value of goodwill of $27.3 million and $126.8 million, respectively, as of both March 31, 2021 and December 31, 2020. The goodwill of the Health Care Services segment is included within assets held for sale within the Company’s condensed consolidated balance sheet as of March 31, 2021.



15


9.  Debt

Long-term debt consists of the following:
(in thousands)March 31, 2021December 31, 2020
Fixed mortgage notes payable due 2022 through 2047; weighted average interest rate of 4.17% and 4.18% as of March 31, 2021 and December 31, 2020, respectively
$2,334,151 $2,366,996 
Variable mortgage notes payable due 2022 through 2030, weighted average interest rate of 2.46% and 2.49% as of March 31, 2021 and December 31, 2020, respectively
1,524,496 1,529,935 
Other notes payable due 2021 to 2025; weighted average interest rate of 7.79% and 8.98% as of March 31, 2021 and December 31, 2020, respectively
57,468 46,557 
Debt discount and deferred financing costs, net(26,324)(27,500)
Total long-term debt3,889,791 3,915,988 
Current portion224,890 68,885 
Total long-term debt, less current portion$3,664,901 $3,847,103 

As of March 31, 2021, 97.9%, or $3.8 billion of the Company's total debt obligations represented non-recourse property-level mortgage financings.

As of March 31, 2021, $69.9 million of letters of credit and no cash borrowings were outstanding under the Company's $80.0 million secured credit facility. The Company also had a separate secured letter of credit facility providing up to $15.0 million of letters of credit as of March 31, 2021 under which $13.6 million had been issued as of that date.

Financial Covenants

Certain of the Company's debt documents contain restrictions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and debt service ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community, and/or entity basis. In addition, the Company's debt documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage.

The Company's failure to comply with applicable covenants could constitute an event of default under the applicable debt documents. Many of the Company's debt documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Furthermore, the Company's debt is secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries.

As of March 31, 2021, the Company is in compliance with the financial covenants of its debt agreements.

10.  Leases

As of March 31, 2021, the Company operated 301 communities under long-term leases (235 operating leases and 66 financing leases). The substantial majority of the Company's lease arrangements are structured as master leases. Under a master lease, numerous communities are leased through an indivisible lease. The Company typically guarantees the performance and lease payment obligations of its subsidiary lessees under the master leases. An event of default related to an individual property or limited number of properties within a master lease portfolio may result in a default on the entire master lease portfolio.

The leases relating to these communities are generally fixed rate leases with annual escalators that are either fixed or based upon changes in the consumer price index or the leased property revenue. The Company is responsible for all operating costs, including repairs, property taxes, and insurance. The leases generally provide for renewal or extension options from 5 to 20 years and in some instances, purchase options.

The community leases contain other customary terms, which may include assignment and change of control restrictions, maintenance and capital expenditure obligations, termination provisions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and lease coverage ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community and/or entity basis. In addition, the

16


Company's lease documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage.

The Company's failure to comply with applicable covenants could constitute an event of default under the applicable lease documents. Many of the Company's debt and lease documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Certain leases contain cure provisions, which generally allow the Company to post an additional lease security deposit if the required covenant is not met. Furthermore, the Company's leases are secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries.

As of March 31, 2021, the Company is in compliance with the financial covenants of its long-term leases.

A summary of operating and financing lease expense (including the respective presentation on the condensed consolidated statements of operations) and net cash outflows from leases is as follows:
Three Months Ended
March 31,
Operating Leases (in thousands)
20212020
Facility operating expense$4,842 $4,850 
Facility lease expense44,418 64,481 
Operating lease expense49,260 69,331 
Operating lease expense adjustment (1)
4,664 6,733 
Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements(7,563)(4,088)
Operating net cash outflows from operating leases$46,361 $71,976 

(1)Represents the difference between the amount of cash operating lease payments and the amount of operating lease expense recognized in accordance with Accounting Standards Codification 842, Leases ("ASC 842").

Three Months Ended
March 31,
Financing Leases (in thousands)
20212020
Depreciation and amortization$7,630 $9,144 
Interest expense: financing lease obligations11,383 13,282 
Financing lease expense$19,013 $22,426 
Operating cash flows from financing leases$11,383 $13,282 
Financing cash flows from financing leases4,789 5,087 
Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement(1,389)(1,739)
Total net cash outflows from financing leases$14,783 $16,630 


17


The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):
Year Ending December 31,Operating LeasesFinancing Leases
2021 (nine months)$151,681 $48,807 
2022203,946 65,609 
2023192,625 66,341 
2024193,377 67,553 
2025191,131 57,595 
Thereafter280,960 109,684 
Total lease payments1,213,720 415,589 
Purchase option liability and non-cash gain on future sale of property 413,617 
Imputed interest and variable lease payments(276,070)(270,052)
Total lease obligations$937,650 $559,154 

11.  Litigation

The Company has been and is currently involved in litigation and claims incidental to the conduct of its business, which it believes are generally comparable to other companies in the senior living and healthcare industries, including, but not limited to, putative class action claims from time to time regarding staffing at the Company’s communities and compliance with consumer protection laws and the Americans with Disabilities Act. Certain claims and lawsuits allege large damage amounts and may require significant costs to defend and resolve. As a result, the Company maintains general liability, professional liability, and other insurance policies in amounts and with coverage and deductibles the Company believes are appropriate, based on the nature and risks of its business, historical experience, availability, and industry standards. The Company's current policies provide for deductibles for each claim and contain various exclusions from coverage. Accordingly, the Company is, in effect, self-insured for claims that are less than the deductible amounts and for claims or portions of claims that are not covered by such policies and/or exceed the policy limits.

Similarly, the senior living and healthcare industries are continuously subject to scrutiny by governmental regulators, which could result in reviews, audits, investigations, enforcement activities or litigation related to regulatory compliance matters. In addition, as a result of the Company's participation in the Medicare and Medicaid programs, the Company is subject to various governmental reviews, audits and investigations, including but not limited to audits under various government programs, such as the Recovery Audit Contractors (RAC), Zone Program Integrity Contractors (ZPIC), and Unified Program Integrity Contractors (UPIC) programs. The costs to respond to and defend such reviews, audits, and investigations may be significant, and an adverse determination could result in citations, sanctions and other criminal or civil fines and penalties, the refund of overpayments, payment suspensions, termination of participation in Medicare and Medicaid programs, and/or damage to the Company's business reputation.

In June 2020, the Company and several current and former executive officers were named as defendants in a putative class action lawsuit alleging violations of the federal securities laws filed in the federal court for the Middle District of Tennessee. The lawsuit asserts that the defendants made material misstatements and omissions concerning the Company's business, operational and compliance policies that caused the Company's stock price to be artificially inflated between August 2016 and April 2020. While the Company cannot predict with certainty the result of this or any other legal proceedings, the Company believes the allegations in the suit are without merit and does not expect this matter to have a material adverse effect on the Company's financial condition, results of operations, or cash flows. In October 2020 and April 2021, alleged stockholders of the Company filed separate stockholder derivative lawsuits in the federal court for the Middle District of Tennessee, asserting claims on behalf of the Company against certain current and former officers and directors for alleged breaches of duties owed to the Company. The complaints refer to the securities lawsuit described above and incorporate substantively similar allegations.


18


12.  Stock-Based Compensation

Grants of restricted stock and restricted stock units under the Company's 2014 Omnibus Incentive Plan were as follows:
(in thousands, except for per share and unit amounts)Restricted Stock and Restricted Stock Unit GrantsWeighted Average Grant Date Fair ValueTotal Grant Date Fair Value
Three months ended March 31, 20211,961 $5.09 $9,988 

13.  Earnings Per Share

Basic earnings per share ("EPS") is calculated by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the components of basic EPS and also gives effect to dilutive common stock equivalents. Under the treasury stock method, diluted EPS reflects the potential dilution that could occur if securities or other instruments that are convertible into common stock were exercised or could result in the issuance of common stock. Potentially dilutive common stock equivalents include unvested restricted stock, restricted stock units, and warrants.

The following table summarizes the computation of basic and diluted earnings (loss) per share amounts presented in the condensed consolidated statement of operations:
Three Months Ended
March 31,
(in thousands, except for per share amounts)20212020
Income attributable to common stockholders:
Net income (loss)
$(108,285)$369,515 
Weighted average shares outstanding - basic184,011 184,186 
Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants 336 
Weighted average shares outstanding - diluted184,011 184,522 
Basic earnings (loss) per common share:
Net income (loss) per share attributable to common stockholders$(0.59)$2.01 
Diluted earnings (loss) per common share:
Net income (loss) per share attributable to common stockholders$(0.59)$2.00 


For the purposes of computing diluted EPS, weighted average shares outstanding do not include potentially dilutive securities that are anti-dilutive under the treasury stock method, and performance-based equity awards are included based on the attainment of the applicable performance metrics as of the end of the reporting period. The following potentially dilutive securities were excluded from the computation of diluted EPS:
Three Months Ended
March 31,
(in millions)
2021(1)
2020
Non-performance-based restricted stock and restricted stock units6.2 6.9 
Performance-based restricted stock and restricted stock units0.4 1.8 
Warrants16.3  

(1)As a result of the net loss reported for the period, all unvested restricted stock, restricted stock units, and potential shares issuable under warrants were antidilutive for the period and as such were not included in the computation of diluted weighted average shares outstanding.


19


14.  Income Taxes

The difference between the Company's effective tax rate for the three months ended March 31, 2021 and 2020 was primarily due to the tax impact of the multi-part transaction with Healthpeak that occurred in the three months ended March 31, 2020. The impact represented the tax expense recorded on the gain of the sale of the Company's interest in the CCRC Venture offset by a decrease in the valuation allowance that was a direct result of the multi-part transaction with Healthpeak.

The Company recorded an aggregate deferred federal, state, and local tax benefit of $25.2 million as a result of the operating loss for the three months ended March 31, 2021, which was offset by a proportionate increase in the valuation allowance of $25.5 million. The Company recorded an aggregate deferred federal, state, and local tax expense of $90.9 million for the three months ended March 31, 2020. The expense included $93.1 million as a result of the gain on the sale of the Company's interest in the CCRC Venture offset by a benefit of $2.2 million as a result of the operating losses (exclusive of the CCRC Venture sale) for the three months ended March 31, 2020. The expense for the three months ended March 31, 2020 was offset by a reduction in the valuation allowance of $112.6 million.

The Company evaluates its deferred tax assets each quarter to determine if a valuation allowance is required based on whether it is more likely than not that some portion of the deferred tax asset would not be realized. The Company's valuation allowance as of March 31, 2021 and December 31, 2020 was $406.5 million and $381.0 million, respectively.

The increase in the valuation allowance for the three months ended March 31, 2021 is the result of current operating losses during the three months ended March 31, 2021. The change in the valuation allowance for the three months ended March 31, 2020 was primarily the result of a reduction in the Company’s valuation allowance of $117.6 million as a result of the Healthpeak transaction offset by the anticipated reversal of future tax liabilities offset by future tax deductions.

The Company recorded interest charges related to its tax contingency reserve for cash tax positions for the three months ended March 31, 2021 and 2020 which are included in income tax expense or benefit for the period. As of March 31, 2021, tax returns for years 2017 through 2019 are subject to future examination by tax authorities. In addition, the net operating losses from prior years are subject to adjustment under examination.

15.  Supplemental Disclosure of Cash Flow Information
Three Months Ended
March 31,
(in thousands)20212020
Supplemental Disclosure of Cash Flow Information:
Interest paid$47,129 $59,479 
Income taxes paid, net of refunds904 957 
Capital expenditures, net of related payables:
Capital expenditures - non-development, net$27,450 $60,556 
Capital expenditures - development, net1,521 3,900 
Capital expenditures - non-development - reimbursable8,951 5,827 
Trade accounts payable2,439 (898)
Net cash paid$40,361 $69,385 
Acquisition of communities from Healthpeak:
Property, plant and equipment and leasehold intangibles, net$ $286,734 
Operating lease right-of-use assets (63,285)
Financing lease obligations 129,196 
Operating lease obligations 74,335 
Loss (gain) on debt modification and extinguishment, net (19,731)
Net cash paid$ $407,249 
Acquisition of other assets, net of related payables and cash received:
Property, plant and equipment and leasehold intangibles, net$ $179 
Financing lease obligations 39,260 
Net cash paid$ $39,439 

20


Proceeds from sale of CCRC Venture, net:
Investments in unconsolidated ventures$ $(14,848)
Current portion of long-term debt 34,706 
Accrued expenses (5,025)
Other liabilities 60,748 
Loss (gain) on sale of assets, net (370,745)
Net cash received$ $(295,164)
Proceeds from sale of other assets, net:
Prepaid expenses and other assets, net$ $(1,261)
Assets held for sale(2,125)(5,274)
Property, plant and equipment and leasehold intangibles, net(597) 
Other liabilities74 (824)
Loss (gain) on sale of assets, net(1,112)(2,094)
Net cash received$(3,760)$(9,453)
Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities:
Healthpeak master lease modification:
Property, plant and equipment and leasehold intangibles, net$ $(57,462)
Operating lease right-of-use assets 88,044 
Financing lease obligations 70,874 
Operating lease obligations (101,456)
Net$ $ 
Other non-cash lease transactions, net:
Property, plant and equipment and leasehold intangibles, net$ $(9,441)
Operating lease right-of-use assets16,721  
Financing lease obligations 9,516 
Operating lease obligations(16,721) 
Other liabilities (75)
Net$ $ 

Restricted cash consists principally of deposits for letters of credit, escrow deposits for real estate taxes, property insurance, and capital expenditures, debt service reserve accounts required by certain lenders under mortgage debt agreements, and deposits as security for self-insured retention risk under workers' compensation programs and property insurance programs. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.
(in thousands)March 31, 2021December 31, 2020
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents$303,952 $380,420 
Restricted cash26,503 28,059 
Long-term restricted cash71,468 56,669 
Total cash, cash equivalents, and restricted cash$401,923 $465,148 

16.  Segment Information

The Company has five reportable segments: Independent Living; Assisted Living and Memory Care; CCRCs; Health Care Services; and Management Services. Operating segments are defined as components of an enterprise that engage in business activities from which it may earn revenues and incur expenses; for which separate financial information is available; and whose operating results are regularly reviewed by the chief operating decision maker to assess the performance of the individual segment and make decisions about resources to be allocated to the segment.


21


Independent Living. The Company's Independent Living segment includes owned or leased communities that are primarily designed for middle to upper income seniors who desire to live in a residential setting that feels like home, without the efforts of ownership. The majority of the Company's independent living communities consist of both independent and assisted living units in a single community, which allows residents to age-in-place by providing them with a broad continuum of senior independent and assisted living services to accommodate their changing needs.

Assisted Living and Memory Care. The Company's Assisted Living and Memory Care segment includes owned or leased communities that offer housing and 24-hour assistance with activities of daily living for mid-acuity and frail elderly residents. The Company's assisted living and memory care communities include both freestanding, multi-story communities, as well as smaller freestanding, single story communities. The Company also provides memory care services at freestanding memory care communities that are specially designed for residents with Alzheimer's disease and other dementias.

CCRCs. The Company's CCRCs segment includes large owned or leased communities that offer a variety of living arrangements and services to accommodate a broad spectrum of physical ability and healthcare needs. Most of the Company's CCRCs have independent living, assisted living, memory care, and skilled nursing available on one campus or within the immediate area.

Health Care Services. The Company's Health Care Services segment includes the home health, hospice, and outpatient therapy services provided to residents of many of its communities and to seniors living outside its communities. The Health Care Services segment does not include the skilled nursing and inpatient healthcare services provided in the Company's skilled nursing units, which are included in the Company's CCRCs segment.

Management Services. The Company's Management Services segment includes communities operated by the Company pursuant to management agreements. In some of the cases, the controlling financial interest in the community is held by third parties and, in other cases, the community is owned in a venture structure in which the Company has an ownership interest. Under the management agreements for these communities, the Company receives management fees as well as reimbursed expenses, which represent the reimbursement of expenses it incurs on behalf of the owners.

The following table sets forth selected segment financial data:
Three Months Ended
March 31,
(in thousands)20212020
Revenue and other operating income:
Independent Living(1)(2)
$120,146 $135,862 
Assisted Living and Memory Care(1)(2)
392,042 457,479 
CCRCs(1)(2)
73,463 94,547 
Health Care Services(1)(2)
89,434 94,819 
Management Services(3)
74,360 231,432 
Total revenue and other operating income$749,445 $1,014,139 
Segment operating income:(4)
Independent Living$37,329 $51,414 
Assisted Living and Memory Care71,433 132,001 
CCRCs7,608 19,931 
Health Care Services2,403 (9,121)
Management Services8,566 108,715 
Total segment operating income127,339 302,940 
General and administrative expense (including non-cash stock-based compensation expense)
49,943 54,595 
Facility operating lease expense44,418 64,481 
Depreciation and amortization83,891 90,738 

22


Asset impairment:
Independent Living520 31,317 
Assisted Living and Memory Care9,642 32,798 
CCRCs515 12,173 
Corporate and Management Services 1,938 
Income (loss) from operations$(61,590)$14,900 

As of
(in thousands)March 31, 2021December 31, 2020
Total assets:
Independent Living$1,399,489 $1,419,838 
Assisted Living and Memory Care3,740,476 3,787,611 
CCRCs728,621 738,121 
Health Care Services233,585 233,178 
Corporate and Management Services643,982 723,010 
Total assets$6,746,153 $6,901,758 

(1)All revenue is earned from external third parties in the United States.

(2)The Independent Living, Assisted Living and Memory Care, CCRCs, and Health Care Services segments include $1.4 million, $5.1 million, $1.7 million, and $2.6 million respectively, for the three months ended March 31, 2021 of other operating income recognized for the credits or grants pursuant to the Employee Retention Credit, Provider Relief Fund, and other government sources, as described in Note 3. Allocations to the applicable segment generally reflect the credits earned by the segment, the segment’s receipt and acceptance of the grant, or the segment’s proportional utilization of the grant.

(3)Management services segment revenue includes management fees and reimbursements of costs incurred on behalf of managed communities.

(4)Segment operating income is defined as segment revenues and other operating income less segment facility operating expenses (excluding facility depreciation and amortization) and costs incurred on behalf of managed communities.


23


Item 2.  Management's Discussion and Analysis of Financial Condition and Results of Operations

SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Certain statements in this Quarterly Report on Form 10-Q may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to various risks and uncertainties and include all statements that are not historical statements of fact and those regarding our intent, belief or expectations. Forward-looking statements are generally identifiable by use of forward-looking terminology such as "may," "will," "should," "could," "would," "potential," "intend," "expect," "endeavor," "seek," "anticipate," "estimate," "believe," "project," "predict," "continue," "plan," "target," or other similar words or expressions. These forward-looking statements are based on certain assumptions and expectations, and our ability to predict results or the actual effect of future plans or strategies is inherently uncertain. Although we believe that expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that our assumptions or expectations will be attained and actual results and performance could differ materially from those projected. Factors which could have a material adverse effect on our operations and future prospects or which could cause events or circumstances to differ from the forward-looking statements include, but are not limited to, the impacts of the COVID-19 pandemic, including the response efforts of federal, state, and local government authorities, businesses, individuals, and us on our business, results of operations, cash flow, liquidity, and our strategic initiatives, including plans for future growth, which will depend on many factors, some of which cannot be foreseen, including the duration, severity, and breadth of the pandemic and any resurgence of the disease, the impact of COVID-19 on the nation’s economy and debt and equity markets and the local economies in our markets, the development, availability, utilization, and efficacy of COVID-19 testing, therapeutic agents, and vaccines and the prioritization of such resources among businesses and demographic groups, government financial and regulatory relief efforts that may become available to business and individuals, including our ability to qualify for and satisfy the terms and conditions of financial relief, perceptions regarding the safety of senior living communities during and after the pandemic, changes in demand for senior living communities and our ability to adapt our sales and marketing efforts to meet that demand, the impact of COVID-19 on our residents’ and their families’ ability to afford our resident fees, including due to changes in unemployment rates, consumer confidence, housing markets, and equity markets caused by COVID-19, changes in the acuity levels of our new residents, the disproportionate impact of COVID-19 on seniors generally and those residing in our communities, the duration and costs of our response efforts, including increased equipment, supplies, labor, litigation, testing, vaccination clinic, and other expenses, the impact of COVID-19 on our ability to complete financings and refinancings of various assets, or other transactions (including dispositions and our pending Health Care Services transaction) or to generate sufficient cash flow to cover required interest and lease payments and to satisfy financial and other covenants in our debt and lease documents, increased regulatory requirements, including unfunded, mandatory testing, increased enforcement actions resulting from COVID-19, government action that may limit our collection or discharge efforts for delinquent accounts, and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or our response efforts; events which adversely affect the ability of seniors to afford resident fees, including downturns in the economy, housing market, consumer confidence, or the equity markets and unemployment among resident family members; changes in reimbursement rates, methods, or timing under governmental reimbursement programs including the Medicare and Medicaid programs; the impact of ongoing healthcare reform efforts; the effects of senior housing construction and development, lower industry occupancy (including due to the pandemic), and increased competition; conditions of housing markets, regulatory changes, acts of nature, and the effects of climate change in geographic areas where we are concentrated; terminations of our resident agreements and vacancies in the living spaces we lease, including due to the pandemic; limits on our ability to use net operating loss carryovers to reduce future tax payments; failure to maintain the security and functionality of our information systems, to prevent a cybersecurity attack or breach, or to comply with applicable privacy and consumer protection laws, including HIPAA; our ability to complete our capital expenditures in accordance with our plans; our ability to identify and pursue development, investment and acquisition opportunities and our ability to successfully integrate acquisitions; competition for the acquisition of assets; our ability to complete pending or expected disposition, acquisition, or other transactions (including our pending Health Care Services transaction) on agreed upon terms or at all, including in respect of the satisfaction of closing conditions, the risk that regulatory approvals are not obtained or are subject to unanticipated conditions, and uncertainties as to the timing of closing, and our ability to identify and pursue any such opportunities in the future; risks related to the implementation of our strategy, including initiatives undertaken to execute on our strategic priorities and their effect on our results; delays in obtaining regulatory approvals; disruptions in the financial markets or decreases in the appraised values or performance of our communities that affect our ability to obtain financing or extend or refinance debt as it matures and our financing costs; our ability to generate sufficient cash flow to cover required interest and long-term lease payments and to fund our planned capital projects; the effect of our non-compliance with any of our debt or lease agreements (including the financial covenants contained therein), including the risk of lenders or lessors declaring a cross default in the event of our non-compliance with any such agreements and the risk of loss of our property securing leases and indebtedness due to any resulting lease terminations and foreclosure actions; the effect of our indebtedness and long-term leases on our liquidity; the potential phasing out of LIBOR which may increase the costs of our debt obligations; our ability to obtain additional capital on terms acceptable to us; departures of key officers and

24


potential disruption caused by changes in management; increased competition for or a shortage of personnel (including due to the pandemic), wage pressures resulting from increased competition, low unemployment levels, minimum wage increases and changes in overtime laws, and union activity; environmental contamination at any of our communities; failure to comply with existing environmental laws; an adverse determination or resolution of complaints filed against us, including class action and stockholder derivative complaints; the cost and difficulty of complying with increasing and evolving regulation; costs to respond to, and adverse determinations resulting from, government reviews, audits and investigations; unanticipated costs to comply with legislative or regulatory developments; the risks associated with current global economic conditions and general economic factors such as inflation, the consumer price index, commodity costs, fuel and other energy costs, costs of salaries, wages, benefits, and insurance, interest rates, and tax rates; the impact of seasonal contagious illness or an outbreak of COVID-19 or other contagious disease in the markets in which we operate; actions of activist stockholders, including a proxy contest; as well as other risks detailed from time to time in our filings with the Securities and Exchange Commission, including those set forth under "Item 1A. Risk Factors" contained in our Annual Report on Form 10-K for the year ended December 31, 2020 and Part II, "Item 1A. Risk Factors" and elsewhere in this Quarterly Report on Form 10-Q. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements in such SEC filings. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect management's views as of the date of this Quarterly Report on Form 10-Q. We cannot guarantee future results, levels of activity, performance or achievements, and, except as required by law, we expressly disclaim any obligation to release publicly any updates or revisions to any forward-looking statements contained in this Quarterly Report on Form 10-Q to reflect any change in our expectations with regard thereto or change in events, conditions or circumstances on which any statement is based.

25


Overview

As of March 31, 2021, we are the largest operator of senior living communities in the United States based on total capacity, with 695 communities in 42 states and the ability to serve approximately 60,000 residents. We offer our residents access to a broad continuum of services across the most attractive sectors of the senior living industry. We operate and manage independent living, assisted living, memory care, and continuing care retirement communities ("CCRCs"). We also offer a range of home health, hospice, and outpatient therapy services to more than 16,000 patients as of that date.

Our goal is to be the first choice in senior living by being the nation's most trusted and effective senior living provider and employer. Our community and service offerings combine housing with hospitality and healthcare services. Our senior living communities offer residents a supportive home-like setting, assistance with activities of daily living such as eating, bathing, dressing, toileting, transferring/walking, and, in certain communities, licensed skilled nursing services. We also provide home health, hospice, and outpatient therapy services to residents of many of our communities and to seniors living outside of our communities. By providing residents with a range of service options as their needs change, we provide greater continuity of care, enabling seniors to age-in-place, which we believe enables them to maintain residency with us for a longer period of time. The ability of residents to age-in-place is also beneficial to our residents and their families who are concerned with care decisions for their elderly relatives.

COVID-19 Pandemic Update

The United States broadly continues to experience the COVID-19 pandemic, which has significantly disrupted, and likely will continue to significantly disrupt for some period, the senior living industry and our business. Due to the average age and prevalence of chronic medical conditions among our residents and patients, they generally are at disproportionately higher risk of hospitalization and adverse outcomes if they contract COVID-19. The health and wellbeing of our residents, patients, and associates is and has been our highest priority as we continue to serve and care for seniors through the pandemic. In addition to the updates below, readers are directed to the "COVID-19 Pandemic" section of Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021 for more information about the impact of the pandemic and our response efforts on our business, results of operations, and financial condition.

Vaccine Clinics Completed. We elected to work with CVS Health Corporation ("CVS") to administer vaccinations on site to our residents and associates through the Pharmacy Partnership for Long-Term Care Program offered through the U.S. Centers for Disease Control and Prevention ("CDC"). We worked extensively to prepare for and host CVS clinics as quickly as possible among our approximately 700 communities, which included extensive planning, gathering insurance information, obtaining consents, scheduling appointments, holding educational sessions with residents, families, and associates, detailed coordination of traffic flow, and staffing observation areas. We hosted our first clinics on December 18, 2020 and had completed at least three vaccine clinics at all of our communities by April 9, 2021. Through April 30, 2021, our resident vaccine acceptance rate was 93%, and our COVID-19 positive resident caseload had decreased by 97% since the peak in mid-December 2020. We continue to promote vaccine acceptance among our residents and associates and to work with state and local resources, including local health departments and pharmacies, to ensure our residents and associates can access the vaccine.

Community Restrictions. To help protect our residents, patients, and associates from contracting COVID-19, we imposed significant restrictions at our communities beginning in March 2020, including closing our communities to visitors and prospective residents, and in some cases restricting new resident move-ins, suspending group outings, modifying communal dining and programming to comply with social distancing and other regulatory guidelines and, in most cases, implementing in-room only dining and activities programming, requesting that residents refrain from leaving the community unless medically necessary, and requiring new residents and residents returning from a hospital or nursing home to isolate in their apartment for fourteen days. We have adopted a framework for determining when to ease restrictions at each of our communities based on several criteria, including regulatory requirements and guidance, completion of baseline testing at the community, and the presence of current confirmed COVID-19 positive cases. We may revert to more restrictive measures if the pandemic worsens, as necessary to comply with regulatory requirements, or at the direction of state or local health authorities. As of December 31, 2020, 89% of our communities were accepting new move-ins. With lower caseloads, restrictions on visits have been relaxed, and as of April 30, 2021, 100% of our communities have opened for visitors and new prospects.

Occupancy and Demand. According to data from the National Investment Center for the Seniors Housing & Care Industry ("NIC"), seniors housing occupancy again decreased to a record low for the first quarter of 2021. In our consolidated seniors housing portfolio, our monthly net move-ins and move-outs turned positive in March 2021 for the first time since the pandemic began. Move-ins increased sequentially each month during the first quarter of 2021 and increased 29% for the first quarter of 2021 compared to the fourth quarter of 2020. Our consolidated senior housing portfolio’s weighted average occupancy

26


decreased 310 basis points for the first quarter of 2021 from the fourth quarter of 2020. Weighted average occupancy for March 2021 increased slightly sequentially and for April 2021 increased 50 basis points sequentially, after having declined sequentially each month from March 2020 through February 2021. The table below sets forth our consolidated occupancy trend during the pandemic.

Q1
2020
Q2
2020
Q3
2020
Q4
2020
Q1
2021
January
2021
February
2021
March
2021
April
2021
Weighted average occupancy83.2 %78.7 %75.3 %72.7 %69.6 %70.0 %69.4 %69.4 %69.9 %
Month-end occupancy82.2 %77.8 %75.0 %71.5 %70.6 %70.4 %70.1 %70.6 %71.1 %

We cannot predict with reasonable certainty whether or when demand for senior living communities will return to pre-COVID-19 levels or the extent to which the pandemic’s effect on demand may adversely affect the amount of resident fees we are able to collect from our residents.

Lost Revenue. Compared to our pre-pandemic expectations for fiscal 2020, we estimate that the pandemic, including the related restrictions at our communities, resulted in $117.5 million of lost resident fee revenue for the first quarter of 2021. Estimated lost resident fee revenue for the first quarter of 2021 includes $94.2 million in our consolidated senior housing portfolio and $23.3 million for our Health Care Services segment. On a cumulative basis, we estimate that the pandemic has resulted in approximately $400 million of lost resident fee revenue compared to our pre-pandemic expectations for fiscal 2020.

Pandemic-Related Expenses. We incurred $27.3 million of facility operating expense during the first quarter of 2021 for incremental direct costs to respond to the pandemic. Such costs include those for: acquisition of additional PPE, medical equipment, and cleaning and disposable food service supplies; enhanced cleaning and environmental sanitation; increased employee-related costs, including labor, workers compensation, and health plan expense; increased expense for general liability claims; and COVID-19 testing of residents and associates where not otherwise covered by government payor or third-party insurance sources. On a cumulative basis, we have incurred $152.9 million of pandemic-related facility operating expense since the beginning of fiscal 2020. We also recorded non-cash impairment charges in our operating results of $9.0 million for the three months ended March 31, 2021, for our operating lease right-of-use assets, primarily due to the COVID-19 pandemic and lower than expected operating performance at communities with impaired assets.

Liquidity. As of March 31, 2021, our total liquidity was $438.9 million, consisting of $304.0 million of unrestricted cash and cash equivalents and $134.9 million of marketable securities. Our cash flows from operations, excluding management agreement termination fees and the impact of the Coronavirus Aid, Relief, and Economic Security Act of 2020 ("CARES Act") funding, have been insufficient to cover our operating expenses, capital expenditures, and required interest and lease payments during the pandemic. However, we were able to satisfy our liquidity needs over such period utilizing a portion of our preexisting liquidity, together with CARES Act funding. We currently estimate that our cash flows from operations, together with cash balances on hand, cash equivalents, marketable securities, and proceeds from the pending sale of 80% of the equity in our Health Care Services segment will be sufficient to fund our liquidity needs for at least the next 12 months. We continue to seek opportunities to enhance and preserve our liquidity, including through maintaining expense discipline and increasing occupancy, continuing to evaluate our financing structure and the state of debt markets, and seeking further government-sponsored financial relief related to the pandemic. There is no assurance that debt financing will continue to be available on terms consistent with our expectations or at all, that our efforts will be successful in seeking further government-sponsored financial relief or regarding the amount of, or conditions required to qualify for, any such relief, or that the closing of the pending transaction will be completed in accordance with our expectations, or at all, or generate cash proceeds to us in the amount we anticipate.

Financial Relief. The CARES Act, signed into law on March 27, 2020, and Paycheck Protection Program and Health Care Enhancement Act, signed into law on April 24, 2020, provide liquidity and financial relief to certain businesses, among other things. Certain impacts of such programs are provided below.

During the first quarter of 2021, we accepted $0.8 million of cash from grants from the Public Health and Social Services Emergency Fund ("Provider Relief Fund") administered by the U.S. Department of Health and Human Services ("HHS"), under which grants have been made available to eligible healthcare providers for healthcare related expenses or lost revenues attributable to COVID-19. The grants represented incentive payments made pursuant to the Nursing Home Infection Control Distribution, which related to our skilled nursing care provided through our CCRCs. HHS continues to evaluate future allocations under the Provider Relief Fund and the regulation and guidance regarding grants made under the Provider Relief Fund. We intend to pursue additional funding that may become available. There can be no assurance that we will qualify for, or receive, such future grants in the amount we expect, that additional restrictions on the permissible

27


uses or terms and conditions of the grants will not be imposed by HHS, or that future funding programs will be made available for which we qualify.

During the year ended December 31, 2020, we received $87.5 million under the Accelerated and Advance Payment Program administered by CMS, $75.2 million of which related to our Health Care Services segment and $12.3 million related to our CCRCs segment. Recoupment of advanced payments will begin one year after payments were issued at a rate of 25% of Medicare payments for the first eleven months following the anniversary of issuance and at a rate of 50% of Medicare payments for the next six months. Any outstanding balance of advanced payments will be due following such recoupment period. Pursuant to the Purchase Agreement providing for the sale of 80% of our equity in our Health Care Services segment (as described below), our net cash proceeds at closing will include a reduction for the then outstanding balance of such advanced payments related to our Health Care Services segment. We expect recoupment of approximately $6 million of advanced payments related to our CCRCs segment during 2021, beginning in the second quarter.

During fiscal 2020, we deferred payment of $72.7 million of the employer portion of social security payroll taxes incurred from March 27, 2020 through December 31, 2020 pursuant to the CARES Act. One-half of such deferral amount will become due on each of December 31, 2021 and December 31, 2022. Pursuant to the Purchase Agreement providing for the sale of 80% of our equity in our Health Care Services segment, our net cash proceeds at closing will include a reduction for the $8.9 million of deferred payroll tax payments related to our Health Care Services segment. We expect to pay approximately $32 million of the deferred payments in both December 2021 and 2022.

We are eligible to claim the employee retention credit for certain of our associates under the CARES Act. The credit for 2020 is available to employers that fully or partially suspended operations during any calendar quarter in 2020 due to orders from an appropriate governmental authority limiting commerce, travel, or group meetings due to COVID-19, and is equal to 50% of qualified wages paid after March 12, 2020 through December 31, 2020 to qualified employees, with a maximum credit of $5,000 per employee. During the first quarter of 2021, we recognized $9.0 million of employee retention credits on wages paid from March 12, 2020 to September 30, 2020 within other operating income. The credit was modified and extended by subsequent legislation for wages paid from January 1, 2021 through December 31, 2021, and we are assessing our eligibility to claim such credit. There can be no assurance that we will qualify for, or receive, credits in the amount or on the timing we expect.

In addition to the grants described above, during the three months ended March 31, 2021, we received and recognized $0.9 million of other operating income from grants from other government sources.

We cannot predict with reasonable certainty the impacts that COVID-19 ultimately will have on our business, results of operations, cash flow, and liquidity, and our response efforts may continue to delay or negatively impact our strategic initiatives, including plans for future growth. The ultimate impacts of COVID-19 will depend on many factors, some of which cannot be foreseen, including the duration, severity, and breadth of the pandemic and any resurgence of the disease; the impact of COVID-19 on the nation’s economy and debt and equity markets and the local economies in our markets; the development, availability, utilization, and efficacy of COVID-19 testing, therapeutic agents, and vaccines and the prioritization of such resources among businesses and demographic groups; government financial and regulatory relief efforts that may become available to business and individuals, including our ability to qualify for and satisfy the terms and conditions of financial relief; perceptions regarding the safety of senior living communities during and after the pandemic; changes in demand for senior living communities and our ability to adapt our sales and marketing efforts to meet that demand; the impact of COVID-19 on our residents’ and their families’ ability to afford our resident fees, including due to changes in unemployment rates, consumer confidence, housing markets, and equity markets caused by COVID-19; changes in the acuity levels of our new residents; the disproportionate impact of COVID-19 on seniors generally and those residing in our communities; the duration and costs of our response efforts, including increased equipment, supplies, labor, litigation, testing, vaccination clinic, and other expenses; the impact of COVID-19 on our ability to complete financings and refinancings of various assets or other transactions (including dispositions and the pending sale of 80% of the equity in our Health Care Services segment) or to generate sufficient cash flow to cover required debt, interest, and lease payments and to satisfy financial and other covenants in our debt and lease documents; increased regulatory requirements, including unfunded, mandatory testing; increased enforcement actions resulting from COVID-19; government action that may limit our collection or discharge efforts for delinquent accounts; and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or our response efforts.



28


Transaction Activity

During the period from January 1, 2020 through March 31, 2021, we terminated triple-net obligations on an aggregate of 32 communities (2,890 units), including through the acquisition of 27 formerly leased communities (2,453 units), we sold three owned communities (417 units), and we sold our ownership interest in our unconsolidated entry fee CCRC venture (the "CCRC Venture") with Healthpeak Properties, Inc. ("Healthpeak"). On July 26, 2020, we entered into definitive agreements with Ventas, Inc. ("Ventas") to restructure our 120 community (10,174 units) triple-net master lease arrangements. In addition, we conveyed to Ventas five communities (471 units) and manage the communities following the closing. See Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021 for more details regarding the terms of significant transactions that occurred prior to 2021.

During the three months ended March 31, 2021, we completed the sale of one owned community (42 units) for cash proceeds of $2.7 million, net of transaction costs, and for which we recognized a net gain on sale of assets of $0.5 million.

During the next twelve months, we expect to sell 80% of our equity in our Health Care Services segment and to close on the disposition of two owned unencumbered communities (207 units) classified as held for sale as of March 31, 2021. We also anticipate terminations of certain of our management arrangements with third parties as we transition to new operators our management on certain communities.

The closings of the various pending and expected transactions described herein are, or will be, subject to the satisfaction of various closing conditions, including (where applicable) the receipt of regulatory approvals. However, there can be no assurance that the transactions will close or, if they do, when the actual closings will occur.

Pending Sale of Health Care Services

On February 24, 2021, we entered into a Securities Purchase Agreement (the "Purchase Agreement") with affiliates of HCA Healthcare, Inc. ("HCA Healthcare"), providing for the sale of 80% of our equity in our Health Care Services segment for a purchase price of $400 million in cash, subject to certain adjustments set forth in the Purchase Agreement, including a reduction for the remaining outstanding balance as of the closing of Medicare advance payments and deferred payroll tax payments related to the Health Care Services segment, which were $75.2 million and $8.9 million, respectively, as of March 31, 2021. We expect our net cash proceeds at the closing will be approximately $300 million, subject to the timing of closing with respect to the adjustments set forth in the Purchase Agreement. The Purchase Agreement also contains certain agreed upon indemnities for the benefit of the purchaser. The closing of the sale transaction is anticipated to occur in the early second half of 2021, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Purchase Agreement. Pursuant to the Purchase Agreement, at closing of the transaction, we will retain a 20% equity interest in the business. Upon closing, we expect that the results and financial position of our Health Care Services segment will be deconsolidated from our financial statements and that our interest in the joint venture will be accounted for under the equity method of accounting. We anticipate that the sale transaction will utilize a portion of our federal net operating loss carryforwards to offset the expected taxable gain on such transaction.


Results of Operations

As of March 31, 2021, our total operations included 695 communities with a capacity to serve approximately 60,000 residents. As of that date we owned 349 communities (31,819 units), leased 301 communities (21,127 units), and managed 45 communities (6,652 units). The following discussion should be read in conjunction with our condensed consolidated financial statements and the related notes, which are included in "Item 1. Financial Statements" of this Quarterly Report on Form 10-Q. The results of operations for any particular period are not necessarily indicative of results for any future period. Transactions completed during the period of January 1, 2020 to March 31, 2021 affect the comparability of our results of operations.

We use the operating measures described below in connection with operating and managing our business and reporting our results of operations.
Senior housing operating results and data presented on a same community basis reflect results and data of a consistent population of communities by excluding the impact of changes in the composition of our portfolio of communities. The operating results exclude natural disaster expense and related insurance recoveries. We define our same community portfolio as communities consolidated and operational for the full period in both comparison years. Consolidated communities excluded from the same community portfolio include communities acquired or disposed of since the

29


beginning of the prior year, communities classified as assets held for sale, certain communities planned for disposition, certain communities that have undergone or are undergoing expansion, redevelopment, and repositioning projects, and certain communities that have experienced a casualty event that significantly impacts their operations. Our management uses same community operating results and data for decision making, and we believe such results and data provide useful information to investors, because it enables comparisons of revenue, expense, and other operating measures for a consistent portfolio over time without giving effect to the impacts of communities that were not consolidated and operational for the comparison periods, communities acquired or disposed during the comparison periods (or planned for disposition), and communities with results that are or likely will be impacted by completed or in-process development-related capital expenditure projects. As presented herein, same community results include the direct costs incurred to respond to the COVID-19 pandemic.

RevPAR, or average monthly senior housing resident fee revenue per available unit, is defined as resident fee revenue for the corresponding portfolio for the period (excluding Health Care Services segment revenue, revenue from private duty services provided to seniors living outside of our communities, and entrance fee amortization), divided by the weighted average number of available units in the corresponding portfolio for the period, divided by the number of months in the period. We measure RevPAR at the consolidated level, as well as at the segment level with respect to our Independent Living, Assisted Living and Memory Care, and CCRCs segments. Our management uses RevPAR for decision making, and we believe the measure provides useful information to investors, because the measure is an indicator of senior housing resident fee revenue performance that reflects the impact of both senior housing occupancy and rate.

RevPOR, or average monthly senior housing resident fee revenue per occupied unit, is defined as resident fee revenue for the corresponding portfolio for the period (excluding Health Care Services segment revenue, revenue from private duty services provided to seniors living outside of our communities, and entrance fee amortization), divided by the weighted average number of occupied units in the corresponding portfolio for the period, divided by the number of months in the period. We measure RevPOR at the consolidated level, as well as at the segment level with respect to our Independent Living, Assisted Living and Memory Care, and CCRCs segments. Our management uses RevPOR for decision making, and we believe the measure provides useful information to investors, because it reflects the average amount of senior housing resident fee revenue we derive from an occupied unit per month without factoring occupancy rates. RevPOR is a significant driver of our senior housing revenue performance.

Weighted average occupancy rate reflects the percentage of units at our owned and leased communities being utilized by residents over a reporting period. We measure occupancy rates with respect to our Independent Living, Assisted Living and Memory Care, and CCRCs segments, and also measure this metric both on a consolidated senior housing and a same community basis. Our management uses weighted average occupancy, and we believe the measure provides useful information to investors, because it is a significant driver of our senior housing revenue performance.

This section includes the non-GAAP performance measure Adjusted EBITDA. See "Non-GAAP Financial Measures" below for our definition of the measure and other important information regarding such measure, including reconciliations to the most comparable GAAP measure.

Comparison of Three Months Ended March 31, 2021 and 2020

Summary Operating Results

The following table summarizes our overall operating results for the three months ended March 31, 2021 and 2020.
Three Months Ended
March 31,
Increase (Decrease)
(in thousands)20212020AmountPercent
Total resident fees and management fees revenue$672,916 $891,422 $(218,506)(24.5)%
Other operating income10,735 — 10,735 NM
Facility operating expense556,312 588,482 (32,170)(5.5)%
Net income (loss)(108,303)369,497 (477,800)NM
Adjusted EBITDA34,981 185,069 (150,088)(81.1)%

The decrease in total resident fees and management fees revenue was primarily attributable to a $118.4 million decrease in resident fees, including a 14.3% decrease in same community RevPAR, comprised of a 1,390 basis point decrease in same

30


community weighted average occupancy and a 2.9% increase in same community RevPOR. Revenue for home health services decreased $9.6 million, as our home health average daily census decreased 16.9% compared to the prior year period primarily due to the COVID-19 pandemic and lower occupancy in our communities. Additionally, the disposition of 13 communities through sales and conveyances of owned communities and lease terminations since the beginning of the prior year period resulted in $15.3 million less in resident fees during the three months ended March 31, 2021 compared to the prior year period. Management fee revenue decreased $100.1 million primarily due to $100.0 million of management agreement termination fees recognized for the three months ended March 31, 2020 for the management agreement termination fee payment received from Healthpeak in connection with the sale of our ownership interest in the CCRC Venture.

During the three months ended March 31, 2021, we recognized $9.0 million of employee retention credits and $1.7 million of government grants as other operating income based on our estimates of our satisfaction of the conditions of the credits and grants during the period.

The decrease in facility operating expense was primarily attributable to a decrease in labor costs for home health services as a result of lower census and as we adjusted our home health services operational structure to better align our facility operating expenses and business model with the new Patient-Driven Grouping Model ("PDGM"), an alternate home health case-mix adjustment methodology with a 30-day unit of payment, which became effective beginning January 1, 2020. Additionally, the disposition of communities since the beginning of the prior year period resulted in $13.6 million less in facility operating expense during the three months ended March 31, 2021 compared to the prior year period. Same community facility operating expense decreased 1.0%, which was primarily due to decreases in food and supplies costs due to reduced occupancy during the period, partially offset by an increase in labor costs. Facility operating expense for the three months ended March 31, 2021 and 2020 includes $27.3 million and $10.0 million, respectively, of incremental direct costs to respond to the COVID-19 pandemic.

The change in net income (loss) was primarily attributable to a $371.7 million decrease in net gain on sale of assets, primarily resulting from the sale of our interest in the CCRC Venture, as well as the net impact of the revenue, other operating income, and facility operating expense factors previously discussed, partially offset by a decrease in asset impairment expense compared to the prior year period.

The decrease in Adjusted EBITDA was primarily attributable to the net impact of the revenue (including the $100.0 million management agreement termination fee payment received from Healthpeak), other operating income, and facility operating expense factors previously discussed, partially offset by decreases in cash facility operating lease payments and general and administrative expense.


31


Operating Results - Senior Housing Segments

The following table summarizes the operating results and data of our three senior housing segments (Independent Living, Assisted Living and Memory Care, and CCRCs) on a combined basis for the three months ended March 31, 2021 and 2020, including operating results and data on a same community basis. See management's discussion and analysis of the operating results on an individual segment basis on the following pages.
(in thousands, except communities, units, occupancy, RevPAR, and RevPOR)Three Months Ended
March 31,
Increase (Decrease)
20212020AmountPercent
Resident fees$577,499 $687,888 $(110,389)(16.0)%
Other operating income$8,152 $— $8,152 NM
Facility operating expense$469,281 $484,542 $(15,261)(3.1)%
Number of communities (period end)650 661 (11)(1.7)%
Number of units (period end)52,946 54,037 (1,091)(2.0)%
Total average units52,971 54,184 (1,213)(2.2)%
RevPAR$3,631 $4,229 $(598)(14.1)%
Occupancy rate (weighted average)69.6 %83.2 %(1,360) bpsn/a
RevPOR$5,219 $5,085 $134 2.6 %
Same Community Operating Results and Data
Resident fees$551,467 $643,232 $(91,765)(14.3)%
Other operating income$7,554 $— $7,554 NM
Facility operating expense$446,339 $450,680 $(4,341)(1.0)%
Number of communities637 637 — — 
Total average units50,455 50,458 (3)— 
RevPAR$3,643 $4,249 $(606)(14.3)%
Occupancy rate (weighted average)69.5 %83.4 %(1,390) bpsn/a
RevPOR$5,244 $5,097 $147 2.9 %


32


Independent Living Segment

The following table summarizes the operating results and data for our Independent Living segment for the three months ended March 31, 2021 and 2020, including operating results and data on a same community basis.
(in thousands, except communities, units, occupancy, RevPAR, and RevPOR)Three Months Ended
March 31,
Increase (Decrease)
20212020AmountPercent
Resident fees$118,782 $135,862 $(17,080)(12.6)%
Other operating income$1,364 $— $1,364 NM
Facility operating expense$82,817 $84,448 $(1,631)(1.9)%
Number of communities (period end)68 68 — — 
Number of units (period end)12,542 12,537 — 
Total average units12,539 12,529 10 0.1 %
RevPAR$3,158 $3,615 $(457)(12.6)%
Occupancy rate (weighted average)73.6 %87.1 %(1,350) bpsn/a
RevPOR$4,290 $4,151 $139 3.3 %
Same Community Operating Results and Data
Resident fees$115,625 $132,556 $(16,931)(12.8)%
Other operating income$1,327 $— $1,327 NM
Facility operating expense$80,367 $82,172 $(1,805)(2.2)%
Number of communities66 66 — — 
Total average units12,161 12,159 — 
RevPAR$3,169 $3,634 $(465)(12.8)%
Occupancy rate (weighted average)73.6 %87.1 %(1,350) bpsn/a
RevPOR$4,307 $4,174 $133 3.2 %

The decrease in the segment's resident fees was primarily attributable to a decrease in the segment's same community RevPAR, comprised of a 1,350 basis point decrease in same community weighted average occupancy and a 3.2% increase in same community RevPOR. The decrease in the segment's same community weighted average occupancy primarily reflects the impact of reduced move-in activity related to the COVID-19 pandemic, including the related restrictions at our communities. The increase in the segment's same community RevPOR was primarily the result of in-place rent increases.

The decrease in the segment's facility operating expense was primarily attributable to a decrease in the segment's same community facility operating expense, including decreases in food and supplies costs due to reduced occupancy during the period. The segment's facility operating expense for the three months ended March 31, 2021 and 2020 includes $3.0 million and $1.2 million, respectively, of incremental direct costs to respond to the COVID-19 pandemic.


33


Assisted Living and Memory Care Segment

The following table summarizes the operating results and data for our Assisted Living and Memory Care segment for the three months ended March 31, 2021 and 2020, including operating results and data on a same community basis.
(in thousands, except communities, units, occupancy, RevPAR, and RevPOR)Three Months Ended
March 31,
Increase (Decrease)
20212020AmountPercent
Resident fees$386,938 $457,479 $(70,541)(15.4)%
Other operating income$5,104 $— $5,104 NM
Facility operating expense$320,609 $325,478 $(4,869)(1.5)%
Number of communities (period end)562 571 (9)(1.6)%
Number of units (period end)35,082 35,789 (707)(2.0)%
Total average units35,110 35,944 (834)(2.3)%
RevPAR$3,673 $4,242 $(569)(13.4)%
Occupancy rate (weighted average)68.3 %81.9 %(1,360) bpsn/a
RevPOR$5,376 $5,178 $198 3.8 %
Same Community Operating Results and Data
Resident fees$381,448 $444,269 $(62,821)(14.1)%
Other operating income$4,967 $— $4,967 NM
Facility operating expense$315,009 $316,338 $(1,329)(0.4)%
Number of communities556 556 — — 
Total average units34,508 34,513 (5)— 
RevPAR$3,685 $4,291 $(606)(14.1)%
Occupancy rate (weighted average)68.3 %82.2 %(1,390) bpsn/a
RevPOR$5,396 $5,221 $175 3.4 %

The decrease in the segment's resident fees was primarily attributable to a decrease in the segment's same community RevPAR, comprised of a 1,390 basis point decrease in same community weighted average occupancy and a 3.4% increase in same community RevPOR. The decrease in the segment's same community weighted average occupancy primarily reflects the impact of reduced move-in activity related to the COVID-19 pandemic, including the related restrictions at our communities. The increase in the segment's same community RevPOR was primarily the result of in-place rent increases. Additionally, the disposition of 11 communities (869 units) since the beginning of the prior year period resulted in $7.3 million less in resident fees during the three months ended March 31, 2021 compared to the prior year period.

The decrease in the segment's facility operating expense was primarily attributable to the disposition of communities since the beginning of the prior year period which resulted in $7.0 million less in facility operating expense during the three months ended March 31, 2021 compared to the prior year period. The decrease in the segment's same community facility operating expense was primarily attributable to decreases in food and supplies costs due to reduced occupancy during the period, partially offset by an increase in labor costs. The segment's facility operating expense for the three months ended March 31, 2021 and 2020 includes $18.9 million and $7.7 million, respectively, of incremental direct costs to respond to the COVID-19 pandemic.

34


CCRCs Segment

The following table summarizes the operating results and data for our CCRCs segment for the three months ended March 31, 2021 and 2020, including operating results and data on a same community basis.
(in thousands, except communities, units, occupancy, RevPAR, and RevPOR)Three Months Ended
March 31,
Increase (Decrease)
20212020AmountPercent
Resident fees$71,779 $94,547 $(22,768)(24.1)%
Other operating income$1,684 $— $1,684 NM
Facility operating expense$65,855 $74,616 $(8,761)(11.7)%
Number of communities (period end)20 22 (2)(9.1)%
Number of units (period end)5,322 5,711 (389)(6.8)%
Total average units5,322 5,711 (389)(6.8)%
RevPAR$4,473 $5,496 $(1,023)(18.6)%
Occupancy rate (weighted average)68.5 %82.4 %(1,390) bpsn/a
RevPOR$6,534 $6,669 $(135)(2.0)%
Same Community Operating Results and Data
Resident fees$54,394 $66,407 $(12,013)(18.1)%
Other operating income$1,260 $— $1,260 NM
Facility operating expense$50,963 $52,170 $(1,207)(2.3)%
Number of communities15 15 — — 
Total average units3,786 3,786 — — 
RevPAR$4,789 $5,847 $(1,058)(18.1)%
Occupancy rate (weighted average)67.1 %82.4 %(1,530) bpsn/a
RevPOR$7,133 $7,093 $40 0.6 %

The decrease in the segment's resident fees was primarily attributable to a decrease in the segment's same community RevPAR, comprised of a 1,530 basis point decrease in same community weighted average occupancy and a 0.6% increase in same community RevPOR. The decrease in the segment's same community weighted average occupancy primarily reflects the impact of reduced move-in activity related to the COVID-19 pandemic, including the related restrictions at our communities. The increase in the segment's same community RevPOR was primarily the result of in-place rent increases, partially offset by a mix shift from less skilled nursing services within the segment. Additionally, the disposition of two communities (456 units) since the beginning of the prior year period resulted in $8.0 million less in resident fees during the three months ended March 31, 2021 compared to the prior year period.

The decrease in the segment's facility operating expense was primarily attributable to the disposition of communities since the beginning of the prior year period, which resulted in $6.6 million less in facility operating expense during the three months ended March 31, 2021 compared to the prior year period and a decrease in the segment's same community facility operating expense. The decrease in the segment's same community facility operating expense was primarily attributable to decreases in healthcare supplies and food costs due to the reduced occupancy during the period and decreases in labor expense arising from fewer hours worked. The segment's facility operating expense for the three months ended March 31, 2021 and 2020 includes $4.0 million and $0.7 million, respectively, of incremental direct costs to respond to the COVID-19 pandemic.




35


Operating Results - Health Care Services Segment

The following table summarizes the operating results and data for our Health Care Services segment for the three months ended March 31, 2021 and 2020.
(in thousands, except census)Three Months Ended
March 31,
Increase (Decrease)
20212020AmountPercent
Resident fees $86,851 $94,819 $(7,968)(8.4)%
Other operating income$2,583 $— $2,583 NM
Facility operating expense$87,031 $103,940 $(16,909)(16.3)%
Home health average daily census11,647 14,020 (2,373)(16.9)%
Hospice average daily census1,509 1,698 (189)(11.1)%

The decrease in the segment's resident fees was primarily attributable to a decrease in revenue for home health services, as our home health average daily census decreased compared to the prior year period primarily due to the COVID-19 pandemic and lower occupancy in our communities.

The decrease in the segment's facility operating expense was primarily attributable to a decrease in labor costs for home health services as a result of the lower census and as we adjusted our home health services operational structure to better align our facility operating expenses and business model with the new payment model. The decrease in the segment's facility operating expense was partially offset by a $1.0 million increase in incremental direct costs to respond to the COVID-19 pandemic. The segment's facility operating expense for the three months ended March 31, 2021 and 2020 includes $1.4 million and $0.4 million, respectively, of incremental direct costs to respond to the COVID-19 pandemic.

As described above, we expect to sell 80% of our equity in our Health Care Services segment pursuant to the Purchase Agreement with HCA Healthcare, which transaction is expected to occur in the early second half of 2021. Upon closing, we expect that the results and financial position of our Health Care Services segment will be deconsolidated from our financial statements.

Operating Results - Management Services Segment

The following table summarizes the operating results and data for our Management Services segment for the three months ended March 31, 2021 and 2020.
(in thousands, except communities and units)Three Months Ended
March 31,
Increase (Decrease)
20212020AmountPercent
Management fees$8,566 $108,715 $(100,149)(92.1)%
Reimbursed costs incurred on behalf of managed communities$65,794 $122,717 $(56,923)(46.4)%
Costs incurred on behalf of managed communities$65,794 $122,717 $(56,923)(46.4)%
Number of communities (period end)45 80 (35)(43.8)%
Number of units (period end)6,652 11,033 (4,381)(39.7)%
Total average units8,258 13,325 (5,067)(38.0)%

The decrease in management fees was primarily attributable to $100.0 million of management agreement termination fees recognized for the three months ended March 31, 2020 for the management agreement termination fee payment received from Healthpeak in connection with the sale of our ownership interest in the CCRC Venture. As of March 31, 2021, we have completed the transition of management arrangements on 55 net communities since the beginning of the prior year period, generally for management arrangements on certain former unconsolidated ventures in which we sold our interest and interim management arrangements on formerly leased communities. Management fees of $8.6 million for the three months ended March 31, 2021 include $4.6 million of management agreement termination fees and $2.0 million of other management fees

36


attributable to communities for which our management agreements were terminated during such period, or we expect the terminations of our management agreements to occur in the next approximately 12 months.

The decrease in reimbursed costs and costs incurred on behalf of managed communities was primarily attributable to terminations of management agreements subsequent to the beginning of the prior year period.

Operating Results - Other Income and Expense Items

The following table summarizes other income and expense items in our operating results for the three months ended March 31, 2021 and 2020.
(in thousands)Three Months Ended
March 31,
Increase (Decrease)
20212020AmountPercent
General and administrative expense$49,943 $54,595 $(4,652)(8.5)%
Facility operating lease expense44,418 64,481 (20,063)(31.1)%
Depreciation and amortization83,891 90,738 (6,847)(7.5)%
Asset impairment10,677 78,226 (67,549)(86.4)%
Interest income421 1,455 (1,034)(71.1)%
Interest expense(48,607)(56,360)(7,753)(13.8)%
Gain (loss) on debt modification and extinguishment, net
— 19,181 (19,181)NM
Equity in earnings (loss) of unconsolidated ventures(531)(1,008)477 47.3 %
Gain (loss) on sale of assets, net1,112 372,839 (371,727)(99.7)%
Other non-operating income (loss)1,644 2,662 (1,018)(38.2)%
Benefit (provision) for income taxes(752)15,828 (16,580)NM

General and Administrative Expense. The decrease in general and administrative expense was primarily attributable to a reduction in our corporate headcount as we scaled our general and administrative costs in connection with community dispositions and a reduction in our travel costs as we intentionally scaled back such activities. General and administrative expense includes transaction and organizational restructuring costs of $1.9 million and $2.0 million for the three months ended March 31, 2021 and 2020, respectively. Transaction costs include those directly related to acquisition, disposition, financing and leasing activity, and stockholder relations advisory matters, and are primarily comprised of legal, finance, consulting, professional fees and other third party costs. Organizational restructuring costs include those related to our efforts to reduce general and administrative expense and our senior leadership changes, including severance costs.

Facility Operating Lease Expense. The decrease in facility operating lease expense was primarily due to the Ventas lease portfolio restructuring during the prior year and lease termination activity since the beginning of the prior year period.

Depreciation and Amortization. The decrease in depreciation and amortization expense was primarily due to disposition activity since the beginning of the prior year period and leasehold improvements for certain leased communities becoming fully depreciated since the beginning of the prior year period.

Asset Impairment. During the current year period, we recorded $10.7 million of non-cash impairment charges, primarily for right-of-use assets for certain leased communities with decreased future cash flow estimates as a result of the COVID-19 pandemic and for natural disaster related property damage sustained at certain communities during the period. During the prior year period, we recorded $78.2 million of non-cash impairment charges, primarily for right-of-use assets for certain leased communities with decreased future cash flow estimates as a result of the COVID-19 pandemic.

Interest Expense. The decrease in interest expense was primarily due to a decrease in interest expense on long-term debt, reflecting the impact of lower interest rates, and the acquisition of communities previously subject to financing leases since the beginning of the prior year period.

Gain (Loss) on Sale of Assets, Net. The decrease in gain on sale of assets, net was primarily due to a $370.7 million gain on sale of assets recognized for the sale of our ownership interest in the CCRC Venture during the prior year period.


37


Benefit (Provision) for Income Taxes. The difference between our effective tax rate for the three months ended March 31, 2021 and 2020 was primarily due to the tax impact of the multi-part transaction with Healthpeak that occurred in the three months ended March 31, 2020. The impact represented the tax expense recorded on the gain of the sale of our interest in the CCRC Venture offset by a decrease in the valuation allowance that was a direct result of the multi-part transaction with Healthpeak.

We recorded an aggregate deferred federal, state, and local tax benefit of $25.2 million as a result of the operating loss for the three months ended March 31, 2021, which was offset by an increase in the valuation allowance of $25.5 million. We recorded an aggregate deferred federal, state, and local tax expense of $90.9 million, of which, $2.2 million was a result of the benefit on our operating loss for the three months ended March 31, 2020. The benefit was offset by $93.1 million of tax expense that was recorded on the sale of our interest in the CCRC Venture. The tax expense was offset by a decrease in the valuation allowance of $112.6 million.

We evaluate our deferred tax assets each quarter to determine if a valuation allowance is required based on whether it is more likely than not that some portion of the deferred tax asset would not be realized. Our valuation allowance as of March 31, 2021 and December 31, 2020 was $406.5 million and $381.0 million, respectively.

Liquidity and Capital Resources

This section includes the non-GAAP liquidity measure Adjusted Free Cash Flow. See "Non-GAAP Financial Measures" below for our definition of the measure and other important information regarding such measure, including reconciliations to the most comparable GAAP measure.

Liquidity and Indebtedness

The following is a summary of cash flows from operating, investing, and financing activities, as reflected in the condensed consolidated statements of cash flows, and our Adjusted Free Cash Flow:
Three Months Ended
March 31,
Increase (Decrease)
(in thousands)20212020AmountPercent
Net cash provided by (used in) operating activities$(23,857)$57,479 $(81,336)NM
Net cash provided by (used in) investing activities(3,806)(247,927)(244,121)(98.5)%
Net cash provided by (used in) financing activities(35,562)347,250 (382,812)NM
Net increase (decrease) in cash, cash equivalents, and restricted cash
(63,225)156,802 (220,027)NM
Cash, cash equivalents, and restricted cash at beginning of period
465,148 301,697 163,451 54.2 %
Cash, cash equivalents, and restricted cash at end of period
$401,923 $458,499 $(56,576)(12.3)%
Adjusted Free Cash Flow$(50,674)$5,182 $(55,856)NM

The change in net cash provided by (used in) operating activities was attributable primarily to the $100.0 million management agreement termination fee payment received from Healthpeak in connection with the sale of our ownership interest in the CCRC Venture in the prior year period and a decrease in same community revenue compared to the prior year period. These changes were partially offset by a decrease in cash payments for accounts payable and accrued expenses compared to the prior year period.

The decrease in net cash used in investing activities was primarily attributable to $446.7 million of cash paid for the acquisition of communities during the prior year period, a $68.0 million increase in proceeds from sales and maturities of marketable securities, a $29.0 million decrease in cash paid for capital expenditures, and a $9.5 million decrease in purchases of marketable securities compared to the prior year period. These changes were partially offset by a $300.9 million decrease in net proceeds from the sale of assets compared to the prior year period.

The change in net cash provided by (used in) financing activities was primarily attributable to a $453.2 million decrease in debt proceeds compared to the prior year period and $166.4 million of draws on our former secured credit facility during the prior year period. These changes were partially offset by a $213.3 million decrease in repayment of debt and financing lease

38


obligations, an $18.1 million decrease in cash paid for share repurchases, and a $5.7 million decrease in cash paid for financing costs compared to the prior year period.

The decrease in Adjusted Free Cash Flow was primarily attributable to the change in net cash provided by (used in) operating activities, partially offset by a $33.1 million decrease in non-development capital expenditures, net compared to the prior year period.

Our principal sources of liquidity have historically been from:

cash balances on hand, cash equivalents, and marketable securities;
cash flows from operations;
proceeds from our credit facilities;
funds generated through unconsolidated venture arrangements;
proceeds from mortgage financing or refinancing of various assets;
funds raised in the debt or equity markets; and
proceeds from the disposition of assets.

Over the longer-term, we expect to continue to fund our business through these principal sources of liquidity. During 2020, we also received cash grants and advanced Medicare payments under programs expanded or created under the CARES Act, and we have elected to utilize the CARES Act payroll tax deferral program, each as described above. As described above, we expect to sell 80% of our equity in our Health Care Services segment pursuant to the Purchase Agreement with HCA Healthcare, which transaction is expected to occur in the early second half of 2021, for expected net cash proceeds of approximately $300 million, subject to the timing of closing with respect to the adjustments set forth in the Purchase Agreement described above. We are evaluating the use of the net proceeds from the pending Health Care Services transaction.

Our liquidity requirements have historically arisen from:

working capital;
operating costs such as employee compensation and related benefits, severance costs, general and administrative expense, and supply costs;
debt, interest, and lease payments;
acquisition consideration, lease termination and restructuring costs, and transaction and integration costs;
capital expenditures and improvements, including the expansion, renovation, redevelopment, and repositioning of our current communities and the development of new communities;
cash collateral required to be posted in connection with our financial instruments and insurance programs;
purchases of common stock under our share repurchase authorizations;
other corporate initiatives (including integration, information systems, branding, and other strategic projects); and
prior to 2009, dividend payments.

Over the near-term, we expect that our liquidity requirements will primarily arise from:

working capital;
operating costs such as employee compensation and related benefits, severance costs, general and administrative expense, and supply costs, including those related to the COVID-19 pandemic;
debt, interest, and lease payments;
payment of deferred payroll taxes under the CARES Act;
recoupment of payments received under the Accelerated and Advance Payment Program;
acquisition consideration;
transaction costs and expansion of our healthcare services;
capital expenditures and improvements, including the expansion, renovation, redevelopment, and repositioning of our existing communities;
cash collateral required to be posted in connection with our financial instruments and insurance programs; and
other corporate initiatives (including information systems and other strategic projects).

We are highly leveraged and have significant debt and lease obligations. As of March 31, 2021, we had $3.9 billion of debt outstanding, at a weighted average interest rate of 3.6%. As of such date, 97.9%, or $3.8 billion of our total debt obligations represented non-recourse property-level mortgage financings. As of March 31, 2021, $1.4 billion of our long-term debt is variable rate debt subject to interest rate cap agreements. The remaining $128.0 million of our long-term variable rate debt is not subject to any interest rate cap agreements. As of March 31, 2021, $69.9 million of letters of credit and no cash borrowings

39


were outstanding under our $80.0 million secured credit facility. We also had a separate secured letter of credit facility providing up to $15.0 million of letters of credit as of March 31, 2021 under which $13.6 million had been issued as of that date.

As of March 31, 2021, we had $1.5 billion of operating and financing lease obligations. For the twelve months ending March 31, 2022, we will be required to make approximately $268.2 million of cash lease payments in connection with our existing operating and financing leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale).

Total liquidity of $438.9 million as of March 31, 2021 included $304.0 million of unrestricted cash and cash equivalents (excluding restricted cash and lease security deposits of $100.7 million in the aggregate) and $134.9 million of marketable securities. Total liquidity as of March 31, 2021 decreased $136.6 million from total liquidity of $575.5 million as of December 31, 2020. The decrease was primarily attributable to the negative $50.7 million of Adjusted Free Cash Flow and $38.3 million of payments of mortgage debt during the three months ended March 31, 2021.

As of March 31, 2021, our current liabilities exceeded current assets by $42.4 million. Included in our current liabilities is $224.9 million of the current portion of long term debt which we have historically refinanced in the normal course. Our current liabilities also include $160.4 million of the current portion of operating and financing lease obligations, for which the associated right-of-use assets are excluded from current assets on our condensed consolidated balance sheets.

We currently estimate that our cash flows from operations, together with cash balances on hand, cash equivalents, marketable securities, and proceeds from the pending sale of 80% of our equity in our Health Care Services segment will be sufficient to fund our liquidity needs for at least the next 12 months.

We continue to seek opportunities to enhance and preserve our liquidity, including through maintaining expense discipline and increasing occupancy, continuing to evaluate our financing structure and the state of debt markets, and seeking further government-sponsored financial relief related to the COVID-19 pandemic. There is no assurance that debt financing will continue to be available on terms consistent with our expectations or at all, that our efforts will be successful in seeking further government-sponsored financial relief or regarding the amount of, or conditions required to qualify for, any such relief, or that the closing of the pending transaction will be completed in accordance with our expectations, or at all, or generate cash proceeds to us in the amount we anticipate.

Our actual liquidity and capital funding requirements depend on numerous factors, including our operating results, our actual level of capital expenditures, general economic conditions, and the cost of capital, as well as other factors described in "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021. Disruptions in the financial markets may have an adverse impact on our liquidity by making it more difficult for us to obtain financing or refinancing of various assets. Since the amount of mortgage financing available for our communities is generally dependent on their appraised values and performance, decreases in their appraised values, including due to adverse changes in real estate market conditions, or their performance, could result in available mortgage refinancing amounts that are less than the communities’ maturing indebtedness. If we are unable to obtain refinancing proceeds sufficient to cover maturing indebtedness, our liquidity could be adversely impacted and we may seek alternative sources of financing, which may be less attractive or unavailable. Shortfalls in cash flows from estimated operating results or other principal sources of liquidity may have an adverse impact on our ability to fund our planned capital expenditures, or to pursue any acquisition, investment, development, or potential lease restructuring opportunities that we identify, or to fund investments to support our strategy. In order to continue some of these activities at historical or planned levels, we may incur additional indebtedness or lease financing to provide additional funding. There can be no assurance that any such additional financing will be available or on terms that are acceptable to us.

Our capital expenditures are comprised of community-level, corporate, and development capital expenditures. Community-level capital expenditures include recurring expenditures (routine maintenance of communities over $1,500 per occurrence and for unit turnovers over $500 per unit) and community renovations, apartment upgrades, and other major building infrastructure projects. Corporate capital expenditures include those for information technology systems and equipment, the expansion of our support platform and healthcare services programs, and the remediation or replacement of assets as a result of casualty losses. Development capital expenditures include community expansions, major community redevelopment and repositioning projects, and the development of new communities.

With our development capital expenditures program, we intend to expand, renovate, redevelop, and reposition certain of our communities where economically advantageous. Certain of our communities may benefit from additions and expansions or

40


from adding a new level of service for residents to meet the evolving needs of our customers. These development projects include converting space from one level of care to another, reconfiguration of existing units, the addition of services that are not currently present, or physical plant modifications.

The following table summarizes our capital expenditures for the three months ended March 31, 2021 for our consolidated business:
(in millions)
Community-level capital expenditures, net(1)
$21.9 
Corporate capital expenditures, net(2)
5.6 
Non-development capital expenditures, net(3)
27.5 
Development capital expenditures, net1.5 
Total capital expenditures, net$29.0 

(1)Reflects the amount invested, net of lessor reimbursements of $9.0 million.

(2)Includes $2.7 million of remediation costs at our communities resulting from natural disasters.

(3)Amount is included in Adjusted Free Cash Flow.

In the aggregate, we expect our full-year 2021 non-development capital expenditures, net of anticipated lessor reimbursements, to be approximately $140 million. In addition, we expect our full-year 2021 development capital expenditures to be approximately $10 million, net of anticipated lessor reimbursements, and such projects include those for expansion, repositioning, redeveloping, and major renovation of selected existing senior living communities. We anticipate that our 2021 capital expenditures will be funded from cash on hand, cash equivalents, marketable securities, cash flows from operations, and reimbursements from lessors.

Funding our planned capital expenditures, pursuing any acquisition, investment, development, or potential lease restructuring opportunities that we identify, or funding investments to support our strategy may require additional capital. We expect to continue to assess our financing alternatives periodically and access the capital markets opportunistically. If our existing resources are insufficient to satisfy our liquidity requirements, we may need to sell additional equity or debt securities. Any such sale of additional equity securities will dilute the percentage ownership of our existing stockholders, and we cannot be certain that additional public or private financing will be available in amounts or on terms acceptable to us, if at all. Any newly issued equity securities may have rights, preferences, or privileges senior to those of our common stock. If we are unable to raise additional funds or obtain them on terms acceptable to us, we may have to delay or abandon our plans.

Credit Facilities

On December 11, 2020, we entered into a revolving credit agreement with Capital One, National Association, as administrative agent and lender and the other lenders from time to time parties thereto. The agreement provides a commitment amount of $80 million which can be drawn in cash or as letters of credit. The agreement matures on January 15, 2024. Amounts drawn under the facility will bear interest at 30-day LIBOR plus an applicable margin which was 2.75% as of March 31, 2021. Additionally, a quarterly commitment fee of 0.25% per annum was applicable on the unused portion of the facility as of March 31, 2021. The revolving credit facility is currently secured by first priority mortgages and negative pledges on certain of our communities and restricted cash deposits. Available capacity under the facility will vary from time to time based upon borrowing base calculations related to the appraised value and performance of the communities securing the credit facility.

As of March 31, 2021, $69.9 million of letters of credit and no cash borrowings were outstanding under our $80.0 million secured credit facility. We also had a separate secured letter of credit facility providing up to $15.0 million of letters of credit as of March 31, 2021 under which $13.6 million had been issued as of that date.

Long-Term Leases

As of March 31, 2021, we operated 301 communities under long-term leases (235 operating leases and 66 financing leases). The substantial majority of our lease arrangements are structured as master leases. Under a master lease, numerous communities are leased through an indivisible lease. We typically guarantee the performance and lease payment obligations of our subsidiary lessees under the master leases. Due to the nature of such master leases, it is difficult to restructure the composition of our

41


leased portfolios or economic terms of the leases without the consent of the applicable landlord. In addition, an event of default related to an individual property or limited number of properties within a master lease portfolio may result in a default on the entire master lease portfolio.

The leases relating to these communities are generally fixed rate leases with annual escalators that are either fixed or based upon changes in the consumer price index or leased property revenue. We are responsible for all operating costs, including repairs, property taxes, and insurance. The lease terms generally provide for renewal or extension options from 5 to 20 years, and, in some instances, purchase options.

The community leases contain other customary terms, which may include assignment and change of control restrictions, maintenance and capital expenditure obligations, termination provisions, and financial covenants, such as those requiring us to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and lease coverage ratios. In addition, our lease documents generally contain non-financial covenants, such as those requiring us to comply with Medicare or Medicaid provider requirements and maintain insurance coverage. Certain leases contain cure provisions, which generally allow us to post an additional lease security deposit if the required covenant is not met.

In addition, certain of our master leases contain radius restrictions, which limit our ability to own, develop, or acquire new communities within a specified distance from certain existing communities covered by such agreements. These radius restrictions could negatively affect our ability to expand, develop, or acquire senior housing communities and operating companies.

For the three months ended March 31, 2021, our cash lease payments for our operating and financing leases were $53.9 million and $16.2 million, respectively. For the twelve months ending March 31, 2022, we will be required to make $268.2 million of cash lease payments in connection with our existing operating and financing leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale). Our capital expenditure plans for 2021 include required minimum spend of approximately $18 million for capital expenditures under certain of our community leases. Additionally, we are required to spend an average of approximately $26 million per year for each of the following four years and approximately $17 million thereafter under the initial lease terms of such leases.

Debt and Lease Covenants

Certain of our debt and lease documents contain restrictions and financial covenants, such as those requiring us to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and debt service and lease coverage ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community, and/or entity basis. Net worth is generally calculated as stockholders' equity as calculated in accordance with GAAP, and in certain circumstances, reduced by intangible assets or liabilities or increased by deferred gains from sale-leaseback transactions and deferred entrance fee revenue. The debt service and lease coverage ratios are generally calculated as revenues less operating expenses, including an implied management fee and a reserve for capital expenditures, divided by the debt (principal and interest) or lease payment. In addition, our debt and lease documents generally contain non-financial covenants, such as those requiring us to comply with Medicare or Medicaid provider requirements and maintain insurance coverage.

Our failure to comply with applicable covenants could constitute an event of default under the applicable debt or lease documents. Many of our debt and lease documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors).

Furthermore, our debt and leases are secured by our communities and, in certain cases, a guaranty by us and/or one or more of our subsidiaries. Therefore, if an event of default has occurred under any of our debt or lease documents, subject to cure provisions in certain instances, the respective lender or lessor would have the right to declare all the related outstanding amounts of indebtedness or cash lease obligations immediately due and payable, to foreclose on our mortgaged communities, to terminate our leasehold interests, to foreclose on other collateral securing the indebtedness and leases, to discontinue our operation of leased communities, and/or to pursue other remedies available to such lender or lessor. Further, an event of default could trigger cross-default provisions in our other debt and lease documents (including documents with other lenders or lessors). We cannot provide assurance that we would be able to pay the debt or lease obligations if they became due upon acceleration following an event of default.

As of March 31, 2021, we are in compliance with the financial covenants of our debt agreements and long-term leases.


42


Contractual Commitments
Significant ongoing commitments consist primarily of leases, debt, and certain other long-term liabilities. For a summary and complete presentation and description of our ongoing commitments and contractual obligations, see the "Contractual Commitments" section of Management's Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021. There have been no material changes outside the ordinary course of business in our contractual commitments during the three months ended March 31, 2021.

Off-Balance Sheet Arrangements

As of March 31, 2021, we do not have an interest in any off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources that is material to investors.

Non-GAAP Financial Measures

This Quarterly Report on Form 10-Q contains the financial measures Adjusted EBITDA and Adjusted Free Cash Flow, which are not calculated in accordance with U.S. generally accepted accounting principles ("GAAP"). Presentations of these non-GAAP financial measures are intended to aid investors in better understanding the factors and trends affecting our performance and liquidity. However, investors should not consider these non-GAAP financial measures as a substitute for financial measures determined in accordance with GAAP, including net income (loss), income (loss) from operations, or net cash provided by (used in) operating activities. We caution investors that amounts presented in accordance with our definitions of these non-GAAP financial measures may not be comparable to similar measures disclosed by other companies because not all companies calculate non-GAAP measures in the same manner. We urge investors to review the following reconciliations of these non-GAAP financial measures from the most comparable financial measures determined in accordance with GAAP.

Adjusted EBITDA

Adjusted EBITDA is a non-GAAP performance measure that we define as net income (loss) excluding: benefit/provision for income taxes, non-operating income/expense items, and depreciation and amortization; and further adjusted to exclude income/expense associated with non-cash, non-operational, transactional, cost reduction, or organizational restructuring items that management does not consider as part of our underlying core operating performance and that management believes impact the comparability of performance between periods. For the periods presented herein, such other items include non-cash impairment charges, gain/loss on facility lease termination and modification, operating lease expense adjustment, amortization of deferred gain, change in future service obligation, non-cash stock-based compensation expense, and transaction and organizational restructuring costs. Transaction costs include those directly related to acquisition, disposition, financing, and leasing activity, and stockholder relations advisory matters, and are primarily comprised of legal, finance, consulting, professional fees, and other third party costs. Organizational restructuring costs include those related to our efforts to reduce general and administrative expense and our senior leadership changes, including severance.

We believe that presentation of Adjusted EBITDA as a performance measure is useful to investors because (i) it is one of the metrics used by our management for budgeting and other planning purposes, to review our historic and prospective core operating performance, and to make day-to-day operating decisions; (ii) it provides an assessment of operational factors that management can impact in the short-term, namely revenues and the controllable cost structure of the organization, by eliminating items related to our financing and capital structure and other items that management does not consider as part of our underlying core operating performance and that management believes impact the comparability of performance between periods; and (iii) we believe that this measure is used by research analysts and investors to evaluate our operating results and to value companies in our industry.

Adjusted EBITDA has material limitations as a performance measure, including: (i) excluded interest and income tax are necessary to operate our business under our current financing and capital structure; (ii) excluded depreciation, amortization, and impairment charges may represent the wear and tear and/or reduction in value of our communities, goodwill, and other assets and may be indicative of future needs for capital expenditures; and (iii) we may incur income/expense similar to those for which adjustments are made, such as gain/loss on sale of assets, facility lease termination and modification, or debt modification and extinguishment, non-cash stock-based compensation expense, and transaction and other costs, and such income/expense may significantly affect our operating results.


43


The table below reconciles Adjusted EBITDA from net income (loss).
Three Months Ended
March 31,
(in thousands)20212020
Net income (loss)$(108,303)$369,497 
Provision (benefit) for income taxes752 (15,828)
Equity in (earnings) loss of unconsolidated ventures531 1,008 
Loss (gain) on debt modification and extinguishment, net— (19,181)
Loss (gain) on sale of assets, net(1,112)(372,839)
Other non-operating (income) loss(1,644)(2,662)
Interest expense48,607 56,360 
Interest income(421)(1,455)
Income (loss) from operations(61,590)14,900 
Depreciation and amortization83,891 90,738 
Asset impairment10,677 78,226 
Operating lease expense adjustment(4,664)(6,733)
Non-cash stock-based compensation expense4,783 5,957 
Transaction and organizational restructuring costs1,884 1,981 
Adjusted EBITDA(1)
$34,981 $185,069 

(1)     Adjusted EBITDA includes:
$10.7 million benefit for the three months ended March 31, 2021 of government grants and credits recognized in other operating income
$100.0 million benefit for the three months ended March 31, 2020 for the management agreement termination fee payment received from Healthpeak in connection with the sale of our ownership interest in the CCRC Venture

Adjusted Free Cash Flow

Adjusted Free Cash Flow is a non-GAAP liquidity measure that we define as net cash provided by (used in) operating activities before: distributions from unconsolidated ventures from cumulative share of net earnings, changes in prepaid insurance premiums financed with notes payable, changes in operating lease liability for lease termination, cash paid/received for gain/loss on facility lease termination and modification, and lessor capital expenditure reimbursements under operating leases; plus: property insurance proceeds and proceeds from refundable entrance fees, net of refunds; less: non-development capital expenditures and payment of financing lease obligations. Non-development capital expenditures are comprised of corporate and community-level capital expenditures, including those related to maintenance, renovations, upgrades, and other major building infrastructure projects for our communities and is presented net of lessor reimbursements. Non-development capital expenditures do not include capital expenditures for: community expansions, major community redevelopment and repositioning projects, and the development of new communities.

We believe that presentation of Adjusted Free Cash Flow as a liquidity measure is useful to investors because (i) it is one of the metrics used by our management for budgeting and other planning purposes, to review our historic and prospective sources of operating liquidity, and to review our ability to service our outstanding indebtedness, pay dividends to stockholders, engage in share repurchases, and make capital expenditures, including development capital expenditures; and (ii) it provides an indicator to management to determine if adjustments to current spending decisions are needed.

Adjusted Free Cash Flow has material limitations as a liquidity measure, including: (i) it does not represent cash available for dividends, share repurchases, or discretionary expenditures since certain non-discretionary expenditures, including mandatory debt principal payments, are not reflected in this measure; (ii) the cash portion of non-recurring charges related to gain/loss on facility lease termination generally represent charges/gains that may significantly affect our liquidity; and (iii) the impact of timing of cash expenditures, including the timing of non-development capital expenditures, limits the usefulness of the measure for short-term comparisons.


44


The table below reconciles Adjusted Free Cash Flow from net cash provided by (used in) operating activities.
Three Months Ended
March 31,
(in thousands)20212020
Net cash provided by (used in) operating activities$(23,857)$57,479 
Net cash provided by (used in) investing activities(3,806)(247,927)
Net cash provided by (used in) financing activities(35,562)347,250 
Net increase (decrease) in cash, cash equivalents, and restricted cash
$(63,225)$156,802 
Net cash provided by (used in) operating activities$(23,857)$57,479 
Changes in prepaid insurance premiums financed with notes payable
12,985 17,434 
Changes in assets and liabilities for lessor capital expenditure reimbursements under operating leases
(7,563)(4,088)
Non-development capital expenditures, net(27,450)(60,556)
Payment of financing lease obligations(4,789)(5,087)
Adjusted Free Cash Flow(1)
$(50,674)$5,182 

(1)     Adjusted Free Cash Flow includes transaction and organizational restructuring costs of $1.9 million and $2.0 million for the three months ended March 31, 2021 and 2020, respectively. Additionally, Adjusted Free Cash Flow includes:
$1.7 million benefit for the three months ended March 31, 2021 from Provider Relief Funds and other government grants accepted
$100.0 million benefit for the three months ended March 31, 2020 for the management agreement termination fee payment received from Healthpeak in connection with the sale of our ownership interest in the CCRC Venture

Item 3.  Quantitative and Qualitative Disclosures About Market Risk

We are subject to market risks from changes in interest rates charged on our credit facilities and other variable-rate indebtedness. The impact on earnings and the value of our long-term debt are subject to change as a result of movements in market rates and prices. As of March 31, 2021, we had $2.4 billion of long-term fixed rate debt and $1.5 billion of long-term variable rate debt. As of March 31, 2021, our total fixed-rate debt and variable-rate debt outstanding had a weighted average interest rate of 3.6%.

In the normal course of business, we enter into certain interest rate cap agreements with major financial institutions to manage our risk above certain interest rates on variable rate debt. As of March 31, 2021, $1.4 billion, or 35.6%, of our long-term debt is variable rate debt subject to interest rate cap agreements and $128.0 million, or 3.3%, of our long-term debt is variable rate debt not subject to any interest rate cap agreements. Our outstanding variable rate debt is indexed to LIBOR, and accordingly our annual interest expense related to variable rate debt is directly affected by movements in LIBOR. After consideration of hedging instruments currently in place, increases in LIBOR of 100, 200, and 500 basis points would have resulted in additional annual interest expense of $15.5 million, $30.9 million, and $66.3 million, respectively. Certain of our variable debt instruments include springing provisions that obligate us to acquire additional interest rate caps in the event that LIBOR increases above certain levels, and the implementation of those provisions would result in additional mitigation of interest costs.

Item 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Our management, under the supervision of and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined under Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) as of the end of the period covered by this report. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer each concluded that, as of March 31, 2021, our disclosure controls and procedures were effective.


45


Changes in Internal Control over Financial Reporting

There has not been any change in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2021 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II.  OTHER INFORMATION

Item 1.  Legal Proceedings

The information contained in Note 11 to the condensed consolidated financial statements contained in Part I, Item 1 of this Quarterly Report on Form 10-Q is incorporated herein by this reference.

Item 1A.  Risk Factors

There have been no material changes to the risk factors set forth in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2020.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

(a)Not applicable.
(b)Not applicable.
(c)The following table contains information regarding purchases of our common stock made during the quarter ended March 31, 2021 by or on behalf of the Company or any ''affiliated purchaser,'' as defined by Rule 10b-18(a)(3) of the Exchange Act:
Period
Total
Number of
Shares
Purchased
(1)
Average
Price Paid
per Share
Total Number of
Shares Purchased as
Part of Publicly
Announced Plans
or Programs
Approximate Dollar Value of
Shares that May Yet Be
Purchased Under the
Plans or Programs ($ in thousands)
(2)
1/1/2021 - 1/31/20212,442 $5.29 — $44,026 
2/1/2021 - 2/28/2021741,479 5.82 — 44,026 
3/1/2021 - 3/31/2021— — — 44,026 
Total743,921 $5.82 — 

(1)Consists entirely of shares withheld to satisfy tax liabilities due upon the vesting of restricted stock and restricted stock units. The average price paid per share for such share withholding is based on the closing price per share on the vesting date of the restricted stock and restricted stock units or, if such date is not a trading day, the trading day immediately prior to such vesting date.
(2)On November 1, 2016, we announced that our Board of Directors had approved a share repurchase program that authorizes us to purchase up to $100.0 million in the aggregate of our common stock. The share repurchase program is intended to be implemented through purchases made from time to time using a variety of methods, which may include open market purchases, privately negotiated transactions or block trades, or by any combination of such methods, in accordance with applicable insider trading and other securities laws and regulations. The size, scope and timing of any purchases will be based on business, market and other conditions and factors, including price, regulatory and contractual requirements, and capital availability. The repurchase program does not obligate us to acquire any particular amount of common stock and the program may be suspended, modified or discontinued at any time at our discretion without prior notice. Shares of stock repurchased under the program will be held as treasury shares. As of March 31, 2021, $44.0 million remained available under the repurchase program.


46


Item 6.  Exhibits
Exhibit No.Description
2.1
3.1
3.2
4.1
4.2
10.1
10.2
10.3
10.4
10.5
31.1
31.2
32
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
104
The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, formatted in Inline XBRL (included in Exhibit 101).
*Schedules and exhibits have been omitted pursuant to Item 601 of Regulation S-K. The Company hereby undertakes to furnish supplementally a copy of any of the omitted schedules and exhibits upon request by the Securities and Exchange Commission.


47


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
BROOKDALE SENIOR LIVING INC. 
(Registrant) 
 
By:/s/ Steven E. Swain 
Name:Steven E. Swain 
Title:Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
 
Date:May 7, 2021 













































48
EX-10.1 2 exhibit101-masterleaseamen.htm EX-10.1 Document

Exhibit 10.1

Portions of this exhibit that have been marked by [***] have been omitted because the Registrant has determined they are not material and would likely cause competitive harm to the Registrant if publicly disclosed.

AMENDMENT NO. 1 TO AMENDED AND RESTATED MASTER LEASE AND SECURITY AGREEMENT
(McMinnville Lease Combination)

THIS AMENDMENT NO. 1 TO AMENDED AND RESTATED MASTER LEASE AND SECURITY AGREEMENT (hereinafter, this “Amendment”) is effective as of April 15, 2021 (the “Combination Effective Date”), by and between each of the entities identified on Schedule 1 (individually and collectively, “Landlord”), and each of the entities identified on Schedule 1 as “Tenant” (individually and collectively, “Tenant”).
RECITALS
A.Landlord and Tenant are parties to that certain Amended and Restated Master Lease and Security Agreement dated as of July 26, 2020 (as amended, the “Master Lease”); and
B.Ventas, Inc. (“Ventas”) and Brookdale Senior Living, Inc. (“Brookdale”) are parties to that certain letter agreement captioned “Combination of Leases” dated July 26, 2020 (the “Side Letter”); and
C.Ventas and Brookdale are parties to that certain letter agreement captioned “Agreements regarding Leased Properties and Summerville Loan” dated July 26, 2020 (the “Master Transaction Letter”); and
D.Nationwide Health Properties, LLC, a Delaware limited liability company (“McMinnville Landlord”) has, or will have as of the Combination Effective Date, fully repaid the indebtedness (the “McMinnville Debt”) encumbering the Subject Facility commonly known as “Brookdale McMinnville Town Center” (“Brookdale McMinnville”), and therefore, pursuant to the terms of Section 6.1 of the Side Letter, effective as of the Combination Effective Date, the Separate Lease (as defined in the Side Letter) for Brookdale McMinnville will automatically terminate and Brookdale McMinnville will be combined into the Master Lease; and
E.Landlord and Tenant wish to amend the Master Lease as set forth herein to set forth the terms of such combination.
    NOW, THEREFORE, in consideration of the foregoing Recitals, which by this reference are incorporated herein, and of other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Landlord and Tenant agree as follows:
1.Capitalized Terms. All capitalized terms used herein and not defined herein shall have the meanings ascribed thereto in the Master Lease.



2.Amendments to Lease. The Master Lease is amended as follows:
2.1.    From and after the Combination Effective Date, the Minimum Rent (the “Old Minimum Rent”) under the Master Lease as of immediately prior to the Combination Effective Date shall be deemed to have been increased by $[***] (being the aggregate Hypothetical Minimum Rent of Brookdale McMinnville immediately prior to the Combination Effective Date), resulting in Minimum Rent for the period from the Combination Effective Date through December 31, 2021 to be equal to $86,462,697.26 per annum. The Initial Term shall be deemed to have commenced, with respect to Brookdale McMinnville, on the commencement date that is applicable to Brookdale McMinnville as provided in the applicable Separate Lease.
2.2.    From and after the Combination Effective Date, the Premises, the Facilities and the Landlord Personal Property shall be deemed to include the property described on Exhibit B to this Amendment, and Exhibit B of the Master Lease is hereby amended accordingly.
2.3.    For the avoidance of doubt, the provisions of Section 2.3 of the Master Lease shall apply with respect to the addition of Brookdale McMinnville, except that with respect to such Facility, the “Effective Date” for such Facility shall be deemed to be the Combination Effective Date.
2.4.    Exhibit G to the Master Lease is hereby amended to add the information as set forth in Exhibit G attached hereto.
2.5.    Schedule 1 to the Master Lease is hereby replaced with Schedule 1 attached hereto to reflect, as of the Combination Effective Date (after giving effect to the addition of Brookdale McMinnville to the Master Lease and the increase in Minimum Rent described above), (i) the Landlords, the Tenants, and the facility information for each of the Facilities, and (ii) the Tenant’s Proportionate Shares (shown to three decimal places).
2.6.    Schedule 1A to the Master Lease is hereby replaced with Schedule 1A attached hereto.
2.7.    Schedule 2.3.5 to the Master Lease is hereby amended to add the information as set forth in Schedule 2.3.5 attached hereto.
3.Lease Combination. As of the Combination Effective Date, Tenant and Landlord under the Separate Lease with respect to Brookdale McMinnville hereby combine the Master Lease and such Separate Lease into a single Lease as provided in Section 14.1 and Exhibit H (the “Lease Combination Provisions”) of the Master Lease. For purposes of the Lease Combination Provisions, the Master Lease is the Surviving Lease, the Combination Effective Date is the Surviving Lease Date, such Separate Lease is a Combination Lease, and Brookdale McMinnville is the “Additional Property.” For the avoidance of doubt, this Section 3 shall be deemed to have combined such Separate Lease, as it relates to Brookdale McMinnville, into the Master Lease, such that the Master Lease governs with respect to Brookdale McMinnville from and after the Combination Effective Date.



4.Assumption by Tenant. As provided in Section 1.2.5 of Exhibit H of the Master Lease, Brookdale Senior Living Communities, Inc., a Delaware corporation, as tenant under the Separate Lease for Brookdale McMinnville, hereby acknowledges and agrees that, as a Master Lease Tenant under the Master Lease, it shall be responsible for the payment, performance and satisfaction of all duties, obligations and liabilities arising under the Combination Lease insofar as they relate to Brookdale McMinnville that were not paid, performed and satisfied in full prior to the Combination Effective Date.
5.Deposits and Escrows; Property Tax and Capital Expenditure Obligations. Pursuant to Section 6.2.4.3 of the Side Letter, Landlord and Tenant agreed to take appropriate steps to cause all deposits and escrows held in connection with the McMinnville Debt to be delivered to Landlord. Landlord and Tenant acknowledge and agree that, as of the Combination Effective Date, (a) Landlord has paid $88,908.53 of property taxes with respect to Brookdale McMinnville pursuant to Section 6.2.4.2 of the Side Letter, and (b) Tenant reimbursed Landlord for such property tax payments on March 19, 2021. No further amounts are due from Tenant to Landlord with respect to such deposits and escrows.
6.Miscellaneous.
6.1.    Consistency. Whether or not specifically modified or amended by the provisions of this Amendment, all of the provisions, schedules and exhibits of the Master Lease and the Separate Lease for Brookdale McMinnville shall be deemed to have been amended (i) to the extent necessary to make such provisions, schedules and exhibits consistent with the modifications and amendments provided for in the preceding portions of this Amendment, and (ii) to the extent necessary to give effect to the purpose and intent of this Amendment.
6.2.    Integrated Agreement; Modifications; Waivers. This Amendment, and the Master Lease as amended hereby, together with the “Transaction Documents” as defined in the Master Transaction Letter, constitute the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes any and all prior representations, understandings and agreements, whether written or oral, with respect to such subject matter. Each of the parties hereto acknowledges that it has not relied upon, in entering into this Amendment, any representation, warranty, promise or condition not specifically set forth in this Amendment.
6.3.    Sealed Writing. The parties acknowledge and agree that the Master Lease, as amended by this Amendment, is intended to be a sealed instrument and to comply with Virginia Code Sections 55-2 and 11-3, and shall be interpreted as if the words “this deed of Lease” were included in the body of the Master Lease.
6.4.    Effect of Amendment. Except as expressly modified in this Amendment, the Master Lease shall remain in full force and effect and is expressly ratified and confirmed by the parties hereto, and Tenant shall lease the Facilities (as modified by this Amendment) from Landlord on the terms set forth in the Master Lease (as modified by this Amendment). In the event of any inconsistencies between the terms of this Amendment and any terms of the Master Lease, the terms of this Amendment shall control.



6.5.    Counterparts. This Amendment may be executed and delivered (including by facsimile, Portable Document Format (pdf) transmission, or Docusign) in counterparts, all of which executed counterparts shall together constitute a single document. Signature pages may be detached from the counterparts and attached to a single copy of this document to physically form one document. Any such facsimile documents and signatures shall have the same force and effect as manually-signed originals and shall be binding on the parties hereto.

[signature pages follow]



































IN WITNESS WHEREOF, this Amendment has been executed by Landlord and Tenant as of the date first written above.

TENANT:
BLC-THE HALLMARK, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-KENWOOD OF LAKE VIEW, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer












BROOKDALE SENIOR LIVING COMMUNITIES, INC. a Delaware corporation (f/k/a Alterra Healthcare Corporation and Alternative Living Services, Inc.)

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

ACKNOWLEDGEMENT

STATE OF Tennessee        )
                    ) :ss.:
COUNTY OF     Williamson        )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared Brookdale Senior Living Communities, Inc., a Delaware corporation (“Company”), by George T. Hicks, its EVP, which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Brentwood, TN, this 12th day of April, 2021.


(SEAL)                    /s/ Linda B. DeVault                
                        Notary Public

                        Print Name:Linda B. Devault            
                        My commission expires: 10-23-23
                        Acting in the County of:Williamson



Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BLC-GABLES AT FARMINGTON, LLC, a Delaware limited liability company

By: /s/ George T. Hicks

Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-DEVONSHIRE OF HOFFMAN ESTATES, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-SPRINGS AT EAST MESA, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-RIVER BAY CLUB, LLC, a Delaware limited liability company
By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BLC-WOODSIDE TERRACE, L.P., a Delaware limited partnership
By:     BLC-Woodside Terrace, LLC, a Delaware limited liability company, its general partner

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

BLC-ATRIUM AT SAN JOSE, L.P., a Delaware limited partnership
By:    BLC-Atrium at San Jose, LLC, a Delaware limited liability company, its general partner
By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

BLC-BROOKDALE PLACE OF SAN MARCOS, L.P., a Delaware limited partnership
By:    BLC-Brookdale Place of San Marcos, LLC, a Delaware limited liability company, its general partner

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BLC-PONCE DE LEON, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-PARK PLACE, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-HAWTHORNE LAKES, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-THE WILLOWS, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer


Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BLC-BRENDENWOOD, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BLC-CHATFIELD, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BROOKDALE LIVING COMMUNITIES OF FLORIDA, INC. a Delaware corporation

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer


Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BROOKDALE LIVING COMMUNITIES OF ILLINOIS-GV, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
BROOKDALE LIVING COMMUNITIES OF ILLINOIS-DNC, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
SW ASSISTED LIVING, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

SUMMERVILLE AT FAIRWOOD MANOR, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer


Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


SUMMERVILLE AT HERITAGE PLACE, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
SUMMERVILLE 5 LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
SUMMERVILLE 4 LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer


Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


SUMMERVILLE 14 LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

SUMMERVILLE 15 LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

SUMMERVILLE 16 LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

SUMMERVILLE 17 LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer





Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


SUMMERVILLE AT RIDGEWOOD GARDENS LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
ALS PROPERTIES TENANT I, LLC,
a Delaware limited liability company


By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
ACKNOWLEDGEMENT

STATE OF Tennessee        )
                    ) :ss.:
COUNTY OF Williamson        )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared ALS Properties Tenant I, LLC, a Delaware limited liability company (“Company”), by George T. Hicks, its EVP, which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Brentwood, TN, this 12th day of April, 2021.


(SEAL)                    /s/ Linda B. DeVault                
                        Notary Public

                        Print Name:Linda B. DeVault            
                        My commission expires:10-23-23        
                        Acting in the County of: Williamson     


Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


ALS PROPERTIES TENANT II, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
ALS LEASING, INC., a Delaware corporation

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer
ACKNOWLEDGEMENT

STATE OF Tennessee        )
                    ) :ss.:
COUNTY OF Williamson        )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared ALS Leasing, Inc., a Delaware corporation (“Company”), by George T. Hicks, its EVP, which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Brentwood, TN, this 12th day of April, 2021.


(SEAL)                    /s/ Linda B. DeVault                
                        Notary Public

                        Print Name:Linda B. DeVault            
                        My commission expires: 10-23-23        
                        Acting in the County of:Williamson        

Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


ASSISTED LIVING PROPERTIES, INC., a Kansas corporation

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

BLC-THE HERITAGE OF DES PLAINES, LLC, a Delaware limited liability company

By: /s/ George T. Hicks
Name: George T. Hicks
Title: Executive Vice President – Finance and Treasurer

Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement



LANDLORD:
VENTAS REALTY, LIMITED PARTNERSHIP, a Delaware limited partnership
By: Ventas, Inc., a Delaware corporation, its general partner

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: Senior Vice President

Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


PSLT-ALS PROPERTIES I, LLC, a Delaware limited liability company
By: PSLT-ALS Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President

ACKNOWLEDGEMENT

STATE OF Illinois         )
                    ) :ss.:
COUNTY OF Cook     )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared Ventas Provident, LLC, a Delaware limited liability company (“Company”), the sole member of PSLT GP, LLC, the general partner of PSLT OP, L.P., the sole member of PSLT-ALS Properties Holdings, LLC, the sole member of PSLT-ALS Properties I, LLC, by Christian N. Cummings, its President, which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Chicago, Illinois, this 14th day of April, 2021.


(SEAL)                    /s/Theresa M. Kwasinski
                        Notary Public

                        Print Name:Theresa M. Kwasinski        
                        My commission expires:08/05/22     
                        Acting in the County of: Cook     
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement



PSLT-ALS PROPERTIES II, LLC, a Delaware limited liability company
By: PSLT-ALS Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President

PSLT-ALS PROPERTIES IV, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


PSLT-ALS PROPERTIES III, LLC, a Delaware
 limited liability company

                                                                        By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
ACKNOWLEDGEMENT

STATE OF Illinois            )
                    ) :ss.:
COUNTY OF     Cook            )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared PSLT-ALS PROPERTIES III, LLC, a Delaware limited liability company (“Company”), which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Chicago, Illinois, this 14th day of April, 2021.


(SEAL)                    /s/Theresa M. Kwasinski
                        Notary Public

                        Print Name:    Theresa M. Kwasinski    
                        My commission expires:08/05/22
                        Acting in the County of:Cook

BROOKDALE LIVING COMMUNITIES OF ILLINOIS-2960, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
BROOKDALE LIVING COMMUNITIES OF ILLINOIS-HV, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


RIVER OAKS PARTNERS, an Illinois general partnership
By: Brookdale Holdings, LLC, its managing partner
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
BROOKDALE LIVING COMMUNITIES OF CONNECTICUT, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


PSLT-BLC PROPERTIES HOLDINGS, LLC, a Delaware limited liability company
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
THE PONDS OF PEMBROKE LIMITED PARTNERSHIP, an Illinois limited partnership
By: Brookdale Holdings, LLC, its general partner
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BROOKDALE LIVING COMMUNITIES OF ARIZONA-EM, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
BROOKDALE LIVING COMMUNITIES OF MASSACHUSETTS-RB, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BROOKDALE LIVING COMMUNITIES OF CALIFORNIA-RC, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
BROOKDALE LIVING COMMUNITIES OF CALIFORNIA, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BLC OF CALIFORNIA-SAN MARCOS, L.P., a Delaware limited partnership
By: Brookdale Living Communities of California-San Marcos, LLC, its general partner
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
BROOKDALE LIVING COMMUNITIES OF WASHINGTON-PP, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BROOKDALE LIVING COMMUNITIES OF ILLINOIS-II, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
By: Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


BROOKDALE LIVING COMMUNITIES OF NEW JERSEY, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
BROOKDALE LIVING COMMUNITIES OF FLORIDA-CL, LLC, a Delaware limited liability company
By: PSLT-BLC Properties Holdings, LLC, its sole member
By: PSLT OP, L.P., its sole member
By: PSLT GP, LLC, its general partner
Ventas Provident, LLC, its sole member

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President


Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


NATIONWIDE HEALTH PROPERTIES, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President


ACKNOWLEDGEMENT

STATE OF Illinois            )
                    ) :ss.:
COUNTY OF     Cook            )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared Nationwide Health Properties, LLC, a Delaware limited liability company corporation (“Company”), by Christian N. Cummings, its President, which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Chicago, Illinois, this 14th day of April, 2021.


(SEAL)                    /s/Theresa M. Kwasinski
                        Notary Public

                        Print Name:Theresa M. Kwasinski            
                        My commission expires:08-05-22            
                        Acting in the County of:Cook                

Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


2010 UNION LIMITED PARTNERSHIP, a Washington limited partnership
By: Nationwide Health Properties, LLC, its general partner

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
NH TEXAS PROPERTIES LIMITED PARTNERSHIP, a Texas limited partnership
By: MLD Texas Corporation, its general partner

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
MLD PROPERTIES, INC., a Delaware corporation

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


JER/NHP SENIOR LIVING ACQUISITION, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President

ACKNOWLEDGEMENT

STATE OF Illinois            )
                    ) :ss.:
COUNTY OF Cook            )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared JER/NHP Senior Living Acquisition, LLC, a Delaware limited liability company (“Company”), by Christian N. Cummings, its President, which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Chicago, Illinois, this 14th day of April, 2021.


(SEAL)                    /s/Theresa M. Kwasinski
                        Notary Public

                        Print Name:Theresa M. Kwasinski        
                        My commission expires:08/05/22        
                        Acting in the County of: Cook         



Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


JER/NHP SENIOR LIVING KANSAS, INC., a Kansas corporation

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
JER/NHP SENIOR LIVING TEXAS, L.P., a Texas limited partnership
By: JER/NHP Management Texas, LLC, its general partner

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
MLD PROPERTIES LIMITED PARTNERSHIP, a Delaware limited partnership
By: MLD Properties II, Inc., its general partner

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


NHP MCCLAIN, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
ACKNOWLEDGEMENT

STATE OF Illinois            )
                    ) :ss.:
COUNTY OF Cook            )

    Before me, the undersigned, a Notary Public in and for said County and State, personally appeared NHP MCCLAIN, LLC, a Delaware limited liability company (“Company”), by Christian N. Cummings, its President, which Company executed the foregoing instrument, who acknowledged that she/he did sign the foregoing instrument for and on behalf of the Company, being thereunto duly authorized and that the same is her/his free act and deed individually and in said capacity and the free and deed of the Company.

    IN TESTIMONY WHEREOF, I have hereunto set my hand and official seal at Chicago, Illinois, this 14th day of April, 2021.


(SEAL)                    /s/Theresa M. Kwasinski
                        Notary Public

                        Print Name:Theresa M. Kwasinski        
                        My commission expires: 08/05/22        
                        Acting in the County of:Cook         


Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


VENTAS FAIRWOOD, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
VENTAS FRAMINGHAM, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
VENTAS WHITEHALL ESTATES, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement


VTR-EMRTS HOLDINGS, LLC, a Delaware limited liability company

By: /s/ Christian N. Cummings
Name: Christian N. Cummings
Title: President
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement



CONSENT AND REAFFIRMATION OF GUARANTOR
THIS CONSENT AND REAFFIRMATION OF GUARANTOR (this “Reaffirmation”) is entered into concurrently with and is attached to and hereby made a part of Amendment No. 1 to Amended and Restated Master Lease and Security Agreement effective as of April 15, 2021 (the “Lease Amendment”) between Landlord and Tenant (both, as defined therein).
BROOKDALE SENIOR LIVING INC., a Delaware corporation (“Guarantor”) executed and delivered that certain Amended and Restated Guaranty dated as of July 26, 2020 (the “Guaranty”), pursuant to which Guarantor guarantied for the benefit of Landlord, the obligations of Tenant under the BKD/VTR Documents (as defined in the Guaranty).
FOR VALUABLE CONSIDERATION, receipt of which is hereby acknowledged, Guarantor hereby acknowledges, reaffirms and agrees:
1.Capitalized terms used but not defined in this Reaffirmation shall have the same meanings for purposes of this Reaffirmation as provided in or for purposes of the Lease Amendment.
2.Guarantor hereby (i) acknowledges and consents to the Lease Amendment, (ii) reaffirms its obligations under the Guaranty with respect to the Master Lease as amended by the Lease Amendment, and (iii) confirms that the Guaranty remains in full force and effect.
3.Although Guarantor has been informed of the terms of the Lease Amendment, Guarantor understands and agrees that Landlord has no duty to so notify it or to seek this or any future acknowledgment, consent or reaffirmation, and nothing contained herein shall create or imply any such duty as to any transactions, past or future.
Guarantor has executed this Consent and Reaffirmation of Guarantor effective as of the Amendment Date.
GUARANTOR:
BROOKDALE SENIOR LIVING INC.,
a Delaware corporation

By:     /s/ George T. Hicks
    Name:    George T. Hicks
    Title:    Executive Vice President – Finance and Treasurer
Signature Page-Amendment No. 1 to Amended and Restated Master Lease and Security Agreement
EX-10.2 3 exhibit102-2021timexbasedr.htm EX-10.2 Document

Exhibit 10.2
RESTRICTED STOCK UNIT AGREEMENT
UNDER THE BROOKDALE SENIOR LIVING INC.
2014 OMNIBUS INCENTIVE PLAN
This Award Agreement, including the Addendum hereto (this “Agreement”), dated as of __________ (the “Date of Grant”), is made by and between Brookdale Senior Living Inc., a Delaware corporation (the “Company”), and _________ (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Brookdale Senior Living Inc. 2014 Omnibus Incentive Plan (as amended and/or restated from time to time, the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
1.Grant of RSUs. The Company hereby grants to the Participant _________ restricted stock units (the “RSUs”) under the Plan, which shall be subject to all of the terms and conditions of this Agreement and the Plan.
2.Vesting.
(a)General. Subject to the provisions set forth below, the RSUs shall vest at such times (each, including as provided in subparagraphs (b) and (c), a “Vesting Date”) and in the amounts set forth below, subject to the continued employment of the Participant by the Company or one of its Subsidiaries or Affiliates (or a successor to any of them) from the Date of Grant to such Vesting Date:

Incremental Number of
RSUs Vested
Scheduled Vesting Date




(b)Award Not Assumed Following Change in Control. Upon the occurrence of a Change in Control, if the outstanding RSUs are not assumed, continued or substituted with an award relating to a publicly-traded security of the acquirer (or the Company) on the same terms and conditions that were applicable to the outstanding RSUs immediately prior to the Change in Control, then all outstanding RSUs immediately prior to the Change in Control shall vest and be settled upon the consummation of the Change in Control.
(c)Following Termination of Employment. Except as otherwise provided in Section 2 of the Addendum, which is incorporated herein, upon termination of the Participant’s employment with the Company and its Subsidiaries and Affiliates for any reason, all unvested RSUs outstanding as of the date of such termination shall automatically and without notice terminate and be forfeited and neither the Participant nor any of the Participant’s successors,



heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such RSUs.
3.Settlement of Restricted Stock Units. As soon as practicable following each Vesting Date (but in no event later than 30 days following the Vesting Date or such earlier time specified in this Agreement), the Company shall issue to the Participant the number of shares of Stock equal to the aggregate number of RSUs that have vested pursuant to this Agreement on such date and the Participant shall thereafter have all the rights of a stockholder of the Company with respect to such shares. Notwithstanding anything in this Agreement to the contrary, no fractional shares shall vest or be issuable under this Agreement, and any such fractional shares shall be rounded down to the next whole share; provided, that the Administrator may, in its sole discretion, provide a cash payment in lieu of any such fractional share.
4.Rights as a Stockholder. Section 4 of the Addendum is incorporated herein.
5.Adjustments. Pursuant to Section 5 of the Plan, in the event of a change in capitalization as described therein, the Administrator shall make such equitable changes or adjustments, as it deems necessary or appropriate, in its discretion, to the number and kind of securities or other property (including cash) issued or issuable in respect of outstanding RSUs.
6.Certain Changes. The Administrator may accelerate the vesting dates or otherwise adjust any of the terms of the RSUs; provided that, subject to Section 5 of the Plan, Section 11(f) of the Addendum to this Agreement, and Section 22 of this Agreement, no action under this Section shall adversely affect the Participant’s rights hereunder.
7.Notices. All notices and other communications under this Agreement shall be in writing and shall be given by facsimile or first class mail, certified or registered with return receipt requested, and shall be deemed to have been duly given three days after mailing or 24 hours after transmission by facsimile to the respective parties, as follows: (i) if to the Company, at Brookdale Senior Living Inc., 111 Westwood Place, Suite 400, Brentwood, TN 37027, Facsimile: (615) 564-8204, Attn: General Counsel and (ii) if to the Participant, using the contact information on file with the Company. Either party hereto may change such party’s address for notices by notice duly given pursuant hereto. Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any notice or other communications related to the RSUs, this Agreement or current or future participation in the Plan by electronic means. The Participant hereby consents to receive such notices and other communications by electronic delivery and agrees to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company (including the Company’s stock plan service provider’s website).
8.Taxes. The Participant has reviewed with the Participant’s own tax advisors the Federal, state, local and foreign tax consequences of the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Participant acknowledges and agrees that the Participant is responsible for the tax consequences associated with the award and vesting of the RSUs.
2



9.Withholding. The provisions of Section 9 of the Addendum to this Agreement are incorporated herein.
10.Failure to Enforce Not a Waiver. The failure of the Company to enforce at any time any provision of this Agreement shall in no way be construed to be a waiver of such provision or of any other provision hereof.
11.Restrictive Covenants. The provisions of Section 11 of the Addendum to this Agreement are incorporated herein.
12.Governing Law. This Agreement shall be governed by and construed according to the laws of the State of Delaware without regard to its principles of conflict of laws.
13.Incorporation of Plan. The Plan is hereby incorporated by reference and made a part hereof, and the RSUs and this Agreement shall be subject to all terms and conditions of the Plan.
14.Amendments; Construction. The Administrator may amend the terms of this Agreement prospectively or retroactively at any time, but no such amendment shall impair the rights of the Participant hereunder without the Participant’s consent. Headings to Sections of this Agreement are intended for convenience of reference only, are not part of this Agreement and shall have no effect on the interpretation hereof.
15.Survival of Terms. This Agreement shall apply to and bind the Participant and the Company and their respective permitted assignees and transferees, heirs, legatees, executors, administrators and legal successors. The terms of Section 11 of the Addendum and Section 22 of this Agreement shall expressly survive the vesting and/or forfeiture of the RSUs and any expiration or termination of this Agreement.
16.Compliance with Stock Ownership and Retention Guidelines. The Participant hereby agrees to comply with the Company’s Stock Ownership and Retention Guidelines (as amended from time to time, the “Guidelines”), to the extent such Guidelines are applicable, or become applicable, to the Participant. The Participant further acknowledges that, if the Participant is not in compliance with such Guidelines (if applicable), the Administrator may refrain from issuing additional equity awards to the Participant and/or elect to pay the Participant’s annual bonus in the form of vested or unvested Common Stock.
17.Agreement Not a Contract for Services. Neither the Plan, the granting of the RSUs, this Agreement nor any other action taken pursuant to the Plan shall constitute or be evidence of any agreement or understanding, express or implied, that the Participant has a right to continue to provide services as an officer, director, employee, consultant or advisor of the Company or any Subsidiary or Affiliate for any period of time or at any specific rate of compensation.
18.Restrictions. The RSUs may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Participant, and any shares of Stock issuable with
3



respect to the RSUs may not be sold, transferred, pledged, assigned or otherwise encumbered or disposed of until such shares of Stock have been issued to the Participant upon vesting of the RSUs in accordance with the terms of the Plan and this Agreement. Unless the Administrator determines otherwise, upon any attempt to transfer RSUs or any rights in respect of RSUs before the lapse of such restrictions, such RSUs, and all of the rights related thereto, shall be immediately forfeited by the Participant and transferred to, and reacquired by, the Company without consideration of any kind.
19.Authority of the Administrator. The Administrator shall have full authority to interpret and construe the terms of the Plan and this Agreement. The determination of the Administrator as to any such matter of interpretation or construction shall be final, binding and conclusive.
20.Severability. Should any provision of this Agreement be held by a court of competent jurisdiction to be unenforceable, or enforceable only if modified, such holding shall not affect the validity of the remainder of this Agreement, the balance of which shall continue to be binding upon the parties hereto with any such modification (if any) to become a part hereof and treated as though contained in this original Agreement. Moreover, if one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to scope, activity, subject or otherwise so as to be unenforceable, in lieu of severing such unenforceable provision, such provision or provisions shall be construed by the appropriate judicial body by limiting or reducing it or them, so as to be enforceable to the maximum extent compatible with the applicable law as it shall then appear, and such determination by such judicial body shall not affect the enforceability of such provision or provisions in any other jurisdiction.
21.Acceptance. The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement. The Participant has read and understands the terms and provisions of the Plan and this Agreement, and accepts the RSUs subject to all the terms and conditions of the Plan and this Agreement. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under this Agreement. By the Participant’s electronically accepting the award of the RSUs using an online or electronic system established and maintained by the Company or a third party designated by the Company (including the Company’s stock plan service provider’s website), the Participant agrees to be bound by the terms and conditions of the Plan and this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The Participant’s electronic acceptance of the award of the RSUs shall have the same validity and effect as a signature affixed to this Agreement by the Participant’s hand.
22.Clawback. Notwithstanding anything herein to the contrary, this award (and any shares of Stock delivered to the Participant upon settlement thereof) shall be subject to forfeiture, reduction, and/or recoupment (i) to the extent provided in the Company’s Clawback and Forfeiture Policy, as it may be amended from time to time (the “Clawback Policy”); (ii) to the extent that Participant becomes subject to any other recoupment or clawback policy hereafter
4



adopted by the Company, including any such policy adopted by the Company to comply with the requirements of any applicable laws, rules, regulations, or stock exchange listing requirements, including pursuant to final SEC rules under the Dodd-Frank Wall Street Reform and Consumer Protection Act, or (iii) to the extent provided under applicable legal requirements which impose recoupment, under circumstances set forth in such applicable legal requirements, including the Sarbanes-Oxley Act of 2002.
23.Section 409A. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of the RSUs are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code. Notwithstanding anything to the contrary in this Agreement or an accompanying election form executed by the Participant, if (i) on the date of the Participant’s Separation from Service with the Company the Participant is a “specified employee” (as such term is defined under Section 1.409A-1(i) of the Treasury Regulations promulgated under Section 409A of the Code) of the Company and (ii) any payments to be provided to the Participant pursuant to this Agreement are or may become subject to the additional tax under Section 409A(a)(1)(B) of the Code, or any other taxes or penalties imposed under Section 409A of the Code if provided at the time otherwise required under this Agreement, then such payments shall be delayed until the date that is six months after the date of the Participant’s separation from service from the Company, or if earlier, his or her death. Any payments delayed pursuant to this paragraph shall be made in a lump sum on the first day of the seventh month following the Participant’s separation from service, or if earlier, the Participant’s death. Each payment upon settlement of RSUs (and any related dividend or related dividend equivalent rights) constitutes a “separate payment” for purposes of Section 409A of the Code. Notwithstanding any other provision of this Agreement, if and to the extent that any payment under this Agreement constitutes non-qualified deferred compensation under Section 409A of the Code, and is payable upon (i) the Participant’s termination of employment, then such payment shall be made or provided to the Participant only upon a “separation from service” as defined for purposes of Section 409A of the Code, or (ii) a Change in Control, then such payment shall be made or provided to the Participant only upon a “change in the ownership”, a “change in effective control” or a “change in the ownership of a substantial portion of the assets” of the applicable corporation as defined for purposes of Section 409A of the Code.

[Signature page to follow.]

5



IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the day and year first above written.

BROOKDALE SENIOR LIVING INC.


By:     
Name:     
Title:     


PARTICIPANT

___________________________________



6



ADDENDUM TO
RESTRICTED STOCK UNIT AGREEMENT
UNDER THE BROOKDALE SENIOR LIVING INC.
2014 OMNIBUS INCENTIVE PLAN
Section 2:
Notwithstanding Section 2(c) or anything in the Agreement to the contrary:
    (i)    [Bracketed language applicable to CEO agreement only] In the event that the Participant’s employment is terminated (other than as described in subparagraph (ii)) (A) by the Company and its Subsidiaries and Affiliates without Cause [or by the Participant for Good Reason (as defined in the Employment Agreement by and between the Company and the Participant dated as of March 1, 2018)], (B) by death, or (C) due to Disability, the RSUs subject to vesting at the next Vesting Date shall vest effective upon the date of such termination and be settled within 30 days following such termination, and any remaining outstanding and unvested RSUs shall be forfeited, effective upon the date of such termination; provided, however, that the acceleration provided by clause (C) shall not apply unless Participant actively provided services on at least one day in the one-year period immediately preceding such next Vesting Date.
    (ii)    [Bracketed language applicable to agreements with executive officers other than CEO] In the event that the Participant’s employment is terminated (A) by the Company (or its successor) and its Subsidiaries and Affiliates without Cause on or after the effective date of a Change in Control but prior to twelve (12) months following such Change in Control, or (B) by the Participant for Good Reason [(as defined in the Company’s Amended and Restated Tier I Severance Pay Policy or the Company’s Amended and Restated Tier II Severance Pay Policy, whichever is applicable to the Participant)] on or after the effective date of a Change in Control but prior to twelve (12) months following such Change in Control, then any unvested RSUs outstanding upon the date of such termination shall vest effective upon the date of such termination and be settled within 30 days following such termination.
Section 4:
The Participant shall have no voting rights with respect to RSUs outstanding on any applicable record date. Any ordinary or extraordinary cash or stock dividend that may be declared and paid on the Common Stock with a record date on or after the Date of Grant and prior to the settlement date of the RSUs shall be deposited (in the same form as was payable to the holders of Common Stock) in an account and be paid upon, and subject to, the vesting and settlement of the RSUs. For the avoidance of doubt, the Participant shall not be entitled to payment of dividends or dividend equivalents with respect to an RSU unless and until the vesting and settlement of such RSU in accordance with this Agreement, and all such dividends or dividend equivalents with respect to any RSU shall forfeit upon the forfeiture of such RSU.



Section 9:
Delivery of shares of Stock is conditioned upon Participant’s making arrangements satisfactory to the Administrator regarding payment of income and employment tax withholding requirements as set forth in Section 15 of the Plan; provided, however, that the Participant may elect, without the consent of the Company, to have the Company withhold from delivery of shares of Stock issuable upon the settlement of the RSUs such number of shares of Stock having a Fair Market Value not exceeding the applicable taxes to be withheld and applied to the tax obligations of the Participant as determined by the Company. In making its determination, the Company may calculate such amount by taking into account applicable withholding rates not exceeding the maximum individual statutory tax rates in the Participant’s applicable jurisdictions.
Section 11:
11.    Restrictive Covenants. The Participant understands the Company has developed, and is continuing to develop, substantial relationships with actual and prospective officers, directors, employees, consultants, agents, customers, residents, patients, referral sources, clients, vendors, suppliers, investors, and equity and financing sources, associate and customer goodwill, and confidential and proprietary business information and trade secrets, which the Company and its Subsidiaries and Affiliates have the right to protect in order to safeguard their legitimate business interests. Any misappropriation of such relationships or goodwill, or any improper disclosure or use of the Company’s and its Subsidiaries’ and Affiliates’ confidential and proprietary business information and trade secrets would be highly detrimental to their business interests in that serious and substantial loss of business and pecuniary damages would result therefrom. The Participant acknowledges that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, the Participant shall have access to the Company’s Confidential Information (as defined below) and will meet and develop such relationships and goodwill. Nothing contained in this Section 11 shall limit any common law or statutory obligation that the Participant may have to the Company or any Subsidiary or Affiliate. For purposes of this Section 11, the “Company” refers to the Company and any incorporated or unincorporated affiliates of the Company, including any entity which becomes the Participant’s employer as a result of any reorganization or restructuring of the Company for any reason. The Company shall be entitled, in connection with its tax planning or other reasons, to terminate the Participant’s employment (which termination shall not be considered a termination for any purposes of this Agreement, any employment agreement or otherwise) in connection with an invitation from another affiliate of the Company to accept employment with such affiliate in which case the terms and conditions hereof shall apply to the Participant’s employment relationship with such entity mutatis mutandis.
(a)    Noncompetition. [Bracketed language applicable to agreements with executive officers other than CEO] The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate and for the one (1) year period immediately following the termination of such employment for any reason or for no reason, the Participant shall not directly or indirectly, either as a principal, agent, employee, employer,
A-2



consultant, partner, shareholder of a closely held corporation or shareholder in excess of five percent of a publicly traded corporation, corporate officer or director, or in any other individual or representative capacity, engage or otherwise participate in any manner or fashion in any business that is a Competing Business (as defined herein). [Notwithstanding the foregoing, (i) if the Participant’s employment is terminated by the Participant after Participant experiences an aggregate reduction to the Participant’s annual target cash compensation by 20% or more, the covenant in this Section 11(a) shall not apply; and (ii) the covenant in this Section 11(a) shall not be interpreted to restrict the Participant’s right to practice law in violation of any rules of professional conduct applicable to the Participant.]

For purposes of this Section 11(a), “Competing Business” means a business (which shall include any sole proprietorship, partnership, limited partnership, limited liability partnership, limited liability company, corporation or other for-profit or not-for-profit business organization) (A) engaged in the business of owning, operating or managing senior living facilities within the United States, or (B) that, itself or with its affiliates, provides healthcare or other services to patients or customers through home health care agencies, hospice agencies, outpatient therapy clinics and/or community based/private duty agencies within any state that the Company or its subsidiaries or affiliates provides now, or provides during the Participant’s employment, such healthcare or other services to patients or customers, and that derives, together with its controlled affiliates or together with its affiliates, more than 10% of its and its controlled affiliates or 10% of its and its affiliates, respectively, revenue from the provision of healthcare or other services to patients or customers through home health care agencies, hospice agencies, outpatient therapy clinics and/or community based/private duty agencies.

    (b)    Solicitation of Employees, Clients, Referral Sources, Vendors, Etc. The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, and for the two (2) year period immediately following the date of termination of such employment for any reason, the Participant shall not, directly or indirectly, jointly or individually, on Participant’s own behalf or on behalf of or in assistance to any individual, person or entity, for any purpose or in any place:

(i)    solicit for employment or service, hire, employ or retain the services of any Covered Employee (as defined below) or induce or encourage any Covered Employee to terminate or sever his, her or its employment or other relationship with the Company or any Subsidiary or Affiliate or any of their successors or assigns; or

(ii)    solicit business from any Covered Person (as defined below) or induce or encourage any Covered Person to terminate, change or reduce his, her or its relationship with the Company or any Subsidiary or Affiliate or any of their successors or assigns.

Notwithstanding the foregoing, a general advertisement or solicitation for employment that is not targeted and that does not have the effect of being targeted to any current or former Covered Employee or Covered Person shall not, by itself, be deemed to be a violation of the restrictions on solicitation contained in this Section 11(b). For purposes of this Section 11(b), “Covered Employee” shall mean any officer, director, employee, consultant or agent who is employed or
A-3



engaged by the Company or any Subsidiary or Affiliate or any of their successors or assigns or was so employed or engaged at any time during the twelve (12) months prior to the Participant’s termination of employment, and “Covered Person” shall mean any customers, residents, patients, referral sources, clients, vendors, suppliers, investors, equity or financing sources, or consultants of the Company or any Subsidiary or Affiliate or any of their successors or assigns.

(c)    Disparaging Comments. [Applicable to CEO award agreement:] The Company and the Participant agree that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, and any time thereafter, the Participant shall not make any disparaging or defamatory comments regarding the Company or any Subsidiary or Affiliate or any of their successors or assigns, and the Company and its Affiliates shall not make or issue any public statements which are disparaging or defamatory regarding the Participant, and after termination of such employment neither party shall make any comments concerning any aspect of the termination of their relationship. The obligations of the Company and the Participant under this Section 11(c) shall not apply to disclosures required by applicable law, regulation or order of any court or governmental agency.

[Applicable to agreements with executive officers other than CEO:] The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, and any time thereafter, the Participant shall not make any disparaging or defamatory comments regarding the Company or any Subsidiary or Affiliate or any of their successors or assigns, or any time after termination of such employment, make any comments concerning any aspect of the termination of their relationship. The obligations of the Participant under this Section 11(c) shall not apply to disclosures required by applicable law, regulation or order of any court or governmental agency.
    (d)    Confidentiality. All books of account, records, systems, correspondence, documents, memoranda, manuals, email, electronic or magnetic recordings or data and any and all other data, in whatever form and any copies thereof, concerning or containing any reference to the works and business of the Company or any Subsidiary or Affiliate shall belong to the Company and shall be given up to the Company whenever the Company requires the Participant to do so. The Participant agrees that the Participant shall not at any time during the term of the Participant’s employment with the Company or any Subsidiary or Affiliate, or at any time thereafter, without the Company’s prior written consent, disclose to any individual, person or entity any information or any trade secrets, plans or other information or data, in whatever form (including, without limitation, (a) any financing strategies and practices, pricing information and methods, training and operational procedures, advertising, marketing, and sales information or methodologies or financial information and (b) any Proprietary Information (as defined below)), concerning the Company’s or any Subsidiary’s or Affiliate’s or any of their customers’, referral sources’ or clients’ practices, businesses, procedures, systems, plans or policies (collectively, “Confidential Information”), nor shall the Participant utilize any such Confidential Information in any way or communicate with or contact any such customer, referral source or client other than in connection with the Participant’s employment by the Company or any Subsidiary or Affiliate. The Participant hereby confirms that all Confidential Information constitutes the Company’s exclusive property, and that all of the restrictions on the Participant’s activities
A-4



contained in this Agreement and such other nondisclosure policies of the Company are required for the Company’s reasonable protection. Confidential Information shall not include any information that has otherwise been disclosed to the public not in violation of this Agreement. This confidentiality provision shall survive the termination of this Agreement and shall not be limited by any other confidentiality agreements entered into with the Company or any Subsidiary or Affiliate. Notwithstanding the foregoing, nothing in this Agreement (or any other Company policy or contract to which the Participant is or was subject) shall be construed to prohibit the Participant from communicating with any federal, state or local governmental agency or commission with oversight of the Company, as provided for, protected under or warranted by applicable law.

With respect to any Confidential Information that constitutes a “trade secret” pursuant to applicable law, the restrictions described above shall remain in force for so long as the particular information remains a trade secret or for the two (2) year period immediately following termination of the Participant’s employment for any reason, whichever is longer. With respect to any Confidential Information that does not constitute a “trade secret” pursuant to applicable law, the restrictions described above shall remain in force during Participant’s employment and for the two (2) year period immediately following termination of such employment for any reason.

The Participant agrees that the Participant shall promptly disclose to the Company in writing all information and inventions generated, conceived or first reduced to practice by the Participant alone or in conjunction with others, during or after working hours, while in the employ of the Company or any Subsidiary or Affiliate (all of which is collectively referred to in this Agreement as “Proprietary Information”); provided, however, that such Proprietary Information shall not include (a) any information that has otherwise been disclosed to the public not in violation of this Agreement and (b) general business knowledge and work skills of the Participant, even if developed or improved by the Participant while in the employ of the Company or any Subsidiary of Affiliate. All such Proprietary Information shall be the exclusive property of the Company and is hereby assigned by the Participant to the Company. The Participant’s obligation relative to the disclosure to the Company of such Proprietary Information anticipated in this Section 11(d) shall continue beyond the Participant’s termination of employment and the Participant shall, at the Company’s expense, give the Company all assistance it reasonably requires to perfect, protect and use its right to the Proprietary Information.
(e)    Enforcement.

(i)    The Participant acknowledges that compliance with all provisions, covenants and agreements set forth in this Agreement, and the duration, terms and geographical area thereof, are reasonable and necessary to protect the legitimate business interests of the Company and its Subsidiaries and Affiliates.

(ii)    The Participant acknowledges that a breach of the Participant’s obligations under this Section 11 will result in irreparable and continuing damage to the Company and/or its Subsidiaries and Affiliates for which there is no adequate remedy at law.
A-5




(iii)    The Participant acknowledges that the Participant’s education, experience and/or abilities are such that the enforcement of the restrictive covenants in this Agreement will not prevent the Participant from earning a living and will not cause any undue hardship upon the Participant.

(iv)    In the event of the violation by the Participant of any of the covenants contained in Section 11, the terms of each such covenant so violated shall be automatically extended from the date on which the Participant permanently ceases such violation for a period equal to the period in which the Participant was in breach of the covenant or for a period of twelve (12) months from the date of the entry by a court of competent jurisdiction of an order or judgment enforcing such covenant(s), whichever period is later.

(v)    The Participant agrees that, in the event of any breach of the restrictive covenants contained in this Agreement, the Company and/or its Subsidiaries and Affiliates shall be entitled to obtain, from any court of competent jurisdiction, preliminary and permanent injunctive relief to restrain the violation of the terms hereof by the Participant, and all persons acting for or on the Participant’s behalf.

(vi)    Each of the restrictive covenants contained in this Agreement is independent of any other contractual obligations of this Agreement or otherwise owed by the Participant to the Company and/or its Subsidiaries and Affiliates. The existence of any claim or cause of action by the Participant against the Company and/or its Subsidiaries or Affiliates, whether based on this Agreement or otherwise, shall not create a defense to the enforcement by the Company and/or its Subsidiaries and Affiliates of any restrictive covenant contained in this Agreement.
    (f)    Remedies.

(i)    It is intended that, in view of the nature of the Company’s and its Subsidiaries’ and Affiliates’ business, the restrictions contained in this Agreement are considered reasonable and necessary to protect the Company’s and its Subsidiaries’ and Affiliates’ legitimate business interests and that any violation of these restrictions would result in irreparable injury to the Company and/or its Subsidiaries and Affiliates. In the event of a breach (a “Covenant Breach”) or threatened breach by the Participant of any provision contained herein, the Company and its Subsidiaries and Affiliates shall be entitled to a temporary restraining order and injunctive relief without the posting of a bond. Nothing contained herein shall be construed as prohibiting the Company or its Subsidiaries or Affiliates from pursuing any other legal or equitable remedies available to it or them for any breach or threatened breach of these provisions, including, without limitation, recoupment and other remedies specified in the Agreement. In the event of a dispute regarding, arising out of, or in connection with the breach, enforcement or interpretation of this Agreement, including, without limitation, any action seeking injunctive relief, and provided that the Company is the prevailing party, the Company shall recover from the Participant all reasonable attorneys’ fees and costs incurred by the Company in connection therewith.
A-6




(ii)    In the event of a Covenant Breach, the Company shall have the authority to (i) cancel all outstanding RSUs, whether vested or unvested; (ii) cancel all shares of Stock beneficially owned by the Participant that were issued in settlement of RSUs within 12 months on or prior to, or at any time after, the date of Participant’s termination of employment (“Cancellable Shares”); and (iii) recoup from the Participant any proceeds from the Participant’s sale, transfer or other disposition of Cancellable Shares. The Company is hereby authorized by the Participant, as the Participant’s attorney-in-fact, to execute all documents and undertake any required action on behalf of the Participant to transfer any Cancellable Shares back to the Company, after which the Participant shall not have any right, title, or interest of any kind to the Cancellable Shares. Participant acknowledges and agrees that the Company has no obligation of any kind to the Participant with respect to the cancellation of RSUs or the Cancellable Shares, or the recoupment of proceeds from the disposition of Cancellable Shares, pursuant to this Section, including, but not limited to, reimbursement for any taxes previously paid by the Participant with respect to Cancellable Shares. This remedy shall be in addition to all other remedies, including those set forth in this Agreement and any other agreements between the parties.
A-7

EX-10.3 4 exhibit103-2021performance.htm EX-10.3 Document
    
    
Exhibit 10.3
PERFORMANCE-BASED CASH AWARD AGREEMENT
UNDER THE BROOKDALE SENIOR LIVING INC.
2014 OMNIBUS INCENTIVE PLAN
This Award Agreement, including the Addendum hereto (this “Agreement”), dated as of _________ (the “Date of Grant”), is made by and between Brookdale Senior Living Inc., a Delaware corporation (the “Company”), and _______________ (the “Participant”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Brookdale Senior Living Inc. 2014 Omnibus Incentive Plan (as amended and/or restated from time to time, the “Plan”). Where the context permits, references to the Company shall include any successor to the Company.
1.Grant of Awards.
(a)The Company hereby grants to the Participant a cash-based Performance Award (the “Award”) representing the right to receive a target cash payment of $_________ (the “Target Award”) under the Plan. The Award is comprised of four tranches (each a “Tranche”), each of which shall be subject to the applicable performance criteria set forth below and the terms and conditions of the Plan and this Agreement.

% of Target AwardPerformance CriteriaScheduled Vesting Date
First Tranche25%Exhibit AFebruary 27, 2024
Second Tranche25%Exhibit BFebruary 27, 2024
Third Tranche25%Exhibit CFebruary 27, 2024
Fourth Tranche25%Exhibit DFebruary 27, 2025
(b)Cash payments in addition to 100% of the target amount for each Tranche may become available to the Participant as set forth in Section 2(a). If and when any such additional amounts become available, they shall be part of the applicable Tranche and subject to all of the terms and conditions of the Plan and this Agreement.
2.Vesting.
(a)General. Except as otherwise provided herein, vesting with respect to each Tranche is subject to the satisfaction of both the Performance Criteria and the Service Condition (each as defined below) applicable to the Tranche. Subject to the provisions set forth below, each Tranche may vest on the scheduled vesting date set forth in Section 1(a) (together with any other date on which any portion of this Award may vest pursuant to this Section 2, a “Vesting Date”), with the exact percentage of each Tranche that vests to be determined by the degree to which the Company’s performance results meet the applicable performance criteria set forth on Exhibit A through Exhibit D hereto (the “Performance Criteria”). Following the completion of the performance period on December 31, 2021 (for the First Tranche), December 31, 2022 (for the Second Tranche), and December 31, 2023 (for the Third Tranche and Fourth
1



Tranche) (as applicable, the “Measurement Date”), the Administrator shall determine the Company’s performance results relative to the applicable Performance Criteria. If the Company’s performance results are less than 100% on the scale set forth in the applicable Performance Criteria, any portion of the applicable Tranche that is not earned shall be forfeited and be deemed no longer to be part of this Agreement effective as of the Measurement Date. If the Company’s performance results exceed 100% on the scale set forth in the applicable Performance Criteria, any additional portion of the applicable Tranche earned in excess of the applicable portion of the Target Award (the “Additional Award Amount”) shall become part of such Tranche effective as of the applicable Measurement Date. Except as otherwise specifically set forth herein, vesting of any portion of this Award on any Vesting Date is subject to the continued employment of the Participant by the Company or one of its Subsidiaries or Affiliates (or a successor to any of them) from the Date of Grant to such Vesting Date (the “Service Condition”).
(b)Change in Control.
(i)    Upon the occurrence of a Change in Control, if the portion of the Award that is outstanding effective immediately prior to such Change in Control is not assumed, continued or substituted on the same terms and conditions that were applicable to the Award outstanding effective immediately prior to the Change in Control, then the entire amount of the outstanding Award (including any unpaid Additional Award Amount that has been determined for a Tranche having a Measurement Date prior to the Change in Control) that has not yet been forfeited shall vest and be settled upon the consummation of the Change in Control.
(ii)    Upon the consummation of a Change in Control in which the portion of the Award that is outstanding effective immediately prior to such Change in Control is assumed, continued or substituted on the same terms and conditions that were applicable to the Award outstanding effective immediately prior to the Change in Control, such portion of the Award shall continue to vest subject to the Service Condition, and the Performance Criteria with respect to a particular Tranche shall no longer apply if the Change in Control occurs prior to the Measurement Date applicable to such Tranche (and for the avoidance of doubt, no Additional Award Amounts shall be paid or payable under this Agreement with respect to a particular Tranche in the event that a Change in Control occurs prior to the Measurement Date for such Tranche).
(iii)    Notwithstanding anything in this Section 2(b) to the contrary, in the event that the Participant’s employment with the Company and its Subsidiaries and Affiliates (or a successor to any of them) is terminated within twelve months following a Change in Control by the Company (or such other entity) without Cause or by the Participant for Good Reason (as defined in the Company’s Amended and Restated Tier I Severance Pay Policy or the Company’s Amended and Restated Tier II Severance Pay Policy, whichever is applicable to Participant), then the portion of the Award that is outstanding effective on the date of such termination shall vest effective upon such termination and be paid within 30 days following such termination.
2



(c)Termination of Employment. Except as otherwise provided in this Section 2(c) and Section 2(b)(iii), upon termination of the Participant’s employment with the Company and its Subsidiaries and Affiliates for any reason, any unvested portion of the Award that is outstanding on the date of such termination shall automatically and without notice terminate and be forfeited and neither the Participant nor any of the Participant’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such portion of the Award. In the event that the Participant’s employment with the Company and its Subsidiaries and Affiliates is terminated by the Company without Cause or on account of the Participant’s death or Disability, the following percentages of the applicable Tranches that are outstanding effective on the date of such termination of employment shall remain outstanding following such termination and shall be eligible to vest (including any Additional Award Amounts that are so determined) subject to the achievement of the Performance Criteria as if the Service Condition shall have been met as of the applicable Vesting Date:
(i)     100% of the First Tranche and 25% of the Fourth Tranche for such termination that occurs on or prior to February 27, 2022 (with 100% of the Second Tranche and Third Tranche, and 75% of the Fourth Tranche, to be forfeited at termination);
(ii)     100% of the First Tranche and Second Tranche, and 50% of the Fourth Tranche, for such termination that occurs after February 27, 2022 and on or prior to February 27, 2023 (with 100% of the Third Tranche and 50% of the Fourth Tranche to be forfeited at termination);
(iii)    100% of the First Tranche, Second Tranche, and Third Tranche, and 75% of the Fourth Tranche, for such termination that occurs after February 27, 2023 and on or prior to February 27, 2024 (with 25% of the Fourth Tranche to be forfeited at termination); and
(iv)    100% of the Fourth Tranche for such termination that occurs after February 27, 2024.
Notwithstanding the foregoing, (A) in the event of a Change in Control following a termination event described in this Section 2(c), the amount of Award outstanding effective on the date of such Change in Control shall vest and be settled upon the consummation of the Change in Control; and (B) in the event Participant’s employment is terminated on account of Disability and Participant did not actively provide services on at least one day in the one-year period immediately preceding the date set forth in clause (i) or the later date set forth in the applicable clause (ii), (iii), or (iv), then the treatment of the outstanding Tranches shall be as set forth in the earlier clause for which Participant actively provided services at least one day in the one-year period immediately preceding such date or later date, as applicable, set forth in such clause (and in the event that Participant did not actively provide services on at least one day in the one-year period immediately preceding the date set forth in clause (i), then 100% of the Tranches shall be forfeited at termination).
3.Settlement of Award. As soon as practicable following each Vesting Date (but in no event later than 30 days following the Vesting Date or such earlier time specified in Section
3



2(b) or Section 2(c)), the Company shall pay to the Participant an amount of cash equal to the portion of the Award that has vested pursuant to this Agreement on such date, subject to Section 7.
4.No Rights as a Stockholder. The Participant shall have no rights as a stockholder of the Company with respect to any portion of this Award.
5.Certain Changes. The Administrator may accelerate the vesting dates or otherwise adjust any of the terms of this Award; provided that, subject to Section 9(f) of the Addendum to this Agreement and Section 19 of this Agreement, no action under this Section shall adversely affect the Participant’s rights hereunder.
6.Notices. All notices and other communications under this Agreement shall be in writing and shall be given by facsimile or first class mail, certified or registered with return receipt requested, and shall be deemed to have been duly given three days after mailing or 24 hours after transmission by facsimile to the respective parties, as follows: (i) if to the Company, at Brookdale Senior Living Inc., 111 Westwood Place, Suite 400, Brentwood, TN 37027, Facsimile: (615) 564-8204, Attn: General Counsel and (ii) if to the Participant, using the contact information on file with the Company. Either party hereto may change such party’s address for notices by notice duly given pursuant hereto. Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any notice or other communications related to the Award, this Agreement or current or future participation in the Plan by electronic means. The Participant hereby consents to receive such notices and other communications by electronic delivery and agrees to participate in the Plan through an online or electronic system established and maintained by the Company or a third party designated by the Company (including the Company’s stock plan service provider’s website).
7.Taxes and Withholding. The Participant has reviewed with the Participant’s own tax advisors the U.S. federal, state, local and foreign tax consequences of the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Participant acknowledges and agrees that the Participant is responsible for the tax consequences associated with the grant and vesting of this Award. The Company shall withhold from the payment of any portion of the Award hereunder such amounts not exceeding the applicable taxes to be withheld and applied to the tax and withholding obligations of the Participant and the Company as determined by the Company. In making its determination, the Company may calculate such amount by taking into account applicable withholding rates not exceeding the maximum individual statutory tax rates in the Participant’s applicable jurisdictions.
8.Failure to Enforce Not a Waiver. The failure of the Company to enforce at any time any provision of this Agreement shall in no way be construed to be a waiver of such provision or of any other provision hereof.
4



9.Restrictive Covenants. The provisions of Section 9 of the Addendum to this Agreement are incorporated herein.
10.Governing Law. This Agreement shall be governed by and construed according to the laws of the State of Delaware without regard to its principles of conflict of laws.
11.Incorporation of Plan. The Plan is hereby incorporated by reference and made a part hereof, and the Award and this Agreement shall be subject to all terms and conditions of the Plan.
12.Amendments; Construction. The Administrator may amend the terms of this Agreement prospectively or retroactively at any time, but no such amendment shall impair the rights of the Participant hereunder without the Participant’s consent. Headings to Sections of this Agreement are intended for convenience of reference only, are not part of this Agreement and shall have no effect on the interpretation hereof.
13.Survival of Terms. This Agreement shall apply to and bind the Participant and the Company and their respective permitted assignees and transferees, heirs, legatees, executors, administrators and legal successors. The terms of Section 9 of the Addendum to this Agreement and Section 19 of this Agreement shall expressly survive the vesting and/or forfeiture of this Award and any expiration or termination of this Agreement.
14.Agreement Not a Contract for Services. Neither the Plan, the granting of this Award, this Agreement nor any other action taken pursuant to the Plan shall constitute or be evidence of any agreement or understanding, express or implied, that the Participant has a right to continue to provide services as an officer, director, employee, consultant or advisor of the Company or any Subsidiary or Affiliate for any period of time or at any specific rate of compensation.
15.Restrictions. No portion of this Award may be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Participant. Unless the Administrator determines otherwise, upon any attempt to transfer this Award or any rights in respect of this Award before the lapse of such restrictions, this Award, and all of the rights related thereto, shall be immediately forfeited by the Participant without consideration of any kind.
16.Authority of the Administrator. The Administrator shall have full authority to interpret and construe the terms of the Plan and this Agreement (including, without limitation, the authority to determine whether, and the extent to which, any Performance Criteria have been achieved). Pursuant to the terms of the Plan, the Administrator shall also have full authority to make equitable adjustments to the Performance Criteria in recognition of unusual or non-recurring events affecting the Company or any Subsidiary or Affiliate or the financial statements of the Company or any Subsidiary or Affiliate, in response to changes in applicable laws or regulations, or to account for items of gain, loss or expense determined to be extraordinary or unusual in nature or infrequent in occurrence or related to the disposal of a segment of a business
5



or related to a change in accounting principles. The determination of the Administrator as to any such matter of interpretation or construction shall be final, binding and conclusive.
17.Severability. Should any provision of this Agreement be held by a court of competent jurisdiction to be unenforceable, or enforceable only if modified, such holding shall not affect the validity of the remainder of this Agreement, the balance of which shall continue to be binding upon the parties hereto with any such modification (if any) to become a part hereof and treated as though contained in this original Agreement. Moreover, if one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to scope, activity, subject or otherwise so as to be unenforceable, in lieu of severing such unenforceable provision, such provision or provisions shall be construed by the appropriate judicial body by limiting or reducing it or them, so as to be enforceable to the maximum extent compatible with the applicable law as it shall then appear, and such determination by such judicial body shall not affect the enforceability of such provision or provisions in any other jurisdiction.
18.Acceptance. The Participant hereby acknowledges receipt of a copy of the Plan and this Agreement. The Participant has read and understands the terms and provisions of the Plan and this Agreement, and accepts the Award subject to all the terms and conditions of the Plan and this Agreement. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under this Agreement. By the Participant’s electronically accepting this Award using an online or electronic system established and maintained by the Company or a third party designated by the Company (including the Company’s stock plan service provider’s website), the Participant agrees to be bound by the terms and conditions of the Plan and this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The Participant’s electronic acceptance of this Award shall have the same validity and effect as a signature affixed to this Agreement by the Participant’s hand.
19.Clawback. Notwithstanding anything herein to the contrary, this Award (and any cash paid to the Participant upon settlement thereof) shall be subject to forfeiture, reduction, and/or recoupment (i) to the extent provided in the Company’s Clawback and Forfeiture Policy, as it may be amended from time to time (the “Clawback Policy”); (ii) to the extent that Participant becomes subject to any other recoupment or clawback policy hereafter adopted by the Company, including any such policy adopted by the Company to comply with the requirements of any applicable laws, rules, regulations, or stock exchange listing requirements, including pursuant to final SEC rules under the Dodd-Frank Wall Street Reform and Consumer Protection Act, or (iii) to the extent provided under applicable legal requirements which impose recoupment, under circumstances set forth in such applicable legal requirements, including the Sarbanes-Oxley Act of 2002.
20.Section 409A. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of this Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code.
6



Notwithstanding anything to the contrary in this Agreement or an accompanying election form executed by the Participant, if (i) on the date of the Participant’s Separation from Service with the Company the Participant is a “specified employee” (as such term is defined under Section 1.409A-1(i) of the Treasury Regulations promulgated under Section 409A of the Code) of the Company and (ii) any payments to be provided to the Participant pursuant to this Agreement are or may become subject to the additional tax under Section 409A(a)(1)(B) of the Code, or any other taxes or penalties imposed under Section 409A of the Code if provided at the time otherwise required under this Agreement, then such payments shall be delayed until the date that is six months after the date of the Participant’s separation from service from the Company, or if earlier, his or her death. Any payments delayed pursuant to this paragraph shall be made in a lump sum on the first day of the seventh month following the Participant’s separation from service, or if earlier, the Participant’s death. Each payment upon settlement of this Award constitutes a “separate payment” for purposes of Section 409A of the Code. Notwithstanding any other provision of this Agreement, if and to the extent that any payment under this Agreement constitutes non-qualified deferred compensation under Section 409A of the Code, and is payable upon (i) the Participant’s termination of employment, then such payment shall be made or provided to the Participant only upon a “separation from service” as defined for purposes of Section 409A of the Code, or (ii) a Change in Control, then such payment shall be made or provided to the Participant only upon a “change in the ownership”, a “change in effective control” or a “change in the ownership of a substantial portion of the assets” of the applicable corporation as defined for purposes of Section 409A of the Code.

[Signature page to follow.]

7



IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the day and year first above written.

BROOKDALE SENIOR LIVING INC.


By:     
Name:     
Title:     


PARTICIPANT

                            

8


    
    
EXHIBIT A

[Strategic Goal]*


% of Target First Tranche to Vest
[___]% (Maximum)150%
[___]% (Target)100%
[___]%75%
[___]%50%
[___]% (Threshold)25%

*Subject in all cases to the terms of the Plan and the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Plan and the Agreement.




            
EXHIBIT B

2022 RevPAR Growth

Vesting of the Second Tranche (plus any Additional Award Amount that becomes payable pursuant to Section 2(a) of the Agreement) will be dependent upon the Company’s one-year growth of Same Community RevPAR for fiscal 2022 compared to a base year of fiscal 2021 as set forth in the grid below, with vesting to be interpolated on a straight-line basis between the applicable levels based on actual results. Same Community RevPAR means the Same Community RevPAR as reported by the Company in its Annual Report on Form 10-K, earnings release and/or supplemental information for the year ended December 31, 2022.

Growth Rate% of Target Second Tranche to Vest
[___]% (Maximum)150%
[___]% (Target)100%
[___]% (Threshold)50%

*Subject in all cases to the terms of the Plan and the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Plan and the Agreement.




            
EXHIBIT C

2023 RevPAR Growth

Vesting of the Third Tranche (plus any Additional Award Amount that becomes payable pursuant to Section 2(a) of the Agreement) will be dependent upon the Company’s one-year growth of Same Community RevPAR for fiscal 2023 compared to a base year of fiscal 2022 as set forth in the grid below, with vesting to be interpolated on a straight-line basis between the applicable levels based on actual results. Same Community RevPAR means the Same Community RevPAR as reported by the Company in its Annual Report on Form 10-K, earnings release and/or supplemental information for the year ended December 31, 2023.

Growth Rate% of Target Third Tranche to Vest
[___]% (Maximum)150%
[___]% (Target)100%
[___]% (Threshold)50%

*Subject in all cases to the terms of the Plan and the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Plan and the Agreement.






            
EXHIBIT D

Relative TSR*

Vesting of the Fourth Tranche (plus any Additional Award Amount that becomes payable pursuant to Section 2(a) of the Agreement) will be dependent upon the Company’s TSR ranking relative to the TSRs of the companies in the Comparator Group during the Performance Period as set forth in the grid below, with vesting to be interpolated on a straight-line basis between the applicable levels based on actual results; provided, however, that in no event shall any Additional Award Amount (above 100%) vest and be paid with respect to the Fourth Tranche if the Company’s TSR is negative for the Performance Period.

Relative TSR Performance% of Target Fourth Tranche to Vest
[___]th Percentile (Maximum)150%
[___]th Percentile (Target)100%
[___]th Percentile (Threshold)50%

For purposes of the foregoing:

Performance Period shall mean January 1, 2021 through December 31, 2023
Comparator Group shall mean the constituent companies of the S&P Midcap 400 as of the beginning of the Performance Period, except that any such companies that have been acquired or delisted from a national securities exchange during the Performance Period will be excluded.
TSR shall mean the compound annual total stockholder return calculated using a beginning price equal to the average closing price over the 20-trading days preceding the beginning of the Performance Period, using an ending price equal to the average closing price over the 20-trading days immediately prior to the end of the Performance Period, and assuming the reinvestment of any dividends or distributions as of the ex-dividend date.


*Subject in all cases to the terms of the Plan and the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Plan and the Agreement.




            
ADDENDUM TO
PERFORMANCE-BASED CASH AWARD AGREEMENT
UNDER THE BROOKDALE SENIOR LIVING INC.
2014 OMNIBUS INCENTIVE PLAN.
Section 9:
9.    Restrictive Covenants. The Participant understands the Company has developed, and is continuing to develop, substantial relationships with actual and prospective officers, directors, employees, consultants, agents, customers, residents, patients, referral sources, clients, vendors, suppliers, investors, and equity and financing sources, associate and customer goodwill, and confidential and proprietary business information and trade secrets, which the Company and its Subsidiaries and Affiliates have the right to protect in order to safeguard their legitimate business interests. Any misappropriation of such relationships or goodwill, or any improper disclosure or use of the Company’s and its Subsidiaries’ and Affiliates’ confidential and proprietary business information and trade secrets would be highly detrimental to their business interests in that serious and substantial loss of business and pecuniary damages would result therefrom. The Participant acknowledges that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, the Participant shall have access to the Company’s Confidential Information (as defined below) and will meet and develop such relationships and goodwill. Nothing contained in this Section 9 shall limit any common law or statutory obligation that the Participant may have to the Company or any Subsidiary or Affiliate. For purposes of this Section 9, the “Company” refers to the Company and any incorporated or unincorporated affiliates of the Company, including any entity which becomes the Participant’s employer as a result of any reorganization or restructuring of the Company for any reason. The Company shall be entitled, in connection with its tax planning or other reasons, to terminate the Participant’s employment (which termination shall not be considered a termination for any purposes of this Agreement, any employment agreement or otherwise) in connection with an invitation from another affiliate of the Company to accept employment with such affiliate in which case the terms and conditions hereof shall apply to the Participant’s employment relationship with such entity mutatis mutandis.
(a)    Noncompetition. The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate and for the one (1) year period immediately following the termination of such employment for any reason or for no reason, the Participant shall not directly or indirectly, either as a principal, agent, employee, employer, consultant, partner, shareholder of a closely held corporation or shareholder in excess of five percent of a publicly traded corporation, corporate officer or director, or in any other individual or representative capacity, engage or otherwise participate in any manner or fashion in any business that is a Competing Business (as defined herein). Notwithstanding the foregoing, (i) if the Participant’s employment is terminated by the Participant after Participant experiences an aggregate reduction to the Participant’s annual target cash compensation by 20% or more, the covenant in this Section 9(a) shall not apply; and (ii) the covenant in this Section 9(a) shall not be interpreted to restrict the Participant’s right to practice law in violation of any rules of professional conduct applicable to the Participant.




For purposes of this Section 9(a), “Competing Business” means a business (which shall include any sole proprietorship, partnership, limited partnership, limited liability partnership, limited liability company, corporation or other for-profit or not-for-profit business organization) (A) engaged in the business of owning, operating or managing senior living facilities within the United States, or (B) that, itself or with its affiliates, provides healthcare or other services to patients or customers through home health care agencies, hospice agencies, outpatient therapy clinics and/or community based/private duty agencies within any state that the Company or its subsidiaries or affiliates provides now, or provides during the Participant’s employment, such healthcare or other services to patients or customers, and that derives, together with its controlled affiliates or together with its affiliates, more than 10% of its and its controlled affiliates or 10% of its and its affiliates, respectively, revenue from the provision of healthcare or other services to patients or customers through home health care agencies, hospice agencies, outpatient therapy clinics and/or community based/private duty agencies.

    (b)    Solicitation of Employees, Clients, Referral Sources, Vendors, Etc. The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, and for the two (2) year period immediately following the date of termination of such employment for any reason, the Participant shall not, directly or indirectly, jointly or individually, on Participant’s own behalf or on behalf of or in assistance to any individual, person or entity, for any purpose or in any place:

(i)    solicit for employment or service, hire, employ or retain the services of any Covered Employee (as defined below) or induce or encourage any Covered Employee to terminate or sever his, her or its employment or other relationship with the Company or any Subsidiary or Affiliate or any of their successors or assigns; or

(ii)    solicit business from any Covered Person (as defined below) or induce or encourage any Covered Person to terminate, change or reduce his, her or its relationship with the Company or any Subsidiary or Affiliate or any of their successors or assigns.

Notwithstanding the foregoing, a general advertisement or solicitation for employment that is not targeted and that does not have the effect of being targeted to any current or former Covered Employee or Covered Person shall not, by itself, be deemed to be a violation of the restrictions on solicitation contained in this Section 9(b). For purposes of this Section 9(b), “Covered Employee” shall mean any officer, director, employee, consultant or agent who is employed or engaged by the Company or any Subsidiary or Affiliate or any of their successors or assigns or was so employed or engaged at any time during the twelve (12) months prior to the Participant’s termination of employment, and “Covered Person” shall mean any customers, residents, patients, referral sources, clients, vendors, suppliers, investors, equity or financing sources, or consultants of the Company or any Subsidiary or Affiliate or any of their successors or assigns.

(c)    Disparaging Comments. The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, and any time thereafter, the Participant shall not make any disparaging or defamatory comments regarding the
A-2



Company or any Subsidiary or Affiliate or any of their successors or assigns, or any time after termination of such employment, make any comments concerning any aspect of the termination of their relationship. The obligations of the Participant under this Section 9(c) shall not apply to disclosures required by applicable law, regulation or order of any court or governmental agency.
    (d)    Confidentiality. All books of account, records, systems, correspondence, documents, memoranda, manuals, email, electronic or magnetic recordings or data and any and all other data, in whatever form and any copies thereof, concerning or containing any reference to the works and business of the Company or any Subsidiary or Affiliate shall belong to the Company and shall be given up to the Company whenever the Company requires the Participant to do so. The Participant agrees that the Participant shall not at any time during the term of the Participant’s employment with the Company or any Subsidiary or Affiliate, or at any time thereafter, without the Company’s prior written consent, disclose to any individual, person or entity any information or any trade secrets, plans or other information or data, in whatever form (including, without limitation, (a) any financing strategies and practices, pricing information and methods, training and operational procedures, advertising, marketing, and sales information or methodologies or financial information and (b) any Proprietary Information (as defined below)), concerning the Company’s or any Subsidiary’s or Affiliate’s or any of their customers’, referral sources’ or clients’ practices, businesses, procedures, systems, plans or policies (collectively, “Confidential Information”), nor shall the Participant utilize any such Confidential Information in any way or communicate with or contact any such customer, referral source or client other than in connection with the Participant’s employment by the Company or any Subsidiary or Affiliate. The Participant hereby confirms that all Confidential Information constitutes the Company’s exclusive property, and that all of the restrictions on the Participant’s activities contained in this Agreement and such other nondisclosure policies of the Company are required for the Company’s reasonable protection. Confidential Information shall not include any information that has otherwise been disclosed to the public not in violation of this Agreement. This confidentiality provision shall survive the termination of this Agreement and shall not be limited by any other confidentiality agreements entered into with the Company or any Subsidiary or Affiliate. Notwithstanding the foregoing, nothing in this Agreement (or any other Company policy or contract to which the Participant is or was subject) shall be construed to prohibit the Participant from communicating with any federal, state or local governmental agency or commission with oversight of the Company, as provided for, protected under or warranted by applicable law.

With respect to any Confidential Information that constitutes a “trade secret” pursuant to applicable law, the restrictions described above shall remain in force for so long as the particular information remains a trade secret or for the two (2) year period immediately following termination of the Participant’s employment for any reason, whichever is longer. With respect to any Confidential Information that does not constitute a “trade secret” pursuant to applicable law, the restrictions described above shall remain in force during Participant’s employment and for the two (2) year period immediately following termination of such employment for any reason.

The Participant agrees that the Participant shall promptly disclose to the Company in writing all information and inventions generated, conceived or first reduced to practice by the Participant
A-3



alone or in conjunction with others, during or after working hours, while in the employ of the Company or any Subsidiary or Affiliate (all of which is collectively referred to in this Agreement as “Proprietary Information”); provided, however, that such Proprietary Information shall not include (a) any information that has otherwise been disclosed to the public not in violation of this Agreement and (b) general business knowledge and work skills of the Participant, even if developed or improved by the Participant while in the employ of the Company or any Subsidiary of Affiliate. All such Proprietary Information shall be the exclusive property of the Company and is hereby assigned by the Participant to the Company. The Participant’s obligation relative to the disclosure to the Company of such Proprietary Information anticipated in this Section 9(d) shall continue beyond the Participant’s termination of employment and the Participant shall, at the Company’s expense, give the Company all assistance it reasonably requires to perfect, protect and use its right to the Proprietary Information.
(e)    Enforcement.

(i)    The Participant acknowledges that compliance with all provisions, covenants and agreements set forth in this Agreement, and the duration, terms and geographical area thereof, are reasonable and necessary to protect the legitimate business interests of the Company and its Subsidiaries and Affiliates.

(ii)    The Participant acknowledges that a breach of the Participant’s obligations under this Section 9 will result in irreparable and continuing damage to the Company and/or its Subsidiaries and Affiliates for which there is no adequate remedy at law.

(iii)    The Participant acknowledges that the Participant’s education, experience and/or abilities are such that the enforcement of the restrictive covenants in this Agreement will not prevent the Participant from earning a living and will not cause any undue hardship upon the Participant.

(iv)    In the event of the violation by the Participant of any of the covenants contained in Section 9, the terms of each such covenant so violated shall be automatically extended from the date on which the Participant permanently ceases such violation for a period equal to the period in which the Participant was in breach of the covenant or for a period of twelve (12) months from the date of the entry by a court of competent jurisdiction of an order or judgment enforcing such covenant(s), whichever period is later.

(v)    The Participant agrees that, in the event of any breach of the restrictive covenants contained in this Agreement, the Company and/or its Subsidiaries and Affiliates shall be entitled to obtain, from any court of competent jurisdiction, preliminary and permanent injunctive relief to restrain the violation of the terms hereof by the Participant, and all persons acting for or on the Participant’s behalf.

(vi)    Each of the restrictive covenants contained in this Agreement is independent of any other contractual obligations of this Agreement or otherwise owed by the Participant to the Company and/or its Subsidiaries and Affiliates. The existence of any claim or
A-4



cause of action by the Participant against the Company and/or its Subsidiaries or Affiliates, whether based on this Agreement or otherwise, shall not create a defense to the enforcement by the Company and/or its Subsidiaries and Affiliates of any restrictive covenant contained in this Agreement.
    (f)    Remedies.

(i)    It is intended that, in view of the nature of the Company’s and its Subsidiaries’ and Affiliates’ business, the restrictions contained in this Agreement are considered reasonable and necessary to protect the Company’s and its Subsidiaries’ and Affiliates’ legitimate business interests and that any violation of these restrictions would result in irreparable injury to the Company and/or its Subsidiaries and Affiliates. In the event of a breach (a “Covenant Breach”) or threatened breach by the Participant of any provision contained herein, the Company and its Subsidiaries and Affiliates shall be entitled to a temporary restraining order and injunctive relief without the posting of a bond. Nothing contained herein shall be construed as prohibiting the Company or its Subsidiaries or Affiliates from pursuing any other legal or equitable remedies available to it or them for any breach or threatened breach of these provisions, including, without limitation, recoupment and other remedies specified in the Agreement. In the event of a dispute regarding, arising out of, or in connection with the breach, enforcement or interpretation of this Agreement, including, without limitation, any action seeking injunctive relief, and provided that the Company is the prevailing party, the Company shall recover from the Participant all reasonable attorneys’ fees and costs incurred by the Company in connection therewith.

(ii)    In the event of a Covenant Breach, the Company shall have the authority to (i) cancel the entire portion of any outstanding Award, whether vested or unvested; and (ii) recoup from the Participant any proceeds delivered pursuant to the Award. Participant acknowledges and agrees that the Company has no obligation of any kind to the Participant with respect to the cancellation or recoupment of amounts paid or payable pursuant to the Award, including, but not limited to, reimbursement for any taxes previously paid by the Participant with respect to amounts previously paid on account of the Award. This remedy shall be in addition to all other remedies, including those set forth in this Agreement and any other agreements between the parties.

A-5

EX-10.4 5 exhibit104-2021ceoperforma.htm EX-10.4 Document

Exhibit 10.4
PERFORMANCE-BASED CASH AWARD AGREEMENT
BROOKDALE SENIOR LIVING INC.
This Performance-Based Cash Award Agreement (this “Agreement”), dated as of February 22, 2021 (the “Date of Grant”), is made by and between Brookdale Senior Living Inc., a Delaware corporation (the “Company”), and Lucinda M. Baier (the “Participant”). Where the context permits, references to the Company shall include any successor to the Company.
1.Grant of Awards.
(a)The Company hereby grants to the Participant a cash-based Performance Award (the “Award”) representing the right to receive a target cash payment of $2,765,000 (the “Target Award”). The Award is comprised of four tranches (each a “Tranche”), each of which shall be subject to the applicable performance criteria set forth below and the terms and conditions of this Agreement.

% of Target AwardPerformance CriteriaScheduled Vesting Date
First Tranche25%Exhibit AFebruary 27, 2024
Second Tranche25%Exhibit BFebruary 27, 2024
Third Tranche25%Exhibit CFebruary 27, 2024
Fourth Tranche25%Exhibit DFebruary 27, 2025
(b)Cash payments in addition to 100% of the target amount for each Tranche may become available to the Participant as set forth in Section 2(a). If and when any such additional amounts become available, they shall be part of the applicable Tranche and subject to all of the terms and conditions of this Agreement.
2.Vesting.
(a)General. Except as otherwise provided herein, vesting with respect to each Tranche is subject to the satisfaction of both the Performance Criteria and the Service Condition (each as defined below) applicable to the Tranche. Subject to the provisions set forth below, each Tranche may vest on the scheduled vesting date set forth in Section 1(a) (together with any other date on which any portion of this Award may vest pursuant to this Section 2, a “Vesting Date”), with the exact percentage of each Tranche that vests to be determined by the degree to which the Company’s performance results meet the applicable performance criteria set forth on Exhibit A through Exhibit D hereto (the “Performance Criteria”). Following the completion of the performance period on December 31, 2021 (for the First Tranche), December 31, 2022 (for the Second Tranche), and December 31, 2023 (for the Third Tranche and Fourth Tranche) (as applicable, the “Measurement Date”), the Administrator shall determine the Company’s performance results relative to the applicable Performance Criteria. If the Company’s performance results are less than 100% on the scale set forth in the applicable Performance Criteria, any portion of the applicable Tranche that is not earned shall be forfeited
1



and be deemed no longer to be part of this Agreement effective as of the Measurement Date. If the Company’s performance results exceed 100% on the scale set forth in the applicable Performance Criteria, any additional portion of the applicable Tranche earned in excess of the applicable portion of the Target Award (the “Additional Award Amount”) shall become part of such Tranche effective as of the applicable Measurement Date. Except as otherwise specifically set forth herein, vesting of any portion of this Award on any Vesting Date is subject to the continued employment of the Participant by the Company or one of its Subsidiaries or Affiliates (or a successor to any of them) from the Date of Grant to such Vesting Date (the “Service Condition”).
(b)Change in Control.
(i)    Upon the occurrence of a Change in Control, if the portion of the Award that is outstanding effective immediately prior to such Change in Control is not assumed, continued or substituted on the same terms and conditions that were applicable to the Award outstanding effective immediately prior to the Change in Control, then the entire amount of the outstanding Award (including any unpaid Additional Award Amount that has been determined for a Tranche having a Measurement Date prior to the Change in Control) that has not yet been forfeited shall vest and be settled upon the consummation of the Change in Control.
(ii)    Upon the consummation of a Change in Control in which the portion of the Award that is outstanding effective immediately prior to such Change in Control is assumed, continued or substituted on the same terms and conditions that were applicable to the Award outstanding effective immediately prior to the Change in Control, such portion of the Award shall continue to vest subject to the Service Condition, and the Performance Criteria with respect to a particular Tranche shall no longer apply if the Change in Control occurs prior to the Measurement Date applicable to such Tranche (and for the avoidance of doubt, no Additional Award Amounts shall be paid or payable under this Agreement with respect to a particular Tranche in the event that a Change in Control occurs prior to the Measurement Date for such Tranche).
(iii)    Notwithstanding anything in this Section 2(b) to the contrary, in the event that the Participant’s employment with the Company and its Subsidiaries and Affiliates (or a successor to any of them) is terminated within twelve months following a Change in Control by the Company (or such other entity) without Cause or by the Participant for Good Reason (as defined in the Employment Agreement by and between the Company and the Participant dated as of March 1, 2018), then the portion of the Award that is outstanding effective on the date of such termination shall vest effective upon such termination and be paid within 30 days following such termination.
(c)Termination of Employment. Except as otherwise provided in this Section 2(c) and Section 2(b)(iii), upon termination of the Participant’s employment with the Company and its Subsidiaries and Affiliates for any reason, any unvested portion of the Award that is outstanding on the date of such termination shall automatically and without notice terminate and be forfeited and neither the Participant nor any of the Participant’s successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such portion of the
2



Award. In the event that the Participant’s employment with the Company and its Subsidiaries and Affiliates is terminated by the Company without Cause, by the Participant for Good Reason, or on account of the Participant’s death or Disability, the following percentages of the applicable Tranches that are outstanding effective on the date of such termination of employment shall remain outstanding following such termination and shall be eligible to vest (including any Additional Award Amounts that are so determined) subject to the achievement of the Performance Criteria as if the Service Condition shall have been met as of the applicable Vesting Date:
(i)     100% of the First Tranche and 25% of the Fourth Tranche for such termination that occurs on or prior to February 27, 2022 (with 100% of the Second Tranche and Third Tranche, and 75% of the Fourth Tranche, to be forfeited at termination);
(ii)     100% of the First Tranche and Second Tranche, and 50% of the Fourth Tranche, for such termination that occurs after February 27, 2022 and on or prior to February 27, 2023 (with 100% of the Third Tranche and 50% of the Fourth Tranche to be forfeited at termination);
(iii)    100% of the First Tranche, Second Tranche, and Third Tranche, and 75% of the Fourth Tranche, for such termination that occurs after February 27, 2023 and on or prior to February 27, 2024 (with 25% of the Fourth Tranche to be forfeited at termination); and
(iv)    100% of the Fourth Tranche for such termination that occurs after February 27, 2024.
Notwithstanding the foregoing, (A) in the event of a Change in Control following a termination event described in this Section 2(c), the amount of Award outstanding effective on the date of such Change in Control shall vest and be settled upon the consummation of the Change in Control, and (B) in the event Participant’s employment is terminated on account of Disability and Participant did not actively provide services on at least one day in the one-year period immediately preceding the date set forth in clause (i) or the later date set forth in the applicable clause (ii), (iii), or (iv), then the treatment of the outstanding Tranches shall be as set forth in the earlier clause for which Participant actively provided services at least one day in the one-year period immediately preceding such date or later date, as applicable, set forth in such clause (and in the event that Participant did not actively provide services on at least one day in the one-year period immediately preceding the date set forth in clause (i), then 100% of the Tranches shall be forfeited at termination).
3.Settlement of Award. As soon as practicable following each Vesting Date (but in no event later than 30 days following the Vesting Date or such earlier time specified in Section 2(b) or Section 2(c)), the Company shall pay to the Participant an amount of cash equal to the
3



portion of the Award that has vested pursuant to this Agreement on such date, subject to Section 7.
4.No Rights as a Stockholder. The Participant shall have no rights as a stockholder of the Company with respect to any portion of this Award.
5.Certain Changes. The Administrator may accelerate the vesting dates or otherwise adjust any of the terms of this Award; provided that, subject to Section 9(f) and Section 18 of this Agreement, no action under this Section shall adversely affect the Participant’s rights hereunder.
6.Notices. All notices and other communications under this Agreement shall be in writing and shall be given by facsimile or first class mail, certified or registered with return receipt requested, and shall be deemed to have been duly given three days after mailing or 24 hours after transmission by facsimile to the respective parties, as follows: (i) if to the Company, at Brookdale Senior Living Inc., 111 Westwood Place, Suite 400, Brentwood, TN 37027, Facsimile: (615) 564-8204, Attn: General Counsel and (ii) if to the Participant, using the contact information on file with the Company. Either party hereto may change such party’s address for notices by notice duly given pursuant hereto. Notwithstanding the foregoing, the Company may, in its sole discretion, decide to deliver any notice or other communications related to the Award or this Agreement by electronic means. The Participant hereby consents to receive such notices and other communications by electronic delivery.
7.Taxes and Withholding. The Participant has reviewed with the Participant’s own tax advisors the U.S. federal, state, local and foreign tax consequences of the transactions contemplated by this Agreement. The Participant is relying solely on such advisors and not on any statements or representations of the Company or any of its agents. The Participant acknowledges and agrees that the Participant is responsible for the tax consequences associated with the grant and vesting of this Award. The Company shall withhold from the payment of any portion of the Award hereunder such amounts not exceeding the applicable taxes to be withheld and applied to the tax and withholding obligations of the Participant and the Company as determined by the Company. In making its determination, the Company may calculate such amount by taking into account applicable withholding rates not exceeding the maximum individual statutory tax rates in the Participant’s applicable jurisdictions.
8.Failure to Enforce Not a Waiver. The failure of the Company to enforce at any time any provision of this Agreement shall in no way be construed to be a waiver of such provision or of any other provision hereof.
9.Restrictive Covenants. The Participant understands the Company has developed, and is continuing to develop, substantial relationships with actual and prospective officers, directors, employees, consultants, agents, customers, residents, patients, referral sources, clients, vendors, suppliers, investors, and equity and financing sources, associate and customer goodwill, and confidential and proprietary business information and trade secrets, which the Company and its Subsidiaries and Affiliates have the right to protect in order to safeguard their legitimate business interests. Any misappropriation of such relationships or goodwill, or any improper
4



disclosure or use of the Company’s and its Subsidiaries’ and Affiliates’ confidential and proprietary business information and trade secrets would be highly detrimental to their business interests in that serious and substantial loss of business and pecuniary damages would result therefrom. The Participant acknowledges that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, the Participant shall have access to the Company’s Confidential Information (as defined below) and will meet and develop such relationships and goodwill. Nothing contained in this Section 9 shall limit any common law or statutory obligation that the Participant may have to the Company or any Subsidiary or Affiliate. For purposes of this Section 9, the “Company” refers to the Company and any incorporated or unincorporated affiliates of the Company, including any entity which becomes the Participant’s employer as a result of any reorganization or restructuring of the Company for any reason. The Company shall be entitled, in connection with its tax planning or other reasons, to terminate the Participant’s employment (which termination shall not be considered a termination for any purposes of this Agreement, any employment agreement or otherwise) in connection with an invitation from another affiliate of the Company to accept employment with such affiliate in which case the terms and conditions hereof shall apply to the Participant’s employment relationship with such entity mutatis mutandis.
(a)Noncompetition. The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate and for the one (1) year period immediately following the termination of such employment for any reason or for no reason, the Participant shall not directly or indirectly, either as a principal, agent, employee, employer, consultant, partner, shareholder of a closely held corporation or shareholder in excess of five percent of a publicly traded corporation, corporate officer or director, or in any other individual or representative capacity, engage or otherwise participate in any manner or fashion in any business that is a Competing Business (as defined herein).

For purposes of this Section 9(a), “Competing Business” means a business (which shall include any sole proprietorship, partnership, limited partnership, limited liability partnership, limited liability company, corporation or other for-profit or not-for-profit business organization) (A) engaged in the business of owning, operating or managing senior living facilities within the United States, or (B) that, itself or with its affiliates, provides healthcare or other services to patients or customers through home health care agencies, hospice agencies, outpatient therapy clinics and/or community based/private duty agencies within any state that the Company or its subsidiaries or affiliates provides now, or provides during the Participant’s employment, such healthcare or other services to patients or customers, and that derives, together with its controlled affiliates or together with its affiliates, more than 10% of its and its controlled affiliates or 10% of its and its affiliates, respectively, revenue from the provision of healthcare or other services to patients or customers through home health care agencies, hospice agencies, outpatient therapy clinics and/or community based/private duty agencies.
(b)Solicitation of Employees, Clients, Referral Sources, Vendors, Etc. The Participant agrees that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, and for the two (2) year period immediately following the date of termination of such employment for any reason, the Participant shall not, directly or indirectly,
5



jointly or individually, on Participant’s own behalf or on behalf of or in assistance to any individual, person or entity, for any purpose or in any place:

(i)    solicit for employment or service, hire, employ or retain the services of any Covered Employee (as defined below) or induce or encourage any Covered Employee to terminate or sever his, her or its employment or other relationship with the Company or any Subsidiary or Affiliate or any of their successors or assigns; or

(ii)    solicit business from any Covered Person (as defined below) or induce or encourage any Covered Person to terminate, change or reduce his, her or its relationship with the Company or any Subsidiary or Affiliate or any of their successors or assigns.

Notwithstanding the foregoing, a general advertisement or solicitation for employment that is not targeted and that does not have the effect of being targeted to any current or former Covered Employee or Covered Person shall not, by itself, be deemed to be a violation of the restrictions on solicitation contained in this Section 9(b). For purposes of this Section 9(b), “Covered Employee” shall mean any officer, director, employee, consultant or agent who is employed or engaged by the Company or any Subsidiary or Affiliate or any of their successors or assigns or was so employed or engaged at any time during the twelve (12) months prior to the Participant’s termination of employment, and “Covered Person” shall mean any customers, residents, patients, referral sources, clients, vendors, suppliers, investors, equity or financing sources, or consultants of the Company or any Subsidiary or Affiliate or any of their successors or assigns.
(c)Disparaging Comments. The Company and the Participant agree that during the period of the Participant’s employment with the Company or any Subsidiary or Affiliate, and any time thereafter, the Participant shall not make any disparaging or defamatory comments regarding the Company or any Subsidiary or Affiliate or any of their successors or assigns, and the Company and its Affiliates shall not make or issue any public statements which are disparaging or defamatory regarding the Participant, and after termination of such employment neither party shall make any comments concerning any aspect of the termination of their relationship. The obligations of the Company and the Participant under this Section 9(c) shall not apply to disclosures required by applicable law, regulation or order of any court or governmental agency.
(d)Confidentiality. All books of account, records, systems, correspondence, documents, memoranda, manuals, email, electronic or magnetic recordings or data and any and all other data, in whatever form and any copies thereof, concerning or containing any reference to the works and business of the Company or any Subsidiary or Affiliate shall belong to the Company and shall be given up to the Company whenever the Company requires the Participant to do so. The Participant agrees that the Participant shall not at any time during the term of the Participant’s employment with the Company or any Subsidiary or Affiliate, or at any time thereafter, without the Company’s prior written consent, disclose to any individual, person or entity any information or any trade secrets, plans or other information or data, in whatever form (including, without limitation, (a) any financing strategies and practices, pricing information and
6



methods, training and operational procedures, advertising, marketing, and sales information or methodologies or financial information and (b) any Proprietary Information (as defined below)), concerning the Company’s or any Subsidiary’s or Affiliate’s or any of their customers’, referral sources’ or clients’ practices, businesses, procedures, systems, plans or policies (collectively, “Confidential Information”), nor shall the Participant utilize any such Confidential Information in any way or communicate with or contact any such customer, referral source or client other than in connection with the Participant’s employment by the Company or any Subsidiary or Affiliate. The Participant hereby confirms that all Confidential Information constitutes the Company’s exclusive property, and that all of the restrictions on the Participant’s activities contained in this Agreement and such other nondisclosure policies of the Company are required for the Company’s reasonable protection. Confidential Information shall not include any information that has otherwise been disclosed to the public not in violation of this Agreement. This confidentiality provision shall survive the termination of this Agreement and shall not be limited by any other confidentiality agreements entered into with the Company or any Subsidiary or Affiliate. Notwithstanding the foregoing, nothing in this Agreement (or any other Company policy or contract to which the Participant is or was subject) shall be construed to prohibit the Participant from communicating with any federal, state or local governmental agency or commission with oversight of the Company, as provided for, protected under or warranted by applicable law.

With respect to any Confidential Information that constitutes a “trade secret” pursuant to applicable law, the restrictions described above shall remain in force for so long as the particular information remains a trade secret or for the two (2) year period immediately following termination of the Participant’s employment for any reason, whichever is longer. With respect to any Confidential Information that does not constitute a “trade secret” pursuant to applicable law, the restrictions described above shall remain in force during Participant’s employment and for the two (2) year period immediately following termination of such employment for any reason.

The Participant agrees that the Participant shall promptly disclose to the Company in writing all information and inventions generated, conceived or first reduced to practice by the Participant alone or in conjunction with others, during or after working hours, while in the employ of the Company or any Subsidiary or Affiliate (all of which is collectively referred to in this Agreement as “Proprietary Information”); provided, however, that such Proprietary Information shall not include (a) any information that has otherwise been disclosed to the public not in violation of this Agreement and (b) general business knowledge and work skills of the Participant, even if developed or improved by the Participant while in the employ of the Company or any Subsidiary of Affiliate. All such Proprietary Information shall be the exclusive property of the Company and is hereby assigned by the Participant to the Company. The Participant’s obligation relative to the disclosure to the Company of such Proprietary Information anticipated in this Section 9(d) shall continue beyond the Participant’s termination of employment and the Participant shall, at the Company’s expense, give the Company all assistance it reasonably requires to perfect, protect and use its right to the Proprietary Information.
7



(e)Enforcement.

(i)    The Participant acknowledges that compliance with all provisions, covenants and agreements set forth in this Agreement, and the duration, terms and geographical area thereof, are reasonable and necessary to protect the legitimate business interests of the Company and its Subsidiaries and Affiliates.

(ii)    The Participant acknowledges that a breach of the Participant’s obligations under this Section 9 will result in irreparable and continuing damage to the Company and/or its Subsidiaries and Affiliates for which there is no adequate remedy at law.

(iii)    The Participant acknowledges that the Participant’s education, experience and/or abilities are such that the enforcement of the restrictive covenants in this Agreement will not prevent the Participant from earning a living and will not cause any undue hardship upon the Participant.

(iv)    In the event of the violation by the Participant of any of the covenants contained in Section 9, the terms of each such covenant so violated shall be automatically extended from the date on which the Participant permanently ceases such violation for a period equal to the period in which the Participant was in breach of the covenant or for a period of twelve (12) months from the date of the entry by a court of competent jurisdiction of an order or judgment enforcing such covenant(s), whichever period is later.

(v)    The Participant agrees that, in the event of any breach of the restrictive covenants contained in this Agreement, the Company and/or its Subsidiaries and Affiliates shall be entitled to obtain, from any court of competent jurisdiction, preliminary and permanent injunctive relief to restrain the violation of the terms hereof by the Participant, and all persons acting for or on the Participant’s behalf.

(vi)    Each of the restrictive covenants contained in this Agreement is independent of any other contractual obligations of this Agreement or otherwise owed by the Participant to the Company and/or its Subsidiaries and Affiliates. The existence of any claim or cause of action by the Participant against the Company and/or its Subsidiaries or Affiliates, whether based on this Agreement or otherwise, shall not create a defense to the enforcement by the Company and/or its Subsidiaries and Affiliates of any restrictive covenant contained in this Agreement.
(f)Remedies.
(i)    It is intended that, in view of the nature of the Company’s and its Subsidiaries’ and Affiliates’ business, the restrictions contained in this Agreement are considered reasonable and necessary to protect the Company’s and its Subsidiaries’ and Affiliates’ legitimate business interests and that any violation of these restrictions would result in irreparable injury to the Company and/or its Subsidiaries and Affiliates. In the event of a breach (a “Covenant Breach”) or threatened breach by the Participant of any provision contained herein,
8



the Company and its Subsidiaries and Affiliates shall be entitled to a temporary restraining order and injunctive relief without the posting of a bond. Nothing contained herein shall be construed as prohibiting the Company or its Subsidiaries or Affiliates from pursuing any other legal or equitable remedies available to it or them for any breach or threatened breach of these provisions, including, without limitation, recoupment and other remedies specified in the Agreement. In the event of a dispute regarding, arising out of, or in connection with the breach, enforcement or interpretation of this Agreement, including, without limitation, any action seeking injunctive relief, and provided that the Company is the prevailing party, the Company shall recover from the Participant all reasonable attorneys’ fees and costs incurred by the Company in connection therewith.

(ii)    In the event of a Covenant Breach, the Company shall have the authority to (i) cancel any outstanding portion of this Award, whether vested or unvested; and (ii) recoup from the Participant any proceeds paid to the Participant pursuant to this Award. Participant acknowledges and agrees that the Company has no obligation of any kind to the Participant with respect to the cancellation or recoupment of amounts paid or payable pursuant to this Award, including, but not limited to, reimbursement for any taxes previously paid by the Participant with respect to amounts previously paid on account of this Award. This remedy shall be in addition to all other remedies, including those set forth in this Agreement and any other agreements between the parties.
10.Governing Law. This Agreement shall be governed by and construed according to the laws of the State of Delaware without regard to its principles of conflict of laws.
11.Amendments; Construction. The Administrator may amend the terms of this Agreement prospectively or retroactively at any time, but no such amendment shall impair the rights of the Participant hereunder without the Participant’s consent. Headings to Sections of this Agreement are intended for convenience of reference only, are not part of this Agreement and shall have no effect on the interpretation hereof.
12.Survival of Terms. This Agreement shall apply to and bind the Participant and the Company and their respective permitted assignees and transferees, heirs, legatees, executors, administrators and legal successors. The terms of Section 9 and Section 18 shall expressly survive the vesting and/or forfeiture of this Award and any expiration or termination of this Agreement.
13.Agreement Not a Contract for Services. Neither the grant of this Award nor the execution of this Agreement shall constitute or be evidence of any agreement or understanding, express or implied, that the Participant has a right to continue to provide services as an officer, director, employee, consultant or advisor of the Company or any Subsidiary or Affiliate for any period of time or at any specific rate of compensation.
14.Restrictions. No portion of this Award may be sold, transferred, pledged, assigned or otherwise encumbered or disposed of by the Participant. Unless the Administrator determines otherwise, upon any attempt to transfer this Award or any rights in respect of this
9



Award before the lapse of such restrictions, this Award, and all of the rights related thereto, shall be immediately forfeited by the Participant without consideration of any kind.
15.Authority of the Administrator. The Administrator shall have full authority to interpret and construe the terms of this Agreement. The determination of the Administrator as to any such matter of interpretation or construction shall be final, binding and conclusive.
16.Severability. Should any provision of this Agreement be held by a court of competent jurisdiction to be unenforceable, or enforceable only if modified, such holding shall not affect the validity of the remainder of this Agreement, the balance of which shall continue to be binding upon the parties hereto with any such modification (if any) to become a part hereof and treated as though contained in this original Agreement. Moreover, if one or more of the provisions contained in this Agreement shall for any reason be held to be excessively broad as to scope, activity, subject or otherwise so as to be unenforceable, in lieu of severing such unenforceable provision, such provision or provisions shall be construed by the appropriate judicial body by limiting or reducing it or them, so as to be enforceable to the maximum extent compatible with the applicable law as it shall then appear, and such determination by such judicial body shall not affect the enforceability of such provision or provisions in any other jurisdiction.
17.Acceptance. The Participant hereby acknowledges receipt of a copy of this Agreement. The Participant has read and understands the terms and provisions of this Agreement, and accepts the Award subject to all the terms and conditions of this Agreement. The Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Administrator upon any questions arising under this Agreement. By the Participant’s electronically accepting this Award using an online or electronic system established and maintained by the Company or a third party designated by the Company, the Participant agrees to be bound by the terms and conditions of this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. The Participant’s electronic acceptance of this Award shall have the same validity and effect as a signature affixed to this Agreement by the Participant’s hand.
18.Clawback. Notwithstanding anything herein to the contrary, this Award (and any cash paid to the Participant upon settlement thereof) shall be subject to forfeiture, reduction, and/or recoupment (i) to the extent provided in the Company’s Clawback and Forfeiture Policy, as it may be amended from time to time (the “Clawback Policy”); (ii) to the extent that Participant becomes subject to any other recoupment or clawback policy hereafter adopted by the Company, including any such policy adopted by the Company to comply with the requirements of any applicable laws, rules, regulations, or stock exchange listing requirements, including pursuant to final SEC rules under the Dodd-Frank Wall Street Reform and Consumer Protection Act, or (iii) to the extent provided under applicable legal requirements which impose recoupment, under
10



circumstances set forth in such applicable legal requirements, including the Sarbanes-Oxley Act of 2002.
19.Section 409A. This Agreement shall be interpreted in such a manner that all provisions relating to the settlement of this Award are exempt from the requirements of Section 409A of the Code as “short-term deferrals” as described in Section 409A of the Code. Notwithstanding anything to the contrary in this Agreement or an accompanying election form executed by the Participant, if (i) on the date of the Participant’s Separation from Service with the Company the Participant is a “specified employee” (as such term is defined under Section 1.409A-1(i) of the Treasury Regulations promulgated under Section 409A of the Code) of the Company and (ii) any payments to be provided to the Participant pursuant to this Agreement are or may become subject to the additional tax under Section 409A(a)(1)(B) of the Code, or any other taxes or penalties imposed under Section 409A of the Code if provided at the time otherwise required under this Agreement, then such payments shall be delayed until the date that is six months after the date of the Participant’s separation from service from the Company, or if earlier, his or her death. Any payments delayed pursuant to this paragraph shall be made in a lump sum on the first day of the seventh month following the Participant’s separation from service, or if earlier, the Participant’s death. Each payment upon settlement of this Award constitutes a “separate payment” for purposes of Section 409A of the Code. Notwithstanding any other provision of this Agreement, if and to the extent that any payment under this Agreement constitutes non-qualified deferred compensation under Section 409A of the Code, and is payable upon (i) the Participant’s termination of employment, then such payment shall be made or provided to the Participant only upon a “separation from service” as defined for purposes of Section 409A of the Code, or (ii) a Change in Control, then such payment shall be made or provided to the Participant only upon a “change in the ownership”, a “change in effective control” or a “change in the ownership of a substantial portion of the assets” of the applicable corporation as defined for purposes of Section 409A of the Code.

20.Definitions. For purposes of this Agreement, the following terms shall have the following meanings:
(a)“Administrator” means the Compensation Committee of the Board of Directors of the Company, or any other person to whom the authority to administer this Agreement is delegated by the Committee consistent with applicable law.
(b)“Affiliate” means an affiliate of the Company (or other referenced entity, as the case may be) as defined in Rule 12b-2 promulgated under Section 12 of the Securities Exchange Act of 1934, as amended.
(c)“Cause” has the meaning set forth in the Participant's employment or other agreement with the Company or any of its Affiliates, provided that if the Participant is not a party to any such agreement or such agreement does not contain a definition of cause, then “Cause” means (i) the continued failure by the Participant to substantially perform his or her duties and obligations to the Company or any of its Affiliates, including without limitation,
11



repeated refusal to follow the reasonable directions of his or her employer, (ii) the Participant's intentional violation of law in the course of performance of the duties of Participant's employment or service with the Company or any of its Affiliates, (iii) the Participant's engagement in misconduct which is materially injurious to the Company or any of its Affiliates, (iv) the Participant's repeated absences from work without a reasonable excuse, (v) the Participant's intoxication with alcohol or illegal drugs while on the Company's or any Affiliate's premises during regular business hours (other than any such failure resulting from his or her incapacity due to physical or mental illness); (vi) the Participant's fraud or material dishonesty against the Company or any of its Affiliates; or (vii) the Participant's conviction or plea of guilty or nolo contendere for the commission of a felony or a crime involving material dishonesty. Determination of Cause shall be made by the Administrator in its sole discretion.
(d)“Change in Control” shall be deemed to have occurred if an event set forth in any one of the following paragraphs shall have occurred:
(i)    any person is or becomes the beneficial owner, directly or indirectly, of securities of the Company (not including in the securities beneficially owned by such person any securities acquired directly from the Company or any of its Affiliates) representing fifty percent (50%) or more of the combined voting power of the Company's then outstanding securities; or
(ii)the following individuals cease for any reason to constitute a majority of the number of directors then serving on the Board: individuals who, on the Date of Grant, constitute the Board and any new director (other than a director whose initial assumption of office is in connection with an actual or threatened election contest, including, but not limited to, a consent solicitation, relating to the election of directors of the Company) whose appointment or election by the Board or nomination for election by the Company's stockholders was approved or recommended by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors on the Date of Grant or whose appointment, election or nomination for election was previously so approved or recommended; or
(iii)there is consummated a merger or consolidation of the Company or any direct or indirect subsidiary of the Company with any other corporation, other than a merger or consolidation immediately following which the individuals who comprise the Board immediately prior thereto constitute at least a majority of the Board of the entity surviving such merger or consolidation or, if the Company or the entity surviving such merger is then a subsidiary, the ultimate parent thereof; or
(iv)the stockholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated an agreement for the sale or disposition by the Company of all or substantially all of the Company's assets, other than (A) a sale or disposition by the Company of all or substantially all of the Company's assets to an entity, at least fifty percent (50%) of the combined voting power of the voting securities of which are owned by stockholders of the Company following the completion of such transaction in substantially the same proportions as their ownership of the Company immediately prior to such sale or (B) a sale or disposition of all or substantially all of the Company's assets immediately
12



following which the individuals who comprise the Board immediately prior thereto constitute at least a majority of the board of directors of the entity to which such assets are sold or disposed or, if such entity is a subsidiary, the ultimate parent thereof.
Notwithstanding the foregoing, (A) a Change in Control shall not be deemed to have occurred by virtue of the consummation of any transaction or series of integrated transactions immediately following which the holders of shares of the Company’s common stock immediately prior to such transaction or series of transactions continue to have substantially the same proportionate ownership in an entity which owns all or substantially all of the assets of the Company immediately following such transaction or series of transactions and (B) if the Award constitutes deferred compensation under Section 409A of the Code, and solely to the extent required to avoid accelerated taxation and/or tax penalties under Section 409A of the Code, a Change in Control shall be deemed to have occurred with respect to this Award only if a change in the ownership or effective control of the Company or a change in ownership of a substantial portion of the assets of the Company shall also be deemed to have occurred under Section 409A of the Code.
(j)     “Code” means the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto.
(k)    “Disability” means that the Participant, as determined by the Administrator in its sole discretion, is (i) unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, or (ii) by reason of any medically determinable physical or mental impairment which can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months, receiving income replacement benefits for a period of not less than three (3) months under an accident and health plan covering employees of the Company or any of its Affiliates.
(l)    “Subsidiary” means any corporation or other entity in a chain of corporations or other entities (beginning with the Company and ending with the Subsidiary to which the service provider provides direct services on the Date of Grant) in which each corporation or other entity has a "controlling interest" in another corporation or other entity in the chain (within the meaning of Treasury Regulation Section 1.409A-1(b)(5)(iii)(E)). 


[Signature page to follow.]

13



IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the day and year first above written.

BROOKDALE SENIOR LIVING INC.


By: /s/ Chad C. White    
Name:     Chad C. White
Title:     Executive Vice President, General Counsel and Secretary


PARTICIPANT

/s/ Lucinda M. Baier            
Lucinda M. Baier

14


    
    
EXHIBIT A

[Strategic Goal]*


% of Target First Tranche to Vest
[__]% (Maximum)150%
[__]% (Target)100%
[__]%75%
[__]%50%
[__]% (Threshold)25%

*Subject in all cases to the terms of the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Agreement.




            
EXHIBIT B

2022 RevPAR Growth

Vesting of the Second Tranche (plus any Additional Award Amount that becomes payable pursuant to Section 2(a) of the Agreement) will be dependent upon the Company’s one-year growth of Same Community RevPAR for fiscal 2022 compared to a base year of fiscal 2021 as set forth in the grid below, with vesting to be interpolated on a straight-line basis between the applicable levels based on actual results. Same Community RevPAR means the Same Community RevPAR as reported by the Company in its Annual Report on Form 10-K, earnings release and/or supplemental information for the year ended December 31, 2022.

Growth Rate% of Target Second Tranche to Vest
[__]% (Maximum)150%
[__]% (Target)100%
[__]% (Threshold)50%

*Subject in all cases to the terms of the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Agreement.




            
EXHIBIT C

2023 RevPAR Growth

Vesting of the Third Tranche (plus any Additional Award Amount that becomes payable pursuant to Section 2(a) of the Agreement) will be dependent upon the Company’s one-year growth of Same Community RevPAR for fiscal 2023 compared to a base year of fiscal 2022 as set forth in the grid below, with vesting to be interpolated on a straight-line basis between the applicable levels based on actual results. Same Community RevPAR means the Same Community RevPAR as reported by the Company in its Annual Report on Form 10-K, earnings release and/or supplemental information for the year ended December 31, 2023.

Growth Rate% of Target Third Tranche to Vest
[__]% (Maximum)150%
[__]% (Target)100%
[__]% (Threshold)50%

*Subject in all cases to the terms of the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Agreement.






            
EXHIBIT D

Relative TSR*

Vesting of the Fourth Tranche (plus any Additional Award Amount that becomes payable pursuant to Section 2(a) of the Agreement) will be dependent upon the Company’s TSR ranking relative to the TSRs of the companies in the Comparator Group during the Performance Period as set forth in the grid below, with vesting to be interpolated on a straight-line basis between the applicable levels based on actual results; provided, however, that in no event shall any Additional Award Amount (above 100%) vest and be paid with respect to the Fourth Tranche if the Company’s TSR is negative for the Performance Period.

Relative TSR Performance% of Target Fourth Tranche to Vest
[__]th Percentile (Maximum)150%
[__]th Percentile (Target)100%
[__]th Percentile (Threshold)
50%

For purposes of the foregoing:

Performance Period shall mean January 1, 2021 through December 31, 2023
Comparator Group shall mean the constituent companies of the S&P Midcap 400 as of the beginning of the Performance Period, except that any such companies that have been acquired or delisted from a national securities exchange during the Performance Period will be excluded.
TSR shall mean the compound annual total stockholder return calculated using a beginning price equal to the average closing price over the 20-trading days preceding the beginning of the Performance Period, using an ending price equal to the average closing price over the 20-trading days immediately prior to the end of the Performance Period, and assuming the reinvestment of any dividends or distributions as of the ex-dividend date.


*Subject in all cases to the terms of the Agreement, including the discretionary and interpretative authority of the Administrator set forth in the Agreement.


EX-10.5 6 exhibit105-formofforfeitur.htm EX-10.5 Document

Exhibit 10.5
February 22, 2021

Dear ________:
The Compensation Committee (the “Committee”) of the Company’s Board of Directors conditionally approved a discretionary cash amount to be paid to you for your extraordinary efforts during the year. Such amount has been separately communicated to you. Your eligibility to receive payment of the discretionary amount is subject to your agreeing to forfeit all your outstanding equity awards granted in 2019 and 2020 that are subject to a same community RevPAR performance goal. If you agree to such forfeiture, the discretionary amount will be paid in the ordinary course, which is expected in March 2021.
Specifically, reference is made to the Restricted Share Agreement (the “RSA”) and the Performance-Based Restricted Stock Unit Agreement (the “RSUA”) pursuant to which awards of performance-based restricted stock and performance-based restricted stock units were granted under the Brookdale Senior Living Inc. Omnibus Incentive Plan, as amended, in 2019 and 2020, respectively. If you agree to the terms of this letter, effective on February 22, 2021:
All of your outstanding First Tranche Restricted Shares (as defined in the RSA), if any, and your outstanding First Tranche PSUs (as defined in the RSUA) will be immediately forfeited by you and transferred to, and reacquired by, the Company. For the avoidance of doubt, no additional restricted shares shall become issuable pursuant to the RSA with respect to the First Tranche Restricted Shares, no additional PSUs shall become issuable pursuant to the RSUA with respect to the First Tranche PSUs, and references in the RSA and RSUA to the First Tranche Shares and First Tranche PSUs shall refer to zero. Neither you nor any of your successors, heirs, assigns, or personal representatives shall thereafter have any further rights or interests in such forfeited equity awards.
Your Second Tranche Restricted Shares (as defined in the RSA) and Second Tranche PSUs (as defined in the RSUA) will remain outstanding and subject to the terms of the RSA and RSUA, as applicable.
If you desire to forfeit the portions of your outstanding awards as set forth above and to be eligible to receive the discretionary cash amount, please sign and return this letter.
Sincerely,

                    

Acknowledged and Agreed:
                
                

EX-31.1 7 exhibit3113312021nextgen.htm EX-31.1 Document

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Lucinda M. Baier, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Brookdale Senior Living Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:May 7, 2021 /s/ Lucinda M. Baier
  Lucinda M. Baier
  President and Chief Executive Officer


EX-31.2 8 exhibit3123312021nextgen.htm EX-31.2 Document

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven E. Swain, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of Brookdale Senior Living Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
Date:May 7, 2021 /s/ Steven E. Swain
  Steven E. Swain
  Executive Vice President and Chief Financial Officer


EX-32 9 exhibit323312021nextgen.htm EX-32 Document

EXHIBIT 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL
OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Brookdale Senior Living Inc. (the “Company”) for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Lucinda M. Baier, as President and Chief Executive Officer of the Company, and Steven E. Swain, as Executive Vice President and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.



/s/ Lucinda M. Baier
Name: Lucinda M. Baier
Title: President and Chief Executive Officer
Date: May 7, 2021


/s/ Steven E. Swain
Name: Steven E. Swain
Title: Executive Vice President and Chief Financial Officer
Date: May 7, 2021


EX-101.SCH 10 bkd-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EQUITY link:presentationLink link:calculationLink link:definitionLink 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 2101101 - Disclosure - Description of Business link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - Description of Business Description of Business (Details) link:presentationLink link:calculationLink link:definitionLink 2103102 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 2105103 - Disclosure - COVID-19 Pandemic link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - COVID-19 Pandemic - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2107104 - Disclosure - Acquisitions, Dispositions and Other Transactions link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Acquisitions, Dispositions and Other Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - Acquisitions, Dispositions and Other Transactions - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2410404 - Disclosure - Acquisitions, Dispositions and Other Transactions - Disclosure of Assets and Liabilities Held-for-sale (Details) link:presentationLink link:calculationLink link:definitionLink 2111105 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2312302 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2413405 - Disclosure - Fair Value Measurements -Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2414406 - Disclosure - Fair Value Measurements - Asset Impairment (Details) link:presentationLink link:calculationLink link:definitionLink 2115106 - Disclosure - Revenue link:presentationLink link:calculationLink link:definitionLink 2316303 - Disclosure - Revenue (Tables) link:presentationLink link:calculationLink link:definitionLink 2417407 - Disclosure - Revenue - Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 2418408 - Disclosure - Revenue - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2119107 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net link:presentationLink link:calculationLink link:definitionLink 2320304 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 2421409 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net (Details) link:presentationLink link:calculationLink link:definitionLink 2122108 - Disclosure - Goodwill link:presentationLink link:calculationLink link:definitionLink 2423410 - Disclosure - Goodwill - Additional Information (Details) link:presentationLink link:calculationLink link:definitionLink 2124109 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 2325305 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 2426411 - Disclosure - Debt - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 2427412 - Disclosure - Debt - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2128110 - Disclosure - Leases link:presentationLink link:calculationLink link:definitionLink 2329306 - Disclosure - Leases (Tables) link:presentationLink link:calculationLink link:definitionLink 2430413 - Disclosure - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2431414 - Disclosure - Leases - Lease Costs (Details) link:presentationLink link:calculationLink link:definitionLink 2432415 - Disclosure - Leases - Maturity ASC 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2432415 - Disclosure - Leases - Maturity ASC 842 (Details) link:presentationLink link:calculationLink link:definitionLink 2133111 - Disclosure - Litigation link:presentationLink link:calculationLink link:definitionLink 2134112 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 2335307 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:calculationLink link:definitionLink 2436416 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:calculationLink link:definitionLink 2137113 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 2338308 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 2439417 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) link:presentationLink link:calculationLink link:definitionLink 2440418 - Disclosure - Earnings Per Share - Schedule of Potentially Dilutive Securities (Details) link:presentationLink link:calculationLink link:definitionLink 2141114 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2442419 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2143115 - Disclosure - Supplemental Disclosure of Cash Flow Information link:presentationLink link:calculationLink link:definitionLink 2344309 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2445420 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 2446421 - Disclosure - Supplemental Disclosure of Cash Flow Information - Schedule of cash, cash equivalents, and restricted cash (Details) link:presentationLink link:calculationLink link:definitionLink 2147116 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2348310 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 2449422 - Disclosure - Segment Information (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 bkd-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 bkd-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 bkd-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Restricted Stock and Restricted Stock Unit Grants (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Document Type Document Type Facility operating expense Facility Operating Expense, COVID-19 Facility Operating Expense, COVID-19 Other non-operating income (loss) Other Nonoperating Income (Expense) Related Party [Axis] Related Party [Axis] Trade accounts payable and accrued expenses Increase (Decrease) in Accounts Payable and Accrued Liabilities Treasury stock: Treasury Stock [Member] Management fees Management Service [Member] Non-development - reimbursable Non-development - Reimbursable [Member] Non-development - Reimbursable [Member] Segments [Axis] Segments [Axis] Recoupment Of Accelerated/Advanced Payments [Domain] Recoupment Of Accelerated/Advanced Payments [Domain] Recoupment Of Accelerated/Advanced Payments [Domain] Lease Accounting Lessee, Leases [Policy Text Block] Sale and maturities of marketable securities Proceeds from Sale and Maturity of Marketable Securities Noncash or Part Noncash Acquisition, Name [Domain] Noncash or Part Noncash Acquisition, Name [Domain] Prepaid insurance premiums financed with notes payable Increase (Decrease) in Prepaid Insurance Premiums Increase (Decrease) in Prepaid Insurance Premiums Statistical Measurement [Domain] Statistical Measurement [Domain] Liabilities and Equity Liabilities and Equity [Abstract] Line of Credit Line of Credit [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Deferred tax liability Deferred Income Tax Liabilities, Net Weighted Average Grant Date Fair Value (in dollars per share) Share Based Compensation Shares Value Per Share The grant date fair values for purposes of disclosing shares potentially issuable under restricted stock awards on all restricted stock plans and other required information pertaining to awards in the customized range. Financing lease obligations Interest expense: financing lease obligations Finance Lease, Right-of-Use Asset, Interest Expense Finance Lease, Right-of-Use Asset, Interest Expense Security Exchange Name Security Exchange Name Proceeds from debt Proceeds from Issuance of Long-term Debt Income (loss) from operations Operating Income (Loss) Payment of financing costs, net of related payables Payments of Debt Issuance Costs Change in lease security deposits and lease acquisition deposits, net Increase (Decrease) in Deposit Assets Total current liabilities Liabilities, Current Performance-based restricted stock and restricted stock units Performance Shares [Member] Prepaid expenses and other current assets, net Prepaid Expense and Other Assets, Current Federal, State, and Local Federal Tax Authority And State And Local Jurisdiction [Member] The designated tax department of Federal and a state or local government entitled to levy and collect income taxes from the entity. Total lease payments Finance Lease, Liability, Payment, Due Shares withheld for employee taxes Share-based Payment Arrangement, Decrease for Tax Withholding Obligation Restricted stock and restricted stock units, net Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Purchase of treasury stock, net of related payables Payments for Repurchase of Common Stock Assets Assets [Abstract] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Accounting Policies [Abstract] Accounting Policies [Abstract] Furniture and equipment Furniture and Fixtures [Member] Entity Address, State or Province Entity Address, State or Province Operating net cash outflows from operating leases Operating Lease, Payments Private pay Self-Pay [Member] Noncash or Part Noncash Acquisitions by Unique Description [Axis] Noncash or Part Noncash Acquisitions by Unique Description [Axis] Operating and financing leases, number of communities Operating and Financing Leases, Number Of Communities Operating and Financing Leases, Number Of Communities Unusual or Infrequent Item, or Both [Line Items] Unusual or Infrequent Item, or Both [Line Items] Accumulated deficit Retained Earnings (Accumulated Deficit) Health Care Organization, Revenue Sources [Axis] Health Care Organization, Revenue Sources [Axis] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Loans Insured or Guaranteed by Government Authorities [Axis] Loans Insured or Guaranteed by Government Authorities [Axis] Gain (loss) on debt modification and extinguishment, net Loss (gain) on debt modification and extinguishment, net Loss (gain) on debt modification and extinguishment, net Gain (Loss) on Extinguishment of Debt Ventas, Inc Ventas, Inc [Member] Ventas, Inc [Member] 2022 Lessee, Operating Lease, Liability, to be Paid, Year One Purchase of treasury stock (in shares) Treasury Stock, Shares, Acquired 2022 Finance Lease, Liability, to be Paid, Year One 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Litigation Legal Matters and Contingencies [Text Block] Preferred stock, $0.01 par value, 50,000,000 shares authorized at March 31, 2021 and December 31, 2020; no shares issued and outstanding Preferred Stock, Value, Issued Property, plant and equipment and leasehold intangibles, net Tangible Asset Impairment Charges Investment in unconsolidated ventures Investments in unconsolidated ventures Payments to Acquire Equity Method Investments Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Other liabilities Other Liabilities, Noncurrent Expense Cost of Revenue [Abstract] Financing cash flows from financing leases Finance Lease, Principal Payments Marketable securities Marketable Securities, Current Depreciation and amortization expense Depreciation and amortization expense for plant and equipment and leasehold intangibles The current period expense charged against earnings on long-lived, physical assets not used in production, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset. Revenue Revenue from Contract with Customer, Excluding Assessed Tax Measurement Frequency [Domain] Measurement Frequency [Domain] Business Acquisition [Axis] Business Acquisition [Axis] Decrease in accrued payroll taxes Increase (Decrease) in Accrued Payroll Taxes Increase (Decrease) in Accrued Payroll Taxes Facility operating lease expense Facility lease expense Operating Lease, Facility Expense Operating Lease, Facility Expense Statement [Line Items] Statement [Line Items] Schedule of Potentially Dilutive Securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Employer portion of payroll taxes delayed Accrued Payroll Taxes Forecast Forecast [Member] Earnings Per Share, Basic and Diluted [Abstract] Earnings Per Share, Basic and Diluted [Abstract] Weighted average interest rate Long-term Debt, Weighted Average Interest Rate, at Point in Time Refundable fees and deferred revenue Disposal Group, Including Discontinued Operation, Deferred Revenue, Current Statement [Table] Statement [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Credit Facility [Axis] Credit Facility [Axis] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Unusual or Infrequent Items, or Both [Abstract] Other liabilities (Increase) Decrease In Other Liabilities (Increase) Decrease In Other Liabilities Nonrecurring Fair Value, Nonrecurring [Member] Business Combinations [Abstract] Business Combinations [Abstract] Government reimbursement Government Reimbursement [Member] Government Reimbursement [Member] Entity Small Business Entity Small Business Principles of Consolidation Consolidation, Policy [Policy Text Block] Operating Leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Percentage of total debt Debt Instrument, Percentage Of Total Debt Debt Instrument, Percentage Of Total Debt Additions to property, plant and equipment and leasehold improvements Additions to property, plant and equipment and leasehold improvements [Member] Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment. Operating lease expense adjustment Operating Lease Expense Adjustments Operating Lease Expense Adjustments Debt Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Non-cash stock-based compensation expense APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition Depreciation and amortization Finance Lease, Right-of-Use Asset, Depreciation and Amortization Finance Lease, Right-of-Use Asset, Depreciation and Amortization Trade accounts payable Disposal Group, Including Discontinued Operation, Accounts Payable, Current Amendment Flag Amendment Flag Schedule of Earnings Per Share, Basic and Diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Percentage of communities accepting new visitors and move-ins Percentage Of Communities Accepting New Visitors And Move-Ins Percentage Of Communities Accepting New Visitors And Move-Ins Leases Lessee, Finance Leases [Text Block] Facility operating expense Real Estate [Member] Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Entity Central Index Key Entity Central Index Key Related Party [Domain] Related Party [Domain] Measurement Frequency [Axis] Measurement Frequency [Axis] Supplemental Disclosure of Cash Flow Information Cash Flow, Supplemental Disclosures [Text Block] Proceeds from sale of assets, net Proceeds from sale of assets, net [Member] The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets. Segments [Domain] Segments [Domain] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Grants of Restricted Stock and Stock Units Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Cash Flows from Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Lease Costs Lease, Cost [Table Text Block] Line of Credit Facility [Table] Line of Credit Facility [Table] 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Other operating income Other Operating Income [Member] Other Operating Income [Member] Other assets, net Other Assets, Noncurrent Financing leases, number of communities Financing Leases, Number Of Communities Financing Leases, Number Of Communities Segment Information Segment Reporting Disclosure [Text Block] CCRCs CCRCs CCRCs Rental [Member] The Company's CCRCs - Rental segment includes large owned or leased communities that offer a variety of living arrangements and services to accommodate all levels of physical ability and health. Most of the Company's CCRCs have independent living, assisted living and skilled nursing available on one campus or within the immediate market, and some also include memory care/Alzheimer's units. Restricted stock and restricted stock units, net (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Operating cash flows from financing leases Finance Lease, Interest Payment on Liability Total assets Total assets Assets Securities Purchase Agreement Securities Purchase Agreement [Member] Securities Purchase Agreement Refundable fees and deferred revenue Refundable Fees And Deferred Revenue, Current Refundable Fees And Deferred Revenue, Current Scenario [Axis] Scenario [Axis] Accrued expenses Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current Title of 12(b) Security Title of 12(b) Security Disposal Group Classification [Axis] Disposal Group Classification [Axis] Financing Leases Finance Lease, Liability, Payment, Due [Abstract] Letter of Credit Sublimit Letter of credit sublimit [Member] Letter of credit sublimit on the secured line of credit facility Amortization of entrance fees Recognition of Contract Liability Recognition of Contract Liability Antidilutive Securities [Axis] Antidilutive Securities [Axis] Employee retention credit, amount recognized Employee Retention Credit, Amount Recognized Employee Retention Credit, Amount Recognized Finance Lease, Liability, Maturity Finance Lease, Liability, Fiscal Year Maturity [Table Text Block] Sale of stock, consideration received on transaction Sale of Stock, Consideration Received on Transaction Acquisitions, Dispositions and Other Transactions Mergers, Acquisitions and Dispositions Disclosures [Text Block] Depreciation and amortization, net Depreciation, Depletion and Amortization Reimbursed costs incurred on behalf of managed communities Reimbursement Costs, Managed Communities [Member] Reimbursement Costs, Managed Communities [Member] Employee retention credit, percent of wages Employee Retention Credit, Percent Of Wages Employee Retention Credit, Percent Of Wages Product and Service [Axis] Product and Service [Axis] Total liabilities Liabilities Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement Increase (Decrease) In Finance Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements Increase (Decrease) In Finance Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements Prepaid expenses and other assets, net Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current CARES Act CARES Act [Member] CARES Act [Member] Supplemental Cash Flow Elements [Abstract] Supplemental Cash Flow Elements [Abstract] Operating lease assets and liabilities for lessor capital expenditure reimbursements Payments (Proceeds) For Lessor Capital Expenditure Impairment Payments (Proceeds) For Lessor Capital Expenditure Impairment Imputed interest and variable lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Assets held for sale Assets Held-for-sale, Long Lived, Fair Value Disclosure Revenue recognized Contract with Customer, Liability, Revenue Recognized Other third-party payor programs Third-Party Payor [Member] Operating lease expense Operating Lease, Expense Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Restricted cash Long-term restricted cash Restricted Cash and Cash Equivalents, Noncurrent Increase (decrease) in valuation allowance Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Debt Instrument [Axis] Debt Instrument [Axis] Additional paid-in-capital: Additional Paid-in Capital [Member] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Operating Segments Operating Segments [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Accrued expenses Increase (Decrease) in Accrued Liabilities Purchase of treasury stock Treasury Stock, Value, Acquired, Cost Method The Continuing Appropriations Act, 2021 and Other Extensions Act The Continuing Appropriations Act, 2021 and Other Extensions Act [Member] The Continuing Appropriations Act, 2021 and Other Extensions Act Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Financing lease expense Finance Lease, Interest Expense Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Net cash proceeds Proceeds from Sales of Business, Affiliate and Productive Assets Common stock, shares outstanding (in shares) Balance at beginning of period (in shares) Balances at end of period (in shares) Common Stock, Shares, Outstanding Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Net cash received Proceeds (Repayments) from Sale of Property, Plant, and Equipment, Net Proceeds (Repayments) from Sale of Property, Plant, and Equipment, Net Revolving Credit Facility Revolving Credit Facility [Member] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Operating lease right-of-use assets Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Purchase option liability and non-cash gain on future sale of property Operating Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale Of Property Operating Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale Of Property Net cash paid Payments to Acquire Businesses, Net of Cash Acquired Letters of credit issued Letters of Credit Outstanding, Amount Common stock, shares authorized (in shares) Common Stock, Shares Authorized Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements Increase (Decrease) In Operating Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements Increase (Decrease) In Operating Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements Schedule of segment reporting information Schedule of Segment Reporting Information, by Segment [Table Text Block] Debt Interest Expense, Debt, Excluding Amortization Income Statement [Abstract] Income Statement [Abstract] Gain (loss) on sale of assets, net Loss (gain) on sale of assets, net Gain on sale of assets Loss (gain) on sale of assets, net Gain (Loss) on Disposition of Assets Period Two Period Two [Member] Period Two Operating lease obligations, less current portion Operating Lease, Liability, Noncurrent Prepaid expenses and other assets, net Prepaid expenses and other assets, net Increase (Decrease) in Prepaid Expense and Other Assets Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Refundable fees and deferred revenue Increase (Decrease) in Refundable Fees and Contract with Customers, Liability Increase (Decrease) in Refundable Fees and Contract with Customers, Liability Noncash lease termination and modification, net Noncash, Lease Termination And Modification, Net [Member] Noncash, Lease Termination And Modification, Net [Member] Debt discount and deferred financing costs, net Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Use of Estimates Use of Estimates, Policy [Policy Text Block] Current assets Assets, Current [Abstract] Interest income Investment Income, Interest Assets held for sale Increase (Decrease) in Assets Held-for-sale Income Tax Authority [Domain] Income Tax Authority [Domain] Recoupment Of Accelerated/Advanced Payments [Axis] Recoupment Of Accelerated/Advanced Payments [Axis] Recoupment Of Accelerated/Advanced Payments Amount received from Accelerated and Advance Payment Program Amount Received From Accelerated And Advance Payment Program Amount Received From Accelerated And Advance Payment Program 2024 Finance Lease, Liability, to be Paid, Year Three Trade accounts payable Increase (Decrease) in Accounts Payable, Trade Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Operating lease obligations Disposal Group, Including Discontinued Operation, Operating Lease Obligations, Current Disposal Group, Including Discontinued Operation, Operating Lease Obligations, Current Scenario [Domain] Scenario [Domain] Counterparty Name [Domain] Counterparty Name [Domain] Capital expenditures, net of related payables Net cash paid Payments to Acquire Property, Plant, and Equipment City Area Code City Area Code Consolidation Items [Domain] Consolidation Items [Domain] Net Net Net amount of non-cash operating, investing and financing activities Income Tax Authority [Axis] Income Tax Authority [Axis] Document Period End Date Document Period End Date Maximum credit amount per employee Employee Retention Credit, Maximum Credit Amount Per Employee Employee Retention Credit, Maximum Credit Amount Per Employee Goodwill Goodwill and Intangible Assets Disclosure [Text Block] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Valuation Allowance [Table] Valuation Allowance [Table] CCRC Ventures, LLC Proceeds from sale of CCRC Venture, net: CCRC Ventures, LLC [Member] CCRC Ventures, LLC Equity in earnings (loss) of unconsolidated ventures Equity in (earnings) loss of unconsolidated ventures Income (Loss) from Equity Method Investments Net income (loss) Net income (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Litigation [Abstract] Litigation [Abstract] Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Resident and leasehold operating intangibles Resident and leasehold operating intangibles [Member] Long-lived, depreciable assets including all assets held by a lessee under a capital lease and any addition or improvement to assets held under lease arrangement (including addition or improvement to asset held by lessee under operating lease arrangement). Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Other notes payable Notes Payable, Other Payables [Member] HCA Healthcare, Inc. HCA Healthcare, Inc. [Member] HCA Healthcare, Inc. Accounts receivable, net Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Non-cash stock-based compensation expense Share-based Payment Arrangement, Noncash Expense Medicare advance payments Medicare Advance Payments Medicare Advance Payments Other Proceeds from (Payments for) Other Financing Activities Payments of employee taxes for withheld shares Payment, Tax Withholding, Share-based Payment Arrangement Cover [Abstract] Cover [Abstract] Healthpeak Healthpeak [Member] Healthpeak [Member] Revenue from government grants Revenue from Government Grants Revenue from Government Grants Goodwill [Line Items] Goodwill [Line Items] Total long-term debt Total long-term debt Long-term Debt Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Leases Lessee, Operating Leases [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Costs of services Cost of Goods and Services Sold Acquisition of assets, net of related payables and cash received Series of Individually Immaterial Business Acquisitions [Member] Depreciation and amortization Cost, Depreciation and Amortization Total operating expense Costs and Expenses Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member] Equity Components [Axis] Equity Components [Axis] Acquisition of assets, net of related payables [Line Items] Noncash or Part Noncash Acquisitions [Line Items] Unvested Restricted Stock Restricted Stock [Member] Restricted cash Restricted cash Restricted Cash and Investments, Current Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Minimum Minimum [Member] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Land Land [Member] Investment in unconsolidated ventures Equity Method Investment, Other than Temporary Impairment Property, plant and equipment and leasehold intangibles, net Property, plant and equipment and leasehold intangibles, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Current portion of operating lease obligations Operating Lease, Liability, Current Disposal Group, Including Discontinued Operation, Assets [Abstract] Disposal Group, Including Discontinued Operation, Assets [Abstract] Supplemental Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Net (income) loss attributable to noncontrolling interest Net Income (Loss) Attributable to Noncontrolling Interest Entity Interactive Data Current Entity Interactive Data Current Total liquidity Investments and Cash Revenue Revenues [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Assets held for sale Disposal Group, Including Discontinued Operation, Assets, Current Unusual or Infrequent Item, or Both [Axis] Unusual or Infrequent Item, or Both [Axis] Proceeds from deferred entrance fee revenue Proceeds From Deferred Entrance Fee Revenue Proceeds From Deferred Entrance Fee Revenue Cumulative Effect Period Of Adoption Adjustment Cumulative Effect, Period of Adoption, Adjustment [Member] Entity Registrant Name Entity Registrant Name Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Cash made available for Provider Relief Fund Grants Made Available, Provider Relief Fund Grants Made Available, Provider Relief Fund Asset impairment Asset impairment Asset impairment Asset Impairment Charges Proceeds from sale of assets, net Proceeds from Sale of Property, Plant, and Equipment Number of reportable segments Number of Reportable Segments Imputed interest and variable lease payments Finance Lease, Liability, Undiscounted Excess Amount Thereafter Lessee, Operating Lease, Liability, To Be Paid, After Year Four Lessee, Operating Lease, Liability, To Be Paid, After Year Four Consolidation Items [Axis] Consolidation Items [Axis] Loans Insured or Guaranteed by Government Authorities [Domain] Loans Insured or Guaranteed by Government Authorities [Domain] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Total lease payments Lessee, Operating Lease, Liability, to be Paid Depreciation and amortization Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Liabilities held for sale Liabilities Held-For-Sale, Not Part Of Disposal Group, Current Liabilities Held-For-Sale, Not Part Of Disposal Group, Current Other, net Adjustments to Additional Paid in Capital, Other Schedule of Cash, Cash Equivalents, and Restricted Cash Schedule of Cash and Cash Equivalents [Table Text Block] Communities Disposed of Through Lease Terminations Communities Disposed Of Through Lease Terminations [Member] Communities Disposed Of Through Lease Terminations [Member] Healthpeak master lease modification: Healthpeak Master Lease Modification [Member] Healthpeak Master Lease Modification [Member] Mortgage debt SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate Entity Address, Postal Zip Code Entity Address, Postal Zip Code Operating lease expense adjustment Operating Lease, Expense, Adjustment Operating Lease, Expense, Adjustment Goodwill Goodwill Monthly resident fees Contract With Customer, Liability, Deferred Revenue, Monthly Resident Fees Contract With Customer, Liability, Deferred Revenue, Monthly Resident Fees Repayment of debt and financing lease obligations Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security Document Transition Report Document Transition Report Total net cash outflows from financing leases Financing Lease, Payments Financing Lease, Payments Sale of stock, percentage of ownership sold in transaction Sale Of Stock, Percentage Of Ownership Sold In Transaction Sale Of Stock, Percentage Of Ownership Sold In Transaction Level 2 Fair Value, Inputs, Level 2 [Member] Buildings and improvements Building and Building Improvements [Member] Summary of Asset Impairment Expense Fair Value Measurements, Nonrecurring [Table Text Block] Document Quarterly Report Document Quarterly Report Purchase option liability and non-cash gain on future sale of property Finance Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale of Property Finance Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale of Property Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Property, plant and equipment and leasehold intangibles, net Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current Supplemental Schedule of Non-cash Operating, Investing and Financing Activities: Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Trade accounts payable Accounts Payable, Trade, Current Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] Credit Facility [Domain] Credit Facility [Domain] Diluted (in shares) Weighted average shares outstanding - diluted Weighted Average Number of Shares Outstanding, Diluted Letter of Credit Letter of Credit [Member] Period One Period One [Member] Period One Basic (in dollars per share) Earnings Per Share, Basic Entity File Number Entity File Number Debt Disclosure [Abstract] Debt Disclosure [Abstract] Relief received from Provider Relief Fund Relief Received, Provider Relief Fund Relief Received, Provider Relief Fund Amortization of deferred financing costs and debt discount Amortization of Debt Issuance Costs and Discounts Non-performance-based restricted stock and restricted stock units Restricted Stock And Restricted Stock Units (RSUs) [Member] Restricted Stock And Restricted Stock Units (RSUs) Disclosure of Assets and Liabilities Held-for-sale Disposal Groups, Including Discontinued Operations [Table Text Block] Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Non-development Non-Development [Member] Non-Development [Member] Non-cash stock-based compensation expense Share-based Payment Arrangement, Expense Balance Sheet Location [Axis] Balance Sheet Location [Axis] Issuance of common stock under Associate Stock Purchase Plan Stock Issued During Period, Value, Employee Stock Purchase Plan Counterparty Name [Axis] Counterparty Name [Axis] Common stock, $0.01 par value, 400,000,000 shares authorized at March 31, 2021 and December 31, 2020; 197,757,065 and 198,331,663 shares issued and 187,229,540 and 187,804,138 shares outstanding (including 2,063,391 and 4,349,421 unvested restricted shares), respectively Common Stock, Value, Issued Acquisition of communities from Healthpeak Acquisition Of Communities From Healthpeak [Member] Acquisition Of Communities From Healthpeak [Member] Fifth Amended and Restated Credit Agreement Fifth Amended And Restated Credit Agreement [Member] Fifth Amended And Restated Credit Agreement [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Disposal Group Name [Axis] Disposal Group Name [Axis] Document Fiscal Year Focus Document Fiscal Year Focus Deferred federal, state and local tax expense (benefit) Net Deferred Income Tax Expense (Benefit) Net amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations, excluding the impact of an increase (decrease) in the valuation allowance for a specified deferred tax asset. Current portion of long-term debt Current portion Long-term Debt, Current Maturities Entity Current Reporting Status Entity Current Reporting Status Number of communities acquired Number Of Communities Acquired Number Of Communities Acquired 2025 Finance Lease, Liability, to be Paid, Year Four Related Party Transaction [Axis] Related Party Transaction [Axis] Management Services Management Services [Member] The Company's management services segment includes communities owned by others and operated by the company pursuant to management agreements. Under the management agreements for these communities, the company receives management fees as well as reimbursed expenses, which represent the reimbursement of certain expenses it incurs on behalf of the owners. Deferred Revenue and Credits Deferred Revenue And Credits [Member] Deferred Revenue And Credits [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Noncontrolling interest Stockholders' Equity Attributable to Noncontrolling Interest Cash Flows from Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Common stock, shares issued (in shares) Common Stock, Shares, Issued Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Capital Expenditure, Type [Domain] Capital Expenditure, Type [Domain] [Domain] for Capital Expenditure, Type [Axis] Communities Disposed of Through Sale Communities Disposed Of Through Sale [Member] Communities Disposed Of Through Sale [Member] Total lease obligations Operating Lease, Liability Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Long-term debt, less current portion Long-term Debt, Excluding Current Maturities Segment Reporting [Abstract] Segment Reporting [Abstract] Accounts receivable, net Increase (Decrease) in Accounts Receivable Long-Term Debt, Capital and Financing Leases and Financing Obligations [Line Items] Debt Instrument [Line Items] Total Brookdale Senior Living Inc. stockholders' equity Stockholders' Equity Attributable to Parent Liabilities held for sale Disposal Group, Including Discontinued Operation, Liabilities, Current Sale of 2 communities Sale Of 2 Communities [Member] Sale Of 2 Communities [Member] Description of Business Nature of Operations [Text Block] Total liabilities and equity Liabilities and Equity Noncash or Part Noncash Acquisitions [Table] Noncash or Part Noncash Acquisitions [Table] Income Taxes Income Tax Disclosure [Text Block] Entity Address, City or Town Entity Address, City or Town Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Communities Acquired Previously Leased Or Managed Communities Acquired Previously Leased Or Managed [Member] Communities Acquired Previously Leased Or Managed [Member] General and administrative expense (including non-cash stock-based compensation expense of $4,783 and $5,957, respectively) General and administrative expense (including non-cash stock-based compensation expense) General and Administrative Expense Credit Facilities [Line Items] Line of Credit Facility [Line Items] Other Other Noncash Income (Expense) Health Care Services Health Care Services Health Care Services [Member] Health Care Services [Member] Equity Component [Domain] Equity Component [Domain] Valuation allowance Deferred Tax Assets, Valuation Allowance Segment operating income Gross Profit Construction in progress Construction in Progress [Member] Entity Tax Identification Number Entity Tax Identification Number Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Stock-Based Compensation Share-based Payment Arrangement [Text Block] Net income (loss) attributable to Brookdale Senior Living Inc. common stockholders Net income (loss) Net Income (Loss) Attributable to Parent Financing lease obligations, less current portion Finance Lease, Liability, Noncurrent Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Health Care Organization, Revenue Sources [Domain] Health Care Organization, Revenue Sources [Domain] Financing lease obligations Financing Lease Obligations Financing Lease Obligations 2021 (nine months) Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Independent Living Independent Living Independent Living [Member] Independent Living [Member] Assets under financing leases and leasehold improvements Assets Under Financing Leases and Leasehold Intangibles [Member] Assets Under Financing Leases and Leasehold Intangibles [Member] Number of owned communities transferred Number Of Owned Communities Transferred Number Of Owned Communities Transferred Leases [Abstract] Leases [Abstract] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Total current assets Assets, Current Current Fiscal Year End Date Current Fiscal Year End Date Recoupment of accelerated/advanced payments period Recoupment Of Accelerated/Advanced Payments Period Recoupment Of Accelerated/Advanced Payments Period Net income (loss) per share attributable to Brookdale Senior Living Inc. common stockholders: Earnings Per Share [Abstract] Earnings Per Share [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Total lease obligations Finance Lease, Liability Gross deferred federal, state and local tax benefit Deferred Federal, State and Local, Tax Expense (Benefit) Property, plant and equipment and leasehold intangibles Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization Sale of 1 community Sale of 1 Community [Member] Sale of 1 Community [Member] Development Development [Member] Development [Member] Disposal Group Name [Domain] Disposal Group Name [Domain] Operating lease right-of-use assets Operating Lease, Right Of Use Assets Operating Lease, Right Of Use Assets Number of warrants (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Document Fiscal Period Focus Document Fiscal Period Focus Accumulated depreciation and amortization Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization Recoupment of accelerated/advanced payments start Recoupment Of Accelerated/Advanced Payments Start Recoupment Of Accelerated/Advanced Payments Start Disposal Group, Including Discontinued Operation, Liabilities [Abstract] Disposal Group, Including Discontinued Operation, Liabilities [Abstract] Supplemental Cash Flow Information [Abstract] Supplemental Cash Flow Information [Abstract] Mortgage notes payable Mortgages Mortgages [Member] Liabilities held for sale Assets Held-for-sale, Not Part of Disposal Group, Current Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Issuance of common stock under Associate Stock Purchase Plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Entity Filer Category Entity Filer Category Common stock: Common Stock [Member] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Product and Service [Domain] Product and Service [Domain] Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Variable Mortgages Variable Mortgages [Member] Variable Mortgages Long-term debt and lines of credit Long-Term Debt And Lines Of Credit [Member] Long-Term Debt And Lines Of Credit [Member] Facility operating expense Operating Lease, Facility Operating Expense Operating Lease, Facility Operating Expense Accelerated and Advance Payment Program Accelerated and Advance Payment Program [Member] Accelerated and Advance Payment Program [Member] Property, Plant and Equipment and Leasehold Intangibles, Net Property, Plant and Equipment [Table Text Block] Assisted Living and Memory Care Assisted Living and Memory Care Assisted Living And Memory Care [Member] Assisted Living And Memory Care [Member] Unusual or Infrequent Item, or Both [Domain] Unusual or Infrequent Item, or Both [Domain] Equity, Number of Shares, Par Value and Other Disclosures [Abstract] Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract] Payments for recoupment of accelerated/advanced payments rate Payments For Recoupment Of Accelerated/Advanced Payments Rate Payments For Recoupment Of Accelerated/Advanced Payments Rate Capital Expenditure, Type [Axis] Capital Expenditure, Type [Axis] Capital Expenditure, Type [Axis] Long-Term Debt, Capital Leases and Financing Obligations [Abstract] Debt Instruments [Abstract] Net increase (decrease) in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Finance lease, right-of-use asset Finance Lease, Right-of-Use Asset, after Accumulated Amortization Lessee, Operating Lease, Liability, Maturity Lessee, Operating Lease, Liability, Maturity [Table Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Weighted average shares outstanding - basic Weighted Average Number of Shares Outstanding, Basic Investment in unconsolidated ventures Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Treasury stock, shares (in shares) Treasury Stock, Shares Number of communities disposed of Disposal Group, Number Of Communities Disposed Of Disposal Group, Number Of Communities Disposed Of Interest paid Interest Paid, Excluding Capitalized Interest, Operating Activities Revenue Revenue from Contract with Customer [Text Block] Current portion of long-term debt Increase (Decrease) of Long-term Debt, Current Maturities Increase (Decrease) of Long-term Debt, Current Maturities Total equity Balance at beginning of period Cumulative effect of change in accounting principle Balance at end of period Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 2021 (nine months) Finance Lease, Liability, to be Paid, Remainder of Fiscal Year Additional paid-in-capital Additional Paid in Capital Acquisition of assets, net of related payables and cash received Payments to Acquire Other Productive Assets Benefit (provision) for income taxes Income Tax Expense (Benefit) Net cash received Proceeds from Divestiture of Businesses Income taxes paid, net of refunds Income Taxes Paid, Net Thereafter Finance Lease, Liability, to be Paid, After Year Four Finance Lease, Liability, to be Paid, After Year Four Cash, cash equivalents, and restricted cash at beginning of period Cash, cash equivalents, and restricted cash at end of period Total cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Property, Plant and Equipment and Leasehold Intangibles, Net Property, Plant and Equipment, Policy [Policy Text Block] Purchase of marketable securities Payments to Acquire Marketable Securities Operating lease obligations Operating Lease Obligation Operating Lease Obligation Sale of stock, percentage of ownership after transaction Sale of Stock, Percentage of Ownership after Transaction Accrued expenses Accrued Liabilities, Current Diluted (in dollars per share) Earnings Per Share, Diluted Resident fees Total resident fee revenue Health Care, Resident Service [Member] Current portion of financing lease obligations Finance Lease, Liability, Current Local Phone Number Local Phone Number Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] Goodwill Disposal Group, Including Discontinued Operation, Goodwill, Current Goodwill Goodwill and Intangible Assets, Policy [Policy Text Block] Schedule of Debt Schedule of Long-term Debt Instruments [Table Text Block] Credit Agreement With Capital One, National Association Credit Agreement With Capital One, National Association [Member] Credit Agreement With Capital One, National Association Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Total Grant Date Fair Value Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture Contract with customer, liability Contract with Customer, Liability Related Party Transaction [Domain] Related Party Transaction [Domain] Entity Emerging Growth Company Entity Emerging Growth Company Unusual or Infrequent Item, or Both [Table] Unusual or Infrequent Item, or Both [Table] Deferred income tax (benefit) provision Deferred Income Tax Expense (Benefit) Credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Award Type [Axis] Award Type [Axis] Valuation Allowance [Line Items] Valuation Allowance [Line Items] Maximum Maximum [Member] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Noncontrolling interest: Noncontrolling Interest [Member] COVID-19 Pandemic Unusual or Infrequent Items, or Both, Disclosure [Text Block] Accumulated deficit: Retained Earnings [Member] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Award Type [Domain] Award Type [Domain] Entity Trading Symbol Trading Symbol Finance and operating lease, renewal term Lessee, Finance and Operating Lease, Renewal Term Lessee, Finance and Operating Lease, Renewal Term Weighted average common shares outstanding: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Property, Plant and Equipment and Leasehold Intangibles, Net Property, Plant and Equipment Disclosure [Text Block] Treasury stock, at cost; 10,527,525 shares at March 31, 2021 and December 31, 2020 Treasury Stock, Value Earnings Per Share Earnings Per Share [Text Block] Interest expense: Interest Expense [Abstract] Number of communities classified as held for sale Number of Communities Classified As Held For Sale Number of communities classified as held for sale during the period. Operating lease, number of communities Operating Leases, Number Of Communities Operating Leases, Number Of Communities Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Current liabilities Liabilities, Current [Abstract] Loans Insured or Guaranteed by US Government Authorities Loans Insured or Guaranteed by US Government Authorities [Member] Entity Shell Company Entity Shell Company Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Shares withheld for employee taxes (in shares) Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 2023 Finance Lease, Liability, to be Paid, Year Two Proceeds from line of credit Proceeds from Lines of Credit Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] One Community Held For Sale One Community Held For Sale [Member] One Community Held For Sale Property, plant and equipment and leasehold intangibles, net Increase (Decrease) In Property, Plant And Equipment And Leasehold Intangibles, Net Increase (Decrease) In Property, Plant And Equipment And Leasehold Intangibles, Net EX-101.PRE 14 bkd-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 15 bkd-20210331_htm.xml IDEA: XBRL DOCUMENT 0001332349 2021-01-01 2021-03-31 0001332349 2021-05-05 0001332349 2021-03-31 0001332349 2020-12-31 0001332349 us-gaap:RestrictedStockMember 2021-03-31 0001332349 us-gaap:RestrictedStockMember 2020-12-31 0001332349 us-gaap:HealthCareResidentServiceMember 2021-01-01 2021-03-31 0001332349 us-gaap:HealthCareResidentServiceMember 2020-01-01 2020-03-31 0001332349 us-gaap:ManagementServiceMember 2021-01-01 2021-03-31 0001332349 us-gaap:ManagementServiceMember 2020-01-01 2020-03-31 0001332349 bkd:ReimbursementCostsManagedCommunitiesMember 2021-01-01 2021-03-31 0001332349 bkd:ReimbursementCostsManagedCommunitiesMember 2020-01-01 2020-03-31 0001332349 bkd:OtherOperatingIncomeMember 2021-01-01 2021-03-31 0001332349 bkd:OtherOperatingIncomeMember 2020-01-01 2020-03-31 0001332349 2020-01-01 2020-03-31 0001332349 us-gaap:RealEstateMember 2021-01-01 2021-03-31 0001332349 us-gaap:RealEstateMember 2020-01-01 2020-03-31 0001332349 2019-12-31 0001332349 us-gaap:CommonStockMember 2020-12-31 0001332349 us-gaap:CommonStockMember 2019-12-31 0001332349 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001332349 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001332349 us-gaap:CommonStockMember 2021-03-31 0001332349 us-gaap:CommonStockMember 2020-03-31 0001332349 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001332349 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001332349 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001332349 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001332349 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001332349 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001332349 us-gaap:TreasuryStockMember 2020-12-31 0001332349 us-gaap:TreasuryStockMember 2019-12-31 0001332349 us-gaap:TreasuryStockMember 2020-01-01 2020-03-31 0001332349 us-gaap:TreasuryStockMember 2021-03-31 0001332349 us-gaap:TreasuryStockMember 2020-03-31 0001332349 us-gaap:RetainedEarningsMember 2020-12-31 0001332349 us-gaap:RetainedEarningsMember 2019-12-31 0001332349 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:RetainedEarningsMember 2019-12-31 0001332349 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001332349 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001332349 us-gaap:RetainedEarningsMember 2021-03-31 0001332349 us-gaap:RetainedEarningsMember 2020-03-31 0001332349 us-gaap:NoncontrollingInterestMember 2020-12-31 0001332349 us-gaap:NoncontrollingInterestMember 2019-12-31 0001332349 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001332349 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0001332349 us-gaap:NoncontrollingInterestMember 2021-03-31 0001332349 us-gaap:NoncontrollingInterestMember 2020-03-31 0001332349 2020-03-31 0001332349 bkd:SecuritiesPurchaseAgreementMember bkd:HCAHealthcareIncMember bkd:HealthCareServicesMember 2021-02-24 2021-02-24 0001332349 bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:CARESActMember 2020-01-01 2021-03-31 0001332349 us-gaap:FairValueMeasurementsNonrecurringMember 2021-01-01 2021-03-31 0001332349 us-gaap:LoansInsuredOrGuaranteedByUsGovernmentAuthoritiesMember bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:AcceleratedandAdvancePaymentProgramMember bkd:CARESActMember 2020-01-01 2020-12-31 0001332349 bkd:AcceleratedandAdvancePaymentProgramMember bkd:HealthCareServicesMember bkd:CARESActMember 2020-01-01 2020-12-31 0001332349 bkd:AcceleratedandAdvancePaymentProgramMember bkd:CCRCVenturesLLCMember bkd:CARESActMember 2020-01-01 2020-12-31 0001332349 bkd:TheContinuingAppropriationsAct2021AndOtherExtensionsActMember bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:PeriodOneMember bkd:TheContinuingAppropriationsAct2021AndOtherExtensionsActMember bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:PeriodTwoMember bkd:TheContinuingAppropriationsAct2021AndOtherExtensionsActMember bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:CARESActMember 2020-12-31 0001332349 srt:ScenarioForecastMember bkd:CARESActMember 2021-12-31 0001332349 srt:ScenarioForecastMember bkd:CARESActMember 2022-12-31 0001332349 bkd:CARESActMember 2021-03-31 0001332349 bkd:CommunitiesAcquiredPreviouslyLeasedOrManagedMember 2020-01-01 2021-03-31 0001332349 bkd:CommunitiesDisposedOfThroughSaleMember 2020-01-01 2021-03-31 0001332349 bkd:VentasIncMember 2020-07-26 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:CommunitiesDisposedOfThroughLeaseTerminationsMember 2020-01-01 2021-03-31 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:OneCommunityHeldForSaleMember bkd:AssistedLivingAndMemoryCareMember 2021-01-01 2021-03-31 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:OneCommunityHeldForSaleMember bkd:CCRCVenturesLLCMember 2021-01-01 2021-03-31 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:OneCommunityHeldForSaleMember 2021-03-31 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:CommunitiesDisposedOfThroughSaleMember 2021-01-01 2021-03-31 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:SaleOf1CommunityMember 2021-01-01 2021-03-31 0001332349 bkd:VentasIncMember 2020-12-31 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:CommunitiesDisposedOfThroughSaleMember 2020-01-01 2020-12-31 0001332349 us-gaap:DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember bkd:SaleOf2CommunitiesMember 2020-01-01 2020-12-31 0001332349 bkd:SaleOf1CommunityMember 2020-01-01 2020-03-31 0001332349 bkd:SecuritiesPurchaseAgreementMember bkd:HCAHealthcareIncMember bkd:HealthCareServicesMember 2021-03-31 0001332349 bkd:HealthCareServicesMember 2021-03-31 0001332349 us-gaap:FairValueInputsLevel2Member 2021-03-31 0001332349 bkd:LongTermDebtAndLinesOfCreditMember 2021-03-31 0001332349 bkd:LongTermDebtAndLinesOfCreditMember 2020-12-31 0001332349 us-gaap:FairValueMeasurementsNonrecurringMember 2020-01-01 2020-03-31 0001332349 us-gaap:SelfPayMember bkd:IndependentLivingMember 2021-01-01 2021-03-31 0001332349 us-gaap:SelfPayMember bkd:AssistedLivingAndMemoryCareMember 2021-01-01 2021-03-31 0001332349 us-gaap:SelfPayMember bkd:CcrcsRentalMember 2021-01-01 2021-03-31 0001332349 us-gaap:SelfPayMember bkd:HealthCareServicesMember 2021-01-01 2021-03-31 0001332349 us-gaap:SelfPayMember 2021-01-01 2021-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:IndependentLivingMember 2021-01-01 2021-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:AssistedLivingAndMemoryCareMember 2021-01-01 2021-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:CcrcsRentalMember 2021-01-01 2021-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:HealthCareServicesMember 2021-01-01 2021-03-31 0001332349 bkd:GovernmentReimbursementMember 2021-01-01 2021-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:IndependentLivingMember 2021-01-01 2021-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:AssistedLivingAndMemoryCareMember 2021-01-01 2021-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:CcrcsRentalMember 2021-01-01 2021-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:HealthCareServicesMember 2021-01-01 2021-03-31 0001332349 us-gaap:ThirdPartyPayorMember 2021-01-01 2021-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:IndependentLivingMember 2021-01-01 2021-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:AssistedLivingAndMemoryCareMember 2021-01-01 2021-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:CcrcsRentalMember 2021-01-01 2021-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:HealthCareServicesMember 2021-01-01 2021-03-31 0001332349 us-gaap:HealthCareResidentServiceMember 2021-01-01 2021-03-31 0001332349 us-gaap:SelfPayMember bkd:IndependentLivingMember 2020-01-01 2020-03-31 0001332349 us-gaap:SelfPayMember bkd:AssistedLivingAndMemoryCareMember 2020-01-01 2020-03-31 0001332349 us-gaap:SelfPayMember bkd:CcrcsRentalMember 2020-01-01 2020-03-31 0001332349 us-gaap:SelfPayMember bkd:HealthCareServicesMember 2020-01-01 2020-03-31 0001332349 us-gaap:SelfPayMember 2020-01-01 2020-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:IndependentLivingMember 2020-01-01 2020-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:AssistedLivingAndMemoryCareMember 2020-01-01 2020-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:CcrcsRentalMember 2020-01-01 2020-03-31 0001332349 bkd:GovernmentReimbursementMember bkd:HealthCareServicesMember 2020-01-01 2020-03-31 0001332349 bkd:GovernmentReimbursementMember 2020-01-01 2020-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:IndependentLivingMember 2020-01-01 2020-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:AssistedLivingAndMemoryCareMember 2020-01-01 2020-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:CcrcsRentalMember 2020-01-01 2020-03-31 0001332349 us-gaap:ThirdPartyPayorMember bkd:HealthCareServicesMember 2020-01-01 2020-03-31 0001332349 us-gaap:ThirdPartyPayorMember 2020-01-01 2020-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:IndependentLivingMember 2020-01-01 2020-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:AssistedLivingAndMemoryCareMember 2020-01-01 2020-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:CcrcsRentalMember 2020-01-01 2020-03-31 0001332349 us-gaap:HealthCareResidentServiceMember bkd:HealthCareServicesMember 2020-01-01 2020-03-31 0001332349 us-gaap:HealthCareResidentServiceMember 2020-01-01 2020-03-31 0001332349 bkd:DeferredRevenueAndCreditsMember 2021-03-31 0001332349 bkd:DeferredRevenueAndCreditsMember 2020-12-31 0001332349 us-gaap:LandMember 2021-03-31 0001332349 us-gaap:LandMember 2020-12-31 0001332349 us-gaap:BuildingAndBuildingImprovementsMember 2021-03-31 0001332349 us-gaap:BuildingAndBuildingImprovementsMember 2020-12-31 0001332349 us-gaap:FurnitureAndFixturesMember 2021-03-31 0001332349 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001332349 bkd:ResidentAndLeaseholdOperatingIntangiblesMember 2021-03-31 0001332349 bkd:ResidentAndLeaseholdOperatingIntangiblesMember 2020-12-31 0001332349 us-gaap:ConstructionInProgressMember 2021-03-31 0001332349 us-gaap:ConstructionInProgressMember 2020-12-31 0001332349 bkd:AssetsUnderFinancingLeasesandLeaseholdIntangiblesMember 2021-03-31 0001332349 bkd:AssetsUnderFinancingLeasesandLeaseholdIntangiblesMember 2020-12-31 0001332349 bkd:IndependentLivingMember 2020-12-31 0001332349 bkd:IndependentLivingMember 2021-03-31 0001332349 bkd:HealthCareServicesMember 2020-12-31 0001332349 bkd:HealthCareServicesMember 2021-03-31 0001332349 us-gaap:MortgagesMember 2021-03-31 0001332349 us-gaap:MortgagesMember 2020-12-31 0001332349 bkd:VariableMortgagesMember 2021-03-31 0001332349 bkd:VariableMortgagesMember 2020-12-31 0001332349 us-gaap:NotesPayableOtherPayablesMember 2021-03-31 0001332349 us-gaap:NotesPayableOtherPayablesMember 2020-12-31 0001332349 bkd:FifthAmendedAndRestatedCreditAgreementMember bkd:LetterOfCreditSublimitMember us-gaap:LineOfCreditMember 2021-03-31 0001332349 bkd:CreditAgreementWithCapitalOneNationalAssociationMember us-gaap:RevolvingCreditFacilityMember us-gaap:LineOfCreditMember 2020-12-11 0001332349 bkd:FifthAmendedAndRestatedCreditAgreementMember us-gaap:LetterOfCreditMember us-gaap:LineOfCreditMember 2021-03-31 0001332349 srt:MinimumMember 2021-01-01 2021-03-31 0001332349 srt:MaximumMember 2021-01-01 2021-03-31 0001332349 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001332349 bkd:RestrictedStockAndRestrictedStockUnitsRSUsMember 2021-01-01 2021-03-31 0001332349 bkd:RestrictedStockAndRestrictedStockUnitsRSUsMember 2020-01-01 2020-03-31 0001332349 us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0001332349 us-gaap:PerformanceSharesMember 2020-01-01 2020-03-31 0001332349 bkd:FederalTaxAuthorityAndStateAndLocalJurisdictionMember 2020-01-01 2020-03-31 0001332349 bkd:CCRCVenturesLLCMember 2020-01-01 2020-03-31 0001332349 bkd:HealthpeakMember 2021-01-01 2021-03-31 0001332349 bkd:NonDevelopmentMember bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2021-01-01 2021-03-31 0001332349 bkd:NonDevelopmentMember bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2020-01-01 2020-03-31 0001332349 bkd:DevelopmentMember bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2021-01-01 2021-03-31 0001332349 bkd:DevelopmentMember bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2020-01-01 2020-03-31 0001332349 bkd:NondevelopmentReimbursableMember bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2021-01-01 2021-03-31 0001332349 bkd:NondevelopmentReimbursableMember bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2020-01-01 2020-03-31 0001332349 bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2021-01-01 2021-03-31 0001332349 bkd:AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember 2020-01-01 2020-03-31 0001332349 bkd:AcquisitionOfCommunitiesFromHealthpeakMember 2021-01-01 2021-03-31 0001332349 bkd:AcquisitionOfCommunitiesFromHealthpeakMember 2020-01-01 2020-03-31 0001332349 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2021-01-01 2021-03-31 0001332349 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2020-01-01 2020-03-31 0001332349 bkd:CCRCVenturesLLCMember 2021-01-01 2021-03-31 0001332349 bkd:CCRCVenturesLLCMember 2020-01-01 2020-03-31 0001332349 bkd:ProceedsFromSaleOfAssetsNetMember 2021-01-01 2021-03-31 0001332349 bkd:ProceedsFromSaleOfAssetsNetMember 2020-01-01 2020-03-31 0001332349 bkd:HealthpeakMasterLeaseModificationMember 2021-01-01 2021-03-31 0001332349 bkd:HealthpeakMasterLeaseModificationMember 2020-01-01 2020-03-31 0001332349 bkd:NoncashLeaseTerminationAndModificationNetMember 2021-01-01 2021-03-31 0001332349 bkd:NoncashLeaseTerminationAndModificationNetMember 2020-01-01 2020-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:IndependentLivingMember 2021-01-01 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:IndependentLivingMember 2020-01-01 2020-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:AssistedLivingAndMemoryCareMember 2021-01-01 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:AssistedLivingAndMemoryCareMember 2020-01-01 2020-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:CcrcsRentalMember 2021-01-01 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:CcrcsRentalMember 2020-01-01 2020-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:HealthCareServicesMember 2021-01-01 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:HealthCareServicesMember 2020-01-01 2020-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:ManagementServicesMember 2021-01-01 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:ManagementServicesMember 2020-01-01 2020-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:IndependentLivingMember 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:IndependentLivingMember 2020-12-31 0001332349 us-gaap:OperatingSegmentsMember bkd:AssistedLivingAndMemoryCareMember 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:AssistedLivingAndMemoryCareMember 2020-12-31 0001332349 us-gaap:OperatingSegmentsMember bkd:CcrcsRentalMember 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:CcrcsRentalMember 2020-12-31 0001332349 us-gaap:OperatingSegmentsMember bkd:HealthCareServicesMember 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:HealthCareServicesMember 2020-12-31 0001332349 us-gaap:OperatingSegmentsMember bkd:ManagementServicesMember 2021-03-31 0001332349 us-gaap:OperatingSegmentsMember bkd:ManagementServicesMember 2020-12-31 0001332349 bkd:IndependentLivingMember bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:AssistedLivingAndMemoryCareMember bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:CcrcsRentalMember bkd:CARESActMember 2021-01-01 2021-03-31 0001332349 bkd:HealthCareServicesMember bkd:CARESActMember 2021-01-01 2021-03-31 shares iso4217:USD iso4217:USD shares bkd:segment pure bkd:community bkd:lease 0001332349 --12-31 2021 Q1 false 10-Q true 2021-03-31 false 001-32641 BROOKDALE SENIOR LIVING INC. DE 20-3068069 111 Westwood Place, Suite 400, Brentwood, TN 37027 615 221-2250 Common Stock, $0.01 Par Value Per Share BKD NYSE Yes Yes Accelerated Filer false false false 185166149 303952000 380420000 134933000 172905000 26503000 28059000 52588000 109221000 247627000 16061000 90949000 66937000 856552000 773603000 5018409000 5068060000 743346000 788138000 71468000 56669000 4972000 4898000 27321000 154131000 24085000 56259000 6746153000 6901758000 224890000 68885000 20083000 19543000 140339000 146226000 65278000 71233000 116142000 0 264117000 287851000 68113000 96995000 898962000 690733000 3664901000 3847103000 539071000 543764000 797311000 819429000 9876000 9557000 140925000 188443000 6051046000 6099029000 0.01 0.01 50000000 50000000 0 0 0 0 0 0 0.01 0.01 400000000 400000000 197757065 198331663 187229540 187804138 2063391 4349421 1978000 1983000 4213095000 4212409000 10527525 10527525 102774000 102774000 -3419469000 -3311184000 692830000 800434000 2277000 2295000 695107000 802729000 6746153000 6901758000 664350000 782707000 8566000 108715000 65794000 122717000 10735000 0 749445000 1014139000 77274000 84301000 556312000 588482000 4783000 5957000 49943000 54595000 44418000 64481000 83891000 90738000 10677000 78226000 65794000 122717000 811035000 999239000 -61590000 14900000 421000 1455000 35351000 41763000 11383000 13282000 1873000 1315000 0 19181000 -531000 -1008000 1112000 372839000 1644000 2662000 -107551000 353669000 752000 -15828000 -108303000 369497000 -18000 -18000 -108285000 369515000 -0.59 2.01 -0.59 2.00 184011000 184186000 184011000 184522000 802729000 698725000 1983000 1996000 1000 2000 -6000 7000 6000 1978000 1985000 4212409000 4172099000 4783000 5957000 224000 168000 -2000 6000 4322000 3892000 3000 18000 4213095000 4174356000 -102774000 -84651000 18123000 -102774000 -102774000 -3311184000 -3393088000 -115000 -108285000 369515000 -3419469000 -3023688000 2295000 2369000 -18000 -18000 2277000 2351000 695107000 1052230000 187804000 192129000 43000 61000 127000 -504000 744000 611000 3063000 187230000 188012000 -108303000 369497000 0 19181000 85764000 92053000 10677000 78226000 -531000 -1008000 364000 377000 670000 343000 319000 -21767000 -4664000 -6733000 1112000 372839000 4783000 5957000 1416000 1460000 5768000 2033000 6769000 1696000 12985000 17434000 -500000 -47919000 7717000 -2254000 -7563000 -4088000 -23857000 57479000 62000 -3211000 79932000 89414000 117995000 50000000 40361000 69385000 0 446688000 5206000 268000 3760000 304617000 -3806000 -247927000 18575000 471785000 49924000 263226000 0 166381000 0 18123000 87000 5815000 4329000 3898000 203000 146000 -35562000 347250000 -63225000 156802000 465148000 301697000 401923000 458499000 Description of BusinessBrookdale Senior Living Inc. ("Brookdale" or the "Company") is an operator of senior living communities throughout the United States. The Company is committed to providing senior living solutions primarily within properties that are designed, purpose-built, and operated to provide quality service, care, and living accommodations for residents. The Company operates and manages independent living, assisted living, memory care, and continuing care retirement communities ("CCRCs"). The Company also offers a range of home health, hospice, and outpatient therapy services to residents of many of its communities and to seniors living outside of its communities. The Company has five reportable segments: Independent Living; Assisted Living and Memory Care; CCRCs; Health Care Services; and Management Services. The Company expects to sell 80% of its equity in its Health Care Services segment, as described in Note 4. 5 0.80 Summary of Significant Accounting Policies<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for quarterly reports on Form 10-Q. In the opinion of management, these financial statements include all adjustments, which are of a normal and recurring nature, necessary to present fairly the financial position, results of operations, and cash flows of the Company for all periods presented. Certain information and footnote disclosures included in annual financial statements have been condensed or omitted. The Company believes that the disclosures included are adequate and provide a fair presentation of interim period results. Interim financial statements are not necessarily indicative of the financial position or operating results for an entire year. These interim financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principles of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the accounts of Brookdale and its consolidated subsidiaries. The ownership interest of consolidated entities not wholly-owned by the Company are presented as noncontrolling interests in the accompanying condensed consolidated financial statements. Intercompany balances and transactions have been eliminated in consolidation, and net income (loss) is reduced by the portion of net income (loss) attributable to noncontrolling interests. The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, revenue, other operating income, asset impairments, self-insurance reserves, performance-based compensation, the allowance for credit losses, depreciation and amortization, leasing transactions, income taxes, and other contingencies. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from the original estimates. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Accounting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, as lessee, recognizes a right-of-use asset and a lease liability on the Company's condensed consolidated balance sheet for its community, office, and equipment leases. As of the commencement date of a lease, a lease liability and corresponding right-of-use asset is established on the Company's condensed consolidated balance sheet at the present value of future minimum lease payments. The Company's community leases generally contain fixed annual rent escalators or annual rent escalators based on an index, such as the consumer price index. The future minimum lease payments recognized on the condensed consolidated balance sheet include fixed payments (including in-substance fixed payments) and variable payments </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimated utilizing the index or rate on the lease commencement date. The Company recognizes lease expense as incurred for additional variable payments. For the Company's leases that do not contain an implicit rate, the Company utilizes its estimated incremental borrowing rate to determine the present value of lease payments based on information available at commencement of the lease. The Company's estimated incremental borrowing rate reflects the fixed rate at which the Company could borrow a similar amount for the same term on a collateralized basis. The Company elected the short-term lease exception policy which permits leases with an initial term of 12 months or less to not be recorded on the Company's condensed consolidated balance sheet and instead to be recognized as lease expense as incurred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, as lessee, makes a determination with respect to each of its community, office, and equipment leases as to whether each should be accounted for as an operating lease or financing lease. The classification criteria is based on estimates regarding the fair value of the leased asset, minimum lease payments, effective cost of funds, economic life of the asset, and certain other terms in the lease agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease right-of-use assets are reviewed for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of right-of-use assets are assessed by a comparison of the carrying amount of the asset to the estimated future undiscounted net cash flows expected to be generated by the asset, calculated utilizing the lowest level of identifiable cash flows. If estimated future undiscounted net cash flows are less than the carrying amount of the asset then the fair value of the asset is estimated. The impairment expense is determined by comparing the estimated fair value of the asset to its carrying amount, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates and estimated lease coverage ratios (Level 3). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes operating lease expense for actual rent paid, generally plus or minus a straight-line adjustment for estimated minimum lease escalators if applicable. The right-of-use asset is generally reduced each period by an amount equal to the difference between the operating lease expense and the amount of expense on the lease liability utilizing the effective interest method. Subsequent to the impairment of an operating lease right-of-use asset, the Company recognizes operating lease expense consisting of the reduction of the right-of-use asset on a straight-line basis over the remaining lease term and the amount of expense on the lease liability utilizing the effective interest method. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing lease right-of-use assets are recognized within property, plant and equipment and leasehold intangibles, net on the Company's condensed consolidated balance sheets. The Company recognizes interest expense on the financing lease liabilities utilizing the effective interest method. The right-of-use asset is generally amortized to depreciation and amortization expense on a straight-line basis over the lease term unless the lease contains an option to purchase the underlying asset that the Company is reasonably certain to exercise. If the Company is reasonably certain to exercise the purchase option, the asset is amortized over the useful life. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For transactions in which an owned community is sold and leased back from the buyer (sale-leaseback transactions), the Company recognizes an asset sale and lease accounting is applied if the Company has transferred control of the community. For such transactions, the Company removes the transferred assets from the condensed consolidated balance sheet and a gain or loss on the sale is recognized for the difference between the carrying amount of the asset and the transaction price for the sale transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For sale‑leaseback transactions in which the Company has not transferred control of the underlying asset, the Company does not recognize an asset sale or derecognize the underlying asset until control is transferred. For such transactions, the Company recognizes the underlying assets within assets under financing leases as a component of property, plant and equipment and leasehold intangibles, net on the condensed consolidated balance sheets and continues to depreciate the assets over their useful lives.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the Company accounts for any amounts received as a financing lease liability and the Company recognizes interest expense on the financing lease liability utilizing the effective interest method with the interest expense limited to an amount that is not greater than the cash payments on the financing lease liability over the term of the lease. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property, Plant and Equipment and Leasehold Intangibles, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset group may not be recoverable. Recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company is required to recognize an impairment loss. The impairment loss is measured by the amount by which the carrying amount of the asset exceeds its estimated fair value, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates, estimated holding periods, and estimated capitalization rates (Level 3). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></div>The Company tests goodwill for impairment annually during the fourth quarter or more frequently if indicators of impairment arise. Factors the Company considers important in its analysis of whether an indicator of impairment exists include a significant decline in the Company's stock price or market capitalization for a sustained period since the last testing date, significant underperformance relative to historical or projected future operating results, and significant negative industry or economic trends. The Company first assesses qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If so, the Company performs a quantitative goodwill impairment test based upon a comparison of the estimated fair value of the reporting unit to which the goodwill has been assigned with the reporting unit's carrying amount. The fair values used in the quantitative goodwill impairment test are estimated using Level 3 inputs based upon discounted future cash flow projections for the reporting unit. These cash flow projections are based upon a number of estimates and assumptions such as revenue and expense growth rates, capitalization rates, and discount rates. The Company also considers market-based measures such as earnings multiples in its analysis of estimated fair values of its reporting units. If the quantitative goodwill impairment test results in a reporting unit's carrying amount exceeding its estimated fair value, an impairment charge will be recorded based on the difference, with the impairment charge limited to the amount of goodwill allocated to the reporting unit. Basis of PresentationThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for quarterly reports on Form 10-Q. In the opinion of management, these financial statements include all adjustments, which are of a normal and recurring nature, necessary to present fairly the financial position, results of operations, and cash flows of the Company for all periods presented. Certain information and footnote disclosures included in annual financial statements have been condensed or omitted. The Company believes that the disclosures included are adequate and provide a fair presentation of interim period results. Interim financial statements are not necessarily indicative of the financial position or operating results for an entire year. These interim financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021. Principles of ConsolidationThe condensed consolidated financial statements include the accounts of Brookdale and its consolidated subsidiaries. The ownership interest of consolidated entities not wholly-owned by the Company are presented as noncontrolling interests in the accompanying condensed consolidated financial statements. Intercompany balances and transactions have been eliminated in consolidation, and net income (loss) is reduced by the portion of net income (loss) attributable to noncontrolling interests. The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting. Use of EstimatesThe preparation of the condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, revenue, other operating income, asset impairments, self-insurance reserves, performance-based compensation, the allowance for credit losses, depreciation and amortization, leasing transactions, income taxes, and other contingencies. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from the original estimates. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lease Accounting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, as lessee, recognizes a right-of-use asset and a lease liability on the Company's condensed consolidated balance sheet for its community, office, and equipment leases. As of the commencement date of a lease, a lease liability and corresponding right-of-use asset is established on the Company's condensed consolidated balance sheet at the present value of future minimum lease payments. The Company's community leases generally contain fixed annual rent escalators or annual rent escalators based on an index, such as the consumer price index. The future minimum lease payments recognized on the condensed consolidated balance sheet include fixed payments (including in-substance fixed payments) and variable payments </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimated utilizing the index or rate on the lease commencement date. The Company recognizes lease expense as incurred for additional variable payments. For the Company's leases that do not contain an implicit rate, the Company utilizes its estimated incremental borrowing rate to determine the present value of lease payments based on information available at commencement of the lease. The Company's estimated incremental borrowing rate reflects the fixed rate at which the Company could borrow a similar amount for the same term on a collateralized basis. The Company elected the short-term lease exception policy which permits leases with an initial term of 12 months or less to not be recorded on the Company's condensed consolidated balance sheet and instead to be recognized as lease expense as incurred. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company, as lessee, makes a determination with respect to each of its community, office, and equipment leases as to whether each should be accounted for as an operating lease or financing lease. The classification criteria is based on estimates regarding the fair value of the leased asset, minimum lease payments, effective cost of funds, economic life of the asset, and certain other terms in the lease agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lease right-of-use assets are reviewed for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of right-of-use assets are assessed by a comparison of the carrying amount of the asset to the estimated future undiscounted net cash flows expected to be generated by the asset, calculated utilizing the lowest level of identifiable cash flows. If estimated future undiscounted net cash flows are less than the carrying amount of the asset then the fair value of the asset is estimated. The impairment expense is determined by comparing the estimated fair value of the asset to its carrying amount, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates and estimated lease coverage ratios (Level 3). </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes operating lease expense for actual rent paid, generally plus or minus a straight-line adjustment for estimated minimum lease escalators if applicable. The right-of-use asset is generally reduced each period by an amount equal to the difference between the operating lease expense and the amount of expense on the lease liability utilizing the effective interest method. Subsequent to the impairment of an operating lease right-of-use asset, the Company recognizes operating lease expense consisting of the reduction of the right-of-use asset on a straight-line basis over the remaining lease term and the amount of expense on the lease liability utilizing the effective interest method. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing Leases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing lease right-of-use assets are recognized within property, plant and equipment and leasehold intangibles, net on the Company's condensed consolidated balance sheets. The Company recognizes interest expense on the financing lease liabilities utilizing the effective interest method. The right-of-use asset is generally amortized to depreciation and amortization expense on a straight-line basis over the lease term unless the lease contains an option to purchase the underlying asset that the Company is reasonably certain to exercise. If the Company is reasonably certain to exercise the purchase option, the asset is amortized over the useful life. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale-Leaseback Transactions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For transactions in which an owned community is sold and leased back from the buyer (sale-leaseback transactions), the Company recognizes an asset sale and lease accounting is applied if the Company has transferred control of the community. For such transactions, the Company removes the transferred assets from the condensed consolidated balance sheet and a gain or loss on the sale is recognized for the difference between the carrying amount of the asset and the transaction price for the sale transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For sale‑leaseback transactions in which the Company has not transferred control of the underlying asset, the Company does not recognize an asset sale or derecognize the underlying asset until control is transferred. For such transactions, the Company recognizes the underlying assets within assets under financing leases as a component of property, plant and equipment and leasehold intangibles, net on the condensed consolidated balance sheets and continues to depreciate the assets over their useful lives.</span></div>Additionally, the Company accounts for any amounts received as a financing lease liability and the Company recognizes interest expense on the financing lease liability utilizing the effective interest method with the interest expense limited to an amount that is not greater than the cash payments on the financing lease liability over the term of the lease. Property, Plant and Equipment and Leasehold Intangibles, NetLong-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset group may not be recoverable. Recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company is required to recognize an impairment loss. The impairment loss is measured by the amount by which the carrying amount of the asset exceeds its estimated fair value, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates, estimated holding periods, and estimated capitalization rates (Level 3). GoodwillThe Company tests goodwill for impairment annually during the fourth quarter or more frequently if indicators of impairment arise. Factors the Company considers important in its analysis of whether an indicator of impairment exists include a significant decline in the Company's stock price or market capitalization for a sustained period since the last testing date, significant underperformance relative to historical or projected future operating results, and significant negative industry or economic trends. The Company first assesses qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If so, the Company performs a quantitative goodwill impairment test based upon a comparison of the estimated fair value of the reporting unit to which the goodwill has been assigned with the reporting unit's carrying amount. The fair values used in the quantitative goodwill impairment test are estimated using Level 3 inputs based upon discounted future cash flow projections for the reporting unit. These cash flow projections are based upon a number of estimates and assumptions such as revenue and expense growth rates, capitalization rates, and discount rates. The Company also considers market-based measures such as earnings multiples in its analysis of estimated fair values of its reporting units. If the quantitative goodwill impairment test results in a reporting unit's carrying amount exceeding its estimated fair value, an impairment charge will be recorded based on the difference, with the impairment charge limited to the amount of goodwill allocated to the reporting unit. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.  COVID-19 Pandemic </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States broadly continues to experience the COVID-19 pandemic, which has significantly disrupted, and likely will continue to significantly disrupt for some period, the senior living industry and the Company's business. Due to the average age and prevalence of chronic medical conditions among the Company's residents and patients, they generally are at disproportionately higher risk of hospitalization and adverse outcomes if they contract COVID-19. The health and wellbeing of the Company's residents, patients, and associates is and has been its highest priority as it continues to serve and care for seniors through the pandemic. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Community Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To help protect the Company's residents, patients, and associates from contracting COVID-19, the Company imposed significant restrictions at its communities beginning in March 2020, including closing its communities to visitors and prospective residents, and in some cases restricting new resident move-ins, suspending group outings, modifying communal dining and programming to comply with social distancing and other regulatory guidelines and, in most cases, implementing in-room only dining and activities programming, requesting that residents refrain from leaving the community unless medically necessary, and requiring new residents and residents returning from a hospital or nursing home to isolate in their apartment for fourteen days. The Company has adopted a framework for determining when to ease restrictions at each of its communities based on several criteria, including regulatory requirements and guidance, completion of baseline testing at the community, and the presence of current confirmed COVID-19 positive cases. The Company may revert to more restrictive measures if the pandemic worsens, as necessary to comply with regulatory requirements, or at the direction of state or local health authorities. As of April 30, 2021, 100% of the Company's communities have opened for visitors and new prospects. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pandemic-Related Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company incurred $27.3 million of facility operating expense during the first quarter of 2021 for incremental direct costs to respond to the pandemic. Such costs include those for: acquisition of additional PPE, medical equipment, and cleaning and disposable food service supplies; enhanced cleaning and environmental sanitation; increased employee-related costs, including labor, workers compensation, and health plan expense; increased expense for general liability claims; and COVID-19 testing of residents and associates where not otherwise covered by government payor or third-party insurance sources. On a cumulative basis, the Company has incurred $152.9 million of pandemic related facility operating expense since the beginning of fiscal 2020. The Company recorded non-cash impairment charges in its operating results of $9.0 million for the three months ended March 31, 2021, for its operating lease right-of-use assets, primarily due to the COVID-19 pandemic and lower than expected operating performance at communities with impaired assets.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of March 31, 2021, the Company's total liquidity was $438.9 million, consisting of $304.0 million of unrestricted cash and cash equivalents and $134.9 million of marketable securities. The Company's cash flows from operations, excluding management agreement termination fees and the impact of the Coronavirus Aid, Relief, and Economic Security Act of 2020 ("CARES Act") funding, have been insufficient to cover its operating expenses, capital expenditures, and required interest and lease payments during the pandemic. However, the Company was able to satisfy its liquidity needs over such period utilizing a portion of its preexisting liquidity, together with CARES Act funding. The Company currently estimates that its cash flows from operations, together with cash balances on hand, cash equivalents, marketable securities, and proceeds from the pending sale of 80% of the equity in its Health Care Services segment will be sufficient to fund its liquidity needs for at least the next 12 months. The Company continues to seek opportunities to enhance and preserve its liquidity, including through maintaining expense discipline and increasing occupancy, continuing to evaluate its financing structure and the state of debt markets, and seeking further government-sponsored financial relief related to the pandemic. There is no assurance that debt financing will continue to be available on terms consistent with the Company's expectations or at all, that its efforts will be successful in seeking further government-sponsored financial relief or regarding the amount of, or conditions required to qualify for, any such relief, or that the closing of the pending transaction will be completed in accordance with the Company's expectations, or at all, or generate cash proceeds to the Company in the amount it anticipates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Relief</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The CARES Act, signed into law on March 27, 2020, and Paycheck Protection Program and Health Care Enhancement Act, signed into law on April 24, 2020, provide liquidity and financial relief to certain businesses, among other things. Certain impacts of such programs are provided below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the first quarter of 2021, the Company accepted $0.8 million of cash from grants from the Public Health and Social Services Emergency Fund ("Provider Relief Fund") administered by the U.S. Department of Health and Human Services ("HHS"), under which grants have been made available to eligible healthcare providers for healthcare related expenses or lost revenues attributable to COVID-19. The grants represented incentive payments made pursuant to the Nursing Home Infection Control Distribution, which related to the Company's skilled nursing care provided through its CCRCs. HHS continues to evaluate future allocations under the Provider Relief Fund and the regulation and guidance regarding grants made under the Provider Relief Fund. The Company intends to pursue additional funding that may become available. There can be no assurance that the Company will qualify for, or receive, such future grants in the amount it expects, that additional restrictions on the permissible uses or terms and conditions of the grants will not be imposed by HHS, or that future funding programs will be made available for which it qualifies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During the year ended December 31, 2020, the Company received $87.5 million under the Accelerated and Advance Payment Program administered by CMS, $75.2 million of which related to its Health Care Services segment and $12.3 million related to its CCRCs segment. Recoupment of advanced payments will begin one year after payments were issued at a rate of 25% of Medicare payments for the first eleven months following the anniversary of issuance and at a rate of 50% of Medicare payments for the next six months. Any outstanding balance of advanced payments will be due following such recoupment period. Pursuant to the Purchase Agreement providing for the sale of 80% of the Company's equity in its Health Care Services segment (as described below), its net cash proceeds at closing will include a reduction for the then outstanding balance of such advanced payments related to its Health Care Services segment.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">During fiscal 2020, the Company deferred payment of $72.7 million of the employer portion of social security payroll taxes incurred from March 27, 2020 through December 31, 2020 pursuant to the CARES Act. One-half of such deferral amount will become due on each of December 31, 2021 and December 31, 2022. Pursuant to the Purchase Agreement providing for the sale of 80% of the Company's equity in its Health Care Services segment, its net cash proceeds at closing will include a reduction for the $8.9 million of deferred payroll tax payments related to its Health Care Services segment. The Company expects to pay approximately $32 million of the deferred payments in both December 2021 and 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company is eligible to claim the employee retention credit for certain of its associates under the CARES Act. The credit for 2020 is available to employers that fully or partially suspended operations during any calendar quarter in 2020 due to orders from an appropriate governmental authority limiting commerce, travel, or group meetings due to COVID-19, and is equal to 50% of qualified wages paid after March 12, 2020 through December 31, 2020 to qualified employees, with a maximum credit of $5,000 per employee. During the first quarter of 2021, the Company recognized $9.0 million of employee retention credits on wages paid from March 12, 2020 through September 30, 2020 within other operating income. The credit was modified and extended by subsequent legislation for wages paid from January 1, 2021 through December 31, 2021, and the Company is assessing its eligibility to claim such credit. There can be no assurance that the Company will qualify for, or receive, credits in the amount or on the timing it expects.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the grants described above, during the three months ended March 31, 2021, the Company has received and recognized $0.9 million of other operating income from grants from other government sources. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict with reasonable certainty the impacts that COVID-19 ultimately will have on its business, results of operations, cash flow, and liquidity, and its response efforts may continue to delay or negatively impact its strategic initiatives, including plans for future growth. The ultimate impacts of COVID-19 will depend on many factors, some of which cannot be foreseen, including the duration, severity, and breadth of the pandemic and any resurgence of the disease; the impact of COVID-19 on the nation’s economy and debt and equity markets and the local economies in the Company's markets; the development, availability, utilization, and efficacy of COVID-19 testing, therapeutic agents, and vaccines and the prioritization of such resources among businesses and demographic groups; government financial and regulatory relief efforts that may become available to business and individuals, including the Company's ability to qualify for and satisfy the terms and conditions of financial relief; perceptions regarding the safety of senior living communities during and after the pandemic; changes in demand for senior living communities and the Company's ability to adapt its sales and marketing efforts to meet that demand; the impact of COVID-19 on the Company's residents’ and their families’ ability to afford its resident fees, including due to changes in unemployment rates, consumer confidence, housing markets, and equity markets caused by COVID-19; changes in the acuity levels of the Company's new residents; the disproportionate impact of COVID-19 on seniors generally and those residing in the Company's communities; the duration and costs of the Company's response efforts, including increased equipment, supplies, labor, litigation, testing, vaccination clinic, and other expenses; the impact of COVID-19 on the Company's ability to complete financings and refinancings of various assets, or other transactions (including dispositions and the pending sale of 80% of the equity in the Company's Health Care Services segment) or to generate sufficient cash flow to cover required debt, interest, and lease payments and to satisfy financial and other covenants in its debt and lease documents; increased regulatory requirements, including unfunded, mandatory testing; increased enforcement actions resulting from COVID-19; government action that may limit the Company's collection or discharge efforts for delinquent accounts; and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or the Company's response efforts.</span></div> 1 27300000 152900000 9000000.0 438900000 304000000.0 134900000 0.80 800000 87500000 75200000 12300000 P1Y 0.25 P11M 0.50 P6M 0.80 72700000 0.80 8900000 32000000 32000000 0.50 5000 9000000.0 900000 0.80 Acquisitions, Dispositions and Other Transactions<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period from January 1, 2020 through March 31, 2021, the Company acquired 27 communities that the Company formerly leased, disposed of eight owned communities (including the conveyance of five communities to Ventas, Inc. ("Ventas")), and sold its ownership interest in its unconsolidated entry fee CCRC Venture (the "CCRC Venture") with Healthpeak Properties, Inc. ("Healthpeak"), and the Company's triple-net lease obligations on five communities were terminated. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company expects to sell 80% of its equity in its Health Care Services segment, as described below. Additionally, one unencumbered community in the Assisted Living and Memory Care segment and one unencumbered community in the CCRCs segment were classified as held for sale, resulting in $14.0 million being recorded as assets held for sale within the condensed consolidated balance sheet for senior housing communities as of March 31, 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The closings of the various pending and expected transactions described within this note are, or will be, subject to the satisfaction of various closing conditions, including (where applicable) the receipt of regulatory approvals. There can be no assurance that the transactions will close or, if they do, when the actual closings will occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Completed Dispositions of Owned Communities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, the Company completed the sale of one owned community for cash proceeds of $2.7 million, net of transaction costs, and recognized a net gain on sale of assets of $0.5 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the conveyance of five communities to Ventas, during the year ended December 31, 2020, the Company completed the sale of two owned communities for cash proceeds of $38.1 million, net of transaction costs, and recognized a net gain on sale of assets of $2.7 million. These dispositions included the sale of one owned community during the three months ended March 31, 2020 for which the Company received cash proceeds of $5.5 million, net of transaction costs, and recognized a net gain on sale of assets of $0.2 million. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pending Sale of Health Care Services</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2021, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") with affiliates of HCA Healthcare, Inc., providing for the sale of 80% of the Company’s equity in its Health Care Services segment for a purchase price of $400 million in cash, subject to certain adjustments set forth in the Purchase Agreement, including a reduction </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for the remaining outstanding balance as of the closing of Medicare advance payments and deferred payroll tax payments related to the Health Care Services segment, which were $75.2 million and $8.9 million respectively, as of March 31, 2021. The Purchase Agreement also contains certain agreed upon indemnities for the benefit of the purchaser. The closing of the sale transaction is anticipated to occur in the early second half of 2021, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Purchase Agreement. Pursuant to the Purchase Agreement, at closing of the transaction, the Company will retain a 20% equity interest in the business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assets and liabilities of the Health Care Services segment are included within assets held for sale and liabilities held for sale, respectively, within the Company’s condensed consolidated balance sheet as of March 31, 2021. As of March 31, 2021, assets held for sale and liabilities held for sale of the Health Care Services segment consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.725%"><tr><td style="width:1.0%"/><td style="width:84.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.212%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,722 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,585 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,030 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable fees and deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,223 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,142 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Refer to Note 16 for selected financial data for the Health Care Services segment.</span></div> 27 8 5 5 0.80 1 1 14000000.0 1 2700000 500000 5 2 38100000 2700000 1 5500000 200000 0.80 400000000 75200000 8900000 0.20 As of March 31, 2021, assets held for sale and liabilities held for sale of the Health Care Services segment consisted of the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.725%"><tr><td style="width:1.0%"/><td style="width:84.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.212%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,401 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,964 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,810 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,722 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,585 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,201 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;text-indent:-4.5pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,030 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refundable fees and deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,223 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,688 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities held for sale</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,142 </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table> 62401000 1964000 9688000 126810000 32722000 233585000 1201000 30030000 75223000 9688000 116142000 Fair Value Measurements<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketable Securities</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, marketable securities of $134.9 million are stated at fair value based on valuations provided by third-party pricing services and are classified within Level 2 of the valuation hierarchy. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates the fair value of its debt using a discounted cash flow analysis based upon the Company's current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding long-term debt with a carrying amount of approximately $3.9 billion as of both March 31, 2021 and December 31, 2020. Fair value of the long-term debt approximates carrying amount in all periods presented. The Company's fair value of long-term debt disclosure is classified within Level 2 of the valuation hierarchy. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment Expense</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of asset impairment expense. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.152%"><tr><td style="width:1.0%"/><td style="width:73.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.324%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in unconsolidated ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 134900000 3900000000 3900000000 <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of asset impairment expense. </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.152%"><tr><td style="width:1.0%"/><td style="width:73.278%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.322%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.324%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.0 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.7 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:4.5pt;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.0 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment in unconsolidated ventures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 9000000.0 65700000 1700000 11000000.0 0 1500000 10700000 78200000 Revenue<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates its revenue from contracts with customers by payor source as the Company believes it best depicts how the nature, amount, timing, and uncertainty of its revenue and cash flows are affected by economic factors. Resident fee revenue by payor source and reportable segment is as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:27.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private pay</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,322 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,494 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,213 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,366 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government reimbursement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,487 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,856 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party payor programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,079 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total resident fee revenue</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,782 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,938 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,779 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,851 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,350 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private pay</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,290 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,613 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,703 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,776 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government reimbursement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,405 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,689 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,532 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party payor programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,439 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,960 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,399 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total resident fee revenue</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,862 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,479 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,547 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,819 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782,707 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment terms and conditions within the Company's revenue-generating contracts vary by contract type and payor source, although terms generally include payment to be made within 30 days. Resident fee revenue for recurring and routine monthly services is generally billed monthly in advance under the Company's independent living, assisted living, and memory care residency agreements. Resident fee revenue for standalone or certain healthcare services is generally billed monthly in arrears. A portion of the Company's reimbursement from Medicare for certain healthcare services is billed near the start of each period of care, and cash is generally received before all services are rendered. The amount of revenue recognized for periods of care which are incomplete at period end is based on the Company's historical average percentage of days complete on each period of care and any unearned amounts are deferred and recognized when the service is performed. Additionally, non-refundable community fees are generally billed and collected in advance or upon move-in of a resident under the Company's independent living, assisted living, and memory care residency agreements. Amounts of revenue that are collected from residents in advance are recognized as deferred revenue until the performance obligations are satisfied. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had total deferred revenue (included within refundable fees and deferred revenue, liabilities held for sale, and other liabilities within the condensed consolidated balance sheets) of $146.0 million and $138.3 million, including $30.1 </span></div>million and $21.1 million of monthly resident fees billed and received in advance, as of March 31, 2021 and December 31, 2020, respectively. Such amount of total deferred revenue as of both March 31, 2021 and December 31, 2020 also included $87.5 million received in the year ended December 31, 2020 under a temporary expansion of the Accelerated and Advance Payment Program administered by CMS. Refer to Note 3 for additional information on such program. For the three months ended March 31, 2021 and 2020, the Company recognized $30.8 million and $48.3 million, respectively, of revenue that was included in the deferred revenue balance as of January 1, 2021 and 2020, respectively. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates its revenue from contracts with customers by payor source as the Company believes it best depicts how the nature, amount, timing, and uncertainty of its revenue and cash flows are affected by economic factors. Resident fee revenue by payor source and reportable segment is as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"/><td style="width:27.576%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.576%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private pay</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,322 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370,494 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,213 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">541,366 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government reimbursement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,444 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,487 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,465 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,856 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party payor programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,079 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,049 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,128 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total resident fee revenue</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118,782 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,938 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,779 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,851 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">664,350 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private pay</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,290 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440,613 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,703 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640,776 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government reimbursement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">572 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,866 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,405 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,689 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,532 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other third-party payor programs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,439 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,960 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,399 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total resident fee revenue</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,862 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,479 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,547 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,819 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">782,707 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 118322000 370494000 52213000 337000 541366000 460000 16444000 12487000 67465000 96856000 0 0 7079000 19049000 26128000 118782000 386938000 71779000 86851000 664350000 135290000 440613000 64703000 170000 640776000 572000 16866000 19405000 73689000 110532000 0 0 10439000 20960000 31399000 135862000 457479000 94547000 94819000 782707000 146000000.0 138300000 30100000 21100000 87500000 30800000 48300000 Property, Plant and Equipment and Leasehold Intangibles, Net<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021 and December 31, 2020, net property, plant and equipment and leasehold intangibles, which include assets under financing leases, consisted of the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,698 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,298 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,222,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,215,460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident and leasehold operating intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,003 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under financing leases and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534,468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,585,643 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,558,158 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,567,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,490,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,018,409 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,068,060 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets under financing leases and leasehold improvements includes $0.4 billion of financing lease right-of-use assets, net of accumulated amortization, as of both March 31, 2021 and December 31, 2020. Refer to Note 10 for further information on the Company's financing leases. </span></div>Long-lived assets with definite useful lives are depreciated or amortized on a straight-line basis over their estimated useful lives (or, in certain cases, the shorter of their estimated useful lives or the lease term) and are tested for impairment whenever indicators of impairment arise. The Company recognized depreciation and amortization expense on its property, plant and equipment and leasehold intangibles of $83.9 million and $90.7 million for the three months ended March 31, 2021 and 2020, respectively. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021 and December 31, 2020, net property, plant and equipment and leasehold intangibles, which include assets under financing leases, consisted of the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">504,698 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,298 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,222,741 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,215,460 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953,773 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945,783 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident and leasehold operating intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">307,071 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,003 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,491 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets under financing leases and leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,534,468 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,523,055 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,585,643 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,558,158 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,567,234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,490,098)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,018,409 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,068,060 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 504698000 505298000 5222741000 5215460000 953773000 945783000 305960000 307071000 64003000 61491000 1534468000 1523055000 8585643000 8558158000 3567234000 3490098000 5018409000 5068060000 400000000 400000000 83900000 90700000 GoodwillThe Company's Independent Living and Health Care Services segments had a carrying value of goodwill of $27.3 million and $126.8 million, respectively, as of both March 31, 2021 and December 31, 2020. The goodwill of the Health Care Services segment is included within assets held for sale within the Company’s condensed consolidated balance sheet as of March 31, 2021. 27300000 27300000 126800000 126800000 Debt<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed mortgage notes payable due 2022 through 2047; weighted average interest rate of 4.17% and 4.18% as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,151 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366,996 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable mortgage notes payable due 2022 through 2030, weighted average interest rate of 2.46% and 2.49% as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529,935 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other notes payable due 2021 to 2025; weighted average interest rate of 7.79% and 8.98% as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount and deferred financing costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,889,791 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915,988 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, less current portion</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664,901 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,847,103 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, 97.9%, or $3.8 billion of the Company's total debt obligations represented non-recourse property-level mortgage financings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, $69.9 million of letters of credit and no cash borrowings were outstanding under the Company's $80.0 million secured credit facility. The Company also had a separate secured letter of credit facility providing up to $15.0 million of letters of credit as of March 31, 2021 under which $13.6 million had been issued as of that date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Covenants </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company's debt documents contain restrictions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and debt service ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community, and/or entity basis. In addition, the Company's debt documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's failure to comply with applicable covenants could constitute an event of default under the applicable debt documents. Many of the Company's debt documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Furthermore, the Company's debt is secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, the Company is in compliance with the financial covenants of its debt agreements.</span></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt consists of the following: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fixed mortgage notes payable due 2022 through 2047; weighted average interest rate of 4.17% and 4.18% as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334,151 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,366,996 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable mortgage notes payable due 2022 through 2030, weighted average interest rate of 2.46% and 2.49% as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524,496 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,529,935 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other notes payable due 2021 to 2025; weighted average interest rate of 7.79% and 8.98% as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,557 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt discount and deferred financing costs, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,500)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,889,791 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,915,988 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224,890 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68,885 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt, less current portion</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,664,901 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,847,103 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 0.0417 0.0418 2334151000 2366996000 0.0246 0.0249 1524496000 1529935000 0.0779 0.0898 57468000 46557000 -26324000 -27500000 3889791000 3915988000 224890000 68885000 3664901000 3847103000 0.979 3800000000 69900000 80000000.0 15000000.0 13600000 Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, the Company operated 301 communities under long-term leases (235 operating leases and 66 financing leases). The substantial majority of the Company's lease arrangements are structured as master leases. Under a master lease, numerous communities are leased through an indivisible lease. The Company typically guarantees the performance and lease payment obligations of its subsidiary lessees under the master leases. An event of default related to an individual property or limited number of properties within a master lease portfolio may result in a default on the entire master lease portfolio. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The leases relating to these communities are generally fixed rate leases with annual escalators that are either fixed or based upon changes in the consumer price index or the leased property revenue. The Company is responsible for all operating costs, including repairs, property taxes, and insurance. The leases generally provide for renewal or extension options from 5 to 20 years and in some instances, purchase options. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The community leases contain other customary terms, which may include assignment and change of control restrictions, maintenance and capital expenditure obligations, termination provisions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and lease coverage ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community and/or entity basis. In addition, the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's lease documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's failure to comply with applicable covenants could constitute an event of default under the applicable lease documents. Many of the Company's debt and lease documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Certain leases contain cure provisions, which generally allow the Company to post an additional lease security deposit if the required covenant is not met. Furthermore, the Company's leases are secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, the Company is in compliance with the financial covenants of its long-term leases.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of operating and financing lease expense (including the respective presentation on the condensed consolidated statements of operations) and net cash outflows from leases is as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility operating expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,850 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,481 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,260 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,331 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,664 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,733 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating net cash outflows from operating leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,361 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,976 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the difference between the amount of cash operating lease payments and the amount of operating lease expense recognized in accordance with Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,630 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,144 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense: financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,013 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,426 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,389)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net cash outflows from financing leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,783 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,630 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (nine months)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,681 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,807 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,609 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,720 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,589 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase option liability and non-cash gain on future sale of property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed interest and variable lease payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270,052)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,650 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,154 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> Leases<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, the Company operated 301 communities under long-term leases (235 operating leases and 66 financing leases). The substantial majority of the Company's lease arrangements are structured as master leases. Under a master lease, numerous communities are leased through an indivisible lease. The Company typically guarantees the performance and lease payment obligations of its subsidiary lessees under the master leases. An event of default related to an individual property or limited number of properties within a master lease portfolio may result in a default on the entire master lease portfolio. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The leases relating to these communities are generally fixed rate leases with annual escalators that are either fixed or based upon changes in the consumer price index or the leased property revenue. The Company is responsible for all operating costs, including repairs, property taxes, and insurance. The leases generally provide for renewal or extension options from 5 to 20 years and in some instances, purchase options. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The community leases contain other customary terms, which may include assignment and change of control restrictions, maintenance and capital expenditure obligations, termination provisions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and lease coverage ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community and/or entity basis. In addition, the </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company's lease documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's failure to comply with applicable covenants could constitute an event of default under the applicable lease documents. Many of the Company's debt and lease documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Certain leases contain cure provisions, which generally allow the Company to post an additional lease security deposit if the required covenant is not met. Furthermore, the Company's leases are secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2021, the Company is in compliance with the financial covenants of its long-term leases.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of operating and financing lease expense (including the respective presentation on the condensed consolidated statements of operations) and net cash outflows from leases is as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility operating expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,850 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,481 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,260 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,331 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,664 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,733 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating net cash outflows from operating leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,361 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,976 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the difference between the amount of cash operating lease payments and the amount of operating lease expense recognized in accordance with Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,630 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,144 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense: financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,013 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,426 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,389)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net cash outflows from financing leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,783 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,630 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (nine months)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,681 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,807 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,609 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,720 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,589 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase option liability and non-cash gain on future sale of property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed interest and variable lease payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270,052)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,650 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,154 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 301 235 66 P5Y P20Y <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of operating and financing lease expense (including the respective presentation on the condensed consolidated statements of operations) and net cash outflows from leases is as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Operating Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility operating expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,842 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,850 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility lease expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,418 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,481 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,260 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,331 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense adjustment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,664 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,733 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,563)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,088)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating net cash outflows from operating leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,361 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,976 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the difference between the amount of cash operating lease payments and the amount of operating lease expense recognized in accordance with Accounting Standards Codification 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("ASC 842"). </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Financing Leases </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,630 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,144 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense: financing lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,383 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing lease expense</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,013 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,426 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash flows from financing leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,383 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,282 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash flows from financing leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,789 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,087 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,389)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,739)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net cash outflows from financing leases</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,783 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,630 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 4842000 4850000 44418000 64481000 49260000 69331000 4664000 6733000 -7563000 -4088000 46361000 71976000 7630000 9144000 11383000 13282000 19013000 22426000 11383000 13282000 4789000 5087000 -1389000 -1739000 14783000 16630000 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (nine months)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,681 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,807 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,609 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,720 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,589 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase option liability and non-cash gain on future sale of property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed interest and variable lease payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270,052)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,650 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,154 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.413%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.778%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (nine months)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,681 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,807 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,946 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,609 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192,625 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,341 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,377 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,553 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">191,131 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,595 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">280,960 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109,684 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,213,720 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415,589 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase option liability and non-cash gain on future sale of property</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413,617 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Imputed interest and variable lease payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(276,070)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(270,052)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937,650 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559,154 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> 9700000 151681000 48807000 203946000 65609000 192625000 66341000 193377000 67553000 191131000 57595000 280960000 109684000 1213720000 415589000 0 413617000 276070000 270052000 937650000 559154000 Litigation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been and is currently involved in litigation and claims incidental to the conduct of its business, which it believes are generally comparable to other companies in the senior living and healthcare industries, including, but not limited to, putative class action claims from time to time regarding staffing at the Company’s communities and compliance with consumer protection laws and the Americans with Disabilities Act. Certain claims and lawsuits allege large damage amounts and may require significant costs to defend and resolve. As a result, the Company maintains general liability, professional liability, and other insurance policies in amounts and with coverage and deductibles the Company believes are appropriate, based on the nature and risks of its business, historical experience, availability, and industry standards. The Company's current policies provide for deductibles for each claim and contain various exclusions from coverage. Accordingly, the Company is, in effect, self-insured for claims that are less than the deductible amounts and for claims or portions of claims that are not covered by such policies and/or exceed the policy limits. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, the senior living and healthcare industries are continuously subject to scrutiny by governmental regulators, which could result in reviews, audits, investigations, enforcement activities or litigation related to regulatory compliance matters. In addition, as a result of the Company's participation in the Medicare and Medicaid programs, the Company is subject to various governmental reviews, audits and investigations, including but not limited to audits under various government programs, such as the Recovery Audit Contractors (RAC), Zone Program Integrity Contractors (ZPIC), and Unified Program Integrity Contractors (UPIC) programs. The costs to respond to and defend such reviews, audits, and investigations may be significant, and an adverse determination could result in citations, sanctions and other criminal or civil fines and penalties, the refund of overpayments, payment suspensions, termination of participation in Medicare and Medicaid programs, and/or damage to the Company's business reputation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company and several current and former executive officers were named as defendants in a putative class action lawsuit alleging violations of the federal securities laws filed in the federal court for the Middle District of Tennessee. The lawsuit asserts that the defendants made material misstatements and omissions concerning the Company's business, operational and compliance policies that caused the Company's stock price to be artificially inflated between August 2016 and April 2020. While the Company cannot predict with certainty the result of this or any other legal proceedings, the Company believes the allegations in the suit are without merit and does not expect this matter to have a material adverse effect on the Company's financial condition, results of operations, or cash flows. In October 2020 and April 2021, alleged stockholders of the Company filed separate stockholder derivative lawsuits in the federal court for the Middle District of Tennessee, asserting claims on behalf of the Company against certain current and former officers and directors for alleged breaches of duties owed to the Company. The complaints refer to the securities lawsuit described above and incorporate substantively similar allegations.</span></div> Stock-Based Compensation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grants of restricted stock and restricted stock units under the Company's 2014 Omnibus Incentive Plan were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except for per share and unit amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock and Restricted Stock Unit Grants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,988 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grants of restricted stock and restricted stock units under the Company's 2014 Omnibus Incentive Plan were as follows: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:50.437%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.567%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except for per share and unit amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Restricted Stock and Restricted Stock Unit Grants</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,961 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.09 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,988 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> 1961000 5.09 9988000 Earnings Per Share<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic earnings per share ("EPS") is calculated by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the components of basic EPS and also gives effect to dilutive common stock equivalents. Under the treasury stock method, diluted EPS reflects the potential dilution that could occur if securities or other instruments that are convertible into common stock were exercised or could result in the issuance of common stock. Potentially dilutive common stock equivalents include unvested restricted stock, restricted stock units, and warrants. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted earnings (loss) per share amounts presented in the condensed consolidated statement of operations: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except for per share amounts)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income attributable to common stockholders:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,011 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,011 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to common stockholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of computing diluted EPS, weighted average shares outstanding do not include potentially dilutive securities that are anti-dilutive under the treasury stock method, and performance-based equity awards are included based on the attainment of the applicable performance metrics as of the end of the reporting period. The following potentially dilutive securities were excluded from the computation of diluted EPS:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-performance-based restricted stock and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock and restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>(1)As a result of the net loss reported for the period, all unvested restricted stock, restricted stock units, and potential shares issuable under warrants were antidilutive for the period and as such were not included in the computation of diluted weighted average shares outstanding. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted earnings (loss) per share amounts presented in the condensed consolidated statement of operations: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.452%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands, except for per share amounts)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income attributable to common stockholders:</span></td><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,285)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369,515 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,011 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,186 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">336 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding - diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,011 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184,522 </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to common stockholders</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.59)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.01 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 16.75pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) per share attributable to common stockholders</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.59)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.00 </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div> -108285000 369515000 184011000 184186000 0 336000 184011000 184522000 -0.59 2.01 -0.59 2.00 The following potentially dilutive securities were excluded from the computation of diluted EPS:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in millions)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-performance-based restricted stock and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:2pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.9 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance-based restricted stock and restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.3 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table>(1)As a result of the net loss reported for the period, all unvested restricted stock, restricted stock units, and potential shares issuable under warrants were antidilutive for the period and as such were not included in the computation of diluted weighted average shares outstanding. 6200000 6900000 400000 1800000 16300000 0 Income Taxes<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The difference between the Company's effective tax rate for the three months ended March 31, 2021 and 2020 was primarily due to the tax impact of the multi-part transaction with Healthpeak that occurred in the three months ended March 31, 2020. The impact represented the tax expense recorded on the gain of the sale of the Company's interest in the CCRC Venture offset by a decrease in the valuation allowance that was a direct result of the multi-part transaction with Healthpeak. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded an aggregate deferred federal, state, and local tax benefit of $25.2 million as a result of the operating loss for the three months ended March 31, 2021, which was offset by a proportionate increase in the valuation allowance of $25.5 million. The Company recorded an aggregate deferred federal, state, and local tax expense of $90.9 million for the three months ended March 31, 2020. The expense included $93.1 million as a result of the gain on the sale of the Company's interest in the CCRC Venture offset by a benefit of $2.2 million as a result of the operating losses (exclusive of the CCRC Venture sale) for the three months ended March 31, 2020. The expense for the three months ended March 31, 2020 was offset by a reduction in the valuation allowance of $112.6 million.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluates its deferred tax assets each quarter to determine if a valuation allowance is required based on whether it is more likely than not that some portion of the deferred tax asset would not be realized. The Company's valuation allowance as of March 31, 2021 and December 31, 2020 was $406.5 million and $381.0 million, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in the valuation allowance for the three months ended March 31, 2021 is the result of current operating losses during the three months ended March 31, 2021. The change in the valuation allowance for the three months ended March 31, 2020 was primarily the result of a reduction in the Company’s valuation allowance of $117.6 million as a result of the Healthpeak transaction offset by the anticipated reversal of future tax liabilities offset by future tax deductions.</span></div>The Company recorded interest charges related to its tax contingency reserve for cash tax positions for the three months ended March 31, 2021 and 2020 which are included in income tax expense or benefit for the period. As of March 31, 2021, tax returns for years 2017 through 2019 are subject to future examination by tax authorities. In addition, the net operating losses from prior years are subject to adjustment under examination. -25200000 25500000 90900000 93100000 -2200000 -112600000 406500000 381000000.0 -117600000 Supplemental Disclosure of Cash Flow Information <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">Supplemental Disclosure of Cash Flow Information:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">47,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">59,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Income taxes paid, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">957 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures, net of related payables:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures - non-development, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">27,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">60,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures - development, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">1,521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">3,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures - non-development - reimbursable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">8,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">5,827 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">2,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash paid</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,361 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,385 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of communities from Healthpeak:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">286,734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(63,285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">129,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">74,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Loss (gain) on debt modification and extinguishment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(19,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash paid</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,249 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Acquisition of other assets, net of related payables and cash received:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">39,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash paid</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,439 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Proceeds from sale of CCRC Venture, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Investments in unconsolidated ventures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(14,848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">34,706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(5,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">60,748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Loss (gain) on sale of assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(370,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash received</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,164)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Proceeds from sale of other assets, net:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(1,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(5,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Loss (gain) on sale of assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(1,112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(2,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash received</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(3,760)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(9,453)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Healthpeak master lease modification:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(57,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">88,044 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">70,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(101,456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other non-cash lease transactions, net:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(9,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">16,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">9,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(16,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restricted cash consists principally of deposits for letters of credit, escrow deposits for real estate taxes, property insurance, and capital expenditures, debt service reserve accounts required by certain lenders under mortgage debt agreements, and deposits as security for self-insured retention risk under workers' compensation programs and property insurance programs. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of cash, cash equivalents, and restricted cash:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,923 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,148 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div> <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">Supplemental Disclosure of Cash Flow Information:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">47,129 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">59,479 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Income taxes paid, net of refunds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">904 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">957 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures, net of related payables:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures - non-development, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">27,450 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">60,556 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures - development, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">1,521 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">3,900 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Capital expenditures - non-development - reimbursable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">8,951 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">5,827 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Trade accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">2,439 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(898)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash paid</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,361 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,385 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of communities from Healthpeak:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">286,734 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(63,285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">129,196 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">74,335 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Loss (gain) on debt modification and extinguishment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(19,731)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash paid</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407,249 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Acquisition of other assets, net of related payables and cash received:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">179 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">39,260 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash paid</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,439 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Proceeds from sale of CCRC Venture, net:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Investments in unconsolidated ventures</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(14,848)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">34,706 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(5,025)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">60,748 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Loss (gain) on sale of assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(370,745)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash received</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(295,164)</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Proceeds from sale of other assets, net:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(1,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Assets held for sale</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(2,125)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(5,274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(597)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">74 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(824)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Loss (gain) on sale of assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(1,112)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(2,094)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net cash received</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(3,760)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(9,453)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:700;line-height:100%">Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Healthpeak master lease modification:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(57,462)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">88,044 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">70,874 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(101,456)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other non-cash lease transactions, net:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Property, plant and equipment and leasehold intangibles, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(9,441)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">16,721 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Financing lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">9,516 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(16,721)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">(75)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.8pt;font-weight:400;line-height:100%">Net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 47129000 59479000 904000 957000 27450000 60556000 1521000 3900000 8951000 5827000 -2439000 898000 40361000 69385000 0 286734000 0 -63285000 0 129196000 0 74335000 0 -19731000 0 407249000 0 179000 0 39260000 0 39439000 0 14848000 0 34706000 0 -5025000 0 -60748000 0 -370745000 0 295164000 0 1261000 2125000 5274000 597000 0 -74000 824000 -1112000 -2094000 -3760000 -9453000 0 -57462000 0 88044000 0 70874000 0 -101456000 0 0 0 -9441000 16721000 0 0 9516000 -16721000 0 0 75000 0 0 The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:62.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.495%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.496%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reconciliation of cash, cash equivalents, and restricted cash:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,952 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">380,420 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,503 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,059 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,468 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,669 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 21.25pt;text-align:left;text-indent:-6.75pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">401,923 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,148 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table> 303952000 380420000 26503000 28059000 71468000 56669000 401923000 465148000 Segment InformationThe Company has five reportable segments: Independent Living; Assisted Living and Memory Care; CCRCs; Health Care Services; and Management Services. Operating segments are defined as components of an enterprise that engage in business activities from which it may earn revenues and incur expenses; for which separate financial information is available; and whose operating results are regularly reviewed by the chief operating decision maker to assess the performance of the individual segment and make decisions about resources to be allocated to the segment. <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Living</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company's Independent Living segment includes owned or leased communities that are primarily designed for middle to upper income seniors who desire to live in a residential setting that feels like home, without the efforts of ownership. The majority of the Company's independent living communities consist of both independent and assisted living units in a single community, which allows residents to age-in-place by providing them with a broad continuum of senior independent and assisted living services to accommodate their changing needs. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assisted Living and Memory Care. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Assisted Living and Memory Care segment includes owned or leased communities that offer housing and 24-hour assistance with activities of daily living for mid-acuity and frail elderly residents. The Company's assisted living and memory care communities include both freestanding, multi-story communities, as well as smaller freestanding, single story communities. The Company also provides memory care services at freestanding memory care communities that are specially designed for residents with Alzheimer's disease and other dementias. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CCRCs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's CCRCs segment includes large owned or leased communities that offer a variety of living arrangements and services to accommodate a broad spectrum of physical ability and healthcare needs. Most of the Company's CCRCs have independent living, assisted living, memory care, and skilled nursing available on one campus or within the immediate area. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Care Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company's Health Care Services segment includes the home health, hospice, and outpatient therapy services provided to residents of many of its communities and to seniors living outside its communities. The Health Care Services segment does not include the skilled nursing and inpatient healthcare services provided in the Company's skilled nursing units, which are included in the Company's CCRCs segment. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management Services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company's Management Services segment includes communities operated by the Company pursuant to management agreements. In some of the cases, the controlling financial interest in the community is held by third parties and, in other cases, the community is owned in a venture structure in which the Company has an ownership interest. Under the management agreements for these communities, the Company receives management fees as well as reimbursed expenses, which represent the reimbursement of expenses it incurs on behalf of the owners. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth selected segment financial data: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue and other operating income:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,463 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue and other operating income</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749,445 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014,139 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,433 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,715 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,339 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,940 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense (including non-cash stock-based compensation expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,891 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,317 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Management Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,590)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,900 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419,838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,740,476 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728,621 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,585 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Management Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,746,153 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,901,758 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">All revenue is earned from external third parties in the United States. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Independent Living, Assisted Living and Memory Care, CCRCs, and Health Care Services segments include $1.4 million, $5.1 million, $1.7 million, and $2.6 million respectively, for the three months ended March 31, 2021 of other operating income recognized for the credits or grants pursuant to the Employee Retention Credit, Provider Relief Fund, and other government sources, as described in Note 3. Allocations to the applicable segment generally reflect the credits earned by the segment, the segment’s receipt and acceptance of the grant, or the segment’s proportional utilization of the grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Management services segment revenue includes management fees and reimbursements of costs incurred on behalf of managed communities. </span></div>(4)Segment operating income is defined as segment revenues and other operating income less segment facility operating expenses (excluding facility depreciation and amortization) and costs incurred on behalf of managed communities. 5 <div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth selected segment financial data: </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue and other operating income:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120,146 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,862 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">392,042 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">457,479 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73,463 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,547 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,434 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,819 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,360 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231,432 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue and other operating income</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">749,445 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,014,139 </span></td><td style="background-color:#ffffff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment operating income:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,329 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,414 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,433 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,001 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,608 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,931 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,403 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,121)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Management Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,566 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,715 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total segment operating income</span></td><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127,339 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,940 </span></td><td style="background-color:#cceeff;border-top:2pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense (including non-cash stock-based compensation expense)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,943 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,595 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,418 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,481 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,891 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,738 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset impairment:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">520 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,317 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,642 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,798 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,173 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Management Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">— </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,938 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61,590)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,900 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:60.630%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.668%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.669%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets:</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Independent Living</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,399,489 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,419,838 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assisted Living and Memory Care</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,740,476 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,787,611 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCRCs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">728,621 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">738,121 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Health Care Services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,585 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233,178 </span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate and Management Services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643,982 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723,010 </span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,746,153 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,901,758 </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">All revenue is earned from external third parties in the United States. </span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Independent Living, Assisted Living and Memory Care, CCRCs, and Health Care Services segments include $1.4 million, $5.1 million, $1.7 million, and $2.6 million respectively, for the three months ended March 31, 2021 of other operating income recognized for the credits or grants pursuant to the Employee Retention Credit, Provider Relief Fund, and other government sources, as described in Note 3. Allocations to the applicable segment generally reflect the credits earned by the segment, the segment’s receipt and acceptance of the grant, or the segment’s proportional utilization of the grant. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Management services segment revenue includes management fees and reimbursements of costs incurred on behalf of managed communities. </span></div>(4)Segment operating income is defined as segment revenues and other operating income less segment facility operating expenses (excluding facility depreciation and amortization) and costs incurred on behalf of managed communities. 120146000 135862000 392042000 457479000 73463000 94547000 89434000 94819000 74360000 231432000 749445000 1014139000 37329000 51414000 71433000 132001000 7608000 19931000 2403000 -9121000 8566000 108715000 127339000 302940000 49943000 54595000 44418000 64481000 83891000 90738000 520000 31317000 9642000 32798000 515000 12173000 0 1938000 -61590000 14900000 1399489000 1419838000 3740476000 3787611000 728621000 738121000 233585000 233178000 643982000 723010000 6746153000 6901758000 1400000 5100000 1700000 2600000 XML 16 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover Page - shares
3 Months Ended
Mar. 31, 2021
May 05, 2021
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2021  
Document Transition Report false  
Entity File Number 001-32641  
Entity Registrant Name BROOKDALE SENIOR LIVING INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 20-3068069  
Entity Address, Address Line One 111 Westwood Place,  
Entity Address, Address Line Two Suite 400,  
Entity Address, City or Town Brentwood,  
Entity Address, State or Province TN  
Entity Address, Postal Zip Code 37027  
City Area Code 615  
Local Phone Number 221-2250  
Title of 12(b) Security Common Stock, $0.01 Par Value Per Share  
Entity Trading Symbol BKD  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   185,166,149
Entity Central Index Key 0001332349  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q1  
Amendment Flag false  
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 303,952 $ 380,420
Marketable securities 134,933 172,905
Restricted cash 26,503 28,059
Accounts receivable, net 52,588 109,221
Liabilities held for sale 247,627 16,061
Prepaid expenses and other current assets, net 90,949 66,937
Total current assets 856,552 773,603
Property, plant and equipment and leasehold intangibles, net 5,018,409 5,068,060
Operating lease right-of-use assets 743,346 788,138
Restricted cash 71,468 56,669
Investment in unconsolidated ventures 4,972 4,898
Goodwill 27,321 154,131
Other assets, net 24,085 56,259
Total assets 6,746,153 6,901,758
Current liabilities    
Current portion of long-term debt 224,890 68,885
Current portion of financing lease obligations 20,083 19,543
Current portion of operating lease obligations 140,339 146,226
Trade accounts payable 65,278 71,233
Liabilities held for sale 116,142 0
Accrued expenses 264,117 287,851
Refundable fees and deferred revenue 68,113 96,995
Total current liabilities 898,962 690,733
Long-term debt, less current portion 3,664,901 3,847,103
Financing lease obligations, less current portion 539,071 543,764
Operating lease obligations, less current portion 797,311 819,429
Deferred tax liability 9,876 9,557
Other liabilities 140,925 188,443
Total liabilities 6,051,046 6,099,029
Preferred stock, $0.01 par value, 50,000,000 shares authorized at March 31, 2021 and December 31, 2020; no shares issued and outstanding 0 0
Common stock, $0.01 par value, 400,000,000 shares authorized at March 31, 2021 and December 31, 2020; 197,757,065 and 198,331,663 shares issued and 187,229,540 and 187,804,138 shares outstanding (including 2,063,391 and 4,349,421 unvested restricted shares), respectively 1,978 1,983
Additional paid-in-capital 4,213,095 4,212,409
Treasury stock, at cost; 10,527,525 shares at March 31, 2021 and December 31, 2020 (102,774) (102,774)
Accumulated deficit (3,419,469) (3,311,184)
Total Brookdale Senior Living Inc. stockholders' equity 692,830 800,434
Noncontrolling interest 2,277 2,295
Total equity 695,107 802,729
Total liabilities and equity $ 6,746,153 $ 6,901,758
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares
Mar. 31, 2021
Dec. 31, 2020
Equity, Number of Shares, Par Value and Other Disclosures [Abstract]    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 50,000,000 50,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, shares issued (in shares) 197,757,065 198,331,663
Common stock, shares outstanding (in shares) 187,229,540 187,804,138
Treasury stock, shares (in shares) 10,527,525 10,527,525
Unvested Restricted Stock    
Equity, Number of Shares, Par Value and Other Disclosures [Abstract]    
Common stock, shares outstanding (in shares) 2,063,391 4,349,421
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue    
Revenue $ 749,445 $ 1,014,139
Expense    
General and administrative expense (including non-cash stock-based compensation expense of $4,783 and $5,957, respectively) 49,943 54,595
Facility operating lease expense 44,418 64,481
Depreciation and amortization 83,891 90,738
Asset impairment 10,677 78,226
Total operating expense 811,035 999,239
Income (loss) from operations (61,590) 14,900
Interest income 421 1,455
Interest expense:    
Debt (35,351) (41,763)
Financing lease obligations (11,383) (13,282)
Amortization of deferred financing costs and debt discount (1,873) (1,315)
Gain (loss) on debt modification and extinguishment, net 0 19,181
Equity in earnings (loss) of unconsolidated ventures (531) (1,008)
Gain (loss) on sale of assets, net 1,112 372,839
Other non-operating income (loss) 1,644 2,662
Income (loss) before income taxes (107,551) 353,669
Benefit (provision) for income taxes (752) 15,828
Net income (loss) (108,303) 369,497
Net (income) loss attributable to noncontrolling interest 18 18
Net income (loss) attributable to Brookdale Senior Living Inc. common stockholders $ (108,285) $ 369,515
Net income (loss) per share attributable to Brookdale Senior Living Inc. common stockholders:    
Basic (in dollars per share) $ (0.59) $ 2.01
Diluted (in dollars per share) $ (0.59) $ 2.00
Weighted average common shares outstanding:    
Weighted average shares outstanding - basic 184,011 184,186
Diluted (in shares) 184,011 184,522
Resident fees    
Revenue    
Revenue $ 664,350 $ 782,707
Management fees    
Revenue    
Revenue 8,566 108,715
Reimbursed costs incurred on behalf of managed communities    
Revenue    
Revenue 65,794 122,717
Expense    
Costs of services 65,794 122,717
Other operating income    
Revenue    
Revenue 10,735 0
Facility operating expense    
Expense    
Costs of services $ 556,312 $ 588,482
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Income Statement [Abstract]    
Depreciation and amortization $ 77,274 $ 84,301
Non-cash stock-based compensation expense $ 4,783 $ 5,957
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common stock:
Additional paid-in-capital:
Treasury stock:
Accumulated deficit:
Noncontrolling interest:
Cumulative Effect Period Of Adoption Adjustment
Accumulated deficit:
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of change in accounting principle $ 698,725 $ 1,996 $ 4,172,099 $ (84,651) $ (3,393,088) $ 2,369 $ (115)
Balance at beginning of period at Dec. 31, 2019 698,725 1,996 4,172,099 (84,651) (3,393,088) 2,369 (115)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan   1 168        
Restricted stock and restricted stock units, net   (6) 6        
Shares withheld for employee taxes   (6) (3,892)        
Non-cash stock-based compensation expense     5,957        
Other, net     18        
Purchase of treasury stock       (18,123)      
Cumulative effect of change in accounting principle 1,052,230 1,985 4,174,356 (102,774) (3,023,688) 2,351 $ (115)
Net income (loss) 369,497       369,515 (18)  
Balance at end of period at Mar. 31, 2020 1,052,230 $ 1,985 4,174,356 (102,774) (3,023,688) 2,351  
Balance at beginning of period (in shares) at Dec. 31, 2019   192,129,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   61,000          
Restricted stock and restricted stock units, net (in shares)   (504,000)          
Shares withheld for employee taxes (in shares)   (611,000)          
Purchase of treasury stock (in shares)   (3,063,000)          
Balances at end of period (in shares) at Mar. 31, 2020   188,012,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of change in accounting principle 1,052,230 $ 1,985 4,174,356 (102,774) (3,023,688) 2,351  
Cumulative effect of change in accounting principle 802,729 1,983 4,212,409 (102,774) (3,311,184) 2,295  
Balance at beginning of period at Dec. 31, 2020 802,729 1,983 4,212,409 (102,774) (3,311,184) 2,295  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan     224        
Restricted stock and restricted stock units, net   2 (2)        
Shares withheld for employee taxes   (7) (4,322)        
Non-cash stock-based compensation expense     4,783        
Other, net     3        
Cumulative effect of change in accounting principle 802,729 1,978 4,213,095 (102,774) (3,419,469) 2,277  
Net income (loss) (108,303)       (108,285) (18)  
Balance at end of period at Mar. 31, 2021 $ 695,107 $ 1,978 4,213,095 (102,774) (3,419,469) 2,277  
Balance at beginning of period (in shares) at Dec. 31, 2020 187,804,138 187,804,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock under Associate Stock Purchase Plan (in shares)   43,000          
Restricted stock and restricted stock units, net (in shares)   127,000          
Shares withheld for employee taxes (in shares)   (744,000)          
Balances at end of period (in shares) at Mar. 31, 2021 187,229,540 187,230,000          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Cumulative effect of change in accounting principle $ 695,107 $ 1,978 $ 4,213,095 $ (102,774) $ (3,419,469) $ 2,277  
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows from Operating Activities    
Net income (loss) $ (108,303) $ 369,497
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Loss (gain) on debt modification and extinguishment, net 0 (19,181)
Depreciation and amortization, net 85,764 92,053
Asset impairment 10,677 78,226
Equity in (earnings) loss of unconsolidated ventures 531 1,008
Amortization of entrance fees (364) (377)
Proceeds from deferred entrance fee revenue 670 343
Deferred income tax (benefit) provision 319 (21,767)
Operating lease expense adjustment (4,664) (6,733)
Loss (gain) on sale of assets, net (1,112) (372,839)
Non-cash stock-based compensation expense 4,783 5,957
Other (1,416) (1,460)
Changes in operating assets and liabilities:    
Accounts receivable, net (5,768) (2,033)
Prepaid expenses and other assets, net (6,769) (1,696)
Prepaid insurance premiums financed with notes payable (12,985) (17,434)
Trade accounts payable and accrued expenses (500) (47,919)
Refundable fees and deferred revenue 7,717 (2,254)
Operating lease assets and liabilities for lessor capital expenditure reimbursements 7,563 4,088
Net cash provided by (used in) operating activities (23,857) 57,479
Cash Flows from Investing Activities    
Change in lease security deposits and lease acquisition deposits, net (62) 3,211
Purchase of marketable securities (79,932) (89,414)
Sale and maturities of marketable securities 117,995 50,000
Capital expenditures, net of related payables (40,361) (69,385)
Acquisition of assets, net of related payables and cash received 0 (446,688)
Investment in unconsolidated ventures (5,206) (268)
Proceeds from sale of assets, net 3,760 304,617
Net cash provided by (used in) investing activities (3,806) (247,927)
Cash Flows from Financing Activities    
Proceeds from debt 18,575 471,785
Repayment of debt and financing lease obligations (49,924) (263,226)
Proceeds from line of credit 0 166,381
Purchase of treasury stock, net of related payables 0 (18,123)
Payment of financing costs, net of related payables (87) (5,815)
Payments of employee taxes for withheld shares (4,329) (3,898)
Other 203 146
Net cash provided by (used in) financing activities (35,562) 347,250
Net increase (decrease) in cash, cash equivalents, and restricted cash (63,225) 156,802
Cash, cash equivalents, and restricted cash at beginning of period 465,148 301,697
Cash, cash equivalents, and restricted cash at end of period $ 401,923 $ 458,499
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Description of Business
3 Months Ended
Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of Business Description of BusinessBrookdale Senior Living Inc. ("Brookdale" or the "Company") is an operator of senior living communities throughout the United States. The Company is committed to providing senior living solutions primarily within properties that are designed, purpose-built, and operated to provide quality service, care, and living accommodations for residents. The Company operates and manages independent living, assisted living, memory care, and continuing care retirement communities ("CCRCs"). The Company also offers a range of home health, hospice, and outpatient therapy services to residents of many of its communities and to seniors living outside of its communities. The Company has five reportable segments: Independent Living; Assisted Living and Memory Care; CCRCs; Health Care Services; and Management Services. The Company expects to sell 80% of its equity in its Health Care Services segment, as described in Note 4.
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for quarterly reports on Form 10-Q. In the opinion of management, these financial statements include all adjustments, which are of a normal and recurring nature, necessary to present fairly the financial position, results of operations, and cash flows of the Company for all periods presented. Certain information and footnote disclosures included in annual financial statements have been condensed or omitted. The Company believes that the disclosures included are adequate and provide a fair presentation of interim period results. Interim financial statements are not necessarily indicative of the financial position or operating results for an entire year. These interim financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Brookdale and its consolidated subsidiaries. The ownership interest of consolidated entities not wholly-owned by the Company are presented as noncontrolling interests in the accompanying condensed consolidated financial statements. Intercompany balances and transactions have been eliminated in consolidation, and net income (loss) is reduced by the portion of net income (loss) attributable to noncontrolling interests. The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting.

Use of Estimates

The preparation of the condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, revenue, other operating income, asset impairments, self-insurance reserves, performance-based compensation, the allowance for credit losses, depreciation and amortization, leasing transactions, income taxes, and other contingencies. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from the original estimates.

Lease Accounting

The Company, as lessee, recognizes a right-of-use asset and a lease liability on the Company's condensed consolidated balance sheet for its community, office, and equipment leases. As of the commencement date of a lease, a lease liability and corresponding right-of-use asset is established on the Company's condensed consolidated balance sheet at the present value of future minimum lease payments. The Company's community leases generally contain fixed annual rent escalators or annual rent escalators based on an index, such as the consumer price index. The future minimum lease payments recognized on the condensed consolidated balance sheet include fixed payments (including in-substance fixed payments) and variable payments
estimated utilizing the index or rate on the lease commencement date. The Company recognizes lease expense as incurred for additional variable payments. For the Company's leases that do not contain an implicit rate, the Company utilizes its estimated incremental borrowing rate to determine the present value of lease payments based on information available at commencement of the lease. The Company's estimated incremental borrowing rate reflects the fixed rate at which the Company could borrow a similar amount for the same term on a collateralized basis. The Company elected the short-term lease exception policy which permits leases with an initial term of 12 months or less to not be recorded on the Company's condensed consolidated balance sheet and instead to be recognized as lease expense as incurred.

The Company, as lessee, makes a determination with respect to each of its community, office, and equipment leases as to whether each should be accounted for as an operating lease or financing lease. The classification criteria is based on estimates regarding the fair value of the leased asset, minimum lease payments, effective cost of funds, economic life of the asset, and certain other terms in the lease agreements.

Lease right-of-use assets are reviewed for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of right-of-use assets are assessed by a comparison of the carrying amount of the asset to the estimated future undiscounted net cash flows expected to be generated by the asset, calculated utilizing the lowest level of identifiable cash flows. If estimated future undiscounted net cash flows are less than the carrying amount of the asset then the fair value of the asset is estimated. The impairment expense is determined by comparing the estimated fair value of the asset to its carrying amount, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates and estimated lease coverage ratios (Level 3).

Operating Leases

The Company recognizes operating lease expense for actual rent paid, generally plus or minus a straight-line adjustment for estimated minimum lease escalators if applicable. The right-of-use asset is generally reduced each period by an amount equal to the difference between the operating lease expense and the amount of expense on the lease liability utilizing the effective interest method. Subsequent to the impairment of an operating lease right-of-use asset, the Company recognizes operating lease expense consisting of the reduction of the right-of-use asset on a straight-line basis over the remaining lease term and the amount of expense on the lease liability utilizing the effective interest method.

Financing Leases

Financing lease right-of-use assets are recognized within property, plant and equipment and leasehold intangibles, net on the Company's condensed consolidated balance sheets. The Company recognizes interest expense on the financing lease liabilities utilizing the effective interest method. The right-of-use asset is generally amortized to depreciation and amortization expense on a straight-line basis over the lease term unless the lease contains an option to purchase the underlying asset that the Company is reasonably certain to exercise. If the Company is reasonably certain to exercise the purchase option, the asset is amortized over the useful life.

Sale-Leaseback Transactions

For transactions in which an owned community is sold and leased back from the buyer (sale-leaseback transactions), the Company recognizes an asset sale and lease accounting is applied if the Company has transferred control of the community. For such transactions, the Company removes the transferred assets from the condensed consolidated balance sheet and a gain or loss on the sale is recognized for the difference between the carrying amount of the asset and the transaction price for the sale transaction.

For sale‑leaseback transactions in which the Company has not transferred control of the underlying asset, the Company does not recognize an asset sale or derecognize the underlying asset until control is transferred. For such transactions, the Company recognizes the underlying assets within assets under financing leases as a component of property, plant and equipment and leasehold intangibles, net on the condensed consolidated balance sheets and continues to depreciate the assets over their useful lives.

Additionally, the Company accounts for any amounts received as a financing lease liability and the Company recognizes interest expense on the financing lease liability utilizing the effective interest method with the interest expense limited to an amount that is not greater than the cash payments on the financing lease liability over the term of the lease.
Property, Plant and Equipment and Leasehold Intangibles, Net

Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset group may not be recoverable. Recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company is required to recognize an impairment loss. The impairment loss is measured by the amount by which the carrying amount of the asset exceeds its estimated fair value, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates, estimated holding periods, and estimated capitalization rates (Level 3).

Goodwill
The Company tests goodwill for impairment annually during the fourth quarter or more frequently if indicators of impairment arise. Factors the Company considers important in its analysis of whether an indicator of impairment exists include a significant decline in the Company's stock price or market capitalization for a sustained period since the last testing date, significant underperformance relative to historical or projected future operating results, and significant negative industry or economic trends. The Company first assesses qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If so, the Company performs a quantitative goodwill impairment test based upon a comparison of the estimated fair value of the reporting unit to which the goodwill has been assigned with the reporting unit's carrying amount. The fair values used in the quantitative goodwill impairment test are estimated using Level 3 inputs based upon discounted future cash flow projections for the reporting unit. These cash flow projections are based upon a number of estimates and assumptions such as revenue and expense growth rates, capitalization rates, and discount rates. The Company also considers market-based measures such as earnings multiples in its analysis of estimated fair values of its reporting units. If the quantitative goodwill impairment test results in a reporting unit's carrying amount exceeding its estimated fair value, an impairment charge will be recorded based on the difference, with the impairment charge limited to the amount of goodwill allocated to the reporting unit.
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.21.1
COVID-19 Pandemic
3 Months Ended
Mar. 31, 2021
Unusual or Infrequent Items, or Both [Abstract]  
COVID-19 Pandemic
3.  COVID-19 Pandemic

The United States broadly continues to experience the COVID-19 pandemic, which has significantly disrupted, and likely will continue to significantly disrupt for some period, the senior living industry and the Company's business. Due to the average age and prevalence of chronic medical conditions among the Company's residents and patients, they generally are at disproportionately higher risk of hospitalization and adverse outcomes if they contract COVID-19. The health and wellbeing of the Company's residents, patients, and associates is and has been its highest priority as it continues to serve and care for seniors through the pandemic.

Community Restrictions. To help protect the Company's residents, patients, and associates from contracting COVID-19, the Company imposed significant restrictions at its communities beginning in March 2020, including closing its communities to visitors and prospective residents, and in some cases restricting new resident move-ins, suspending group outings, modifying communal dining and programming to comply with social distancing and other regulatory guidelines and, in most cases, implementing in-room only dining and activities programming, requesting that residents refrain from leaving the community unless medically necessary, and requiring new residents and residents returning from a hospital or nursing home to isolate in their apartment for fourteen days. The Company has adopted a framework for determining when to ease restrictions at each of its communities based on several criteria, including regulatory requirements and guidance, completion of baseline testing at the community, and the presence of current confirmed COVID-19 positive cases. The Company may revert to more restrictive measures if the pandemic worsens, as necessary to comply with regulatory requirements, or at the direction of state or local health authorities. As of April 30, 2021, 100% of the Company's communities have opened for visitors and new prospects.

Pandemic-Related Expenses. The Company incurred $27.3 million of facility operating expense during the first quarter of 2021 for incremental direct costs to respond to the pandemic. Such costs include those for: acquisition of additional PPE, medical equipment, and cleaning and disposable food service supplies; enhanced cleaning and environmental sanitation; increased employee-related costs, including labor, workers compensation, and health plan expense; increased expense for general liability claims; and COVID-19 testing of residents and associates where not otherwise covered by government payor or third-party insurance sources. On a cumulative basis, the Company has incurred $152.9 million of pandemic related facility operating expense since the beginning of fiscal 2020. The Company recorded non-cash impairment charges in its operating results of $9.0 million for the three months ended March 31, 2021, for its operating lease right-of-use assets, primarily due to the COVID-19 pandemic and lower than expected operating performance at communities with impaired assets.
Liquidity. As of March 31, 2021, the Company's total liquidity was $438.9 million, consisting of $304.0 million of unrestricted cash and cash equivalents and $134.9 million of marketable securities. The Company's cash flows from operations, excluding management agreement termination fees and the impact of the Coronavirus Aid, Relief, and Economic Security Act of 2020 ("CARES Act") funding, have been insufficient to cover its operating expenses, capital expenditures, and required interest and lease payments during the pandemic. However, the Company was able to satisfy its liquidity needs over such period utilizing a portion of its preexisting liquidity, together with CARES Act funding. The Company currently estimates that its cash flows from operations, together with cash balances on hand, cash equivalents, marketable securities, and proceeds from the pending sale of 80% of the equity in its Health Care Services segment will be sufficient to fund its liquidity needs for at least the next 12 months. The Company continues to seek opportunities to enhance and preserve its liquidity, including through maintaining expense discipline and increasing occupancy, continuing to evaluate its financing structure and the state of debt markets, and seeking further government-sponsored financial relief related to the pandemic. There is no assurance that debt financing will continue to be available on terms consistent with the Company's expectations or at all, that its efforts will be successful in seeking further government-sponsored financial relief or regarding the amount of, or conditions required to qualify for, any such relief, or that the closing of the pending transaction will be completed in accordance with the Company's expectations, or at all, or generate cash proceeds to the Company in the amount it anticipates.

Financial Relief. The CARES Act, signed into law on March 27, 2020, and Paycheck Protection Program and Health Care Enhancement Act, signed into law on April 24, 2020, provide liquidity and financial relief to certain businesses, among other things. Certain impacts of such programs are provided below.

During the first quarter of 2021, the Company accepted $0.8 million of cash from grants from the Public Health and Social Services Emergency Fund ("Provider Relief Fund") administered by the U.S. Department of Health and Human Services ("HHS"), under which grants have been made available to eligible healthcare providers for healthcare related expenses or lost revenues attributable to COVID-19. The grants represented incentive payments made pursuant to the Nursing Home Infection Control Distribution, which related to the Company's skilled nursing care provided through its CCRCs. HHS continues to evaluate future allocations under the Provider Relief Fund and the regulation and guidance regarding grants made under the Provider Relief Fund. The Company intends to pursue additional funding that may become available. There can be no assurance that the Company will qualify for, or receive, such future grants in the amount it expects, that additional restrictions on the permissible uses or terms and conditions of the grants will not be imposed by HHS, or that future funding programs will be made available for which it qualifies.

During the year ended December 31, 2020, the Company received $87.5 million under the Accelerated and Advance Payment Program administered by CMS, $75.2 million of which related to its Health Care Services segment and $12.3 million related to its CCRCs segment. Recoupment of advanced payments will begin one year after payments were issued at a rate of 25% of Medicare payments for the first eleven months following the anniversary of issuance and at a rate of 50% of Medicare payments for the next six months. Any outstanding balance of advanced payments will be due following such recoupment period. Pursuant to the Purchase Agreement providing for the sale of 80% of the Company's equity in its Health Care Services segment (as described below), its net cash proceeds at closing will include a reduction for the then outstanding balance of such advanced payments related to its Health Care Services segment.

During fiscal 2020, the Company deferred payment of $72.7 million of the employer portion of social security payroll taxes incurred from March 27, 2020 through December 31, 2020 pursuant to the CARES Act. One-half of such deferral amount will become due on each of December 31, 2021 and December 31, 2022. Pursuant to the Purchase Agreement providing for the sale of 80% of the Company's equity in its Health Care Services segment, its net cash proceeds at closing will include a reduction for the $8.9 million of deferred payroll tax payments related to its Health Care Services segment. The Company expects to pay approximately $32 million of the deferred payments in both December 2021 and 2022.

The Company is eligible to claim the employee retention credit for certain of its associates under the CARES Act. The credit for 2020 is available to employers that fully or partially suspended operations during any calendar quarter in 2020 due to orders from an appropriate governmental authority limiting commerce, travel, or group meetings due to COVID-19, and is equal to 50% of qualified wages paid after March 12, 2020 through December 31, 2020 to qualified employees, with a maximum credit of $5,000 per employee. During the first quarter of 2021, the Company recognized $9.0 million of employee retention credits on wages paid from March 12, 2020 through September 30, 2020 within other operating income. The credit was modified and extended by subsequent legislation for wages paid from January 1, 2021 through December 31, 2021, and the Company is assessing its eligibility to claim such credit. There can be no assurance that the Company will qualify for, or receive, credits in the amount or on the timing it expects.
In addition to the grants described above, during the three months ended March 31, 2021, the Company has received and recognized $0.9 million of other operating income from grants from other government sources.

The Company cannot predict with reasonable certainty the impacts that COVID-19 ultimately will have on its business, results of operations, cash flow, and liquidity, and its response efforts may continue to delay or negatively impact its strategic initiatives, including plans for future growth. The ultimate impacts of COVID-19 will depend on many factors, some of which cannot be foreseen, including the duration, severity, and breadth of the pandemic and any resurgence of the disease; the impact of COVID-19 on the nation’s economy and debt and equity markets and the local economies in the Company's markets; the development, availability, utilization, and efficacy of COVID-19 testing, therapeutic agents, and vaccines and the prioritization of such resources among businesses and demographic groups; government financial and regulatory relief efforts that may become available to business and individuals, including the Company's ability to qualify for and satisfy the terms and conditions of financial relief; perceptions regarding the safety of senior living communities during and after the pandemic; changes in demand for senior living communities and the Company's ability to adapt its sales and marketing efforts to meet that demand; the impact of COVID-19 on the Company's residents’ and their families’ ability to afford its resident fees, including due to changes in unemployment rates, consumer confidence, housing markets, and equity markets caused by COVID-19; changes in the acuity levels of the Company's new residents; the disproportionate impact of COVID-19 on seniors generally and those residing in the Company's communities; the duration and costs of the Company's response efforts, including increased equipment, supplies, labor, litigation, testing, vaccination clinic, and other expenses; the impact of COVID-19 on the Company's ability to complete financings and refinancings of various assets, or other transactions (including dispositions and the pending sale of 80% of the equity in the Company's Health Care Services segment) or to generate sufficient cash flow to cover required debt, interest, and lease payments and to satisfy financial and other covenants in its debt and lease documents; increased regulatory requirements, including unfunded, mandatory testing; increased enforcement actions resulting from COVID-19; government action that may limit the Company's collection or discharge efforts for delinquent accounts; and the frequency and magnitude of legal actions and liability claims that may arise due to COVID-19 or the Company's response efforts.
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions, Dispositions and Other Transactions
3 Months Ended
Mar. 31, 2021
Business Combinations [Abstract]  
Acquisitions, Dispositions and Other Transactions Acquisitions, Dispositions and Other Transactions
During the period from January 1, 2020 through March 31, 2021, the Company acquired 27 communities that the Company formerly leased, disposed of eight owned communities (including the conveyance of five communities to Ventas, Inc. ("Ventas")), and sold its ownership interest in its unconsolidated entry fee CCRC Venture (the "CCRC Venture") with Healthpeak Properties, Inc. ("Healthpeak"), and the Company's triple-net lease obligations on five communities were terminated.

The Company expects to sell 80% of its equity in its Health Care Services segment, as described below. Additionally, one unencumbered community in the Assisted Living and Memory Care segment and one unencumbered community in the CCRCs segment were classified as held for sale, resulting in $14.0 million being recorded as assets held for sale within the condensed consolidated balance sheet for senior housing communities as of March 31, 2021.

The closings of the various pending and expected transactions described within this note are, or will be, subject to the satisfaction of various closing conditions, including (where applicable) the receipt of regulatory approvals. There can be no assurance that the transactions will close or, if they do, when the actual closings will occur.

Completed Dispositions of Owned Communities

During the three months ended March 31, 2021, the Company completed the sale of one owned community for cash proceeds of $2.7 million, net of transaction costs, and recognized a net gain on sale of assets of $0.5 million.

In addition to the conveyance of five communities to Ventas, during the year ended December 31, 2020, the Company completed the sale of two owned communities for cash proceeds of $38.1 million, net of transaction costs, and recognized a net gain on sale of assets of $2.7 million. These dispositions included the sale of one owned community during the three months ended March 31, 2020 for which the Company received cash proceeds of $5.5 million, net of transaction costs, and recognized a net gain on sale of assets of $0.2 million.

Pending Sale of Health Care Services

On February 24, 2021, the Company entered into a Securities Purchase Agreement (the "Purchase Agreement") with affiliates of HCA Healthcare, Inc., providing for the sale of 80% of the Company’s equity in its Health Care Services segment for a purchase price of $400 million in cash, subject to certain adjustments set forth in the Purchase Agreement, including a reduction
for the remaining outstanding balance as of the closing of Medicare advance payments and deferred payroll tax payments related to the Health Care Services segment, which were $75.2 million and $8.9 million respectively, as of March 31, 2021. The Purchase Agreement also contains certain agreed upon indemnities for the benefit of the purchaser. The closing of the sale transaction is anticipated to occur in the early second half of 2021, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Purchase Agreement. Pursuant to the Purchase Agreement, at closing of the transaction, the Company will retain a 20% equity interest in the business.

The assets and liabilities of the Health Care Services segment are included within assets held for sale and liabilities held for sale, respectively, within the Company’s condensed consolidated balance sheet as of March 31, 2021. As of March 31, 2021, assets held for sale and liabilities held for sale of the Health Care Services segment consisted of the following:

(in thousands)
Accounts receivable, net$62,401 
Property, plant and equipment and leasehold intangibles, net1,964 
Operating lease right-of-use assets9,688 
Goodwill126,810 
Prepaid expenses and other assets, net32,722 
Assets held for sale$233,585 
Trade accounts payable$1,201 
Accrued expenses30,030 
Refundable fees and deferred revenue75,223 
Operating lease obligations9,688 
Liabilities held for sale$116,142 
Refer to Note 16 for selected financial data for the Health Care Services segment.
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
Marketable Securities

As of March 31, 2021, marketable securities of $134.9 million are stated at fair value based on valuations provided by third-party pricing services and are classified within Level 2 of the valuation hierarchy.

Debt

The Company estimates the fair value of its debt using a discounted cash flow analysis based upon the Company's current borrowing rate for debt with similar maturities and collateral securing the indebtedness. The Company had outstanding long-term debt with a carrying amount of approximately $3.9 billion as of both March 31, 2021 and December 31, 2020. Fair value of the long-term debt approximates carrying amount in all periods presented. The Company's fair value of long-term debt disclosure is classified within Level 2 of the valuation hierarchy.
Asset Impairment Expense

The following is a summary of asset impairment expense.
Three Months Ended
March 31,
(in millions)20212020
Operating lease right-of-use assets$9.0 $65.7 
Property, plant and equipment and leasehold intangibles, net
1.7 11.0 
Investment in unconsolidated ventures— 1.5 
Asset impairment$10.7 $78.2 
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue
3 Months Ended
Mar. 31, 2021
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregation of Revenue

The Company disaggregates its revenue from contracts with customers by payor source as the Company believes it best depicts how the nature, amount, timing, and uncertainty of its revenue and cash flows are affected by economic factors. Resident fee revenue by payor source and reportable segment is as follows:
Three Months Ended March 31, 2021
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$118,322 $370,494 $52,213 $337 $541,366 
Government reimbursement460 16,444 12,487 67,465 96,856 
Other third-party payor programs— — 7,079 19,049 26,128 
Total resident fee revenue$118,782 $386,938 $71,779 $86,851 $664,350 
Three Months Ended March 31, 2020
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$135,290 $440,613 $64,703 $170 $640,776 
Government reimbursement572 16,866 19,405 73,689 110,532 
Other third-party payor programs— — 10,439 20,960 31,399 
Total resident fee revenue$135,862 $457,479 $94,547 $94,819 $782,707 

Contract Balances

The payment terms and conditions within the Company's revenue-generating contracts vary by contract type and payor source, although terms generally include payment to be made within 30 days. Resident fee revenue for recurring and routine monthly services is generally billed monthly in advance under the Company's independent living, assisted living, and memory care residency agreements. Resident fee revenue for standalone or certain healthcare services is generally billed monthly in arrears. A portion of the Company's reimbursement from Medicare for certain healthcare services is billed near the start of each period of care, and cash is generally received before all services are rendered. The amount of revenue recognized for periods of care which are incomplete at period end is based on the Company's historical average percentage of days complete on each period of care and any unearned amounts are deferred and recognized when the service is performed. Additionally, non-refundable community fees are generally billed and collected in advance or upon move-in of a resident under the Company's independent living, assisted living, and memory care residency agreements. Amounts of revenue that are collected from residents in advance are recognized as deferred revenue until the performance obligations are satisfied.

The Company had total deferred revenue (included within refundable fees and deferred revenue, liabilities held for sale, and other liabilities within the condensed consolidated balance sheets) of $146.0 million and $138.3 million, including $30.1
million and $21.1 million of monthly resident fees billed and received in advance, as of March 31, 2021 and December 31, 2020, respectively. Such amount of total deferred revenue as of both March 31, 2021 and December 31, 2020 also included $87.5 million received in the year ended December 31, 2020 under a temporary expansion of the Accelerated and Advance Payment Program administered by CMS. Refer to Note 3 for additional information on such program. For the three months ended March 31, 2021 and 2020, the Company recognized $30.8 million and $48.3 million, respectively, of revenue that was included in the deferred revenue balance as of January 1, 2021 and 2020, respectively.
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Property, Plant and Equipment and Leasehold Intangibles, Net
3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment and Leasehold Intangibles, Net Property, Plant and Equipment and Leasehold Intangibles, Net
As of March 31, 2021 and December 31, 2020, net property, plant and equipment and leasehold intangibles, which include assets under financing leases, consisted of the following:
(in thousands)March 31, 2021December 31, 2020
Land$504,698 $505,298 
Buildings and improvements5,222,741 5,215,460 
Furniture and equipment953,773 945,783 
Resident and leasehold operating intangibles305,960 307,071 
Construction in progress64,003 61,491 
Assets under financing leases and leasehold improvements1,534,468 1,523,055 
Property, plant and equipment and leasehold intangibles8,585,643 8,558,158 
Accumulated depreciation and amortization(3,567,234)(3,490,098)
Property, plant and equipment and leasehold intangibles, net$5,018,409 $5,068,060 

Assets under financing leases and leasehold improvements includes $0.4 billion of financing lease right-of-use assets, net of accumulated amortization, as of both March 31, 2021 and December 31, 2020. Refer to Note 10 for further information on the Company's financing leases.
Long-lived assets with definite useful lives are depreciated or amortized on a straight-line basis over their estimated useful lives (or, in certain cases, the shorter of their estimated useful lives or the lease term) and are tested for impairment whenever indicators of impairment arise. The Company recognized depreciation and amortization expense on its property, plant and equipment and leasehold intangibles of $83.9 million and $90.7 million for the three months ended March 31, 2021 and 2020, respectively.
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Goodwill
3 Months Ended
Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill GoodwillThe Company's Independent Living and Health Care Services segments had a carrying value of goodwill of $27.3 million and $126.8 million, respectively, as of both March 31, 2021 and December 31, 2020. The goodwill of the Health Care Services segment is included within assets held for sale within the Company’s condensed consolidated balance sheet as of March 31, 2021.
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Debt
3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]  
Debt Debt
Long-term debt consists of the following:
(in thousands)March 31, 2021December 31, 2020
Fixed mortgage notes payable due 2022 through 2047; weighted average interest rate of 4.17% and 4.18% as of March 31, 2021 and December 31, 2020, respectively
$2,334,151 $2,366,996 
Variable mortgage notes payable due 2022 through 2030, weighted average interest rate of 2.46% and 2.49% as of March 31, 2021 and December 31, 2020, respectively
1,524,496 1,529,935 
Other notes payable due 2021 to 2025; weighted average interest rate of 7.79% and 8.98% as of March 31, 2021 and December 31, 2020, respectively
57,468 46,557 
Debt discount and deferred financing costs, net(26,324)(27,500)
Total long-term debt3,889,791 3,915,988 
Current portion224,890 68,885 
Total long-term debt, less current portion$3,664,901 $3,847,103 

As of March 31, 2021, 97.9%, or $3.8 billion of the Company's total debt obligations represented non-recourse property-level mortgage financings.

As of March 31, 2021, $69.9 million of letters of credit and no cash borrowings were outstanding under the Company's $80.0 million secured credit facility. The Company also had a separate secured letter of credit facility providing up to $15.0 million of letters of credit as of March 31, 2021 under which $13.6 million had been issued as of that date.

Financial Covenants

Certain of the Company's debt documents contain restrictions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and debt service ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community, and/or entity basis. In addition, the Company's debt documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage.

The Company's failure to comply with applicable covenants could constitute an event of default under the applicable debt documents. Many of the Company's debt documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Furthermore, the Company's debt is secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries.

As of March 31, 2021, the Company is in compliance with the financial covenants of its debt agreements.
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Leases
3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Leases Leases
As of March 31, 2021, the Company operated 301 communities under long-term leases (235 operating leases and 66 financing leases). The substantial majority of the Company's lease arrangements are structured as master leases. Under a master lease, numerous communities are leased through an indivisible lease. The Company typically guarantees the performance and lease payment obligations of its subsidiary lessees under the master leases. An event of default related to an individual property or limited number of properties within a master lease portfolio may result in a default on the entire master lease portfolio.

The leases relating to these communities are generally fixed rate leases with annual escalators that are either fixed or based upon changes in the consumer price index or the leased property revenue. The Company is responsible for all operating costs, including repairs, property taxes, and insurance. The leases generally provide for renewal or extension options from 5 to 20 years and in some instances, purchase options.

The community leases contain other customary terms, which may include assignment and change of control restrictions, maintenance and capital expenditure obligations, termination provisions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and lease coverage ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community and/or entity basis. In addition, the
Company's lease documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage.

The Company's failure to comply with applicable covenants could constitute an event of default under the applicable lease documents. Many of the Company's debt and lease documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Certain leases contain cure provisions, which generally allow the Company to post an additional lease security deposit if the required covenant is not met. Furthermore, the Company's leases are secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries.

As of March 31, 2021, the Company is in compliance with the financial covenants of its long-term leases.

A summary of operating and financing lease expense (including the respective presentation on the condensed consolidated statements of operations) and net cash outflows from leases is as follows:
Three Months Ended
March 31,
Operating Leases (in thousands)
20212020
Facility operating expense$4,842 $4,850 
Facility lease expense44,418 64,481 
Operating lease expense49,260 69,331 
Operating lease expense adjustment (1)
4,664 6,733 
Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements(7,563)(4,088)
Operating net cash outflows from operating leases$46,361 $71,976 

(1)Represents the difference between the amount of cash operating lease payments and the amount of operating lease expense recognized in accordance with Accounting Standards Codification 842, Leases ("ASC 842").

Three Months Ended
March 31,
Financing Leases (in thousands)
20212020
Depreciation and amortization$7,630 $9,144 
Interest expense: financing lease obligations11,383 13,282 
Financing lease expense$19,013 $22,426 
Operating cash flows from financing leases$11,383 $13,282 
Financing cash flows from financing leases4,789 5,087 
Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement(1,389)(1,739)
Total net cash outflows from financing leases$14,783 $16,630 
The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):
Year Ending December 31,Operating LeasesFinancing Leases
2021 (nine months)$151,681 $48,807 
2022203,946 65,609 
2023192,625 66,341 
2024193,377 67,553 
2025191,131 57,595 
Thereafter280,960 109,684 
Total lease payments1,213,720 415,589 
Purchase option liability and non-cash gain on future sale of property— 413,617 
Imputed interest and variable lease payments(276,070)(270,052)
Total lease obligations$937,650 $559,154 
Leases Leases
As of March 31, 2021, the Company operated 301 communities under long-term leases (235 operating leases and 66 financing leases). The substantial majority of the Company's lease arrangements are structured as master leases. Under a master lease, numerous communities are leased through an indivisible lease. The Company typically guarantees the performance and lease payment obligations of its subsidiary lessees under the master leases. An event of default related to an individual property or limited number of properties within a master lease portfolio may result in a default on the entire master lease portfolio.

The leases relating to these communities are generally fixed rate leases with annual escalators that are either fixed or based upon changes in the consumer price index or the leased property revenue. The Company is responsible for all operating costs, including repairs, property taxes, and insurance. The leases generally provide for renewal or extension options from 5 to 20 years and in some instances, purchase options.

The community leases contain other customary terms, which may include assignment and change of control restrictions, maintenance and capital expenditure obligations, termination provisions and financial covenants, such as those requiring the Company to maintain prescribed minimum liquidity, net worth, and stockholders' equity levels and lease coverage ratios, in each case on a consolidated, portfolio-wide, multi-community, single-community and/or entity basis. In addition, the
Company's lease documents generally contain non-financial covenants, such as those requiring the Company to comply with Medicare or Medicaid provider requirements and maintain insurance coverage.

The Company's failure to comply with applicable covenants could constitute an event of default under the applicable lease documents. Many of the Company's debt and lease documents contain cross-default provisions so that a default under one of these instruments could cause a default under other debt and lease documents (including documents with other lenders and lessors). Certain leases contain cure provisions, which generally allow the Company to post an additional lease security deposit if the required covenant is not met. Furthermore, the Company's leases are secured by its communities and, in certain cases, a guaranty by the Company and/or one or more of its subsidiaries.

As of March 31, 2021, the Company is in compliance with the financial covenants of its long-term leases.

A summary of operating and financing lease expense (including the respective presentation on the condensed consolidated statements of operations) and net cash outflows from leases is as follows:
Three Months Ended
March 31,
Operating Leases (in thousands)
20212020
Facility operating expense$4,842 $4,850 
Facility lease expense44,418 64,481 
Operating lease expense49,260 69,331 
Operating lease expense adjustment (1)
4,664 6,733 
Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements(7,563)(4,088)
Operating net cash outflows from operating leases$46,361 $71,976 

(1)Represents the difference between the amount of cash operating lease payments and the amount of operating lease expense recognized in accordance with Accounting Standards Codification 842, Leases ("ASC 842").

Three Months Ended
March 31,
Financing Leases (in thousands)
20212020
Depreciation and amortization$7,630 $9,144 
Interest expense: financing lease obligations11,383 13,282 
Financing lease expense$19,013 $22,426 
Operating cash flows from financing leases$11,383 $13,282 
Financing cash flows from financing leases4,789 5,087 
Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement(1,389)(1,739)
Total net cash outflows from financing leases$14,783 $16,630 
The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):
Year Ending December 31,Operating LeasesFinancing Leases
2021 (nine months)$151,681 $48,807 
2022203,946 65,609 
2023192,625 66,341 
2024193,377 67,553 
2025191,131 57,595 
Thereafter280,960 109,684 
Total lease payments1,213,720 415,589 
Purchase option liability and non-cash gain on future sale of property— 413,617 
Imputed interest and variable lease payments(276,070)(270,052)
Total lease obligations$937,650 $559,154 
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Litigation
3 Months Ended
Mar. 31, 2021
Litigation [Abstract]  
Litigation Litigation
The Company has been and is currently involved in litigation and claims incidental to the conduct of its business, which it believes are generally comparable to other companies in the senior living and healthcare industries, including, but not limited to, putative class action claims from time to time regarding staffing at the Company’s communities and compliance with consumer protection laws and the Americans with Disabilities Act. Certain claims and lawsuits allege large damage amounts and may require significant costs to defend and resolve. As a result, the Company maintains general liability, professional liability, and other insurance policies in amounts and with coverage and deductibles the Company believes are appropriate, based on the nature and risks of its business, historical experience, availability, and industry standards. The Company's current policies provide for deductibles for each claim and contain various exclusions from coverage. Accordingly, the Company is, in effect, self-insured for claims that are less than the deductible amounts and for claims or portions of claims that are not covered by such policies and/or exceed the policy limits.

Similarly, the senior living and healthcare industries are continuously subject to scrutiny by governmental regulators, which could result in reviews, audits, investigations, enforcement activities or litigation related to regulatory compliance matters. In addition, as a result of the Company's participation in the Medicare and Medicaid programs, the Company is subject to various governmental reviews, audits and investigations, including but not limited to audits under various government programs, such as the Recovery Audit Contractors (RAC), Zone Program Integrity Contractors (ZPIC), and Unified Program Integrity Contractors (UPIC) programs. The costs to respond to and defend such reviews, audits, and investigations may be significant, and an adverse determination could result in citations, sanctions and other criminal or civil fines and penalties, the refund of overpayments, payment suspensions, termination of participation in Medicare and Medicaid programs, and/or damage to the Company's business reputation.

In June 2020, the Company and several current and former executive officers were named as defendants in a putative class action lawsuit alleging violations of the federal securities laws filed in the federal court for the Middle District of Tennessee. The lawsuit asserts that the defendants made material misstatements and omissions concerning the Company's business, operational and compliance policies that caused the Company's stock price to be artificially inflated between August 2016 and April 2020. While the Company cannot predict with certainty the result of this or any other legal proceedings, the Company believes the allegations in the suit are without merit and does not expect this matter to have a material adverse effect on the Company's financial condition, results of operations, or cash flows. In October 2020 and April 2021, alleged stockholders of the Company filed separate stockholder derivative lawsuits in the federal court for the Middle District of Tennessee, asserting claims on behalf of the Company against certain current and former officers and directors for alleged breaches of duties owed to the Company. The complaints refer to the securities lawsuit described above and incorporate substantively similar allegations.
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
Grants of restricted stock and restricted stock units under the Company's 2014 Omnibus Incentive Plan were as follows:
(in thousands, except for per share and unit amounts)Restricted Stock and Restricted Stock Unit GrantsWeighted Average Grant Date Fair ValueTotal Grant Date Fair Value
Three months ended March 31, 20211,961 $5.09 $9,988 
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
Basic earnings per share ("EPS") is calculated by dividing net income (loss) by the weighted average number of shares of common stock outstanding. Diluted EPS includes the components of basic EPS and also gives effect to dilutive common stock equivalents. Under the treasury stock method, diluted EPS reflects the potential dilution that could occur if securities or other instruments that are convertible into common stock were exercised or could result in the issuance of common stock. Potentially dilutive common stock equivalents include unvested restricted stock, restricted stock units, and warrants.

The following table summarizes the computation of basic and diluted earnings (loss) per share amounts presented in the condensed consolidated statement of operations:
Three Months Ended
March 31,
(in thousands, except for per share amounts)20212020
Income attributable to common stockholders:
Net income (loss)
$(108,285)$369,515 
Weighted average shares outstanding - basic184,011 184,186 
Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants— 336 
Weighted average shares outstanding - diluted184,011 184,522 
Basic earnings (loss) per common share:
Net income (loss) per share attributable to common stockholders$(0.59)$2.01 
Diluted earnings (loss) per common share:
Net income (loss) per share attributable to common stockholders$(0.59)$2.00 


For the purposes of computing diluted EPS, weighted average shares outstanding do not include potentially dilutive securities that are anti-dilutive under the treasury stock method, and performance-based equity awards are included based on the attainment of the applicable performance metrics as of the end of the reporting period. The following potentially dilutive securities were excluded from the computation of diluted EPS:
Three Months Ended
March 31,
(in millions)
2021(1)
2020
Non-performance-based restricted stock and restricted stock units6.2 6.9 
Performance-based restricted stock and restricted stock units0.4 1.8 
Warrants16.3 — 
(1)As a result of the net loss reported for the period, all unvested restricted stock, restricted stock units, and potential shares issuable under warrants were antidilutive for the period and as such were not included in the computation of diluted weighted average shares outstanding.
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes
3 Months Ended
Mar. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
The difference between the Company's effective tax rate for the three months ended March 31, 2021 and 2020 was primarily due to the tax impact of the multi-part transaction with Healthpeak that occurred in the three months ended March 31, 2020. The impact represented the tax expense recorded on the gain of the sale of the Company's interest in the CCRC Venture offset by a decrease in the valuation allowance that was a direct result of the multi-part transaction with Healthpeak.

The Company recorded an aggregate deferred federal, state, and local tax benefit of $25.2 million as a result of the operating loss for the three months ended March 31, 2021, which was offset by a proportionate increase in the valuation allowance of $25.5 million. The Company recorded an aggregate deferred federal, state, and local tax expense of $90.9 million for the three months ended March 31, 2020. The expense included $93.1 million as a result of the gain on the sale of the Company's interest in the CCRC Venture offset by a benefit of $2.2 million as a result of the operating losses (exclusive of the CCRC Venture sale) for the three months ended March 31, 2020. The expense for the three months ended March 31, 2020 was offset by a reduction in the valuation allowance of $112.6 million.

The Company evaluates its deferred tax assets each quarter to determine if a valuation allowance is required based on whether it is more likely than not that some portion of the deferred tax asset would not be realized. The Company's valuation allowance as of March 31, 2021 and December 31, 2020 was $406.5 million and $381.0 million, respectively.

The increase in the valuation allowance for the three months ended March 31, 2021 is the result of current operating losses during the three months ended March 31, 2021. The change in the valuation allowance for the three months ended March 31, 2020 was primarily the result of a reduction in the Company’s valuation allowance of $117.6 million as a result of the Healthpeak transaction offset by the anticipated reversal of future tax liabilities offset by future tax deductions.
The Company recorded interest charges related to its tax contingency reserve for cash tax positions for the three months ended March 31, 2021 and 2020 which are included in income tax expense or benefit for the period. As of March 31, 2021, tax returns for years 2017 through 2019 are subject to future examination by tax authorities. In addition, the net operating losses from prior years are subject to adjustment under examination.
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Supplemental Disclosure of Cash Flow Information
3 Months Ended
Mar. 31, 2021
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information Supplemental Disclosure of Cash Flow Information
Three Months Ended
March 31,
(in thousands)20212020
Supplemental Disclosure of Cash Flow Information:
Interest paid$47,129 $59,479 
Income taxes paid, net of refunds904 957 
Capital expenditures, net of related payables:
Capital expenditures - non-development, net$27,450 $60,556 
Capital expenditures - development, net1,521 3,900 
Capital expenditures - non-development - reimbursable8,951 5,827 
Trade accounts payable2,439 (898)
Net cash paid$40,361 $69,385 
Acquisition of communities from Healthpeak:
Property, plant and equipment and leasehold intangibles, net$— $286,734 
Operating lease right-of-use assets— (63,285)
Financing lease obligations— 129,196 
Operating lease obligations— 74,335 
Loss (gain) on debt modification and extinguishment, net— (19,731)
Net cash paid$— $407,249 
Acquisition of other assets, net of related payables and cash received:
Property, plant and equipment and leasehold intangibles, net$— $179 
Financing lease obligations— 39,260 
Net cash paid$— $39,439 
Proceeds from sale of CCRC Venture, net:
Investments in unconsolidated ventures$— $(14,848)
Current portion of long-term debt— 34,706 
Accrued expenses— (5,025)
Other liabilities— 60,748 
Loss (gain) on sale of assets, net— (370,745)
Net cash received$— $(295,164)
Proceeds from sale of other assets, net:
Prepaid expenses and other assets, net$— $(1,261)
Assets held for sale(2,125)(5,274)
Property, plant and equipment and leasehold intangibles, net(597)— 
Other liabilities74 (824)
Loss (gain) on sale of assets, net(1,112)(2,094)
Net cash received$(3,760)$(9,453)
Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities:
Healthpeak master lease modification:
Property, plant and equipment and leasehold intangibles, net$— $(57,462)
Operating lease right-of-use assets— 88,044 
Financing lease obligations— 70,874 
Operating lease obligations— (101,456)
Net$— $— 
Other non-cash lease transactions, net:
Property, plant and equipment and leasehold intangibles, net$— $(9,441)
Operating lease right-of-use assets16,721 — 
Financing lease obligations— 9,516 
Operating lease obligations(16,721)— 
Other liabilities— (75)
Net$— $— 

Restricted cash consists principally of deposits for letters of credit, escrow deposits for real estate taxes, property insurance, and capital expenditures, debt service reserve accounts required by certain lenders under mortgage debt agreements, and deposits as security for self-insured retention risk under workers' compensation programs and property insurance programs. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.
(in thousands)March 31, 2021December 31, 2020
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents$303,952 $380,420 
Restricted cash26,503 28,059 
Long-term restricted cash71,468 56,669 
Total cash, cash equivalents, and restricted cash$401,923 $465,148 
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Segment Information Segment InformationThe Company has five reportable segments: Independent Living; Assisted Living and Memory Care; CCRCs; Health Care Services; and Management Services. Operating segments are defined as components of an enterprise that engage in business activities from which it may earn revenues and incur expenses; for which separate financial information is available; and whose operating results are regularly reviewed by the chief operating decision maker to assess the performance of the individual segment and make decisions about resources to be allocated to the segment.
Independent Living. The Company's Independent Living segment includes owned or leased communities that are primarily designed for middle to upper income seniors who desire to live in a residential setting that feels like home, without the efforts of ownership. The majority of the Company's independent living communities consist of both independent and assisted living units in a single community, which allows residents to age-in-place by providing them with a broad continuum of senior independent and assisted living services to accommodate their changing needs.

Assisted Living and Memory Care. The Company's Assisted Living and Memory Care segment includes owned or leased communities that offer housing and 24-hour assistance with activities of daily living for mid-acuity and frail elderly residents. The Company's assisted living and memory care communities include both freestanding, multi-story communities, as well as smaller freestanding, single story communities. The Company also provides memory care services at freestanding memory care communities that are specially designed for residents with Alzheimer's disease and other dementias.

CCRCs. The Company's CCRCs segment includes large owned or leased communities that offer a variety of living arrangements and services to accommodate a broad spectrum of physical ability and healthcare needs. Most of the Company's CCRCs have independent living, assisted living, memory care, and skilled nursing available on one campus or within the immediate area.

Health Care Services. The Company's Health Care Services segment includes the home health, hospice, and outpatient therapy services provided to residents of many of its communities and to seniors living outside its communities. The Health Care Services segment does not include the skilled nursing and inpatient healthcare services provided in the Company's skilled nursing units, which are included in the Company's CCRCs segment.

Management Services. The Company's Management Services segment includes communities operated by the Company pursuant to management agreements. In some of the cases, the controlling financial interest in the community is held by third parties and, in other cases, the community is owned in a venture structure in which the Company has an ownership interest. Under the management agreements for these communities, the Company receives management fees as well as reimbursed expenses, which represent the reimbursement of expenses it incurs on behalf of the owners.

The following table sets forth selected segment financial data:
Three Months Ended
March 31,
(in thousands)20212020
Revenue and other operating income:
Independent Living(1)(2)
$120,146 $135,862 
Assisted Living and Memory Care(1)(2)
392,042 457,479 
CCRCs(1)(2)
73,463 94,547 
Health Care Services(1)(2)
89,434 94,819 
Management Services(3)
74,360 231,432 
Total revenue and other operating income$749,445 $1,014,139 
Segment operating income:(4)
Independent Living$37,329 $51,414 
Assisted Living and Memory Care71,433 132,001 
CCRCs7,608 19,931 
Health Care Services2,403 (9,121)
Management Services8,566 108,715 
Total segment operating income127,339 302,940 
General and administrative expense (including non-cash stock-based compensation expense)
49,943 54,595 
Facility operating lease expense44,418 64,481 
Depreciation and amortization83,891 90,738 
Asset impairment:
Independent Living520 31,317 
Assisted Living and Memory Care9,642 32,798 
CCRCs515 12,173 
Corporate and Management Services— 1,938 
Income (loss) from operations$(61,590)$14,900 

As of
(in thousands)March 31, 2021December 31, 2020
Total assets:
Independent Living$1,399,489 $1,419,838 
Assisted Living and Memory Care3,740,476 3,787,611 
CCRCs728,621 738,121 
Health Care Services233,585 233,178 
Corporate and Management Services643,982 723,010 
Total assets$6,746,153 $6,901,758 

(1)All revenue is earned from external third parties in the United States.

(2)The Independent Living, Assisted Living and Memory Care, CCRCs, and Health Care Services segments include $1.4 million, $5.1 million, $1.7 million, and $2.6 million respectively, for the three months ended March 31, 2021 of other operating income recognized for the credits or grants pursuant to the Employee Retention Credit, Provider Relief Fund, and other government sources, as described in Note 3. Allocations to the applicable segment generally reflect the credits earned by the segment, the segment’s receipt and acceptance of the grant, or the segment’s proportional utilization of the grant.

(3)Management services segment revenue includes management fees and reimbursements of costs incurred on behalf of managed communities.
(4)Segment operating income is defined as segment revenues and other operating income less segment facility operating expenses (excluding facility depreciation and amortization) and costs incurred on behalf of managed communities.
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2021
Accounting Policies [Abstract]  
Basis of Presentation Basis of PresentationThe accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States ("GAAP") and pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC") for quarterly reports on Form 10-Q. In the opinion of management, these financial statements include all adjustments, which are of a normal and recurring nature, necessary to present fairly the financial position, results of operations, and cash flows of the Company for all periods presented. Certain information and footnote disclosures included in annual financial statements have been condensed or omitted. The Company believes that the disclosures included are adequate and provide a fair presentation of interim period results. Interim financial statements are not necessarily indicative of the financial position or operating results for an entire year. These interim financial statements should be read in conjunction with the audited financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 filed with the SEC on February 25, 2021.
Principles of Consolidation Principles of ConsolidationThe condensed consolidated financial statements include the accounts of Brookdale and its consolidated subsidiaries. The ownership interest of consolidated entities not wholly-owned by the Company are presented as noncontrolling interests in the accompanying condensed consolidated financial statements. Intercompany balances and transactions have been eliminated in consolidation, and net income (loss) is reduced by the portion of net income (loss) attributable to noncontrolling interests. The Company reports investments in unconsolidated entities over whose operating and financial policies it has the ability to exercise significant influence under the equity method of accounting.
Use of Estimates Use of EstimatesThe preparation of the condensed consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Estimates are used for, but not limited to, revenue, other operating income, asset impairments, self-insurance reserves, performance-based compensation, the allowance for credit losses, depreciation and amortization, leasing transactions, income taxes, and other contingencies. Although these estimates are based on management's best knowledge of current events and actions that the Company may undertake in the future, actual results may differ from the original estimates.
Lease Accounting
Lease Accounting

The Company, as lessee, recognizes a right-of-use asset and a lease liability on the Company's condensed consolidated balance sheet for its community, office, and equipment leases. As of the commencement date of a lease, a lease liability and corresponding right-of-use asset is established on the Company's condensed consolidated balance sheet at the present value of future minimum lease payments. The Company's community leases generally contain fixed annual rent escalators or annual rent escalators based on an index, such as the consumer price index. The future minimum lease payments recognized on the condensed consolidated balance sheet include fixed payments (including in-substance fixed payments) and variable payments
estimated utilizing the index or rate on the lease commencement date. The Company recognizes lease expense as incurred for additional variable payments. For the Company's leases that do not contain an implicit rate, the Company utilizes its estimated incremental borrowing rate to determine the present value of lease payments based on information available at commencement of the lease. The Company's estimated incremental borrowing rate reflects the fixed rate at which the Company could borrow a similar amount for the same term on a collateralized basis. The Company elected the short-term lease exception policy which permits leases with an initial term of 12 months or less to not be recorded on the Company's condensed consolidated balance sheet and instead to be recognized as lease expense as incurred.

The Company, as lessee, makes a determination with respect to each of its community, office, and equipment leases as to whether each should be accounted for as an operating lease or financing lease. The classification criteria is based on estimates regarding the fair value of the leased asset, minimum lease payments, effective cost of funds, economic life of the asset, and certain other terms in the lease agreements.

Lease right-of-use assets are reviewed for impairment whenever changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of right-of-use assets are assessed by a comparison of the carrying amount of the asset to the estimated future undiscounted net cash flows expected to be generated by the asset, calculated utilizing the lowest level of identifiable cash flows. If estimated future undiscounted net cash flows are less than the carrying amount of the asset then the fair value of the asset is estimated. The impairment expense is determined by comparing the estimated fair value of the asset to its carrying amount, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates and estimated lease coverage ratios (Level 3).

Operating Leases

The Company recognizes operating lease expense for actual rent paid, generally plus or minus a straight-line adjustment for estimated minimum lease escalators if applicable. The right-of-use asset is generally reduced each period by an amount equal to the difference between the operating lease expense and the amount of expense on the lease liability utilizing the effective interest method. Subsequent to the impairment of an operating lease right-of-use asset, the Company recognizes operating lease expense consisting of the reduction of the right-of-use asset on a straight-line basis over the remaining lease term and the amount of expense on the lease liability utilizing the effective interest method.

Financing Leases

Financing lease right-of-use assets are recognized within property, plant and equipment and leasehold intangibles, net on the Company's condensed consolidated balance sheets. The Company recognizes interest expense on the financing lease liabilities utilizing the effective interest method. The right-of-use asset is generally amortized to depreciation and amortization expense on a straight-line basis over the lease term unless the lease contains an option to purchase the underlying asset that the Company is reasonably certain to exercise. If the Company is reasonably certain to exercise the purchase option, the asset is amortized over the useful life.

Sale-Leaseback Transactions

For transactions in which an owned community is sold and leased back from the buyer (sale-leaseback transactions), the Company recognizes an asset sale and lease accounting is applied if the Company has transferred control of the community. For such transactions, the Company removes the transferred assets from the condensed consolidated balance sheet and a gain or loss on the sale is recognized for the difference between the carrying amount of the asset and the transaction price for the sale transaction.

For sale‑leaseback transactions in which the Company has not transferred control of the underlying asset, the Company does not recognize an asset sale or derecognize the underlying asset until control is transferred. For such transactions, the Company recognizes the underlying assets within assets under financing leases as a component of property, plant and equipment and leasehold intangibles, net on the condensed consolidated balance sheets and continues to depreciate the assets over their useful lives.
Additionally, the Company accounts for any amounts received as a financing lease liability and the Company recognizes interest expense on the financing lease liability utilizing the effective interest method with the interest expense limited to an amount that is not greater than the cash payments on the financing lease liability over the term of the lease.
Property, Plant and Equipment and Leasehold Intangibles, Net Property, Plant and Equipment and Leasehold Intangibles, NetLong-lived assets are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset group may not be recoverable. Recoverability of an asset group is assessed by comparing its carrying amount to the estimated future undiscounted net cash flows expected to be generated by the asset group through operation or disposition, calculated utilizing the lowest level of identifiable cash flows. If this comparison indicates that the carrying amount of an asset group is not recoverable, the Company is required to recognize an impairment loss. The impairment loss is measured by the amount by which the carrying amount of the asset exceeds its estimated fair value, with any amount in excess of fair value recognized as an expense in the current period. Undiscounted cash flow projections and estimates of fair value amounts are based on a number of assumptions such as revenue and expense growth rates, estimated holding periods, and estimated capitalization rates (Level 3).
Goodwill GoodwillThe Company tests goodwill for impairment annually during the fourth quarter or more frequently if indicators of impairment arise. Factors the Company considers important in its analysis of whether an indicator of impairment exists include a significant decline in the Company's stock price or market capitalization for a sustained period since the last testing date, significant underperformance relative to historical or projected future operating results, and significant negative industry or economic trends. The Company first assesses qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If so, the Company performs a quantitative goodwill impairment test based upon a comparison of the estimated fair value of the reporting unit to which the goodwill has been assigned with the reporting unit's carrying amount. The fair values used in the quantitative goodwill impairment test are estimated using Level 3 inputs based upon discounted future cash flow projections for the reporting unit. These cash flow projections are based upon a number of estimates and assumptions such as revenue and expense growth rates, capitalization rates, and discount rates. The Company also considers market-based measures such as earnings multiples in its analysis of estimated fair values of its reporting units. If the quantitative goodwill impairment test results in a reporting unit's carrying amount exceeding its estimated fair value, an impairment charge will be recorded based on the difference, with the impairment charge limited to the amount of goodwill allocated to the reporting unit.
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions, Dispositions and Other Transactions (Tables)
3 Months Ended
Mar. 31, 2021
Business Combinations [Abstract]  
Disclosure of Assets and Liabilities Held-for-sale As of March 31, 2021, assets held for sale and liabilities held for sale of the Health Care Services segment consisted of the following:
(in thousands)
Accounts receivable, net$62,401 
Property, plant and equipment and leasehold intangibles, net1,964 
Operating lease right-of-use assets9,688 
Goodwill126,810 
Prepaid expenses and other assets, net32,722 
Assets held for sale$233,585 
Trade accounts payable$1,201 
Accrued expenses30,030 
Refundable fees and deferred revenue75,223 
Operating lease obligations9,688 
Liabilities held for sale$116,142 
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Summary of Asset Impairment Expense
The following is a summary of asset impairment expense.
Three Months Ended
March 31,
(in millions)20212020
Operating lease right-of-use assets$9.0 $65.7 
Property, plant and equipment and leasehold intangibles, net
1.7 11.0 
Investment in unconsolidated ventures— 1.5 
Asset impairment$10.7 $78.2 
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2021
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by payor source as the Company believes it best depicts how the nature, amount, timing, and uncertainty of its revenue and cash flows are affected by economic factors. Resident fee revenue by payor source and reportable segment is as follows:
Three Months Ended March 31, 2021
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$118,322 $370,494 $52,213 $337 $541,366 
Government reimbursement460 16,444 12,487 67,465 96,856 
Other third-party payor programs— — 7,079 19,049 26,128 
Total resident fee revenue$118,782 $386,938 $71,779 $86,851 $664,350 
Three Months Ended March 31, 2020
(in thousands)Independent LivingAssisted Living and Memory CareCCRCsHealth Care ServicesTotal
Private pay$135,290 $440,613 $64,703 $170 $640,776 
Government reimbursement572 16,866 19,405 73,689 110,532 
Other third-party payor programs— — 10,439 20,960 31,399 
Total resident fee revenue$135,862 $457,479 $94,547 $94,819 $782,707 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Property, Plant and Equipment and Leasehold Intangibles, Net (Tables)
3 Months Ended
Mar. 31, 2021
Property, Plant and Equipment [Abstract]  
Property, Plant and Equipment and Leasehold Intangibles, Net
As of March 31, 2021 and December 31, 2020, net property, plant and equipment and leasehold intangibles, which include assets under financing leases, consisted of the following:
(in thousands)March 31, 2021December 31, 2020
Land$504,698 $505,298 
Buildings and improvements5,222,741 5,215,460 
Furniture and equipment953,773 945,783 
Resident and leasehold operating intangibles305,960 307,071 
Construction in progress64,003 61,491 
Assets under financing leases and leasehold improvements1,534,468 1,523,055 
Property, plant and equipment and leasehold intangibles8,585,643 8,558,158 
Accumulated depreciation and amortization(3,567,234)(3,490,098)
Property, plant and equipment and leasehold intangibles, net$5,018,409 $5,068,060 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Debt (Tables)
3 Months Ended
Mar. 31, 2021
Debt Disclosure [Abstract]  
Schedule of Debt
Long-term debt consists of the following:
(in thousands)March 31, 2021December 31, 2020
Fixed mortgage notes payable due 2022 through 2047; weighted average interest rate of 4.17% and 4.18% as of March 31, 2021 and December 31, 2020, respectively
$2,334,151 $2,366,996 
Variable mortgage notes payable due 2022 through 2030, weighted average interest rate of 2.46% and 2.49% as of March 31, 2021 and December 31, 2020, respectively
1,524,496 1,529,935 
Other notes payable due 2021 to 2025; weighted average interest rate of 7.79% and 8.98% as of March 31, 2021 and December 31, 2020, respectively
57,468 46,557 
Debt discount and deferred financing costs, net(26,324)(27,500)
Total long-term debt3,889,791 3,915,988 
Current portion224,890 68,885 
Total long-term debt, less current portion$3,664,901 $3,847,103 
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.21.1
Leases (Tables)
3 Months Ended
Mar. 31, 2021
Leases [Abstract]  
Lease Costs
A summary of operating and financing lease expense (including the respective presentation on the condensed consolidated statements of operations) and net cash outflows from leases is as follows:
Three Months Ended
March 31,
Operating Leases (in thousands)
20212020
Facility operating expense$4,842 $4,850 
Facility lease expense44,418 64,481 
Operating lease expense49,260 69,331 
Operating lease expense adjustment (1)
4,664 6,733 
Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements(7,563)(4,088)
Operating net cash outflows from operating leases$46,361 $71,976 

(1)Represents the difference between the amount of cash operating lease payments and the amount of operating lease expense recognized in accordance with Accounting Standards Codification 842, Leases ("ASC 842").

Three Months Ended
March 31,
Financing Leases (in thousands)
20212020
Depreciation and amortization$7,630 $9,144 
Interest expense: financing lease obligations11,383 13,282 
Financing lease expense$19,013 $22,426 
Operating cash flows from financing leases$11,383 $13,282 
Financing cash flows from financing leases4,789 5,087 
Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement(1,389)(1,739)
Total net cash outflows from financing leases$14,783 $16,630 
Finance Lease, Liability, Maturity
The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):
Year Ending December 31,Operating LeasesFinancing Leases
2021 (nine months)$151,681 $48,807 
2022203,946 65,609 
2023192,625 66,341 
2024193,377 67,553 
2025191,131 57,595 
Thereafter280,960 109,684 
Total lease payments1,213,720 415,589 
Purchase option liability and non-cash gain on future sale of property— 413,617 
Imputed interest and variable lease payments(276,070)(270,052)
Total lease obligations$937,650 $559,154 
Lessee, Operating Lease, Liability, Maturity
The aggregate amounts of future minimum lease payments, including community, office, and equipment leases (excluding minimum lease payments related to $9.7 million of operating lease obligations included within liabilities held for sale) recognized on the condensed consolidated balance sheet as of March 31, 2021 are as follows (in thousands):
Year Ending December 31,Operating LeasesFinancing Leases
2021 (nine months)$151,681 $48,807 
2022203,946 65,609 
2023192,625 66,341 
2024193,377 67,553 
2025191,131 57,595 
Thereafter280,960 109,684 
Total lease payments1,213,720 415,589 
Purchase option liability and non-cash gain on future sale of property— 413,617 
Imputed interest and variable lease payments(276,070)(270,052)
Total lease obligations$937,650 $559,154 
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Grants of Restricted Stock and Stock Units
Grants of restricted stock and restricted stock units under the Company's 2014 Omnibus Incentive Plan were as follows:
(in thousands, except for per share and unit amounts)Restricted Stock and Restricted Stock Unit GrantsWeighted Average Grant Date Fair ValueTotal Grant Date Fair Value
Three months ended March 31, 20211,961 $5.09 $9,988 
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share (Tables)
3 Months Ended
Mar. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table summarizes the computation of basic and diluted earnings (loss) per share amounts presented in the condensed consolidated statement of operations:
Three Months Ended
March 31,
(in thousands, except for per share amounts)20212020
Income attributable to common stockholders:
Net income (loss)
$(108,285)$369,515 
Weighted average shares outstanding - basic184,011 184,186 
Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants— 336 
Weighted average shares outstanding - diluted184,011 184,522 
Basic earnings (loss) per common share:
Net income (loss) per share attributable to common stockholders$(0.59)$2.01 
Diluted earnings (loss) per common share:
Net income (loss) per share attributable to common stockholders$(0.59)$2.00 
Schedule of Potentially Dilutive Securities The following potentially dilutive securities were excluded from the computation of diluted EPS:
Three Months Ended
March 31,
(in millions)
2021(1)
2020
Non-performance-based restricted stock and restricted stock units6.2 6.9 
Performance-based restricted stock and restricted stock units0.4 1.8 
Warrants16.3 — 
(1)As a result of the net loss reported for the period, all unvested restricted stock, restricted stock units, and potential shares issuable under warrants were antidilutive for the period and as such were not included in the computation of diluted weighted average shares outstanding.
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.21.1
Supplemental Disclosure of Cash Flow Information (Tables)
3 Months Ended
Mar. 31, 2021
Supplemental Cash Flow Elements [Abstract]  
Supplemental Cash Flow Information
Three Months Ended
March 31,
(in thousands)20212020
Supplemental Disclosure of Cash Flow Information:
Interest paid$47,129 $59,479 
Income taxes paid, net of refunds904 957 
Capital expenditures, net of related payables:
Capital expenditures - non-development, net$27,450 $60,556 
Capital expenditures - development, net1,521 3,900 
Capital expenditures - non-development - reimbursable8,951 5,827 
Trade accounts payable2,439 (898)
Net cash paid$40,361 $69,385 
Acquisition of communities from Healthpeak:
Property, plant and equipment and leasehold intangibles, net$— $286,734 
Operating lease right-of-use assets— (63,285)
Financing lease obligations— 129,196 
Operating lease obligations— 74,335 
Loss (gain) on debt modification and extinguishment, net— (19,731)
Net cash paid$— $407,249 
Acquisition of other assets, net of related payables and cash received:
Property, plant and equipment and leasehold intangibles, net$— $179 
Financing lease obligations— 39,260 
Net cash paid$— $39,439 
Proceeds from sale of CCRC Venture, net:
Investments in unconsolidated ventures$— $(14,848)
Current portion of long-term debt— 34,706 
Accrued expenses— (5,025)
Other liabilities— 60,748 
Loss (gain) on sale of assets, net— (370,745)
Net cash received$— $(295,164)
Proceeds from sale of other assets, net:
Prepaid expenses and other assets, net$— $(1,261)
Assets held for sale(2,125)(5,274)
Property, plant and equipment and leasehold intangibles, net(597)— 
Other liabilities74 (824)
Loss (gain) on sale of assets, net(1,112)(2,094)
Net cash received$(3,760)$(9,453)
Supplemental Schedule of Non-cash Operating, Investing, and Financing Activities:
Healthpeak master lease modification:
Property, plant and equipment and leasehold intangibles, net$— $(57,462)
Operating lease right-of-use assets— 88,044 
Financing lease obligations— 70,874 
Operating lease obligations— (101,456)
Net$— $— 
Other non-cash lease transactions, net:
Property, plant and equipment and leasehold intangibles, net$— $(9,441)
Operating lease right-of-use assets16,721 — 
Financing lease obligations— 9,516 
Operating lease obligations(16,721)— 
Other liabilities— (75)
Net$— $— 
Schedule of Cash, Cash Equivalents, and Restricted Cash The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sums to the total of the same such amounts shown in the condensed consolidated statements of cash flows.
(in thousands)March 31, 2021December 31, 2020
Reconciliation of cash, cash equivalents, and restricted cash:
Cash and cash equivalents$303,952 $380,420 
Restricted cash26,503 28,059 
Long-term restricted cash71,468 56,669 
Total cash, cash equivalents, and restricted cash$401,923 $465,148 
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2021
Segment Reporting [Abstract]  
Schedule of segment reporting information
The following table sets forth selected segment financial data:
Three Months Ended
March 31,
(in thousands)20212020
Revenue and other operating income:
Independent Living(1)(2)
$120,146 $135,862 
Assisted Living and Memory Care(1)(2)
392,042 457,479 
CCRCs(1)(2)
73,463 94,547 
Health Care Services(1)(2)
89,434 94,819 
Management Services(3)
74,360 231,432 
Total revenue and other operating income$749,445 $1,014,139 
Segment operating income:(4)
Independent Living$37,329 $51,414 
Assisted Living and Memory Care71,433 132,001 
CCRCs7,608 19,931 
Health Care Services2,403 (9,121)
Management Services8,566 108,715 
Total segment operating income127,339 302,940 
General and administrative expense (including non-cash stock-based compensation expense)
49,943 54,595 
Facility operating lease expense44,418 64,481 
Depreciation and amortization83,891 90,738 
Asset impairment:
Independent Living520 31,317 
Assisted Living and Memory Care9,642 32,798 
CCRCs515 12,173 
Corporate and Management Services— 1,938 
Income (loss) from operations$(61,590)$14,900 

As of
(in thousands)March 31, 2021December 31, 2020
Total assets:
Independent Living$1,399,489 $1,419,838 
Assisted Living and Memory Care3,740,476 3,787,611 
CCRCs728,621 738,121 
Health Care Services233,585 233,178 
Corporate and Management Services643,982 723,010 
Total assets$6,746,153 $6,901,758 

(1)All revenue is earned from external third parties in the United States.

(2)The Independent Living, Assisted Living and Memory Care, CCRCs, and Health Care Services segments include $1.4 million, $5.1 million, $1.7 million, and $2.6 million respectively, for the three months ended March 31, 2021 of other operating income recognized for the credits or grants pursuant to the Employee Retention Credit, Provider Relief Fund, and other government sources, as described in Note 3. Allocations to the applicable segment generally reflect the credits earned by the segment, the segment’s receipt and acceptance of the grant, or the segment’s proportional utilization of the grant.

(3)Management services segment revenue includes management fees and reimbursements of costs incurred on behalf of managed communities.
(4)Segment operating income is defined as segment revenues and other operating income less segment facility operating expenses (excluding facility depreciation and amortization) and costs incurred on behalf of managed communities.
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.21.1
Description of Business Description of Business (Details) - segment
3 Months Ended
Feb. 24, 2021
Mar. 31, 2021
Segment Reporting Information [Line Items]    
Number of reportable segments   5
Securities Purchase Agreement | HCA Healthcare, Inc. | Health Care Services    
Segment Reporting Information [Line Items]    
Sale of stock, percentage of ownership sold in transaction 80.00%  
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.21.1
COVID-19 Pandemic - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended 15 Months Ended
Feb. 24, 2021
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Mar. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Unusual or Infrequent Item, or Both [Line Items]              
Percentage of communities accepting new visitors and move-ins   100.00%     100.00%    
Total liquidity   $ 438,900     $ 438,900    
Cash and cash equivalents   303,952   $ 380,420 303,952    
Marketable securities   134,933   172,905 134,933    
Revenue from government grants   900          
Nonrecurring              
Unusual or Infrequent Item, or Both [Line Items]              
Operating lease right-of-use assets   9,000 $ 65,700        
CARES Act              
Unusual or Infrequent Item, or Both [Line Items]              
Facility operating expense   $ 27,300     $ 152,900    
Employer portion of payroll taxes delayed       72,700      
Employee retention credit, percent of wages   50.00%     50.00%    
Maximum credit amount per employee   $ 5          
Employee retention credit, amount recognized   $ 9,000          
CARES Act | Forecast              
Unusual or Infrequent Item, or Both [Line Items]              
Employer portion of payroll taxes delayed           $ 32,000 $ 32,000
CARES Act | Accelerated and Advance Payment Program              
Unusual or Infrequent Item, or Both [Line Items]              
Amount received from Accelerated and Advance Payment Program       87,500      
CARES Act | The Continuing Appropriations Act, 2021 and Other Extensions Act              
Unusual or Infrequent Item, or Both [Line Items]              
Recoupment of accelerated/advanced payments start   1 year          
CARES Act | The Continuing Appropriations Act, 2021 and Other Extensions Act | Period One              
Unusual or Infrequent Item, or Both [Line Items]              
Payments for recoupment of accelerated/advanced payments rate   25.00%          
Recoupment of accelerated/advanced payments period   11 months          
CARES Act | The Continuing Appropriations Act, 2021 and Other Extensions Act | Period Two              
Unusual or Infrequent Item, or Both [Line Items]              
Payments for recoupment of accelerated/advanced payments rate   50.00%          
Recoupment of accelerated/advanced payments period   6 months          
Loans Insured or Guaranteed by US Government Authorities | CARES Act              
Unusual or Infrequent Item, or Both [Line Items]              
Relief received from Provider Relief Fund   $ 800          
Health Care Services | CARES Act | Accelerated and Advance Payment Program              
Unusual or Infrequent Item, or Both [Line Items]              
Amount received from Accelerated and Advance Payment Program       75,200      
CCRC Ventures, LLC | CARES Act | Accelerated and Advance Payment Program              
Unusual or Infrequent Item, or Both [Line Items]              
Amount received from Accelerated and Advance Payment Program       $ 12,300      
Securities Purchase Agreement | HCA Healthcare, Inc. | Health Care Services              
Unusual or Infrequent Item, or Both [Line Items]              
Sale of stock, percentage of ownership sold in transaction 80.00%            
Employer portion of payroll taxes delayed   $ 8,900     $ 8,900    
Decrease in accrued payroll taxes $ 8,900            
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions, Dispositions and Other Transactions - Additional Information (Details)
$ in Thousands
3 Months Ended 12 Months Ended 15 Months Ended
Feb. 24, 2021
USD ($)
Mar. 31, 2021
USD ($)
community
Mar. 31, 2020
USD ($)
community
Dec. 31, 2020
USD ($)
community
Mar. 31, 2021
USD ($)
community
Jul. 26, 2020
community
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of communities disposed of | community     1      
Gain on sale of assets   $ 1,112 $ 372,839      
Securities Purchase Agreement | HCA Healthcare, Inc. | Health Care Services            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Sale of stock, percentage of ownership sold in transaction 80.00%          
Sale of stock, consideration received on transaction $ 400,000          
Medicare advance payments   75,200     $ 75,200  
Employer portion of payroll taxes delayed   $ 8,900     $ 8,900  
Sale of stock, percentage of ownership after transaction 20.00%          
Communities Disposed of Through Sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of communities disposed of | community         8  
Sale of 1 community            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Net cash proceeds     5,500      
Gain on sale of assets     $ 200      
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Communities Disposed of Through Sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of communities disposed of | community   1   2    
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Communities Disposed of Through Lease Terminations            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of communities disposed of | community         5  
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | One Community Held For Sale            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Assets held for sale   $ 14,000     $ 14,000  
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | One Community Held For Sale | Assisted Living and Memory Care            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of communities classified as held for sale | community   1        
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | One Community Held For Sale | CCRC Ventures, LLC            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of communities classified as held for sale | community   1        
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Sale of 1 community            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Net cash proceeds   $ 2,700        
Gain on sale of assets   $ 500        
Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations | Sale of 2 communities            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Net cash proceeds       $ 38,100    
Gain on sale of assets       $ 2,700    
Communities Acquired Previously Leased Or Managed            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of communities acquired | community         27  
Ventas, Inc            
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]            
Number of owned communities transferred | community       5   5
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.21.1
Acquisitions, Dispositions and Other Transactions - Disclosure of Assets and Liabilities Held-for-sale (Details) - Health Care Services
$ in Thousands
Mar. 31, 2021
USD ($)
Disposal Group, Including Discontinued Operation, Assets [Abstract]  
Accounts receivable, net $ 62,401
Property, plant and equipment and leasehold intangibles, net 1,964
Operating lease right-of-use assets 9,688
Goodwill 126,810
Prepaid expenses and other assets, net 32,722
Assets held for sale 233,585
Disposal Group, Including Discontinued Operation, Liabilities [Abstract]  
Trade accounts payable 1,201
Accrued expenses 30,030
Refundable fees and deferred revenue 75,223
Operating lease obligations 9,688
Liabilities held for sale $ 116,142
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements -Narrative (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities $ 134,933 $ 172,905
Total long-term debt 3,889,791 3,915,988
Long-term debt and lines of credit    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total long-term debt 3,900,000 $ 3,900,000
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Marketable securities $ 134,900  
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value Measurements - Asset Impairment (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Asset impairment $ 10,677 $ 78,226
Nonrecurring    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Operating lease right-of-use assets 9,000 65,700
Property, plant and equipment and leasehold intangibles, net 1,700 11,000
Investment in unconsolidated ventures 0 1,500
Asset impairment $ 10,700 $ 78,200
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue - Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Disaggregation of Revenue [Line Items]    
Revenue $ 749,445 $ 1,014,139
Private pay    
Disaggregation of Revenue [Line Items]    
Revenue 541,366 640,776
Government reimbursement    
Disaggregation of Revenue [Line Items]    
Revenue 96,856 110,532
Other third-party payor programs    
Disaggregation of Revenue [Line Items]    
Revenue 26,128 31,399
Total resident fee revenue    
Disaggregation of Revenue [Line Items]    
Revenue 664,350 782,707
Independent Living | Private pay    
Disaggregation of Revenue [Line Items]    
Revenue 118,322 135,290
Independent Living | Government reimbursement    
Disaggregation of Revenue [Line Items]    
Revenue 460 572
Independent Living | Other third-party payor programs    
Disaggregation of Revenue [Line Items]    
Revenue 0 0
Independent Living | Total resident fee revenue    
Disaggregation of Revenue [Line Items]    
Revenue 118,782 135,862
Assisted Living and Memory Care | Private pay    
Disaggregation of Revenue [Line Items]    
Revenue 370,494 440,613
Assisted Living and Memory Care | Government reimbursement    
Disaggregation of Revenue [Line Items]    
Revenue 16,444 16,866
Assisted Living and Memory Care | Other third-party payor programs    
Disaggregation of Revenue [Line Items]    
Revenue 0 0
Assisted Living and Memory Care | Total resident fee revenue    
Disaggregation of Revenue [Line Items]    
Revenue 386,938 457,479
CCRCs | Private pay    
Disaggregation of Revenue [Line Items]    
Revenue 52,213 64,703
CCRCs | Government reimbursement    
Disaggregation of Revenue [Line Items]    
Revenue 12,487 19,405
CCRCs | Other third-party payor programs    
Disaggregation of Revenue [Line Items]    
Revenue 7,079 10,439
CCRCs | Total resident fee revenue    
Disaggregation of Revenue [Line Items]    
Revenue 71,779 94,547
Health Care Services | Private pay    
Disaggregation of Revenue [Line Items]    
Revenue 337 170
Health Care Services | Government reimbursement    
Disaggregation of Revenue [Line Items]    
Revenue 67,465 73,689
Health Care Services | Other third-party payor programs    
Disaggregation of Revenue [Line Items]    
Revenue 19,049 20,960
Health Care Services | Total resident fee revenue    
Disaggregation of Revenue [Line Items]    
Revenue $ 86,851 $ 94,819
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.21.1
Revenue - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Disaggregation of Revenue [Line Items]      
Monthly resident fees $ 30.1   $ 21.1
Revenue recognized 30.8 $ 48.3  
Deferred Revenue and Credits      
Disaggregation of Revenue [Line Items]      
Contract with customer, liability $ 146.0   138.3
CARES Act | Accelerated and Advance Payment Program      
Disaggregation of Revenue [Line Items]      
Amount received from Accelerated and Advance Payment Program     $ 87.5
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.21.1
Property, Plant and Equipment and Leasehold Intangibles, Net (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Property, Plant and Equipment [Line Items]      
Property, plant and equipment and leasehold intangibles $ 8,585,643   $ 8,558,158
Accumulated depreciation and amortization (3,567,234)   (3,490,098)
Property, plant and equipment and leasehold intangibles, net 5,018,409   5,068,060
Finance lease, right-of-use asset 400,000   400,000
Depreciation and amortization expense 83,900 $ 90,700  
Land      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment and leasehold intangibles 504,698   505,298
Buildings and improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment and leasehold intangibles 5,222,741   5,215,460
Furniture and equipment      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment and leasehold intangibles 953,773   945,783
Resident and leasehold operating intangibles      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment and leasehold intangibles 305,960   307,071
Construction in progress      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment and leasehold intangibles 64,003   61,491
Assets under financing leases and leasehold improvements      
Property, Plant and Equipment [Line Items]      
Property, plant and equipment and leasehold intangibles $ 1,534,468   $ 1,523,055
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.21.1
Goodwill - Additional Information (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Goodwill [Line Items]    
Goodwill $ 27,321 $ 154,131
Independent Living    
Goodwill [Line Items]    
Goodwill 27,300 27,300
Health Care Services    
Goodwill [Line Items]    
Goodwill $ 126,800 $ 126,800
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.21.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Long-Term Debt, Capital and Financing Leases and Financing Obligations [Line Items]    
Debt discount and deferred financing costs, net $ (26,324) $ (27,500)
Total long-term debt 3,889,791 3,915,988
Current portion 224,890 68,885
Long-term debt, less current portion 3,664,901 3,847,103
Mortgage notes payable    
Long-Term Debt, Capital and Financing Leases and Financing Obligations [Line Items]    
Total long-term debt $ 2,334,151 $ 2,366,996
Weighted average interest rate 4.17% 4.18%
Variable Mortgages    
Long-Term Debt, Capital and Financing Leases and Financing Obligations [Line Items]    
Total long-term debt $ 1,524,496 $ 1,529,935
Weighted average interest rate 2.46% 2.49%
Other notes payable    
Long-Term Debt, Capital and Financing Leases and Financing Obligations [Line Items]    
Total long-term debt $ 57,468 $ 46,557
Weighted average interest rate 7.79% 8.98%
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.21.1
Debt - Narrative (Details) - USD ($)
Mar. 31, 2021
Dec. 11, 2020
Credit Facilities [Line Items]    
Percentage of total debt 97.90%  
Mortgages    
Credit Facilities [Line Items]    
Mortgage debt $ 3,800,000,000  
Fifth Amended and Restated Credit Agreement | Line of Credit | Letter of Credit Sublimit    
Credit Facilities [Line Items]    
Letters of credit issued 69,900,000  
Fifth Amended and Restated Credit Agreement | Line of Credit | Letter of Credit    
Credit Facilities [Line Items]    
Letters of credit issued 13,600,000  
Credit facility, maximum borrowing capacity $ 15,000,000.0  
Credit Agreement With Capital One, National Association | Line of Credit | Revolving Credit Facility    
Credit Facilities [Line Items]    
Credit facility, maximum borrowing capacity   $ 80,000,000.0
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.21.1
Leases (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2021
USD ($)
lease
community
Lessee, Lease, Description [Line Items]  
Operating and financing leases, number of communities | community 301
Operating lease, number of communities 235
Financing leases, number of communities 66
Health Care Services  
Lessee, Lease, Description [Line Items]  
Operating lease obligations | $ $ 9,688
Minimum  
Lessee, Lease, Description [Line Items]  
Finance and operating lease, renewal term 5 years
Maximum  
Lessee, Lease, Description [Line Items]  
Finance and operating lease, renewal term 20 years
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.21.1
Leases - Lease Costs (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Leases [Abstract]    
Facility operating expense $ 4,842 $ 4,850
Facility lease expense 44,418 64,481
Operating lease expense 49,260 69,331
Operating lease expense adjustment 4,664 6,733
Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements (7,563) (4,088)
Operating net cash outflows from operating leases 46,361 71,976
Depreciation and amortization 7,630 9,144
Interest expense: financing lease obligations 11,383 13,282
Financing lease expense 19,013 22,426
Operating cash flows from financing leases 11,383 13,282
Financing cash flows from financing leases 4,789 5,087
Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement (1,389) (1,739)
Total net cash outflows from financing leases $ 14,783 $ 16,630
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.21.1
Leases - Maturity ASC 842 (Details)
$ in Thousands
Mar. 31, 2021
USD ($)
Operating Leases  
2021 (nine months) $ 151,681
2022 203,946
2023 192,625
2024 193,377
2025 191,131
Thereafter 280,960
Total lease payments 1,213,720
Purchase option liability and non-cash gain on future sale of property 0
Imputed interest and variable lease payments (276,070)
Total lease obligations 937,650
Financing Leases  
2021 (nine months) 48,807
2022 65,609
2023 66,341
2024 67,553
2025 57,595
Thereafter 109,684
Total lease payments 415,589
Purchase option liability and non-cash gain on future sale of property 413,617
Imputed interest and variable lease payments (270,052)
Total lease obligations $ 559,154
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.21.1
Stock-Based Compensation (Details) - Unvested Restricted Stock
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Restricted Stock and Restricted Stock Unit Grants (in shares) | shares 1,961
Weighted Average Grant Date Fair Value (in dollars per share) | $ / shares $ 5.09
Total Grant Date Fair Value | $ $ 9,988
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Earnings Per Share [Abstract]    
Net income (loss) $ (108,285) $ 369,515
Weighted average common shares outstanding:    
Weighted average shares outstanding - basic 184,011 184,186
Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants (in shares) 0 336
Weighted average shares outstanding - diluted 184,011 184,522
Earnings Per Share, Basic and Diluted [Abstract]    
Basic (in dollars per share) $ (0.59) $ 2.01
Diluted (in dollars per share) $ (0.59) $ 2.00
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.21.1
Earnings Per Share - Schedule of Potentially Dilutive Securities (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted (in shares) 184,011 184,522
Number of warrants (in shares) 16,300 0
Non-performance-based restricted stock and restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted (in shares) 6,200 6,900
Performance-based restricted stock and restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Diluted (in shares) 400 1,800
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.21.1
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Valuation Allowance [Line Items]      
Gross deferred federal, state and local tax benefit $ 25,200    
Increase (decrease) in valuation allowance 25,500 $ (112,600)  
Deferred federal, state and local tax expense (benefit)   (2,200)  
Gain on sale of assets 1,112 372,839  
Valuation allowance 406,500   $ 381,000
Federal, State, and Local      
Valuation Allowance [Line Items]      
Deferred federal, state and local tax expense (benefit)   90,900  
CCRC Ventures, LLC      
Valuation Allowance [Line Items]      
Gain on sale of assets   $ 93,100  
Healthpeak      
Valuation Allowance [Line Items]      
Increase (decrease) in valuation allowance $ (117,600)    
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.21.1
Supplemental Disclosure of Cash Flow Information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Supplemental Cash Flow Information [Abstract]    
Interest paid $ 47,129 $ 59,479
Income taxes paid, net of refunds 904 957
Net cash paid 40,361 69,385
Loss (gain) on debt modification and extinguishment, net 0 19,181
Investments in unconsolidated ventures (5,206) (268)
Loss (gain) on sale of assets, net 1,112 372,839
Prepaid expenses and other assets, net (6,769) (1,696)
Additions to property, plant and equipment and leasehold improvements    
Supplemental Cash Flow Information [Abstract]    
Net cash paid 40,361 69,385
Trade accounts payable 2,439 (898)
Acquisition of communities from Healthpeak    
Supplemental Cash Flow Information [Abstract]    
Property, plant and equipment and leasehold intangibles, net 0 286,734
Operating lease right-of-use assets 0 (63,285)
Financing lease obligations 0 129,196
Operating lease obligations 0 74,335
Loss (gain) on debt modification and extinguishment, net 0 (19,731)
Net cash paid 0 407,249
Acquisition of assets, net of related payables and cash received    
Supplemental Cash Flow Information [Abstract]    
Property, plant and equipment and leasehold intangibles, net 0 179
Financing lease obligations 0 39,260
Net cash paid 0 39,439
Proceeds from sale of CCRC Venture, net:    
Supplemental Cash Flow Information [Abstract]    
Investments in unconsolidated ventures 0 (14,848)
Current portion of long-term debt 0 34,706
Accrued expenses 0 (5,025)
Other liabilities 0 60,748
Loss (gain) on sale of assets, net 0 (370,745)
Net cash received 0 (295,164)
Proceeds from sale of assets, net    
Supplemental Cash Flow Information [Abstract]    
Property, plant and equipment and leasehold intangibles, net 597 0
Other liabilities 74 (824)
Loss (gain) on sale of assets, net (1,112) (2,094)
Prepaid expenses and other assets, net 0 (1,261)
Assets held for sale (2,125) (5,274)
Net cash received (3,760) (9,453)
Healthpeak master lease modification:    
Supplemental Cash Flow Information [Abstract]    
Property, plant and equipment and leasehold intangibles, net 0 (57,462)
Operating lease right-of-use assets 0 88,044
Financing lease obligations 0 70,874
Operating lease obligations 0 (101,456)
Net 0 0
Noncash lease termination and modification, net    
Supplemental Cash Flow Information [Abstract]    
Property, plant and equipment and leasehold intangibles, net 0 (9,441)
Operating lease right-of-use assets 16,721 0
Financing lease obligations 0 9,516
Operating lease obligations (16,721) 0
Other liabilities 0 (75)
Net 0 0
Non-development | Additions to property, plant and equipment and leasehold improvements    
Supplemental Cash Flow Information [Abstract]    
Net cash paid 27,450 60,556
Development | Additions to property, plant and equipment and leasehold improvements    
Supplemental Cash Flow Information [Abstract]    
Net cash paid 1,521 3,900
Non-development - reimbursable | Additions to property, plant and equipment and leasehold improvements    
Supplemental Cash Flow Information [Abstract]    
Net cash paid $ 8,951 $ 5,827
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.21.1
Supplemental Disclosure of Cash Flow Information - Schedule of cash, cash equivalents, and restricted cash (Details) - USD ($)
$ in Thousands
Mar. 31, 2021
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Supplemental Cash Flow Elements [Abstract]        
Cash and cash equivalents $ 303,952 $ 380,420    
Restricted cash 26,503 28,059    
Long-term restricted cash 71,468 56,669    
Total cash, cash equivalents, and restricted cash $ 401,923 $ 465,148 $ 458,499 $ 301,697
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.21.1
Segment Information (Details)
$ in Thousands
3 Months Ended
Mar. 31, 2021
USD ($)
segment
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Segment Reporting Information [Line Items]      
Number of reportable segments | segment 5    
Revenue $ 749,445 $ 1,014,139  
Segment operating income 127,339 302,940  
General and administrative expense (including non-cash stock-based compensation expense) 49,943 54,595  
Facility lease expense 44,418 64,481  
Depreciation and amortization 83,891 90,738  
Asset impairment 10,677 78,226  
Income (loss) from operations (61,590) 14,900  
Total assets 6,746,153   $ 6,901,758
Operating Segments | Independent Living      
Segment Reporting Information [Line Items]      
Revenue 120,146 135,862  
Segment operating income 37,329 51,414  
Asset impairment 520 31,317  
Total assets 1,399,489   1,419,838
Operating Segments | Assisted Living and Memory Care      
Segment Reporting Information [Line Items]      
Revenue 392,042 457,479  
Segment operating income 71,433 132,001  
Asset impairment 9,642 32,798  
Total assets 3,740,476   3,787,611
Operating Segments | CCRCs      
Segment Reporting Information [Line Items]      
Revenue 73,463 94,547  
Segment operating income 7,608 19,931  
Asset impairment 515 12,173  
Total assets 728,621   738,121
Operating Segments | Health Care Services      
Segment Reporting Information [Line Items]      
Revenue 89,434 94,819  
Segment operating income 2,403 (9,121)  
Total assets 233,585   233,178
Operating Segments | Management Services      
Segment Reporting Information [Line Items]      
Revenue 74,360 231,432  
Segment operating income 8,566 108,715  
Asset impairment 0 $ 1,938  
Total assets 643,982   $ 723,010
CARES Act | Independent Living      
Segment Reporting Information [Line Items]      
Cash made available for Provider Relief Fund 1,400    
CARES Act | Assisted Living and Memory Care      
Segment Reporting Information [Line Items]      
Cash made available for Provider Relief Fund 5,100    
CARES Act | CCRCs      
Segment Reporting Information [Line Items]      
Cash made available for Provider Relief Fund 1,700    
CARES Act | Health Care Services      
Segment Reporting Information [Line Items]      
Cash made available for Provider Relief Fund $ 2,600    
EXCEL 72 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 74 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 75 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 204 361 1 false 77 0 false 7 false false R1.htm 0001001 - Document - Cover Page Sheet http://brookdale.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Sheet http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Sheet http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY CONDENSED CONSOLIDATED STATEMENTS OF EQUITY Statements 6 false false R7.htm 1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 2101101 - Disclosure - Description of Business Sheet http://brookdale.com/role/DescriptionofBusiness Description of Business Notes 8 false false R9.htm 2103102 - Disclosure - Summary of Significant Accounting Policies Sheet http://brookdale.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 2105103 - Disclosure - COVID-19 Pandemic Sheet http://brookdale.com/role/COVID19Pandemic COVID-19 Pandemic Notes 10 false false R11.htm 2107104 - Disclosure - Acquisitions, Dispositions and Other Transactions Sheet http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactions Acquisitions, Dispositions and Other Transactions Notes 11 false false R12.htm 2111105 - Disclosure - Fair Value Measurements Sheet http://brookdale.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 2115106 - Disclosure - Revenue Sheet http://brookdale.com/role/Revenue Revenue Notes 13 false false R14.htm 2119107 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net Sheet http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNet Property, Plant and Equipment and Leasehold Intangibles, Net Notes 14 false false R15.htm 2122108 - Disclosure - Goodwill Sheet http://brookdale.com/role/Goodwill Goodwill Notes 15 false false R16.htm 2124109 - Disclosure - Debt Sheet http://brookdale.com/role/Debt Debt Notes 16 false false R17.htm 2128110 - Disclosure - Leases Sheet http://brookdale.com/role/Leases Leases Notes 17 false false R18.htm 2133111 - Disclosure - Litigation Sheet http://brookdale.com/role/Litigation Litigation Notes 18 false false R19.htm 2134112 - Disclosure - Stock-Based Compensation Sheet http://brookdale.com/role/StockBasedCompensation Stock-Based Compensation Notes 19 false false R20.htm 2137113 - Disclosure - Earnings Per Share Sheet http://brookdale.com/role/EarningsPerShare Earnings Per Share Notes 20 false false R21.htm 2141114 - Disclosure - Income Taxes Sheet http://brookdale.com/role/IncomeTaxes Income Taxes Notes 21 false false R22.htm 2143115 - Disclosure - Supplemental Disclosure of Cash Flow Information Sheet http://brookdale.com/role/SupplementalDisclosureofCashFlowInformation Supplemental Disclosure of Cash Flow Information Notes 22 false false R23.htm 2147116 - Disclosure - Segment Information Sheet http://brookdale.com/role/SegmentInformation Segment Information Notes 23 false false R24.htm 2204201 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://brookdale.com/role/SummaryofSignificantAccountingPolicies 24 false false R25.htm 2308301 - Disclosure - Acquisitions, Dispositions and Other Transactions (Tables) Sheet http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsTables Acquisitions, Dispositions and Other Transactions (Tables) Tables http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactions 25 false false R26.htm 2312302 - Disclosure - Fair Value Measurements (Tables) Sheet http://brookdale.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://brookdale.com/role/FairValueMeasurements 26 false false R27.htm 2316303 - Disclosure - Revenue (Tables) Sheet http://brookdale.com/role/RevenueTables Revenue (Tables) Tables http://brookdale.com/role/Revenue 27 false false R28.htm 2320304 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net (Tables) Sheet http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetTables Property, Plant and Equipment and Leasehold Intangibles, Net (Tables) Tables http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNet 28 false false R29.htm 2325305 - Disclosure - Debt (Tables) Sheet http://brookdale.com/role/DebtTables Debt (Tables) Tables http://brookdale.com/role/Debt 29 false false R30.htm 2329306 - Disclosure - Leases (Tables) Sheet http://brookdale.com/role/LeasesTables Leases (Tables) Tables http://brookdale.com/role/Leases 30 false false R31.htm 2335307 - Disclosure - Stock-Based Compensation (Tables) Sheet http://brookdale.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://brookdale.com/role/StockBasedCompensation 31 false false R32.htm 2338308 - Disclosure - Earnings Per Share (Tables) Sheet http://brookdale.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://brookdale.com/role/EarningsPerShare 32 false false R33.htm 2344309 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables) Sheet http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationTables Supplemental Disclosure of Cash Flow Information (Tables) Tables http://brookdale.com/role/SupplementalDisclosureofCashFlowInformation 33 false false R34.htm 2348310 - Disclosure - Segment Information (Tables) Sheet http://brookdale.com/role/SegmentInformationTables Segment Information (Tables) Tables http://brookdale.com/role/SegmentInformation 34 false false R35.htm 2402401 - Disclosure - Description of Business Description of Business (Details) Sheet http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails Description of Business Description of Business (Details) Details 35 false false R36.htm 2406402 - Disclosure - COVID-19 Pandemic - Narrative (Details) Sheet http://brookdale.com/role/COVID19PandemicNarrativeDetails COVID-19 Pandemic - Narrative (Details) Details 36 false false R37.htm 2409403 - Disclosure - Acquisitions, Dispositions and Other Transactions - Additional Information (Details) Sheet http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails Acquisitions, Dispositions and Other Transactions - Additional Information (Details) Details 37 false false R38.htm 2410404 - Disclosure - Acquisitions, Dispositions and Other Transactions - Disclosure of Assets and Liabilities Held-for-sale (Details) Sheet http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails Acquisitions, Dispositions and Other Transactions - Disclosure of Assets and Liabilities Held-for-sale (Details) Details 38 false false R39.htm 2413405 - Disclosure - Fair Value Measurements -Narrative (Details) Sheet http://brookdale.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements -Narrative (Details) Details 39 false false R40.htm 2414406 - Disclosure - Fair Value Measurements - Asset Impairment (Details) Sheet http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails Fair Value Measurements - Asset Impairment (Details) Details 40 false false R41.htm 2417407 - Disclosure - Revenue - Disaggregation of Revenue (Details) Sheet http://brookdale.com/role/RevenueDisaggregationofRevenueDetails Revenue - Disaggregation of Revenue (Details) Details 41 false false R42.htm 2418408 - Disclosure - Revenue - Additional Information (Details) Sheet http://brookdale.com/role/RevenueAdditionalInformationDetails Revenue - Additional Information (Details) Details 42 false false R43.htm 2421409 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net (Details) Sheet http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails Property, Plant and Equipment and Leasehold Intangibles, Net (Details) Details http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetTables 43 false false R44.htm 2423410 - Disclosure - Goodwill - Additional Information (Details) Sheet http://brookdale.com/role/GoodwillAdditionalInformationDetails Goodwill - Additional Information (Details) Details 44 false false R45.htm 2426411 - Disclosure - Debt - Schedule of Debt (Details) Sheet http://brookdale.com/role/DebtScheduleofDebtDetails Debt - Schedule of Debt (Details) Details 45 false false R46.htm 2427412 - Disclosure - Debt - Narrative (Details) Sheet http://brookdale.com/role/DebtNarrativeDetails Debt - Narrative (Details) Details 46 false false R47.htm 2430413 - Disclosure - Leases (Details) Sheet http://brookdale.com/role/LeasesDetails Leases (Details) Details http://brookdale.com/role/LeasesTables 47 false false R48.htm 2431414 - Disclosure - Leases - Lease Costs (Details) Sheet http://brookdale.com/role/LeasesLeaseCostsDetails Leases - Lease Costs (Details) Details 48 false false R49.htm 2432415 - Disclosure - Leases - Maturity ASC 842 (Details) Sheet http://brookdale.com/role/LeasesMaturityASC842Details Leases - Maturity ASC 842 (Details) Details 49 false false R50.htm 2436416 - Disclosure - Stock-Based Compensation (Details) Sheet http://brookdale.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://brookdale.com/role/StockBasedCompensationTables 50 false false R51.htm 2439417 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Sheet http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details) Details 51 false false R52.htm 2440418 - Disclosure - Earnings Per Share - Schedule of Potentially Dilutive Securities (Details) Sheet http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails Earnings Per Share - Schedule of Potentially Dilutive Securities (Details) Details 52 false false R53.htm 2442419 - Disclosure - Income Taxes (Details) Sheet http://brookdale.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://brookdale.com/role/IncomeTaxes 53 false false R54.htm 2445420 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details) Sheet http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails Supplemental Disclosure of Cash Flow Information (Details) Details http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationTables 54 false false R55.htm 2446421 - Disclosure - Supplemental Disclosure of Cash Flow Information - Schedule of cash, cash equivalents, and restricted cash (Details) Sheet http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails Supplemental Disclosure of Cash Flow Information - Schedule of cash, cash equivalents, and restricted cash (Details) Details 55 false false R56.htm 2449422 - Disclosure - Segment Information (Details) Sheet http://brookdale.com/role/SegmentInformationDetails Segment Information (Details) Details http://brookdale.com/role/SegmentInformationTables 56 false false All Reports Book All Reports bkd-20210331.htm bkd-20210331.xsd bkd-20210331_cal.xml bkd-20210331_def.xml bkd-20210331_lab.xml bkd-20210331_pre.xml exhibit101-masterleaseamen.htm exhibit102-2021timexbasedr.htm exhibit103-2021performance.htm exhibit104-2021ceoperforma.htm exhibit105-formofforfeitur.htm exhibit3113312021nextgen.htm exhibit3123312021nextgen.htm exhibit323312021nextgen.htm http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true JSON 77 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "bkd-20210331.htm": { "axisCustom": 2, "axisStandard": 27, "contextCount": 204, "dts": { "calculationLink": { "local": [ "bkd-20210331_cal.xml" ] }, "definitionLink": { "local": [ "bkd-20210331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "bkd-20210331.htm" ] }, "labelLink": { "local": [ "bkd-20210331_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "bkd-20210331_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "bkd-20210331.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 500, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 5 }, "keyCustom": 58, "keyStandard": 303, "memberCustom": 42, "memberStandard": 31, "nsprefix": "bkd", "nsuri": "http://brookdale.com/20210331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover Page", "role": "http://brookdale.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105103 - Disclosure - COVID-19 Pandemic", "role": "http://brookdale.com/role/COVID19Pandemic", "shortName": "COVID-19 Pandemic", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107104 - Disclosure - Acquisitions, Dispositions and Other Transactions", "role": "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactions", "shortName": "Acquisitions, Dispositions and Other Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111105 - Disclosure - Fair Value Measurements", "role": "http://brookdale.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2115106 - Disclosure - Revenue", "role": "http://brookdale.com/role/Revenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2119107 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net", "role": "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNet", "shortName": "Property, Plant and Equipment and Leasehold Intangibles, Net", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2122108 - Disclosure - Goodwill", "role": "http://brookdale.com/role/Goodwill", "shortName": "Goodwill", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2124109 - Disclosure - Debt", "role": "http://brookdale.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2128110 - Disclosure - Leases", "role": "http://brookdale.com/role/Leases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeFinanceLeasesTextBlock", "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2133111 - Disclosure - Litigation", "role": "http://brookdale.com/role/Litigation", "shortName": "Litigation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2134112 - Disclosure - Stock-Based Compensation", "role": "http://brookdale.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS", "role": "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2137113 - Disclosure - Earnings Per Share", "role": "http://brookdale.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2141114 - Disclosure - Income Taxes", "role": "http://brookdale.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2143115 - Disclosure - Supplemental Disclosure of Cash Flow Information", "role": "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformation", "shortName": "Supplemental Disclosure of Cash Flow Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2147116 - Disclosure - Segment Information", "role": "http://brookdale.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Acquisitions, Dispositions and Other Transactions (Tables)", "role": "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsTables", "shortName": "Acquisitions, Dispositions and Other Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312302 - Disclosure - Fair Value Measurements (Tables)", "role": "http://brookdale.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2316303 - Disclosure - Revenue (Tables)", "role": "http://brookdale.com/role/RevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2320304 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net (Tables)", "role": "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetTables", "shortName": "Property, Plant and Equipment and Leasehold Intangibles, Net (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2325305 - Disclosure - Debt (Tables)", "role": "http://brookdale.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "role": "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPerShare", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2329306 - Disclosure - Leases (Tables)", "role": "http://brookdale.com/role/LeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2335307 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://brookdale.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2338308 - Disclosure - Earnings Per Share (Tables)", "role": "http://brookdale.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2344309 - Disclosure - Supplemental Disclosure of Cash Flow Information (Tables)", "role": "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationTables", "shortName": "Supplemental Disclosure of Cash Flow Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2348310 - Disclosure - Segment Information (Tables)", "role": "http://brookdale.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402401 - Disclosure - Description of Business Description of Business (Details)", "role": "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails", "shortName": "Description of Business Description of Business (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R36": { "firstAnchor": { "ancestors": [ "span", "div", "us-gaap:UnusualOrInfrequentItemsDisclosureTextBlock", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "3", "first": true, "lang": "en-US", "name": "bkd:PercentageOfCommunitiesAcceptingNewVisitorsAndMoveIns", "reportCount": 1, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - COVID-19 Pandemic - Narrative (Details)", "role": "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "shortName": "COVID-19 Pandemic - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-5", "lang": "en-US", "name": "bkd:RevenueFromGovernmentGrants", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "ib4c234667fcc4ab68f26337ccde84cc1_D20200101-20200331", "decimals": "INF", "first": true, "lang": "en-US", "name": "bkd:DisposalGroupNumberOfCommunitiesDisposedOf", "reportCount": 1, "unique": true, "unitRef": "community", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - Acquisitions, Dispositions and Other Transactions - Additional Information (Details)", "role": "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "shortName": "Acquisitions, Dispositions and Other Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "ib4c234667fcc4ab68f26337ccde84cc1_D20200101-20200331", "decimals": "INF", "first": true, "lang": "en-US", "name": "bkd:DisposalGroupNumberOfCommunitiesDisposedOf", "reportCount": 1, "unique": true, "unitRef": "community", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i4e1f64b41a544f659de832c79b16d1a3_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410404 - Disclosure - Acquisitions, Dispositions and Other Transactions - Disclosure of Assets and Liabilities Held-for-sale (Details)", "role": "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails", "shortName": "Acquisitions, Dispositions and Other Transactions - Disclosure of Assets and Liabilities Held-for-sale (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i4e1f64b41a544f659de832c79b16d1a3_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2413405 - Disclosure - Fair Value Measurements -Narrative (Details)", "role": "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements -Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i330d236f478845c488b558e2718a45e5_I20210331", "decimals": "-8", "lang": "en-US", "name": "us-gaap:LongTermDebt", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "role": "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:CostsAndExpenses", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:AssetImpairmentCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414406 - Disclosure - Fair Value Measurements - Asset Impairment (Details)", "role": "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails", "shortName": "Fair Value Measurements - Asset Impairment (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i2449ea636a174f53898270225e8487ba_D20210101-20210331", "decimals": "-5", "lang": "en-US", "name": "us-gaap:TangibleAssetImpairmentCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417407 - Disclosure - Revenue - Disaggregation of Revenue (Details)", "role": "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "shortName": "Revenue - Disaggregation of Revenue (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "iac9ac4def40e4b60851bf66b61d42083_D20210101-20210331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-5", "first": true, "lang": "en-US", "name": "bkd:ContractWithCustomerLiabilityDeferredRevenueMonthlyResidentFees", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418408 - Disclosure - Revenue - Additional Information (Details)", "role": "http://brookdale.com/role/RevenueAdditionalInformationDetails", "shortName": "Revenue - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-5", "first": true, "lang": "en-US", "name": "bkd:ContractWithCustomerLiabilityDeferredRevenueMonthlyResidentFees", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2421409 - Disclosure - Property, Plant and Equipment and Leasehold Intangibles, Net (Details)", "role": "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails", "shortName": "Property, Plant and Equipment and Leasehold Intangibles, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2423410 - Disclosure - Goodwill - Additional Information (Details)", "role": "http://brookdale.com/role/GoodwillAdditionalInformationDetails", "shortName": "Goodwill - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:Goodwill", "ix:continuation", "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i75bc823f4e854c5195f8ed7e60eff0e4_I20210331", "decimals": "-5", "lang": "en-US", "name": "us-gaap:Goodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2426411 - Disclosure - Debt - Schedule of Debt (Details)", "role": "http://brookdale.com/role/DebtScheduleofDebtDetails", "shortName": "Debt - Schedule of Debt (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "3", "first": true, "lang": "en-US", "name": "bkd:DebtInstrumentPercentageOfTotalDebt", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2427412 - Disclosure - Debt - Narrative (Details)", "role": "http://brookdale.com/role/DebtNarrativeDetails", "shortName": "Debt - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "3", "first": true, "lang": "en-US", "name": "bkd:DebtInstrumentPercentageOfTotalDebt", "reportCount": 1, "unique": true, "unitRef": "number", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "bkd:OperatingandFinancingLeasesNumberOfCommunities", "reportCount": 1, "unique": true, "unitRef": "community", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2430413 - Disclosure - Leases (Details)", "role": "http://brookdale.com/role/LeasesDetails", "shortName": "Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "bkd:OperatingandFinancingLeasesNumberOfCommunities", "reportCount": 1, "unique": true, "unitRef": "community", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "bkd:OperatingLeaseFacilityOperatingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2431414 - Disclosure - Leases - Lease Costs (Details)", "role": "http://brookdale.com/role/LeasesLeaseCostsDetails", "shortName": "Leases - Lease Costs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "bkd:OperatingLeaseFacilityOperatingExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2432415 - Disclosure - Leases - Maturity ASC 842 (Details)", "role": "http://brookdale.com/role/LeasesMaturityASC842Details", "shortName": "Leases - Maturity ASC 842 (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "role": "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CostOfGoodsAndServicesSoldDepreciationAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i45caa42592054c3f8a7071f3e338af02_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2436416 - Disclosure - Stock-Based Compensation (Details)", "role": "http://brookdale.com/role/StockBasedCompensationDetails", "shortName": "Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i45caa42592054c3f8a7071f3e338af02_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2439417 - Disclosure - Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)", "role": "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails", "shortName": "Earnings Per Share - Schedule of Earnings Per Share, Basic and Diluted (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2440418 - Disclosure - Earnings Per Share - Schedule of Potentially Dilutive Securities (Details)", "role": "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails", "shortName": "Earnings Per Share - Schedule of Potentially Dilutive Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-5", "lang": "en-US", "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2442419 - Disclosure - Income Taxes (Details)", "role": "http://brookdale.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-5", "first": true, "lang": "en-US", "name": "us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2445420 - Disclosure - Supplemental Disclosure of Cash Flow Information (Details)", "role": "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails", "shortName": "Supplemental Disclosure of Cash Flow Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:InterestPaidNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i09593dfbf1a245feb7eaf713aef63e1d_I20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2446421 - Disclosure - Supplemental Disclosure of Cash Flow Information - Schedule of cash, cash equivalents, and restricted cash (Details)", "role": "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails", "shortName": "Supplemental Disclosure of Cash Flow Information - Schedule of cash, cash equivalents, and restricted cash (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R56": { "firstAnchor": { "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "INF", "first": true, "lang": "en-US", "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unitRef": "segment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2449422 - Disclosure - Segment Information (Details)", "role": "http://brookdale.com/role/SegmentInformationDetails", "shortName": "Segment Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i96dd8f42e3144aafb805d2ae1dabc1a4_I20191231", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF EQUITY", "role": "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i5b467755066846e680e2619b7be1aab0_D20200101-20200331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "first": true, "lang": "en-US", "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006007 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": "-3", "lang": "en-US", "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101101 - Disclosure - Description of Business", "role": "http://brookdale.com/role/DescriptionofBusiness", "shortName": "Description of Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies", "role": "http://brookdale.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "bkd-20210331.htm", "contextRef": "i04d4686065d34278838ffd8d80048f7e_D20210101-20210331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 77, "tag": { "bkd_AcceleratedandAdvancePaymentProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accelerated and Advance Payment Program [Member]", "label": "Accelerated and Advance Payment Program [Member]", "terseLabel": "Accelerated and Advance Payment Program" } } }, "localname": "AcceleratedandAdvancePaymentProgramMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_AcquisitionOfCommunitiesFromHealthpeakMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquisition Of Communities From Healthpeak [Member]", "label": "Acquisition Of Communities From Healthpeak [Member]", "terseLabel": "Acquisition of communities from Healthpeak" } } }, "localname": "AcquisitionOfCommunitiesFromHealthpeakMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Additions to property, plant and equipment and leasehold improvements [Member]", "terseLabel": "Additions to property, plant and equipment and leasehold improvements" } } }, "localname": "AdditionsToPropertyPlantAndEquipmentAndLeaseholdImprovementsMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_AmountReceivedFromAcceleratedAndAdvancePaymentProgram": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount Received From Accelerated And Advance Payment Program", "label": "Amount Received From Accelerated And Advance Payment Program", "terseLabel": "Amount received from Accelerated and Advance Payment Program" } } }, "localname": "AmountReceivedFromAcceleratedAndAdvancePaymentProgram", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_AssetsUnderFinancingLeasesandLeaseholdIntangiblesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assets Under Financing Leases and Leasehold Intangibles [Member]", "label": "Assets Under Financing Leases and Leasehold Intangibles [Member]", "terseLabel": "Assets under financing leases and leasehold improvements" } } }, "localname": "AssetsUnderFinancingLeasesandLeaseholdIntangiblesMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "domainItemType" }, "bkd_AssistedLivingAndMemoryCareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Assisted Living And Memory Care [Member]", "label": "Assisted Living And Memory Care [Member]", "terseLabel": "Assisted Living and Memory Care", "verboseLabel": "Assisted Living and Memory Care" } } }, "localname": "AssistedLivingAndMemoryCareMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_CARESActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CARES Act [Member]", "label": "CARES Act [Member]", "terseLabel": "CARES Act" } } }, "localname": "CARESActMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/RevenueAdditionalInformationDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_CCRCVenturesLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CCRC Ventures, LLC", "label": "CCRC Ventures, LLC [Member]", "terseLabel": "CCRC Ventures, LLC", "verboseLabel": "Proceeds from sale of CCRC Venture, net:" } } }, "localname": "CCRCVenturesLLCMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/IncomeTaxesDetails", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_CapitalExpenditureTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital Expenditure, Type [Axis]", "label": "Capital Expenditure, Type [Axis]", "terseLabel": "Capital Expenditure, Type [Axis]" } } }, "localname": "CapitalExpenditureTypeAxis", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "bkd_CapitalExpenditureTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Domain] for Capital Expenditure, Type [Axis]", "label": "Capital Expenditure, Type [Domain]", "terseLabel": "Capital Expenditure, Type [Domain]" } } }, "localname": "CapitalExpenditureTypeDomain", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_CcrcsRentalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company's CCRCs - Rental segment includes large owned or leased communities that offer a variety of living arrangements and services to accommodate all levels of physical ability and health. Most of the Company's CCRCs have independent living, assisted living and skilled nursing available on one campus or within the immediate market, and some also include memory care/Alzheimer's units.", "label": "CCRCs Rental [Member]", "terseLabel": "CCRCs", "verboseLabel": "CCRCs" } } }, "localname": "CcrcsRentalMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_CommunitiesAcquiredPreviouslyLeasedOrManagedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Communities Acquired Previously Leased Or Managed [Member]", "label": "Communities Acquired Previously Leased Or Managed [Member]", "terseLabel": "Communities Acquired Previously Leased Or Managed" } } }, "localname": "CommunitiesAcquiredPreviouslyLeasedOrManagedMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_CommunitiesDisposedOfThroughLeaseTerminationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Communities Disposed Of Through Lease Terminations [Member]", "label": "Communities Disposed Of Through Lease Terminations [Member]", "terseLabel": "Communities Disposed of Through Lease Terminations" } } }, "localname": "CommunitiesDisposedOfThroughLeaseTerminationsMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_CommunitiesDisposedOfThroughSaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Communities Disposed Of Through Sale [Member]", "label": "Communities Disposed Of Through Sale [Member]", "terseLabel": "Communities Disposed of Through Sale" } } }, "localname": "CommunitiesDisposedOfThroughSaleMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_ContractWithCustomerLiabilityDeferredRevenueMonthlyResidentFees": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Contract With Customer, Liability, Deferred Revenue, Monthly Resident Fees", "label": "Contract With Customer, Liability, Deferred Revenue, Monthly Resident Fees", "terseLabel": "Monthly resident fees" } } }, "localname": "ContractWithCustomerLiabilityDeferredRevenueMonthlyResidentFees", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_CreditAgreementWithCapitalOneNationalAssociationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement With Capital One, National Association", "label": "Credit Agreement With Capital One, National Association [Member]", "terseLabel": "Credit Agreement With Capital One, National Association" } } }, "localname": "CreditAgreementWithCapitalOneNationalAssociationMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_DebtInstrumentPercentageOfTotalDebt": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt Instrument, Percentage Of Total Debt", "label": "Debt Instrument, Percentage Of Total Debt", "terseLabel": "Percentage of total debt" } } }, "localname": "DebtInstrumentPercentageOfTotalDebt", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "percentItemType" }, "bkd_DeferredRevenueAndCreditsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred Revenue And Credits [Member]", "label": "Deferred Revenue And Credits [Member]", "terseLabel": "Deferred Revenue and Credits" } } }, "localname": "DeferredRevenueAndCreditsMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_DepreciationAndAmortizationExpenseForPlantAndEquipmentAndLeaseholdIntangibles": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset.", "label": "Depreciation and amortization expense for plant and equipment and leasehold intangibles", "terseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationAndAmortizationExpenseForPlantAndEquipmentAndLeaseholdIntangibles", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "monetaryItemType" }, "bkd_DevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Development [Member]", "label": "Development [Member]", "terseLabel": "Development" } } }, "localname": "DevelopmentMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseObligationsCurrent": { "auth_ref": [], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease Obligations, Current", "label": "Disposal Group, Including Discontinued Operation, Operating Lease Obligations, Current", "terseLabel": "Operating lease obligations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseObligationsCurrent", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails", "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "monetaryItemType" }, "bkd_DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent": { "auth_ref": [], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current", "label": "Disposal Group, Including Discontinued Operation, Operating Lease, Right-of-Use Asset, Current", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingLeaseRightOfUseAssetCurrent", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "bkd_DisposalGroupNumberOfCommunitiesDisposedOf": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disposal Group, Number Of Communities Disposed Of", "label": "Disposal Group, Number Of Communities Disposed Of", "terseLabel": "Number of communities disposed of" } } }, "localname": "DisposalGroupNumberOfCommunitiesDisposedOf", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "bkd_EmployeeRetentionCreditAmountRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee Retention Credit, Amount Recognized", "label": "Employee Retention Credit, Amount Recognized", "terseLabel": "Employee retention credit, amount recognized" } } }, "localname": "EmployeeRetentionCreditAmountRecognized", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "bkd_EmployeeRetentionCreditMaximumCreditAmountPerEmployee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Employee Retention Credit, Maximum Credit Amount Per Employee", "label": "Employee Retention Credit, Maximum Credit Amount Per Employee", "terseLabel": "Maximum credit amount per employee" } } }, "localname": "EmployeeRetentionCreditMaximumCreditAmountPerEmployee", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "bkd_EmployeeRetentionCreditPercentOfWages": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employee Retention Credit, Percent Of Wages", "label": "Employee Retention Credit, Percent Of Wages", "terseLabel": "Employee retention credit, percent of wages" } } }, "localname": "EmployeeRetentionCreditPercentOfWages", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "percentItemType" }, "bkd_FacilityOperatingExpenseCOVID19": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Facility Operating Expense, COVID-19", "label": "Facility Operating Expense, COVID-19", "terseLabel": "Facility operating expense" } } }, "localname": "FacilityOperatingExpenseCOVID19", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "bkd_FederalTaxAuthorityAndStateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The designated tax department of Federal and a state or local government entitled to levy and collect income taxes from the entity.", "label": "Federal Tax Authority And State And Local Jurisdiction [Member]", "terseLabel": "Federal, State, and Local" } } }, "localname": "FederalTaxAuthorityAndStateAndLocalJurisdictionMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "bkd_FifthAmendedAndRestatedCreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fifth Amended And Restated Credit Agreement [Member]", "label": "Fifth Amended And Restated Credit Agreement [Member]", "terseLabel": "Fifth Amended and Restated Credit Agreement" } } }, "localname": "FifthAmendedAndRestatedCreditAgreementMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_FinanceLeaseLiabilityOptionToPurchaseAndNonCashGainOnFutureSaleofProperty": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale of Property", "label": "Finance Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale of Property", "terseLabel": "Purchase option liability and non-cash gain on future sale of property" } } }, "localname": "FinanceLeaseLiabilityOptionToPurchaseAndNonCashGainOnFutureSaleofProperty", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "bkd_FinanceLeaseLiabilitytobePaidAfterYearFour": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 6.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Liability, to be Paid, After Year Four", "label": "Finance Lease, Liability, to be Paid, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilitytobePaidAfterYearFour", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "bkd_FinanceLeaseRightofUseAssetDepreciationandAmortization": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseInterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Right-of-Use Asset, Depreciation and Amortization", "label": "Finance Lease, Right-of-Use Asset, Depreciation and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "FinanceLeaseRightofUseAssetDepreciationandAmortization", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "bkd_FinanceLeaseRightofUseAssetInterestExpense": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 8.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 }, "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseInterestExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance Lease, Right-of-Use Asset, Interest Expense", "label": "Finance Lease, Right-of-Use Asset, Interest Expense", "negatedLabel": "Financing lease obligations", "terseLabel": "Interest expense: financing lease obligations" } } }, "localname": "FinanceLeaseRightofUseAssetInterestExpense", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "bkd_FinancingLeaseObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Lease Obligations", "label": "Financing Lease Obligations", "terseLabel": "Financing lease obligations" } } }, "localname": "FinancingLeaseObligations", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_FinancingLeasePayments": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Financing Lease, Payments", "label": "Financing Lease, Payments", "totalLabel": "Total net cash outflows from financing leases" } } }, "localname": "FinancingLeasePayments", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "bkd_FinancingLeasesNumberOfCommunities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing Leases, Number Of Communities", "label": "Financing Leases, Number Of Communities", "terseLabel": "Financing leases, number of communities" } } }, "localname": "FinancingLeasesNumberOfCommunities", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "integerItemType" }, "bkd_GovernmentReimbursementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Government Reimbursement [Member]", "label": "Government Reimbursement [Member]", "terseLabel": "Government reimbursement" } } }, "localname": "GovernmentReimbursementMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "bkd_GrantsMadeAvailableProviderReliefFund": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Grants Made Available, Provider Relief Fund", "label": "Grants Made Available, Provider Relief Fund", "terseLabel": "Cash made available for Provider Relief Fund" } } }, "localname": "GrantsMadeAvailableProviderReliefFund", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_HCAHealthcareIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HCA Healthcare, Inc.", "label": "HCA Healthcare, Inc. [Member]", "terseLabel": "HCA Healthcare, Inc." } } }, "localname": "HCAHealthcareIncMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "bkd_HealthCareServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health Care Services [Member]", "label": "Health Care Services [Member]", "terseLabel": "Health Care Services", "verboseLabel": "Health Care Services" } } }, "localname": "HealthCareServicesMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails", "http://brookdale.com/role/GoodwillAdditionalInformationDetails", "http://brookdale.com/role/LeasesDetails", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_HealthpeakMasterLeaseModificationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthpeak Master Lease Modification [Member]", "label": "Healthpeak Master Lease Modification [Member]", "terseLabel": "Healthpeak master lease modification:" } } }, "localname": "HealthpeakMasterLeaseModificationMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_HealthpeakMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthpeak [Member]", "label": "Healthpeak [Member]", "terseLabel": "Healthpeak" } } }, "localname": "HealthpeakMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "bkd_IncreaseDecreaseInAccruedPayrollTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Accrued Payroll Taxes", "label": "Increase (Decrease) in Accrued Payroll Taxes", "terseLabel": "Decrease in accrued payroll taxes" } } }, "localname": "IncreaseDecreaseInAccruedPayrollTaxes", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "bkd_IncreaseDecreaseInFinanceLeaseAssetsAndLiabilitiesForLessorCapitalExpenditureReimbursements": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": 3.0, "parentTag": "bkd_FinancingLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Finance Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements", "label": "Increase (Decrease) In Finance Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements", "terseLabel": "Changes in financing lease assets and liabilities for lessor capital expenditure reimbursement" } } }, "localname": "IncreaseDecreaseInFinanceLeaseAssetsAndLiabilitiesForLessorCapitalExpenditureReimbursements", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "bkd_IncreaseDecreaseInOperatingLeaseAssetsAndLiabilitiesForLessorCapitalExpenditureReimbursements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Operating Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements", "label": "Increase (Decrease) In Operating Lease Assets And Liabilities For Lessor Capital Expenditure Reimbursements", "terseLabel": "Changes in operating lease assets and liabilities for lessor capital expenditure reimbursements" } } }, "localname": "IncreaseDecreaseInOperatingLeaseAssetsAndLiabilitiesForLessorCapitalExpenditureReimbursements", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "bkd_IncreaseDecreaseInOtherLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "(Increase) Decrease In Other Liabilities", "label": "(Increase) Decrease In Other Liabilities", "negatedTerseLabel": "Other liabilities" } } }, "localname": "IncreaseDecreaseInOtherLiabilities", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_IncreaseDecreaseInPropertyPlantAndEquipmentAndLeaseholdIntangiblesNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) In Property, Plant And Equipment And Leasehold Intangibles, Net", "label": "Increase (Decrease) In Property, Plant And Equipment And Leasehold Intangibles, Net", "terseLabel": "Property, plant and equipment and leasehold intangibles, net" } } }, "localname": "IncreaseDecreaseInPropertyPlantAndEquipmentAndLeaseholdIntangiblesNet", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_IncreaseDecreaseinPrepaidInsurancePremiums": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Prepaid Insurance Premiums", "label": "Increase (Decrease) in Prepaid Insurance Premiums", "negatedTerseLabel": "Prepaid insurance premiums financed with notes payable" } } }, "localname": "IncreaseDecreaseinPrepaidInsurancePremiums", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "bkd_IncreaseDecreaseinRefundableFeesandContractwithCustomersLiability": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) in Refundable Fees and Contract with Customers, Liability", "label": "Increase (Decrease) in Refundable Fees and Contract with Customers, Liability", "verboseLabel": "Refundable fees and deferred revenue" } } }, "localname": "IncreaseDecreaseinRefundableFeesandContractwithCustomersLiability", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "bkd_IncreaseDecreaseofLongtermDebtCurrentMaturities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (Decrease) of Long-term Debt, Current Maturities", "label": "Increase (Decrease) of Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt" } } }, "localname": "IncreaseDecreaseofLongtermDebtCurrentMaturities", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_IndependentLivingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Independent Living [Member]", "label": "Independent Living [Member]", "terseLabel": "Independent Living", "verboseLabel": "Independent Living" } } }, "localname": "IndependentLivingMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/GoodwillAdditionalInformationDetails", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_LesseeFinanceandOperatingLeaseRenewalTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee, Finance and Operating Lease, Renewal Term", "label": "Lessee, Finance and Operating Lease, Renewal Term", "terseLabel": "Finance and operating lease, renewal term" } } }, "localname": "LesseeFinanceandOperatingLeaseRenewalTerm", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "durationItemType" }, "bkd_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "label": "Lessee, Operating Lease, Liability, To Be Paid, After Year Four", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "bkd_LetterOfCreditSublimitMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Letter of credit sublimit on the secured line of credit facility", "label": "Letter of credit sublimit [Member]", "terseLabel": "Letter of Credit Sublimit" } } }, "localname": "LetterOfCreditSublimitMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_LiabilitiesHeldForSaleNotPartOfDisposalGroupCurrent": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liabilities Held-For-Sale, Not Part Of Disposal Group, Current", "label": "Liabilities Held-For-Sale, Not Part Of Disposal Group, Current", "terseLabel": "Liabilities held for sale" } } }, "localname": "LiabilitiesHeldForSaleNotPartOfDisposalGroupCurrent", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "bkd_LitigationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Litigation [Abstract]", "terseLabel": "Litigation [Abstract]" } } }, "localname": "LitigationAbstract", "nsuri": "http://brookdale.com/20210331", "xbrltype": "stringItemType" }, "bkd_LongTermDebtAndLinesOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-Term Debt And Lines Of Credit [Member]", "label": "Long-Term Debt And Lines Of Credit [Member]", "terseLabel": "Long-term debt and lines of credit" } } }, "localname": "LongTermDebtAndLinesOfCreditMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_ManagementServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Company's management services segment includes communities owned by others and operated by the company pursuant to management agreements. Under the management agreements for these communities, the company receives management fees as well as reimbursed expenses, which represent the reimbursement of certain expenses it incurs on behalf of the owners.", "label": "Management Services [Member]", "terseLabel": "Management Services" } } }, "localname": "ManagementServicesMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_MedicareAdvancePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Medicare Advance Payments", "label": "Medicare Advance Payments", "terseLabel": "Medicare advance payments" } } }, "localname": "MedicareAdvancePayments", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_Net": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net amount of non-cash operating, investing and financing activities", "label": "Net", "terseLabel": "Net" } } }, "localname": "Net", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_NetDeferredIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations, excluding the impact of an increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Net Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred federal, state and local tax expense (benefit)" } } }, "localname": "NetDeferredIncomeTaxExpenseBenefit", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "bkd_NonDevelopmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Development [Member]", "label": "Non-Development [Member]", "terseLabel": "Non-development" } } }, "localname": "NonDevelopmentMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_NoncashLeaseTerminationAndModificationNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncash, Lease Termination And Modification, Net [Member]", "label": "Noncash, Lease Termination And Modification, Net [Member]", "terseLabel": "Noncash lease termination and modification, net" } } }, "localname": "NoncashLeaseTerminationAndModificationNetMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_NondevelopmentReimbursableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-development - Reimbursable [Member]", "label": "Non-development - Reimbursable [Member]", "terseLabel": "Non-development - reimbursable" } } }, "localname": "NondevelopmentReimbursableMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_NumberOfCommunitiesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Communities Acquired", "label": "Number Of Communities Acquired", "terseLabel": "Number of communities acquired" } } }, "localname": "NumberOfCommunitiesAcquired", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "bkd_NumberOfOwnedCommunitiesTransferred": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Owned Communities Transferred", "label": "Number Of Owned Communities Transferred", "terseLabel": "Number of owned communities transferred" } } }, "localname": "NumberOfOwnedCommunitiesTransferred", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "bkd_NumberofCommunitiesClassifiedAsHeldForSale": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of communities classified as held for sale during the period.", "label": "Number of Communities Classified As Held For Sale", "terseLabel": "Number of communities classified as held for sale" } } }, "localname": "NumberofCommunitiesClassifiedAsHeldForSale", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "bkd_OneCommunityHeldForSaleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Community Held For Sale", "label": "One Community Held For Sale [Member]", "terseLabel": "One Community Held For Sale" } } }, "localname": "OneCommunityHeldForSaleMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_OperatingLeaseExpenseAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Expense, Adjustment", "label": "Operating Lease, Expense, Adjustment", "terseLabel": "Operating lease expense adjustment" } } }, "localname": "OperatingLeaseExpenseAdjustment", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "bkd_OperatingLeaseExpenseAdjustments": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease Expense Adjustments", "label": "Operating Lease Expense Adjustments", "verboseLabel": "Operating lease expense adjustment" } } }, "localname": "OperatingLeaseExpenseAdjustments", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "bkd_OperatingLeaseFacilityExpense": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0 }, "http://brookdale.com/role/SegmentInformationDetails": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Facility Expense", "label": "Operating Lease, Facility Expense", "terseLabel": "Facility lease expense", "verboseLabel": "Facility operating lease expense" } } }, "localname": "OperatingLeaseFacilityExpense", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/LeasesLeaseCostsDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_OperatingLeaseFacilityOperatingExpense": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Facility Operating Expense", "label": "Operating Lease, Facility Operating Expense", "terseLabel": "Facility operating expense" } } }, "localname": "OperatingLeaseFacilityOperatingExpense", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "bkd_OperatingLeaseLiabilityOptionToPurchaseAndNonCashGainOnFutureSaleOfProperty": { "auth_ref": [], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale Of Property", "label": "Operating Lease, Liability, Option To Purchase And Non-Cash Gain On Future Sale Of Property", "terseLabel": "Purchase option liability and non-cash gain on future sale of property" } } }, "localname": "OperatingLeaseLiabilityOptionToPurchaseAndNonCashGainOnFutureSaleOfProperty", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "bkd_OperatingLeaseObligation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease Obligation", "label": "Operating Lease Obligation", "terseLabel": "Operating lease obligations" } } }, "localname": "OperatingLeaseObligation", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_OperatingLeaseRightOfUseAssets": { "auth_ref": [], "calculation": { "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails": { "order": 2.0, "parentTag": "us-gaap_AssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating Lease, Right Of Use Assets", "label": "Operating Lease, Right Of Use Assets", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssets", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_OperatingLeasesNumberOfCommunities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating Leases, Number Of Communities", "label": "Operating Leases, Number Of Communities", "verboseLabel": "Operating lease, number of communities" } } }, "localname": "OperatingLeasesNumberOfCommunities", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "integerItemType" }, "bkd_OperatingandFinancingLeasesNumberOfCommunities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating and Financing Leases, Number Of Communities", "label": "Operating and Financing Leases, Number Of Communities", "terseLabel": "Operating and financing leases, number of communities" } } }, "localname": "OperatingandFinancingLeasesNumberOfCommunities", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "integerItemType" }, "bkd_OtherOperatingIncomeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Operating Income [Member]", "label": "Other Operating Income [Member]", "terseLabel": "Other operating income" } } }, "localname": "OtherOperatingIncomeMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "bkd_PaymentsForRecoupmentOfAcceleratedAdvancedPaymentsRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payments For Recoupment Of Accelerated/Advanced Payments Rate", "label": "Payments For Recoupment Of Accelerated/Advanced Payments Rate", "terseLabel": "Payments for recoupment of accelerated/advanced payments rate" } } }, "localname": "PaymentsForRecoupmentOfAcceleratedAdvancedPaymentsRate", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "percentItemType" }, "bkd_PaymentsProceedsForLessorCapitalExpenditureImpairment": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments (Proceeds) For Lessor Capital Expenditure Impairment", "label": "Payments (Proceeds) For Lessor Capital Expenditure Impairment", "negatedTerseLabel": "Operating lease assets and liabilities for lessor capital expenditure reimbursements" } } }, "localname": "PaymentsProceedsForLessorCapitalExpenditureImpairment", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "bkd_PercentageOfCommunitiesAcceptingNewVisitorsAndMoveIns": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Communities Accepting New Visitors And Move-Ins", "label": "Percentage Of Communities Accepting New Visitors And Move-Ins", "terseLabel": "Percentage of communities accepting new visitors and move-ins" } } }, "localname": "PercentageOfCommunitiesAcceptingNewVisitorsAndMoveIns", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "percentItemType" }, "bkd_PeriodOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period One", "label": "Period One [Member]", "terseLabel": "Period One" } } }, "localname": "PeriodOneMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_PeriodTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period Two", "label": "Period Two [Member]", "terseLabel": "Period Two" } } }, "localname": "PeriodTwoMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_ProceedsFromDeferredEntranceFeeRevenue": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds From Deferred Entrance Fee Revenue", "label": "Proceeds From Deferred Entrance Fee Revenue", "terseLabel": "Proceeds from deferred entrance fee revenue" } } }, "localname": "ProceedsFromDeferredEntranceFeeRevenue", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "bkd_ProceedsFromSaleOfAssetsNetMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from sale of assets, net [Member]", "terseLabel": "Proceeds from sale of assets, net" } } }, "localname": "ProceedsFromSaleOfAssetsNetMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_ProceedsRepaymentsfromSaleofPropertyPlantandEquipmentNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds (Repayments) from Sale of Property, Plant, and Equipment, Net", "label": "Proceeds (Repayments) from Sale of Property, Plant, and Equipment, Net", "verboseLabel": "Net cash received" } } }, "localname": "ProceedsRepaymentsfromSaleofPropertyPlantandEquipmentNet", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "bkd_RecognitionofContractLiability": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recognition of Contract Liability", "label": "Recognition of Contract Liability", "negatedLabel": "Amortization of entrance fees" } } }, "localname": "RecognitionofContractLiability", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "bkd_RecoupmentOfAcceleratedAdvancedPaymentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment Of Accelerated/Advanced Payments", "label": "Recoupment Of Accelerated/Advanced Payments [Axis]", "terseLabel": "Recoupment Of Accelerated/Advanced Payments [Axis]" } } }, "localname": "RecoupmentOfAcceleratedAdvancedPaymentsAxis", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "stringItemType" }, "bkd_RecoupmentOfAcceleratedAdvancedPaymentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment Of Accelerated/Advanced Payments [Domain]", "label": "Recoupment Of Accelerated/Advanced Payments [Domain]", "terseLabel": "Recoupment Of Accelerated/Advanced Payments [Domain]" } } }, "localname": "RecoupmentOfAcceleratedAdvancedPaymentsDomain", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_RecoupmentOfAcceleratedAdvancedPaymentsPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment Of Accelerated/Advanced Payments Period", "label": "Recoupment Of Accelerated/Advanced Payments Period", "terseLabel": "Recoupment of accelerated/advanced payments period" } } }, "localname": "RecoupmentOfAcceleratedAdvancedPaymentsPeriod", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "durationItemType" }, "bkd_RecoupmentOfAcceleratedAdvancedPaymentsStart": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recoupment Of Accelerated/Advanced Payments Start", "label": "Recoupment Of Accelerated/Advanced Payments Start", "terseLabel": "Recoupment of accelerated/advanced payments start" } } }, "localname": "RecoupmentOfAcceleratedAdvancedPaymentsStart", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "durationItemType" }, "bkd_RefundableFeesAndDeferredRevenueCurrent": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Refundable Fees And Deferred Revenue, Current", "label": "Refundable Fees And Deferred Revenue, Current", "terseLabel": "Refundable fees and deferred revenue" } } }, "localname": "RefundableFeesAndDeferredRevenueCurrent", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "bkd_ReimbursementCostsManagedCommunitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Reimbursement Costs, Managed Communities [Member]", "label": "Reimbursement Costs, Managed Communities [Member]", "terseLabel": "Reimbursed costs incurred on behalf of managed communities" } } }, "localname": "ReimbursementCostsManagedCommunitiesMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "bkd_ReliefReceivedProviderReliefFund": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Relief Received, Provider Relief Fund", "label": "Relief Received, Provider Relief Fund", "terseLabel": "Relief received from Provider Relief Fund" } } }, "localname": "ReliefReceivedProviderReliefFund", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "bkd_ResidentAndLeaseholdOperatingIntangiblesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long-lived, depreciable assets including all assets held by a lessee under a capital lease and any addition or improvement to assets held under lease arrangement (including addition or improvement to asset held by lessee under operating lease arrangement).", "label": "Resident and leasehold operating intangibles [Member]", "terseLabel": "Resident and leasehold operating intangibles" } } }, "localname": "ResidentAndLeaseholdOperatingIntangiblesMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "domainItemType" }, "bkd_RestrictedStockAndRestrictedStockUnitsRSUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted Stock And Restricted Stock Units (RSUs)", "label": "Restricted Stock And Restricted Stock Units (RSUs) [Member]", "terseLabel": "Non-performance-based restricted stock and restricted stock units" } } }, "localname": "RestrictedStockAndRestrictedStockUnitsRSUsMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "bkd_RevenueFromGovernmentGrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Revenue from Government Grants", "label": "Revenue from Government Grants", "terseLabel": "Revenue from government grants" } } }, "localname": "RevenueFromGovernmentGrants", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "bkd_SaleOf1CommunityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of 1 Community [Member]", "label": "Sale of 1 Community [Member]", "terseLabel": "Sale of 1 community" } } }, "localname": "SaleOf1CommunityMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_SaleOf2CommunitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of 2 Communities [Member]", "label": "Sale Of 2 Communities [Member]", "terseLabel": "Sale of 2 communities" } } }, "localname": "SaleOf2CommunitiesMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "bkd_SaleOfStockPercentageOfOwnershipSoldInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale Of Stock, Percentage Of Ownership Sold In Transaction", "label": "Sale Of Stock, Percentage Of Ownership Sold In Transaction", "terseLabel": "Sale of stock, percentage of ownership sold in transaction" } } }, "localname": "SaleOfStockPercentageOfOwnershipSoldInTransaction", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails" ], "xbrltype": "percentItemType" }, "bkd_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement", "label": "Securities Purchase Agreement [Member]", "terseLabel": "Securities Purchase Agreement" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "bkd_ShareBasedCompensationSharesValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The grant date fair values for purposes of disclosing shares potentially issuable under restricted stock awards on all restricted stock plans and other required information pertaining to awards in the customized range.", "label": "Share Based Compensation Shares Value Per Share", "verboseLabel": "Weighted Average Grant Date Fair Value (in dollars per share)" } } }, "localname": "ShareBasedCompensationSharesValuePerShare", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "perShareItemType" }, "bkd_TheContinuingAppropriationsAct2021AndOtherExtensionsActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The Continuing Appropriations Act, 2021 and Other Extensions Act", "label": "The Continuing Appropriations Act, 2021 and Other Extensions Act [Member]", "terseLabel": "The Continuing Appropriations Act, 2021 and Other Extensions Act" } } }, "localname": "TheContinuingAppropriationsAct2021AndOtherExtensionsActMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "bkd_VariableMortgagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable Mortgages", "label": "Variable Mortgages [Member]", "terseLabel": "Variable Mortgages" } } }, "localname": "VariableMortgagesMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "bkd_VentasIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ventas, Inc [Member]", "label": "Ventas, Inc [Member]", "terseLabel": "Ventas, Inc" } } }, "localname": "VentasIncMember", "nsuri": "http://brookdale.com/20210331", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Entity Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://brookdale.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r151", "r164", "r165", "r166", "r167", "r169", "r171", "r175" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r151", "r164", "r165", "r166", "r167", "r169", "r171", "r175" ], "lang": { "en-us": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r58", "r104" ], "lang": { "en-us": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name [Axis]" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r112", "r117", "r189", "r274", "r275", "r276", "r290", "r291" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]", "terseLabel": "Cumulative Effect Period Of Adoption Adjustment" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r112", "r117", "r189", "r274", "r275", "r276", "r290", "r291" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption [Axis]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r112", "r117", "r189", "r274", "r275", "r276", "r290", "r291" ], "lang": { "en-us": { "role": { "label": "Cumulative Effect, Period of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption [Domain]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r263", "r266", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r413", "r415" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r263", "r266", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r413", "r415" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r177", "r240", "r244", "r372", "r412", "r414" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r177", "r240", "r244", "r372", "r412", "r414" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r252", "r263", "r266", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r413", "r415" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r252", "r263", "r266", "r365", "r366", "r367", "r368", "r369", "r370", "r371", "r413", "r415" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Counterparty Name [Domain]", "terseLabel": "Counterparty Name [Domain]" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]", "terseLabel": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r213", "r264", "r361" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r23", "r44" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "verboseLabel": "Trade accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r18", "r31", "r182", "r183" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrentAndNoncurrent": { "auth_ref": [ "r392", "r406" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs.", "label": "Accrued Payroll Taxes", "terseLabel": "Employer portion of payroll taxes delayed" } } }, "localname": "AccruedPayrollTaxesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r32", "r277" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "verboseLabel": "Additional paid-in-capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r109", "r110", "r111", "r274", "r275", "r276" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional paid-in-capital:" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation", "negatedLabel": "Shares withheld for employee taxes" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Adjustments to Additional Paid in Capital, Other", "terseLabel": "Other, net" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.", "label": "APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition", "terseLabel": "Non-cash stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r268", "r272", "r278" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-based Payment Arrangement, Expense", "verboseLabel": "Non-cash stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r92", "r341" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 9.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "negatedLabel": "Amortization of deferred financing costs and debt discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r92", "r198" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://brookdale.com/role/SegmentInformationDetails": { "order": 4.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Asset impairment", "totalLabel": "Asset impairment", "verboseLabel": "Asset impairment" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r102", "r159", "r166", "r173", "r188", "r308", "r314", "r331", "r387", "r400" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Total assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "verboseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r20", "r21", "r56", "r102", "r188", "r308", "r314", "r331" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "verboseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldForSaleLongLivedFairValueDisclosure": { "auth_ref": [ "r321" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of assets classified as held for sale.", "label": "Assets Held-for-sale, Long Lived, Fair Value Disclosure", "terseLabel": "Assets held for sale" } } }, "localname": "AssetsHeldForSaleLongLivedFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": { "auth_ref": [ "r196" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.", "label": "Assets Held-for-sale, Not Part of Disposal Group, Current", "terseLabel": "Liabilities held for sale" } } }, "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Assets [Abstract]", "terseLabel": "Disposal Group, Including Discontinued Operation, Assets [Abstract]" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r0", "r1", "r10", "r12", "r15", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "totalLabel": "Assets held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r269", "r273" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r319", "r320" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BuildingAndBuildingImprovementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities and any addition, improvement, or renovation to the structure, for example, but not limited to, interior masonry, interior flooring, electrical, and plumbing.", "label": "Building and Building Improvements [Member]", "terseLabel": "Buildings and improvements" } } }, "localname": "BuildingAndBuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r262", "r265" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r262", "r265", "r302", "r303" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]", "terseLabel": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r17", "r39", "r94" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r88", "r94", "r99" ], "calculation": { "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents, and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents, and restricted cash at beginning of period", "totalLabel": "Total cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r88", "r332" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental Schedule of Non-cash Operating, Investing and Financing Activities:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r100" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "verboseLabel": "Supplemental Disclosure of Cash Flow Information" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "verboseLabel": "Number of warrants (in shares)" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r109", "r110" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common stock:" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "verboseLabel": "Common stock, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "verboseLabel": "Common stock, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r30", "r221" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Balances at end of period (in shares)", "periodStartLabel": "Balance at beginning of period (in shares)", "terseLabel": "Common stock, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r30" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.01 par value, 400,000,000 shares authorized at March\u00a031, 2021 and December\u00a031, 2020; 197,757,065 and 198,331,663 shares issued and 187,229,540 and 187,804,138 shares outstanding (including 2,063,391 and 4,349,421 unvested restricted shares), respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r101", "r310" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation, Policy [Policy Text Block]", "terseLabel": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction in Progress [Member]", "terseLabel": "Construction in progress" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r229", "r230", "r241" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract with customer, liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "auth_ref": [ "r242" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.", "label": "Contract with Customer, Liability, Revenue Recognized", "terseLabel": "Revenue recognized" } } }, "localname": "ContractWithCustomerLiabilityRevenueRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r68", "r372" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "verboseLabel": "Costs of services" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSoldDepreciationAndAmortization": { "auth_ref": [ "r65" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for allocation of cost of tangible and intangible assets over their useful lives directly used in production of good and rendering of service.", "label": "Cost, Depreciation and Amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "CostOfGoodsAndServicesSoldDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of Revenue [Abstract]", "terseLabel": "Expense" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r66" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total operating expense" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]", "terseLabel": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r26", "r27", "r28", "r388", "r389", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DebtNarrativeDetails", "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "verboseLabel": "Long-Term Debt, Capital and Financing Leases and Financing Obligations [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DebtNarrativeDetails", "http://brookdale.com/role/RevenueAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r51", "r105", "r222", "r223", "r224", "r225", "r339", "r340", "r342", "r398" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]", "terseLabel": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "auth_ref": [ "r216", "r341" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "terseLabel": "Debt discount and deferred financing costs, net" } } }, "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instruments [Abstract]", "terseLabel": "Long-Term Debt, Capital Leases and Financing Obligations [Abstract]" } } }, "localname": "DebtInstrumentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal, State and Local, Tax Expense (Benefit)", "negatedLabel": "Gross deferred federal, state and local tax benefit" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r92", "r103", "r289", "r294", "r295", "r296" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "verboseLabel": "Deferred income tax (benefit) provision" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r280", "r281" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities, Net", "verboseLabel": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r286" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "verboseLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r92", "r201" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://brookdale.com/role/SegmentInformationDetails": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r92", "r154" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "verboseLabel": "Depreciation and amortization, net" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r240", "r244", "r245", "r246", "r247", "r248", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueAdditionalInformationDetails", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Disaggregation of Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r279" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-based Payment Arrangement [Text Block]", "verboseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-based Payment Arrangement [Abstract]", "terseLabel": "Share-based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]", "terseLabel": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.", "label": "Disposal Group Classification [Domain]", "terseLabel": "Disposal Group Classification [Domain]" } } }, "localname": "DisposalGroupClassificationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember": { "auth_ref": [ "r197", "r199", "r208" ], "lang": { "en-us": { "role": { "documentation": "Disposal group that either has been sold or is classified as held-for-sale. Excludes disposals classified as discontinued operations.", "label": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations [Member]", "terseLabel": "Disposal Group, Held-for-sale or Disposed of by Sale, Not Discontinued Operations" } } }, "localname": "DisposalGroupHeldForSaleOrDisposedOfBySaleNotDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r0", "r1", "r10", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "terseLabel": "Accounts receivable, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent": { "auth_ref": [ "r0", "r1", "r10", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable, Current", "terseLabel": "Trade accounts payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": { "auth_ref": [ "r0", "r1", "r10", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current", "terseLabel": "Accrued expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent": { "auth_ref": [ "r0", "r1", "r10", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue, Current", "terseLabel": "Refundable fees and deferred revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent": { "auth_ref": [ "r0", "r1", "r10", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Goodwill, Current", "terseLabel": "Goodwill" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": { "auth_ref": [ "r0", "r1", "r10", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current", "terseLabel": "Prepaid expenses and other assets, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent": { "auth_ref": [ "r0", "r1", "r10", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Current", "terseLabel": "Property, plant and equipment and leasehold intangibles, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r262", "r265" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Group Name [Domain]", "terseLabel": "Disposal Group Name [Domain]" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails", "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]", "verboseLabel": "Net income (loss) per share attributable to Brookdale Senior Living Inc. common stockholders:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r64", "r115", "r116", "r117", "r118", "r119", "r123", "r125", "r127", "r128", "r129", "r133", "r134", "r396", "r409" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Earnings Per Share, Basic and Diluted [Abstract]" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r64", "r115", "r116", "r117", "r118", "r119", "r125", "r127", "r128", "r129", "r133", "r134", "r396", "r409" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r130", "r131", "r132", "r135" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "verboseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r109", "r110", "r111", "r114", "r120", "r122", "r136", "r189", "r221", "r226", "r274", "r275", "r276", "r290", "r291", "r333", "r334", "r335", "r336", "r337", "r338", "r416", "r417", "r418" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": { "auth_ref": [ "r186" ], "calculation": { "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails": { "order": 3.0, "parentTag": "us-gaap_AssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.", "label": "Equity Method Investment, Other than Temporary Impairment", "terseLabel": "Investment in unconsolidated ventures" } } }, "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ExtraordinaryAndUnusualItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Unusual or Infrequent Items, or Both [Abstract]" } } }, "localname": "ExtraordinaryAndUnusualItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails", "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r321", "r322", "r323", "r329" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails", "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": { "auth_ref": [ "r321", "r322", "r324" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).", "label": "Fair Value Measurements, Nonrecurring [Table Text Block]", "terseLabel": "Summary of Asset Impairment Expense" } } }, "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r261", "r322", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r321", "r322", "r325", "r326", "r330" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]", "terseLabel": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r328" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r253", "r254", "r259", "r261", "r322", "r363" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r261", "r362", "r363", "r364" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsNonrecurringMember": { "auth_ref": [ "r321", "r322", "r325", "r326", "r327", "r330" ], "lang": { "en-us": { "role": { "documentation": "Infrequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, not frequently measured at fair value.", "label": "Fair Value, Nonrecurring [Member]", "terseLabel": "Nonrecurring" } } }, "localname": "FairValueMeasurementsNonrecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r345", "r352", "r356" ], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease, Interest Expense", "totalLabel": "Financing lease expense" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r348", "r353" ], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": 1.0, "parentTag": "bkd_FinancingLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease, Interest Payment on Liability", "terseLabel": "Operating cash flows from financing leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Financing Leases" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r344", "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease, Liability", "verboseLabel": "Total lease obligations" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r344" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease, Liability, Current", "terseLabel": "Current portion of financing lease obligations" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.", "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]", "terseLabel": "Finance Lease, Liability, Maturity" } } }, "localname": "FinanceLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r344" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease, Liability, Noncurrent", "terseLabel": "Financing lease obligations, less current portion" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Payment, Due", "totalLabel": "Total lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 5.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 4.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 3.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 1.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.", "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2021 (nine months)" } } }, "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 2.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Imputed interest and variable lease payments" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r347", "r353" ], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": 2.0, "parentTag": "bkd_FinancingLeasePayments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease, Principal Payments", "terseLabel": "Financing cash flows from financing leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r343" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization", "terseLabel": "Finance lease, right-of-use asset" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Furniture and equipment" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r92" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 6.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedLabel": "Loss (gain) on sale of assets, net", "netLabel": "Gain on sale of assets", "terseLabel": "Gain (loss) on sale of assets, net", "verboseLabel": "Loss (gain) on sale of assets, net" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/IncomeTaxesDetails", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r92", "r218", "r219" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 4.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain (Loss) on Extinguishment of Debt", "negatedTerseLabel": "Loss (gain) on debt modification and extinguishment, net", "terseLabel": "Gain (loss) on debt modification and extinguishment, net", "verboseLabel": "Loss (gain) on debt modification and extinguishment, net" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r69" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 }, "http://brookdale.com/role/SegmentInformationDetails": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "netLabel": "General\u00a0and administrative expense (including non-cash stock-based compensation expense)", "terseLabel": "General and administrative expense (including non-cash stock-based compensation expense of $4,783 and $5,957, respectively)" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r190", "r191", "r386" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/GoodwillAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r101", "r192", "r194" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/GoodwillAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r67", "r102", "r159", "r165", "r169", "r172", "r175", "r188", "r331" ], "calculation": { "http://brookdale.com/role/SegmentInformationDetails": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "verboseLabel": "Segment\u00a0operating income" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HealthCareOrganizationRevenueSourcesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by major payor source of revenue for health care organizations.", "label": "Health Care Organization, Revenue Sources [Axis]", "terseLabel": "Health Care Organization, Revenue Sources [Axis]" } } }, "localname": "HealthCareOrganizationRevenueSourcesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HealthCareOrganizationRevenueSourcesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Major payor source of revenue for health care organizations.", "label": "Health Care Organization, Revenue Sources [Domain]", "terseLabel": "Health Care Organization, Revenue Sources [Domain]" } } }, "localname": "HealthCareOrganizationRevenueSourcesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HealthCareResidentServiceMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Service provided to resident in health care facility, for maintenance, diagnosis and treatment of physical and mental health.", "label": "Health Care, Resident Service [Member]", "terseLabel": "Resident fees", "verboseLabel": "Total resident fee revenue" } } }, "localname": "HealthCareResidentServiceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r61", "r159", "r165", "r169", "r172", "r175", "r385", "r394", "r397", "r410" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Income (loss) before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r62", "r92", "r156", "r187", "r393", "r407" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 5.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Income (Loss) from Equity Method Investments", "negatedLabel": "Equity in (earnings) loss of unconsolidated ventures", "terseLabel": "Equity in earnings (loss) of unconsolidated ventures" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]", "terseLabel": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r262", "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Disposal Group Name [Axis]", "terseLabel": "Disposal Group Name [Axis]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails", "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r1", "r4", "r5", "r6", "r7", "r8", "r9", "r11", "r13", "r14", "r15", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]", "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r283", "r285", "r288", "r292", "r297", "r299", "r300", "r301" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "verboseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r103", "r121", "r122", "r157", "r282", "r293", "r298", "r411" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "Benefit (provision) for income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r95" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Income taxes paid, net of refunds" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r91" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Trade accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "negatedLabel": "Trade accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r91" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable, net" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "terseLabel": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAssetsHeldForSale": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in book value of long-lived assets that the reporting entity plans to sell within one year (or one business cycle).", "label": "Increase (Decrease) in Assets Held-for-sale", "negatedTerseLabel": "Assets held for sale" } } }, "localname": "IncreaseDecreaseInAssetsHeldForSale", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "auth_ref": [ "r91" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits.", "label": "Increase (Decrease) in Deposit Assets", "negatedTerseLabel": "Change in lease security deposits and lease acquisition deposits, net" } } }, "localname": "IncreaseDecreaseInDepositOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r91" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets, net", "negatedTerseLabel": "Prepaid expenses and other assets, net" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Interest Expense [Abstract]", "terseLabel": "Interest expense:" } } }, "localname": "InterestExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r72" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense, Debt, Excluding Amortization", "negatedLabel": "Debt" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r86", "r89", "r95" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r70", "r152" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "verboseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsAndCash": { "auth_ref": [ "r405" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of investments and unrestricted cash as of the balance sheet date.", "label": "Investments and Cash", "terseLabel": "Total liquidity" } } }, "localname": "InvestmentsAndCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "auth_ref": [ "r40" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate.", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "verboseLabel": "Investment in unconsolidated ventures" } } }, "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease Costs" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]", "terseLabel": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters and Contingencies [Text Block]", "verboseLabel": "Litigation" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/Litigation" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeFinanceLeasesTextBlock": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.", "label": "Lessee, Finance Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeFinanceLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee, Lease, Description [Line Items]", "terseLabel": "Lessee, Lease, Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee, Lease, Description [Table]", "terseLabel": "Lessee, Lease, Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r350" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "terseLabel": "Lease Accounting" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]", "terseLabel": "Lessee, Operating Lease, Liability, Maturity" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details_1": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year", "terseLabel": "2021 (nine months)" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r355" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedTerseLabel": "Imputed interest and variable lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "Lessee, Operating Leases [Text Block]", "terseLabel": "Leases" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_LetterOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).", "label": "Letter of Credit [Member]", "terseLabel": "Letter of Credit" } } }, "localname": "LetterOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LettersOfCreditOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.", "label": "Letters of Credit Outstanding, Amount", "terseLabel": "Letters of credit issued" } } }, "localname": "LettersOfCreditOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r47", "r102", "r167", "r188", "r309", "r314", "r315", "r331" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r36", "r102", "r188", "r331", "r391", "r404" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r50", "r102", "r188", "r309", "r314", "r315", "r331" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "verboseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]", "terseLabel": "Disposal Group, Including Discontinued Operation, Liabilities [Abstract]" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r0", "r1", "r10", "r12", "r15", "r200", "r206" ], "calculation": { "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "totalLabel": "Liabilities held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsDisclosureofAssetsandLiabilitiesHeldforsaleDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Line of Credit Facility [Line Items]", "terseLabel": "Credit Facilities [Line Items]" } } }, "localname": "LineOfCreditFacilityLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r45" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r45", "r105" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]", "terseLabel": "Line of Credit" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansInsuredOrGuaranteedByGovernmentAuthoritiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by US and non-US government sponsored enterprise, authority, agency and program guarantees for government insured loans.", "label": "Loans Insured or Guaranteed by Government Authorities [Axis]", "terseLabel": "Loans Insured or Guaranteed by Government Authorities [Axis]" } } }, "localname": "LoansInsuredOrGuaranteedByGovernmentAuthoritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LoansInsuredOrGuaranteedByGovernmentAuthoritiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guarantee by US and non-US government sponsored enterprises, authorities, agencies and programs for government insured loans.", "label": "Loans Insured or Guaranteed by Government Authorities [Domain]", "terseLabel": "Loans Insured or Guaranteed by Government Authorities [Domain]" } } }, "localname": "LoansInsuredOrGuaranteedByGovernmentAuthoritiesDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LoansInsuredOrGuaranteedByUsGovernmentAuthoritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guarantee by US government authority for government insured loans.", "label": "Loans Insured or Guaranteed by US Government Authorities [Member]", "terseLabel": "Loans Insured or Guaranteed by US Government Authorities" } } }, "localname": "LoansInsuredOrGuaranteedByUsGovernmentAuthoritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r28", "r217", "r389", "r401" ], "calculation": { "http://brookdale.com/role/DebtScheduleofDebtDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt", "terseLabel": "Total long-term debt", "totalLabel": "Total long-term debt" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails", "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://brookdale.com/role/DebtScheduleofDebtDetails": { "order": 2.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Current Maturities", "terseLabel": "Current portion of long-term debt", "verboseLabel": "Current portion" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r51" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://brookdale.com/role/DebtScheduleofDebtDetails": { "order": 1.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, less current portion" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r51" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]", "terseLabel": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails", "http://brookdale.com/role/DebtScheduleofDebtDetails", "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r51", "r215" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]", "terseLabel": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails", "http://brookdale.com/role/DebtScheduleofDebtDetails", "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.", "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time", "terseLabel": "Weighted average interest rate" } } }, "localname": "LongtermDebtWeightedAverageInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ManagementServiceMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Contractually stipulated right to receive compensation for operating and managing business.", "label": "Management Service [Member]", "terseLabel": "Management fees" } } }, "localname": "ManagementServiceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [ "r19", "r48" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable Securities, Current", "terseLabel": "Marketable securities" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": { "auth_ref": [ "r16", "r304" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures. This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.", "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]", "verboseLabel": "Acquisitions, Dispositions and Other Transactions" } } }, "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r55", "r102", "r188", "r331", "r390", "r403" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageLoansOnRealEstate": { "auth_ref": [ "r421" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in mortgage loan on real estate by entity with substantial portion of business acquiring and holding investment real estate or interest in real estate.", "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate", "terseLabel": "Mortgage debt" } } }, "localname": "MortgageLoansOnRealEstate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgagesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan.", "label": "Mortgages [Member]", "terseLabel": "Mortgages", "verboseLabel": "Mortgage notes payable" } } }, "localname": "MortgagesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails", "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r137", "r145" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "verboseLabel": "Description of Business" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DescriptionofBusiness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r88" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r88" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r88", "r90", "r93" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by (used in) operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r15", "r59", "r60", "r63", "r93", "r102", "r113", "r115", "r116", "r117", "r118", "r121", "r122", "r126", "r159", "r165", "r169", "r172", "r175", "r188", "r331", "r395", "r408" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net income (loss) attributable to Brookdale Senior Living Inc. common stockholders", "verboseLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r59", "r60", "r121", "r122", "r312", "r317" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "negatedLabel": "Net (income) loss attributable to noncontrolling interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionNameDomain": { "auth_ref": [ "r96", "r97", "r98" ], "lang": { "en-us": { "role": { "documentation": "The name of the sale of an asset or business acquired through a noncash (or part noncash) transaction.", "label": "Noncash or Part Noncash Acquisition, Name [Domain]", "terseLabel": "Noncash or Part Noncash Acquisition, Name [Domain]" } } }, "localname": "NoncashOrPartNoncashAcquisitionNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionsByUniqueDescriptionAxis": { "auth_ref": [ "r96", "r97", "r98" ], "lang": { "en-us": { "role": { "documentation": "This table is organized by a unique description of the noncash or part noncash acquisition.", "label": "Noncash or Part Noncash Acquisitions by Unique Description [Axis]", "terseLabel": "Noncash or Part Noncash Acquisitions by Unique Description [Axis]" } } }, "localname": "NoncashOrPartNoncashAcquisitionsByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Noncash or Part Noncash Acquisitions [Line Items]", "terseLabel": "Acquisition of assets, net of related payables [Line Items]" } } }, "localname": "NoncashOrPartNoncashAcquisitionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionsTable": { "auth_ref": [ "r96", "r97", "r98" ], "lang": { "en-us": { "role": { "documentation": "The process of acquiring assets or a business through noncash (or part noncash) transactions. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisitions [Table]", "terseLabel": "Noncash or Part Noncash Acquisitions [Table]" } } }, "localname": "NoncashOrPartNoncashAcquisitionsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r109", "r110", "r111", "r226", "r305" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling interest:" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableOtherPayablesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A written promise to pay a note to a third party.", "label": "Notes Payable, Other Payables [Member]", "terseLabel": "Other notes payable" } } }, "localname": "NotesPayableOtherPayablesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtScheduleofDebtDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number of Reportable Segments", "terseLabel": "Number of reportable segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r159", "r165", "r169", "r172", "r175" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 }, "http://brookdale.com/role/SegmentInformationDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income (loss) from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r346" ], "calculation": { "http://brookdale.com/role/LeasesLeaseCostsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "totalLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]", "terseLabel": "Operating Leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r344" ], "calculation": { "http://brookdale.com/role/LeasesMaturityASC842Details": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Total lease obligations" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesMaturityASC842Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r344" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Current portion of operating lease obligations" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r344" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Operating lease obligations, less current portion" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r349", "r353" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease, Payments", "terseLabel": "Operating net cash outflows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/LeasesLeaseCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r343" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r164", "r165", "r166", "r167", "r169", "r175" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other assets, net" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r52" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "verboseLabel": "Other liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income (Expense)", "negatedLabel": "Other" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r71" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 7.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "verboseLabel": "Other non-operating income (loss)" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r82" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Purchase of treasury stock, net of related payables" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r84" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs", "negatedLabel": "Payment of financing costs, net of related payables" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r82" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payment, Tax Withholding, Share-based Payment Arrangement", "negatedTerseLabel": "Payments of employee taxes for withheld shares" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r78" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "terseLabel": "Net cash paid" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireEquityMethodInvestments": { "auth_ref": [ "r78" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence.", "label": "Payments to Acquire Equity Method Investments", "negatedLabel": "Investment in unconsolidated ventures", "negatedTerseLabel": "Investments in unconsolidated ventures" } } }, "localname": "PaymentsToAcquireEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r185" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchase of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireOtherProductiveAssets": { "auth_ref": [ "r79" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.", "label": "Payments to Acquire Other Productive Assets", "negatedLabel": "Acquisition of assets, net of related payables and cash received" } } }, "localname": "PaymentsToAcquireOtherProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r79" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital expenditures, net of related payables", "terseLabel": "Net cash paid" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PerformanceSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement awarded for meeting performance target.", "label": "Performance Shares [Member]", "terseLabel": "Performance-based restricted stock and restricted stock units" } } }, "localname": "PerformanceSharesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "verboseLabel": "Preferred stock, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r29" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.01 par value, 50,000,000 shares authorized at March\u00a031, 2021 and December\u00a031, 2020; no shares issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r20", "r37", "r38" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets, net" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r75" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Proceeds from Divestiture of Businesses", "negatedTerseLabel": "Net cash received" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r80" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds from Issuance of Long-term Debt", "terseLabel": "Proceeds from debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLinesOfCredit": { "auth_ref": [ "r80", "r106" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.", "label": "Proceeds from Lines of Credit", "terseLabel": "Proceeds from line of credit" } } }, "localname": "ProceedsFromLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r81", "r85", "r107" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "verboseLabel": "Other" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Sale and maturities of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment": { "auth_ref": [ "r76" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.", "label": "Proceeds from Sale of Property, Plant, and Equipment", "verboseLabel": "Proceeds from sale of assets, net" } } }, "localname": "ProceedsFromSaleOfPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets": { "auth_ref": [ "r77" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate cash proceeds received from a combination of transactions in which noncurrent assets are sold, which may include the sale of a business, an investment in an affiliate (including an equity method investee), property, plant and equipment and intangible assets. Excludes sales of trading, available-for-sale, and held-to-maturity securities.", "label": "Proceeds from Sales of Business, Affiliate and Productive Assets", "terseLabel": "Net cash proceeds" } } }, "localname": "ProceedsFromSalesOfBusinessAffiliateAndProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r15", "r59", "r60", "r87", "r102", "r113", "r121", "r122", "r159", "r165", "r169", "r172", "r175", "r188", "r307", "r311", "r313", "r317", "r318", "r331", "r397" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r203", "r345", "r352" ], "calculation": { "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization", "negatedLabel": "Accumulated depreciation and amortization" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r57", "r204", "r352" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization", "terseLabel": "Property, plant and equipment and leasehold intangibles, net", "totalLabel": "Property, plant and equipment and leasehold intangibles, net" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": { "auth_ref": [ "r24", "r202", "r343" ], "calculation": { "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.", "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization", "terseLabel": "Property, plant and equipment and leasehold intangibles" } } }, "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r42", "r204" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]", "terseLabel": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r210", "r423", "r424", "r425" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "verboseLabel": "Property, Plant and Equipment and Leasehold Intangibles, Net" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r41", "r101", "r204", "r423", "r424" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "terseLabel": "Property, Plant and Equipment and Leasehold Intangibles, Net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r24", "r204" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "verboseLabel": "Property, Plant and Equipment and Leasehold Intangibles, Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r24", "r202" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]", "terseLabel": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RealEstateMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Property consisting of land, land improvement and buildings.", "label": "Real Estate [Member]", "terseLabel": "Facility operating expense" } } }, "localname": "RealEstateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r260", "r358", "r359" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r260", "r358", "r359", "r360" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r260", "r358", "r360", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383", "r384" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]", "terseLabel": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfLongTermDebtAndCapitalSecurities": { "auth_ref": [ "r83" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for debt, mandatory redeemable security, and principal payment for finance lease obligation.", "label": "Repayment of Long-term Debt, Long-term Lease Obligation, and Capital Security", "negatedLabel": "Repayment of debt and financing lease obligations" } } }, "localname": "RepaymentsOfLongTermDebtAndCapitalSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": { "auth_ref": [ "r22", "r25", "r94", "r99", "r422" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 }, "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash and Cash Equivalents, Noncurrent", "terseLabel": "Long-term restricted cash", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalentsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndInvestmentsCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current cash, cash equivalents and investments that are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes current cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.", "label": "Restricted Cash and Investments, Current", "terseLabel": "Restricted cash", "verboseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndInvestmentsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationScheduleofcashcashequivalentsandrestrictedcashDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Unvested Restricted Stock" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r33", "r226", "r277", "r402", "r419", "r420" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r109", "r110", "r111", "r114", "r120", "r122", "r189", "r274", "r275", "r276", "r290", "r291", "r416", "r418" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated deficit:" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]", "terseLabel": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r150", "r151", "r164", "r170", "r171", "r177", "r178", "r180", "r239", "r240", "r372" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r243", "r251" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "verboseLabel": "Revenue" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of Stock, Consideration Received on Transaction", "terseLabel": "Sale of stock, consideration received on transaction" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.", "label": "Sale of Stock, Percentage of Ownership after Transaction", "terseLabel": "Sale of stock, percentage of ownership after transaction" } } }, "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]", "terseLabel": "Schedule of Potentially Dilutive Securities" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of cash and cash equivalents.", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "terseLabel": "Schedule of Cash, Cash Equivalents, and Restricted Cash" } } }, "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r51", "r105", "r222", "r223", "r224", "r225", "r339", "r340", "r342", "r398" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Debt" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r1", "r4", "r5", "r6", "r7", "r8", "r9", "r11", "r13", "r14", "r15", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Disclosure of Assets and Liabilities Held-for-sale" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r129" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/GoodwillAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r42", "r204" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/PropertyPlantandEquipmentandLeaseholdIntangiblesNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r159", "r162", "r168", "r192" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r159", "r162", "r168", "r192" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of segment reporting information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r269", "r273" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year.", "label": "Share-based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]", "verboseLabel": "Grants of Restricted Stock and Stock Units" } } }, "localname": "ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r146", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r164", "r165", "r166", "r167", "r169", "r170", "r171", "r172", "r173", "r175", "r180", "r412" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails", "http://brookdale.com/role/GoodwillAdditionalInformationDetails", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]", "terseLabel": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r146", "r148", "r149", "r159", "r163", "r169", "r173", "r174", "r175", "r176", "r177", "r179", "r180", "r181" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "verboseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SelfPayMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Patients who pay out of pocket for a health-related service in absence of insurance to cover the medical or surgical procedure performed.", "label": "Self-Pay [Member]", "terseLabel": "Private pay" } } }, "localname": "SelfPayMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r303" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Acquisition of assets, net of related payables and cash received" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r91" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-based Payment Arrangement, Noncash Expense", "terseLabel": "Non-cash stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period", "terseLabel": "Restricted Stock and Restricted Stock Unit Grants (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r267", "r270" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]", "terseLabel": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation", "negatedTerseLabel": "Shares withheld for employee taxes (in shares)" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r108" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "verboseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r3", "r146", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r158", "r159", "r160", "r161", "r164", "r165", "r166", "r167", "r169", "r170", "r171", "r172", "r173", "r175", "r180", "r192", "r207", "r211", "r212", "r412" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/AcquisitionsDispositionsandOtherTransactionsAdditionalInformationDetails", "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/DescriptionofBusinessDescriptionofBusinessDetails", "http://brookdale.com/role/GoodwillAdditionalInformationDetails", "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r54", "r109", "r110", "r111", "r114", "r120", "r122", "r136", "r189", "r221", "r226", "r274", "r275", "r276", "r290", "r291", "r333", "r334", "r335", "r336", "r337", "r338", "r416", "r417", "r418" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]", "terseLabel": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]", "terseLabel": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]", "terseLabel": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r109", "r110", "r111", "r136", "r372" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r29", "r30", "r221", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock under Associate Stock Purchase Plan (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r29", "r30", "r221", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Restricted stock and restricted stock units, net (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r29", "r30", "r221", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock under Associate Stock Purchase Plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "auth_ref": [ "r221", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "terseLabel": "Restricted stock and restricted stock units, net" } } }, "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationGross": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture", "verboseLabel": "Total Grant Date Fair Value" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r30", "r34", "r35", "r102", "r184", "r188", "r331" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Total Brookdale Senior Living Inc. stockholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r102", "r109", "r110", "r111", "r114", "r120", "r188", "r189", "r226", "r274", "r275", "r276", "r290", "r291", "r305", "r306", "r316", "r331", "r333", "r334", "r338", "r417", "r418" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance at end of period", "periodStartLabel": "Balance at beginning of period", "terseLabel": "Cumulative effect of change in accounting principle", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS", "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Number of Shares, Par Value and Other Disclosures [Abstract]", "terseLabel": "Equity, Number of Shares, Par Value and Other Disclosures [Abstract]" } } }, "localname": "StockholdersEquityNumberOfSharesParValueAndOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Elements [Abstract]", "terseLabel": "Supplemental Cash Flow Elements [Abstract]" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SupplementalDisclosureofCashFlowInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TangibleAssetImpairmentCharges": { "auth_ref": [ "r2", "r205" ], "calculation": { "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails": { "order": 1.0, "parentTag": "us-gaap_AssetImpairmentCharges", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.", "label": "Tangible Asset Impairment Charges", "terseLabel": "Property, plant and equipment and leasehold intangibles, net" } } }, "localname": "TangibleAssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/FairValueMeasurementsAssetImpairmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ThirdPartyPayorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Organization other than the patient (first party) or health care provider (second party) involved in the financing of personal health services.", "label": "Third-Party Payor [Member]", "terseLabel": "Other third-party payor programs" } } }, "localname": "ThirdPartyPayorMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/RevenueDisaggregationofRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r53", "r227" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury stock:" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r53", "r227" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock, Shares", "terseLabel": "Treasury stock, shares (in shares)" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r30", "r221", "r226" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock, Shares, Acquired", "negatedLabel": "Purchase of treasury stock (in shares)" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r53", "r227", "r228" ], "calculation": { "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost; 10,527,525 shares at March\u00a031, 2021 and December\u00a031, 2020" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r221", "r226", "r227" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock, Value, Acquired, Cost Method", "negatedLabel": "Purchase of treasury stock" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFEQUITY" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnusualOrInfrequentItemAxis": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Information by an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Axis]", "terseLabel": "Unusual or Infrequent Item, or Both [Axis]" } } }, "localname": "UnusualOrInfrequentItemAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/RevenueAdditionalInformationDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemDomain": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Domain]", "terseLabel": "Unusual or Infrequent Item, or Both [Domain]" } } }, "localname": "UnusualOrInfrequentItemDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails", "http://brookdale.com/role/RevenueAdditionalInformationDetails", "http://brookdale.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnusualOrInfrequentItemLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Unusual or Infrequent Item, or Both [Line Items]", "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]" } } }, "localname": "UnusualOrInfrequentItemLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemTable": { "auth_ref": [ "r73" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Item, or Both [Table]", "terseLabel": "Unusual or Infrequent Item, or Both [Table]" } } }, "localname": "UnusualOrInfrequentItemTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19PandemicNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock": { "auth_ref": [ "r74" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both.", "label": "Unusual or Infrequent Items, or Both, Disclosure [Text Block]", "terseLabel": "COVID-19 Pandemic" } } }, "localname": "UnusualOrInfrequentItemsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/COVID19Pandemic" ], "xbrltype": "textBlockItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r138", "r139", "r140", "r141", "r142", "r143", "r144" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/SummaryofSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r287" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "verboseLabel": "Increase (decrease) in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationAllowanceLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Valuation Allowance [Line Items]", "terseLabel": "Valuation Allowance [Line Items]" } } }, "localname": "ValuationAllowanceLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationAllowanceTable": { "auth_ref": [ "r286" ], "lang": { "en-us": { "role": { "documentation": "A listing of an entity's valuation allowances to reduce deferred tax assets to amounts which it is more likely than not will not be realized, including a description of the deferred tax assets for which the valuation allowance has been recorded and the amount of the valuation allowance.", "label": "Valuation Allowance [Table]", "terseLabel": "Valuation Allowance [Table]" } } }, "localname": "ValuationAllowanceTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/IncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r129" ], "calculation": { "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Effect of dilutive securities - Unvested restricted stock, restricted stock units, and warrants (in shares)" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r124", "r129" ], "calculation": { "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted (in shares)", "totalLabel": "Weighted average shares outstanding - diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails", "http://brookdale.com/role/EarningsPerShareScheduleofPotentiallyDilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r123", "r129" ], "calculation": { "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares outstanding - basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]", "terseLabel": "Weighted average common shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://brookdale.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS", "http://brookdale.com/role/EarningsPerShareScheduleofEarningsPerShareBasicandDilutedDetails" ], "xbrltype": "stringItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r100": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "http://asc.fasb.org/topic&trid=2134446" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r135": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r145": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r16": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/subtopic&trid=2122178" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r181": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r195": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=121558832&loc=d3e400-110220" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2599-110228" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r220": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r251": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r279": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r301": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r357": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/subtopic&trid=77888251" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.1,2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Column G))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r426": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r427": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r428": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r429": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r431": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.2)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(2))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233" }, "r74": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "220", "URI": "http://asc.fasb.org/subtopic&trid=114868817" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" } }, "version": "2.1" } ZIP 78 0001332349-21-000065-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001332349-21-000065-xbrl.zip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end